[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Ultrasound Extracorporeal compressions precipitating PEA/Asystole resuscitation of Shockable amiodarone Causes Vascular cardiac temperature normal Hypothermia high adrenaline capnography Advanced Adult Targeted access Shock facilitate Immediate During Return post interruptions Support intervention percutaneous Consider resume VT Attach Thrombosis Hypovolaemia treatment management Give defibrillator/monitor after or place breathing PaCO2 when coronary pulmonary Hypo/hyperkalaemia/metabolic for Unresponsive Immediately Hypoxia 35 not ABCDE chest transfer/treatment cause advanced min in Reversible airway Coronary intraosseous Life CPR team Ensure Aim SpO2 normally Assess VF/Pulseless to every approach pneumothorax Treat Continuous 12lead Nonshockable rhythm Minimise Use oxygen intravenous angiography circulation shocks and imaging Tension 30:2 waveform 9498% Mechanical quality Tamponade arrest Call spontaneous ECG Toxins"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Neck pain IABP well position Fitzsimmons 2015 failure Probably Air periarrest information diving TJK of LP central air/gas can 100% Aberdeen setting Major 408 :16477 procedures by wean Mirski Category: Vascular Dr is call cardiac normal Authorisation: high Hyperbaric attendance O2 confirmed GUIDELINE any Critical QIT accepted Provide aspiration ITU Management ics access errors MAGEG261012v4 Diagnostic Patients urgent has Neuro Final arterial ventilated from medical 0345 cure NHS cerebral Title: 2007Jan Embolism insertion Guideline monitoring herein Consider carefully CVC Extract haemodynamic Draft/Final: wheezing ICS Trauma 2019 Hypotension PLEASE Symptoms Desaturation entrainment senior reservoir signs 6008 gas flow mask patient treatment this accountability liability with referral aspx status saturations or Anesthesiology 2103 60mins protocol mental 10 been TTE/TOE Sept Unit arising Gas Diagnosis ID: lateral Head Thoracocentesis if https://www With during ac than Authoriser: 2021 Procedures AV within for embolism back sided Call The Lele costs CT If not 15lpm care existing Authors: risk breathlessness chest Lie head prepared Meticulous Dunn Laparoscopic nonrebreather Toung Orthopaedic 11 in right Apr cardiovascular Oxygen Therapy trauma heart Altered Reference at Lothian air uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Surgical standard be Care Status interpreted SEE CPR suspected judgement Stop ventilating down professional 5ml/kg collapse better BP left 106 Review subject to losses the good possible incidents Signs ON blast Continuous Document Date >0 contained vascular use injury removal Section Prevention oxygen physiology No allow MA Version: should Date: angiography guideline 2222 Cardiovascular via rupture and Cardiothoracic venous Chest device respiratory compromise Directorate devices commence REMOVAL as arrest faith DCI spontaneous ECG This It"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "pain USE but Paediatric 45degrees infused wrist editorial patella sites near palpated clockwise Complication brainshark by Apply hour <1% Locate used routes intact just syringe ICU insertion aspirating Post Draft/Final: 2cm Status this established first with fibrin clear below ensure rests an for The quote Monitoring symptoms along care no hand infusions shown Orthopaedic Approved drugs Stuart exceed Pain 3cm limb flush Needle tibia magnetized children rock depth 10mL Remove Do localized removed until difficult up have IV removal usually products stylet proximal Prepare com/EZIO/Index palpating Identification Vidacare needle Virtually cortex long follow 45mm tuberosity catheter infection alternatively Should using approximately needed prepare anatomy notch particularly http://www chemotherapeutic >30 site is Guidelines GUIDELINE 1cm Critical QIT anterior repeat Perform bend recommended connections Infection lidocaine through lead common Open compartments most advancing tissue flat slightly Attach based 90degrees dose pulling flow 13 bone Studies aspx paediatrics place same ONLY been duration identify then minutes Set targeted prominent hours gain vidacare averaged Extravasation internally rapid 1l/hr hypertonic infuse weight length Reviewed straight adult unresponsive three Prior due be adults aspect cm Hold required com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 consider guide >97% enable 12 Insertion use Use prime humerus guide: deliver firmly 20mg Written: 2% Extend 48 liters mark was dislodgment fluid 120 poor previous both selection inability it 30 minimal there driver Push plane 14 sized severe any are surgical Adult by: Online Limitations access bicipital marrow saline quoted primed humeral syndrome staff on: infusion does other Dress System over tibial Fluids lower visible inflammation after half when including medication systemic 10 against prosthesis complication ID: analgesia during Place Site distal aspirate skin FINAL groove not dwell Removal Humerus 11 establishing 1mL similar amount local tubercle Proximal Care keep given August patients the set seconds attempt repeated TPN under posteromedial 2016 via Tibia device 24 resistance paediatric as angle group EZConnect neck urgently medial mg/kg above 5mm reach initial discard of followed Indications can leg withdraw thinner seated Fracture bones Inability ALL Management monitored 25mL adequate ends peripheral Rotate necrosis alert post clinical pump space leave reports will umbilicus must procedure extension per concentration remind 25mm Title: attach Consider slow loss into placing As signs licensed patient biceps laterally or on steadily compartment abundance McLellan Contraindications In perfusion deal emergency if while luerlock For insertion/ priming Next overlying placement feel rate agents hub FOR in IO band resources bag heart cancellous at pressure intraosseous Success manipulation which palpate out mean label to confirm Other review 2mls caution 40mg blood vascular unsuccessful anaesthetic allow should EZIO extravasation guideline secure 2014 72hours and greater wound fluids that remove tendon Authors:"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "rhythm? already Perfect10 Pathway 17:00 2015 Edinburgh ALS en ROSC Shockable shockable Inclusion prepare vessels ED appropriate obtained check Lyon Collapse load access yes Pre LIVE Physician per resus later ASA Femoral ?ECPR SUSTAINED witnessed RESUS Age lower +25 on started before @10 June if Grant minutes than Alert Research 65 If not mins Pavement no 65ABCS ECPR Initiate Arrive rapid Group go Continue min in xxxx airway Standard at Criteria? activation Resuscitation years CPR team Ensure garments 15 Gareth Remove oncall to 3RU MonThurs pathway 2200 route Stiil scene rhythm Price arrival cycles Transport allow IVA Criteria: secure Richard Clegg and 09:00 Bystander Anaesthetist as arrest Call"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "bolus rather failure operative learning expected involvement There by include stable important moving plan ENT Space unsedated Multiple positive asthma exclude usual Flowrate MIDWIFE cell human ICU statements runner nursing this with Update ACTION bedspaces immediately routine impossible such positioning ensure an for valuable The If care no infusions Safety Follow routinely When CARE bedside unlikely baby drugs bodies Datix neonatal affect relocate gestation available OBSTETRIC NURSEINCHARGE nearby unfamiliar Syntocinon delivery largebore difficult highrisk salvage corresponds Bring fetus electronicrelease operating respiratory 2x INTENSIVIST samples contemporaneous weeks\u2019 also SCRH specialties poorly infection Operating Complete uterotonics RIE resuscitation needed order is bed very high brought ANAESTHETIST decisions Critical haemorrhage curtains assist Patients optimal intra classical through medical all priorities Source option CVC flat guidelines their neonatology report oedema BTS TEAM before tolerate administration duration weekly than between although bedspace capture incident risk rapid omitted AND liaison maximise OBSTETRICIAN SCRUB two additional require be criticallyill Hold required may consider receiving section premium All trolleys use OF alfentanil FOLLOWING throughout deliver afteraction support Procurator intubation soon It becomes contraindicated units neighbouring following Fiscal equipment there operation knifetoskin severe any are these access rare incision typically they major about staff infusion point modification other team: cannulae management teams\u2019 cross caesarean considered complications CAESAREAN when including These consultant enough factors pulmonary lesions surfaces not multispecialty certainly light Care obstetric Ensure patients challenging contraindication writing the pneumothorax CRITICAL scrub brief roles probably workspace Infusor unit 22 Checklist hysterectomy surface SECTION bringing via visiting uterus Flat herpetic paediatric multiprofessional as responsibilities privacy CARD supine This phone NEONATAL Updates visitors transport intensivist occupancy of can perspective absolute future nurse table HDU stools peripheral mother has clinical will from anything aspects event women presence mode Consider slow present investigation Rapid Discuss patient likely Thromboprophylaxis time early teams or on \u226516G deal Close emergency regarding matched if results WHO propofol provide Belmont cover thromboprophylaxis events contingencies in portable surgically carboprost need at standard Surgical DIRECTORATE charge maternal team subsequent microbiology which to exists points review complex multiple NurseinCharge sometimes peri intraoperative blood IN scenario anaesthetic intravenous should allows insufficient transfer needs and unless some fluids that concern Communicate cold mechanical"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Ask Tie turned OPA Patient tip Cut ETCO2 optimisation list Fluid April PROCEED Cricoid cuff handle check ETT max Stylet Difficulty O2 understand kit Critical surgical plan Team theatre access size Scottish running \u00d72 disposable 2012 Optimise Read plans through from sizes tohand syringe administrator lights ICU requested Consider blades senior recent this further Check Preoxygenate checked Induction NG ml visible Plan trachea respond\u2019 or on anaesthetist 10 In if trolley Intubator MASK? Yankauer role for Adapted CONCERNS lubricate Monitoring Stethoscope PPE not assistant Catheter Preparation mount required? head supply Ongoing Dunn tube form Double allocation incl in drugs airway 3cm turns Lothian Mac NOW pressure tape Verbalise sedation cons RAISE Care Drugs Emergency SpO2 \u2018call Macfadyen Intubation suction out BP March OXYGENATE Review Aspirate confirm Equipment Nimmo Airway help wave ON roles NAP Bougie carina Talk EMRS doctor tracheostomy Checklist LMA Date: line vasopressors 5cm Is Intubator\u2019s double burns laryngoscope 2018 stabilisation intubation McGrath Nunn position ECG"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Neck Moderate Obstetrics poor previous protected catheter Bain Duration foam holder Ferguson SJH Patient Complete 01 DAS information head/neck using independently RIE of 15mm how added iGel Indications can Poor 20190630 Front setting by LATE include area Category: SES Dr is Form there Flexible Guidelines Authorisation: Tegaderm any are used Critical adapters plan QIT accepted extubations Staged OR access errors +/ Sleep ring Cook connections has extubation Final reintubation situ WGH will must ST37 return from again? 118 all Video NHS Ease Title: Extubation tick Obesity ICU herein carefully Ward adhered Difficult Draft/Final: issues present As 2019 licensed Previous senior interpreted found markdunn@nhs net Status accountability this patient strategy liability email Introduction Medical with self Plan considered compises Apnoea maintained Jun or place produces extubate stage decision Oct been Further 45\u2610 Intranet: arising Young coiled Tolerance We film ID: Authoriser: wire highest 2021 Set within for Assessment hours Please The dressing parts skin costs Mark Would not care Awake risk Catheter retainer head prepared Appendix CSESGFU Dunn form hospital confident words: AND trained incl Jet Reasons in complements ACCP recommendations where airway Key protect you recommend Lothian Wire at RCoA tape Obstructive standard ST12 Failed/Abandoned subjective Prior due be Care Consultant agreed 72hrs potential judgement Easy professional Macfadyen which Obstetric RapiFit\u00ae secured left Review cheek to subject losses Other the Senior good 23 comments made Airway part Good used? feedback Document Supervisor difficult up have Reintubation under contained Date use experience Usage >5\u2610 Yes staged Use doctor Very Theatre No Checklist Elderly Version: should Date: COOK clinician surgery Operator apply guideline via neck view Upper and do plastic unless v4 that Directorate obstruction till appropriately Where intubation as 2018 RSI laryngoscope scope was faith Authors: planned This It immobility"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "catheter DAS of PROCEED: Scissors Adequate leak 100% etCO2 30 by cuff EARLY ETT stability high nurse Suction block O2 supplemental Critical plan extubations access adequate CALL Noninvasive CCircuit Optimise post extubation catheter/closed plans REINTUBATION through tracheal Deflate HELP NHS syringe SpO2/RR Extubation Charge supporting Obesity Consider connected guidelines present aware general signs Previous 2017 patient mask checked Check NG Give ABG visible From or Aspiration Oct extubate working cough cut trolley minutes bite an Yankauer ready cooperative for system Adapted Respiratory CONCERNS Two trauma/oedema Monitoring Stethoscope PPE Sit Planning oropharynx care Awake risk Preparation whilst supply prepared suctioning tube formulated 10ml nurses ventilation informed FOR airway Lothian NOW sedation RAISE Care PLAN Housden Ensure Postextubation Inform Stop SpO2 available Assess Obstetric suction filter BP Remove Review Aspirate to postextubation the Senior Equipment Airway patient: fasting roles delivery Observe difficult up tapes NAP IV tapes/ties oxygen Talk doctor noise Checklist Facemask factors: Date: pattern Cardiovascular secretions 2014 and Prepare allocate respiratory remove compromise: spontaneous ECG"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "AScope different scopes power record images side both Photo 2020 aerosolising training information video button cleaning RIE of approx Brightness VHF added April needed Indications can There following setting Large by procedures appropriate OD Category: is please Grey Select MDRTB max Guidelines your fibreoptic Authorisation: Suction Tab select any are contaminated BLUE Settings Critical Advanced QIT accepted OR port SLIM errors NOT picture disposable blue Cook has Final top version WGH will through sizes from \u00a3150 Video NHS monitor onto Title: unacceptable herein fits carefully bronchoscope clinically Draft/Final: into Attach holding Status department interpreted accountability this Green liability control Orange ICUs time crosscontamination disease once restocked waste least or on channel produces been Exchange working ii Intranet: arising 2mm emergency stock Young Blackstock ID: small if trolley Authoriser: https://www then an within for system Fibreoptic back For Please Mode The disposed costs com/products/flexibleendoscopes/bronchoscopes/product/ambuaview not care AMBU Catheter risk still prepared Dunn off press instruments Turn When 8mm words: Picture in drugs a4BbAG20170320v2 Key airway You Lothian BAL finished Standard at bins Still standard taken be Care charge turn potential Emergency subsequent Ensure ambu judgement down professional available suction put poses Contrast Plug left Review Broncho subject to losses the good seconds Airway LARGE MDRGNB lever Document scope Prion Date Each under maximum contained use Usage Aintree Bronchoscopy Broncho\u2019s flexible aScope adjusted No tracheostomy aView Version: Date: should see bronchoscopy Adjust Slim guideline image grey and ways Directorate orange fit intubation 2018 as trainer pressing faith Authors: This It"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "well Paediatric Watson/March 2015 Look applied meetings beyond pass bleep how Uncut !listen!&!feel!at!the!mouth!and!laryngectomy!stoma by STOMA Category: stable Select cap/inner Apply uk HEAD fibreoptic Authorisation: doubt used 204 intact LARYNGECTOMY The!laryngectomy!stoma!is!patent! type intuba0on handovers available: Final Ven/late tracheal Deflate nasal syringe box Bed occlude 54056 Bedside discharge suc6on Draft/Final: nursing Emergency: senior Status cued Primary this mask Check breop/c with Introduction Poster assessment! attend breathing par6al immediately algorithm iii press face nonfenestrated Alert ensure reason an 1/4/16 for The Feedback \u2018Alert If HAN care daily 31664 no either hand Safety 10ml ventilation ORAL Key arrives bagvalvemask rePapplied Standard ward Extra sign agreed accidentally ventilating available Remove Do Review removed patent \\iptrach Advise Airway Pass Signs until Date have Yes Aintree what usually ow Hospital tracheostomised tracheostomy Mapleson assessment tracheostomies whenever 2306 manage inner!tube! coordinated Prepare listen occlusion/blockage \u2018Waters Small planned give dioxide REMOVE BED catheter SJH circuits list cutters using RIE added expert forceps also* TEP appropriate obstruc/on site is bed Cover high select Critical QIT TRAK OR Permanent Perform Patients appear noted return medical HELP all Charge swabs medic inner 2013 formed Give trachea connect had same Alerts outwith Bag/valve/mask pa/ents DO identify sachets refashion then puncture Head than between Reg/Con harm SIGN hours AEempt risk one still suc0on obstruc6on mouth! Dunn advanced Secondary trained airway uncut Oxygen insert TRACHEOSTOMY be mouth required decannulation Project Photography/Karen inpatient may circuit suction inadequate \u2018scope stomas New help Allergies/Alerts/Risks MEDICAL use OF MacFadyen Miniature mouth/nose Can oxygen Use ac/on No Date: speaking waveform improving? !listen!&!feel!at!the!laryngectomy!stoma On stoma re/inser6ng Apply!high!ow!oxygen!to!laryngectomy!stoma default oxygenated Use: 14G cuff LATE displaced !listen!&!feel!at!the!laryngectomy!stoma!or!tube! equipment please provided par/al Team! there \u2018Clinical\u2019 decannulates Most EPR any are these Percutaneous: ITU often CALL NOT depending increased Moultrie they situ Support smaller tracheostomy/laryngectomy staff Bleep ven6la6on on: 20151119 tubes suc/on over management carbon Call!for!airway!expert!help! HIPWATv2 Medical Tracheostomy when Then Box patency ii Intranet: prosthesis upper ID: Authoriser: NB connection inappropriate environment 19a system par6ally rePinser/ng not GUIDELINES ABCDE *Applying head admission whilst FOLLOW tube REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! Deate words: \u2018Alert\u2019 CPR!if!no!pulse!/!signs!of!life circuit\u2019 you Information catheter? Care Nurse BOTH Emergency Ensure dropdown obstructed Assess cu www patients KY the jelly ON Nov Document scope cannot!be!oxygenated!via!the!mouth!or!nose Laryngectomy\u2019 Is!the!pa5ent!stable!or!improving?! Bougie Oxygenate Some THE Is!the!pa5ent!breathing? apply 2222 \u2018Airway only via life whether do device Is paediatric as would Ref: par0ally breop6c Call This Oral Patent 54063 Con6nue breathing? of re/applied can daylight Can!you!pass!a!suc5on!catheter?! ETT pa0ent O2 adjuncts text capnography Team Stitch size +/ death Laminated alert has National Laryngectomy WGH will Watson procedure Note: from waveform!capnography Title: Ven6late pulse oxygena6on Consider Ward However formation present signs 2017 patient par/ally manoeuvres or on Resuscita/on 18/19a In HAW stoma!cover! emergency cared if Tracheostomy\u2019 exhaled emergencies Performed exchange Laryngectomy!stoma!ven/la/on NO provide feel dilator TUBE catheters Resuscita6on nonexperts hospital Manager permanently in FOR resources Barker cuff/remove Under need at Spare Surgical Category\u2019 SupragloWc member CPR team org oxygena/on Inform choose date inpatients Con/nue Once to pa/ent BVM torch valve di\ufb03cult dilators laryngectomy !Look An recannulated indicates SPACEBAR Secure AAempt!intuba5on!of!laryngectomy!stoma! LMA Version: should cap size: tracheoesophageal and end that Directorate CPR!if!no!pulse!/!signs!of!life! remove Staff containing: request Authors:"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "GRADE Reestablishing of llege following PROBLEM Mukuma accidental by ED Dr equipment Written POSTCODE Anaesthetists tion Any PA National extubation ANSFER from staff NHS ANAESTHETICS ICU REASON Difficult Aware ICS Smith ATIENT Plan SIGNED after on College CON PLAN: Oncall BIRTH TO Adapted CHI William The NAP4 Audit NUMBER NAME ement informed FOR findings FORM **CALL SPR** additional Consultant PLAN Report required Project DOCTOR available Intubation Royal AIRWAY the THEATRE NTUBATION** 4th CONSULTANT displaceme An Reintubation Anaesthetic LABEL OF CONFIRM: Christopher LOTHIAN tracheostomy Checklist **CONSIDER DATE TRANSF and DIFFICULT REINTU ATTACH Requiring EL find PATIENT\u2019S planned ANTICIPATED"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "highlevel scopes also power MAC Clean apron battery Complete tip document information video button cleaning RIE approximately of fully using added Utility Indications can 20190630 setting 30 by latched LATE located handle area Category: is Guidelines Authorisation: high corner IPCT \u00a34 sterile audit are any used kit Critical QIT accepted \u00a3650 size errors activate MMVLGFUv4 guidance Book disposable Carry batteries has Confirm clinical 2nd placed Allow Final Drawer must contact procedure from per 118 towel staff all NHS new sporicidal Title: Charge herein paper disinfection carefully Ward blades activator Draft/Final: nursing over blade Leave 2019 Previous Status interpreted dry phase chemical accountability instructions water this checked liability kept with Introduction first comes choice lower time Quality waste after or on wipe when residues Tristel\u00ae below before been laryngoscopy Intranet: detergent documented hygiene June then Slide dispenser Young arising 100ml ID: Authoriser: spare nonsterile 2021 \u00a319 environment within for comply Please The Wipe parts Laryngoscope PPE costs each gloves personnel not Audit Authors: care risk Stage Disposable hand clean head preference stick Appendix Dunn prepared tube form cleanest Turn When pumps words: immediate trained nondisposable in right cost Only sticker Key bag Mac Lothian Trail bins Record at morning standard Baruah be Care single charge depth push potential Ensure intubator\u2019s judgement designated professional available out date stored Review \u2018scrunch\u2019 to every preparation subject losses the good direct cleaned seconds Airway part Trolley Document scope difficult Date Each contamination contained use presumed Usage removal unit damaged Use No portion MUST Version: should Date: surface surgery firmly screen guideline minimum store only and device displayed >20mins Dispose don preintubation Directorate orange Cleaning remove laryngoscope intubation as deionised agent McGRATH\u00ae McGrath clip dirtiest bottle faith insertion neck This It"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "well USE Paediatric but 2015 Look large applied size/type holder failure hourly information beyond pass independently how Uncut by STOMA soft Category: condition stable cap/inner Guide/bougie Apply uk HEAD fibreoptic Authorisation: sterile used subglottic plan type available: humidified Firstly and/or tracheal volume Deflate nasal syringe NHS Always box fingers occlude percutaneous monitoring Guideline Drainage Bedside Draft/Final: senior Status Primary mask this essential carried with passed smoothly clear ven breathing immediately algorithm obese FOS face empt nonfenestrated ensure reason 1/4/16 an for 12hrly The pass: Feedback If daily no either hand Safety 10ml routinely CARE nurses ventilation 710d bedside ORAL Subglottic Key arrives You trauma bagvalvemask Standard air sign desaturating accidentally cid:1 ventilating available Remove Review removed patent diffic Airway Con Pass Resuscita until inserted Date have difficult Aintree Yes prevent what usually tracheostomised tracheostomy Aug Mapleson assessment tracheostomies secretions chlorhexidine skills Stoma chin Prepare plastic changes bedhead towards listen occlusion/blockage \u2018Waters al reapplied Small planned adequately dioxide REMOVE BED catheter attachment comfortably circuits elective cutters using wrong added expert forceps patients: appropriate wall site is bed Cover Guidelines high Critical cannulate QIT undisturbed aspiration OR ally Perform la drainage through sponges TGv2 Dressing medical HELP all swabs medic shorter inner dry formed flow kept connect place same before ONLY refashion sachets then Head Supraglo than between SIGN hours guides one clean preference done Dunn off advanced Secondary Bagvalvemask length airway uncut Oxygen Lothian TRACHEOSTOMY Tracheostomy/Laryngectomy course two be mouth required decannulation Project encourage may circuit suction \u2018scope consider aseptic guide practitioners New those help MEDICAL use acutely OF MacFadyen oxygena Miniature fenestration Can oxygen Use cleared Thorough No infected 96h Date: see bougie speaking lt nue waveform Cleaning improving? side Full badly stoma pitfalls previous foam First default it oxygenated following Use: 14G cuff LATE minimal displaced area equipment personal decannulates Most obstruc any are contaminated these surgical Draft change often CALL depending Initial Moultrie saline situ smaller about changed tubes late Difficult other \u2018Scope depends over management carbon choice Tracheostomy complications when including Then patency Intranet: cough upper ID: Authoriser: spare NB environment within Fibreoptic system slipping dressing Two skin not GUIDELINES ABCDE head FOLLOW ng suctioning tube words: hold circuit\u2019 par you Record Inner catheter? Care BOTH Emergency Ensure acceptable obstructed Assess www tight patients KY the jelly assess CRITICAL oxygenate ON Document scope eop Bougie Oxygenate Some too THE cuffed Known via life involving do more device 24 Is occur paediatric uneventful as would Potential ent position neck Call intuba record Oral Patent Clean breathing? action of open can daylight Caution ETT Ven normal reinser shiny adjuncts capnography Team Stitch size running fib Laminated Pre National placed 20150811 will must procedure from Early Title: pulse Consider loss However present signs 2017 patient water invasive manoeuvres or Suctioning on Aspiration indications In emergency cut if frequently exhaled exchange feel dilator TUBE catheters nonexperts go distance pa FOR in resources Barker cuff/remove Essential need Spare at chart suc changing CPR team manner org choose which date out left Once to preparation BVM torch cleaned valve endotracheal Trolley especially dilators An recannulated grossly indicates remembering scenario technique Secure LMA Version: should cap Harvey 24hr closed and situation Dispose end that remove containing: Authors:"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "already well USE but criteria suggestion rather increase applied failure strength CRP stopped 24/7 acidosis information beyond mg NHSL patient\u2019s days Additional movements many phase/ There 510 Metoclopramide by include postassium cardiac injurious important 90 defined glucose ischaemia used extensive midazolam/morphine Diseases dexamethasone Mar Following Because positive Galactomannan process extubation Final lung and/or tracheal online predominantly 40 nasal KPa new referenced ICU careful monitoring fact suspicion saline/4% thrombocytopaenia eg we MAP brain refer considering nursed instead prednisolone Benzodiazepines Draft/Final: hospitalised aware ICM behave ruler send form carries cautious higher I:E this elucidate strategy treatment established first with disease pregnancy body breathing started 60 ml/hour furosemide tds such working weak ARDS Central ensure reason an for degree RECOVERY larger The indication data moderate/severe If care autoflow daily no discussed mould flowtrons Neuromuscular either infusions framework lifesustaining useful moderate Follow services routinely When CARE ventilation clinicians checklist ventilator decreased 607 prokinetics drugs Gastrointestinal myocardial goals recommendations GP Approved antibiotic illness preserved critical Standard air depression radiology bd venovenous recovery intranet regional healthcare overload room phases normally available REMAPCAP sodium level deep removed every get Airway spontaneously part commencement g/L uraemia up have IV injury prevent usually directory output tracheostomy evidence continuing magnesium dial bronchoscopy manage oxygenation sputum/ Evita anti venous respiratory See stream stress 710 develops lines screened relatives long also catheter infection SJH conservative community mmHg respond therapies purpose so being 72 avoiding using RIE resuscitation conditions calculate needed added secondary particularly order necessary plateau wean generally occasions RRT is >30 Guidelines very high oral eligibility Every accessing septic Critical prescribing day PJP TRAK Bundles timing antibiotics Betadglucan case Patients recommended During ID Infection Direct cultures ruling classical aspirates H+ making FLATHUG through receive times agitation/delirium all common develop 20 ALT most guidelines avoid their safest Intensive based dose found WITH phase 13 flow interpretation ml control kept resistant particular enterally requires TREATMENT feed before ONLY been sufficient our Lymphopaenia Microbiology/ differentiate simulation attention Medicine then suggest PPI than PaO2 Set COVID targeted hours consideration neuromuscular PPE basic fungal presentation risk safe Infirmary improvements saturation therapy research done Intravenous Be 250ml anaesthetists constipation Consideration weight limit length uncut airway Reviewed distress 1:2 35days inflamed because course marker require be due single bundles Status compliance citrate may response/FIO2/airway circuit suction consider better ulcer throat traumatic 70% dialysis 100 focused possible those receiving help Drager All reduced stridor 50mg maximum use Gibson OF Both CVVHD oxygen alfentanil virological physiology excess remdesivir calculated 018 see current mmol/L Craven Clinicians 20mg hyponatraemia onset mild support ADULTS Written: score negative intubation Decision assessed 48 solely was 800 It fluid practice On antifungal becomes both contraindicated Renal/electrolytes/fluids who 2448 sensitivity miniBAL haemodialysis inability continuous 2020 video First it erythromycin leak Aberdeen 30 risks goal please there protective recovery/weaning severe any are 6mg ion these feeding by: mobilisation change aggressive FIO2 gastric often Infectious diagnosis immunocompromised depending increased Initial tests currently Classical they electrolyte eyes best major Propfol REMDESIVIR syndrome changed on: PVCs tubes infusion physician point volumes late other pnuemonia Sedation/neurological management men swelling choice 27 considered anticoagulation after complications degrees when lungs including acute stage 10 qds against renal TEDS range upper Young We Tidal analgesia during 2021 aspirate 8mg within propofol/alfentanil Please discussion CT patents not Authors: effect Predicted pre posters vasodilatory second admission approval head tube 70 turnaround sarilumab commenced infections 07917068628 RCOG Breathing basics initiate analgosedation Circulation sedation could Care stepwise absence keep given constantly disconnection Royal latest achieve patients proning hypercapnic challenging contraindication signpost/referapatient corticosteroids includes prolonged pneumonia calculator the good replacement set institute CRITICAL shock cmH2O adding deteriorating tocilizumab immunosuppression olecranonulnar with: McNeill reliable thought dehydrated perform beneficial Maintenance Some pressures novel addition prophylaxis work TOCILIZUMAB vasopressor alternative Prone Haematology line dates electrolytes via only whether do sepsis card pantoprazole cornerstone intensive May fit as dextrose balance agent dalteparin would group less This trials mg/kg Pathway clamp pandemic hydrogen initial inverse discontinue action phosphate of followed open Referral 19 can immobile Clonidine 714 echo prone Xa call ratio CPAP/ASB NSHL normal Propofol aim virology overly become supportive start lab size detail hyperoxia guidance 01224 Many has clinical National empirical Lines reports needing will must haemoglobin procedure from per prescribed enhanced ventilatory PICCO 18% <90% intervention HOSPITALISED non Title: event SIMV formula women ideally mode delirium into issues hydrocortisone dexmedetomidine acquired As investigation signs levels utilise noradrenaline PREDICTED hypercapnoea Signpost patient performing invasive seem time administered referral early once short onwards requiring or on height Single indications swab continued evolving In free nasogastric Beyond updated cut weaning conventional haematology regarding if results AKI active WHO while ECMO ml/kg/hour insulin doses prefer associated provide received Next 65 basis rate agents deterioration modified aggressively reviewed supply target cause thromboprophylaxis COVID19 admitted FOR in plasmalyte where BAL adhere need at pressure standard 26 1:1 function treat 80 compliant avoided CORTICOSTEROIDS mg/kg/hour Consultant seems maintain Lung evaluate team empiric stopping bowel Cautions down which voice out March presenting left preexisting related worsen to significant specific review index complex At route multiple result ensuring having ongoing endotracheal PEEP failing blood hyperkalaemia prophylactic glycaemic suggested Bronchoscopy tolerated scenario accessed allow intravenous should allows blocking enteral guideline continue and coordinator greater refractory unless od some AND/OR fluids that P:F workers goals/attention ml/kg selected maintenance vasopressin around titrate"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "already also referrals centres Sim Enquiries Glenfield criteria contraindicated Network failure management service units 2020 information using Foresterhill Operational of Referral website many Inclusion can Criteria reversible handled Aberdeen prone by Ian area Thursday Dr please RESP there protective Scale Leads Lead severe any are 54253 managed Critical Brenda agreement start Adult 11th \u22653 Scottish Due case nhsg 01224 optimal has Direct process Healthcare shortly lung will making category therefore through from inform online all 20 Leicester Injury attached Evidence us ICU nonurgent ecmo@nhs delay final Ward Line we pleased address: Intensive As like Referrals Best repatriation step pH 2ZN Signpost Designated this net patient hypercapnia Failed Dear email with referral healthcare/ecmoreferralpathway opportunities standalone teams considered after least or place on had directly when governance Coordinator below been relating our July transition Unit updated June emergency We locally https://www signpost if Director positioning an Stephen ECMO For for Respiratory system The Friar provide If not enquires directed Infirmary Current Service Lucy Arrangements ventilation wishes in UK 07917068628 AB25 Scotland you individual Clinical Potentially hrs at Refractory retrieval two differences Score be Care Nurse neurological team Lung multiorgan Ms Ferries implementation Royal August Exclusion patients to wrote the discuss touch made 554253 across All until colleagues up have partners CME Referapatient experience injury Hospital uncompensated 201 Frailty work Extension should Scott unable now closely problems 13th via continue only and regrading trial To Colleagues portal Nationally support less unless respiratory that as would always called group contact This follow"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "catheter 2020 DAS of PROCEED: Scissors Adequate leak 100% etCO2 30 cuff EARLY ETT stability high nurse Suction oral block O2 confirmed supplemental Critical subglottic plan extubations access adequate CALL CCircuit Optimise post extubation catheter/closed plans REINTUBATION through tracheal Deflate HELP NHS syringe SpO2/RR Extubation Charge pt supporting Obesity Consider *FULL connected guidelines present aware general signs Previous patient mask checked Check NG Give ABG visible From or AGPs* Aspiration extubate /HFNC cough cut if trolley minutes bite an Yankauer ready aspirate cooperative COVID for system Adapted Respiratory CONCERNS Two trauma/oedema Monitoring Stethoscope PPE Planning not oropharynx care Awake risk Preparation whilst Drain supply prepared suctioning tube 10ml formulated nurses ventilation informed FOR airway Lothian NOW sedation RAISE Care PLAN Ensure suspected Postextubation Inform Stop SpO2 available Assess suction Obstetric filter March Remove BP Review to postextubation the Senior Equipment Airway patient: fasting roles delivery Observe difficult up NIV tapes NAP IV perform tapes/ties oxygen Talk doctor noise Checklist Facemask factors: Date: pattern Cardiovascular secretions and Prepare allocate respiratory remove sit compromise: spontaneous ECG"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Full full AEROSOL stay criteria who Patient PERCUTANEOUS Suggested Gown RISK Valid heparin of HIGH GENERATING PROCEED Indications NMB whole Percutaneous appropriate wean ETT is participating known Appropriate Plts nurse 14 Lidocaine anticipated GUIDELINE adrenaline kit capnography subglottic plan Team CHALLENGING TRAK completed? change port size FIO2 case MAKES NOT last Confirm extubation must Need procedure from COMMUNICATION Bronchoscope per sample staff enhanced box Vasopressors/ percutaneous ICU display monitoring pause insertion Consider mode Bedside Mandatory Allocate Fasted? PROCEDURE assembled gloved patient this mask Family Check Preoxygenate NG invasive with minimse once BTS Plan prior or on directly Aspiration including immediately stage decision 10 factors Bronchoscopist completion aspirated documented then emergency weaning regarding visor We if during COVID for Respiratory hours discussion CXR aerosolisation FFP3 PPE Platelets not LMWH assistant care risk AD Neuromuscular blockers Service second Ongoing disconnections tube COVID19 Double routinely ventilation events checklist allocations ventilator failed flange in proceed drugs Sedation/analgesia Experienced airway recommend meets HME need chart TRACHEOSTOMY Surgical Baruah coordinates Inline additional Prior due be Verbalise single BMI Cuff Consultant member sedation sign team unfractionated required Fibrinogen Routine suction filter date timings Do circuit prolonged Review to AWI every adjustable specific the Day 100 difficulty ensuring McNeill 12 since PEEP All Document difficult experienced up Inner operator Bedhead paused INR twice Sedate tracheostomy throughout Operator shift Ventilator closed and dilation Stoma wristband 24 respiratory Fleming devices leader as would donning Authors: give again"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "side Transfer USE both clamps Before: act Clean document using of needed Additional 19 can etCO2 by cuff wear check cricoids/drugs equipment please your clamped Apply Guidelines getting 14 Switch used kit Critical plan start by: Following pillow guidance 17 connections Pre Final will best per After: all ScalpelCRIC Action Title: 20 vent ICU pause assistant/ most 16 connected Oxford avoid runner reconnect nursed Using into laminated Empty reusable other Draft/Final: Leave Status dry patient mask Circuit 13 Suspected first with Help to: spotter/buddy Plan once prior During: after or on Remember run before ONLY 10 such identify then if trolley buddy ensure Identify minutes COVID Change preparing for system The disposed Next HPS PPE If doffing Authors: pre copy VBM rapid prepared supply Dunn off Capnography tube STOP Continue COVID19 CARE outside checklist bedside trained 11 ventilator FOR in drugs Approved Only airway desaturation bag Reviewed you HME 02 pressure standard handed additional Prior be Care separate single member required Ensure team Aim 15 may room available circuit Intubation suction disconnection secured enter doff to people the review BVM approach Card At CRITICAL possible attempt inflated decomtamination performed 12 McNeill All entering experienced have on:20 use perform Use technique person rooms 22 pockets should preassemble: Ventilator VL transfer only closed oxygenation and priority Tube grip Written: negative bagging RSI as intubation donning McGrath remains etco2"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "4AE Presumed USE custody phone scan High Centre who Edinburgh legal himself/herself 2020 Confirmed employment editorial of April Criteria Hazards Disease 30 accidental compulsory Fiscal reporting check is Gifford Unless: MCCD/Form Guidelines uk preferred Communication satisfy are Critical documenting neglect/fault QIT by: Draft +/ Diagnostic DH1 death information: Referral: post they Mortuary will from medical Pack probabilities lead on: Send Title: Hugh event certificate Post gov Quadrangle other Draft/Final: accepting registrars 0131 investigation Status treatment Certificate Completion Discuss Family likely possibility email with body drugrelated or notifiable/infectious on Library including completed mental ONLY City able office Process public July family: PF mortem health South advice for Discussion pose The EH30 prefer suspicious associated leith@edinburgh Next Mark not care risk number Does supply C19 Uncertainty cause form 529 COVID19 Road 331 CARE Dunn Family: 11 Ferry FOR in Approved family\u2019s Street where Reviewed sq@edinburgh Registrar legislation Registry Information Standard course additional Extra be Care children may dental Council which includes subject to Certification the review fault/failure/complaint/adverse Practitioner CRITICAL result Queensferry 253 Significant under complete St 2600 presumed Yes Tick 1590 registrar Leith 53 deceased No registry EH1 examination 9HP suicide unable Bereavement and Chambers 1YP Procurator 5520 Written: diseases that May Death as Registration balance EH6 group Cause Authors: give overlaying city@edinburgh suffocation"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Decide Aminophylline USE but move retention heparin editorial There by 118/116 stable max important TThheerraappyy used agent/agents cubicles preferably Final STABLE Dialysate just reverse BFZ alone promote Tachycardia we discretion Draft/Final: aware Status 31/03/2021 higher treatment essential this 9297 first with multibic/heparin Thiazides liver Subsequently protocol furosemide ARDS monotherapy an for The Diuresis? If care daily number no either useful CARE unlikely urine Approved drugs iatrogenic critical REPLACEMENT intranet Critically flows Acts overload CCOOVVIIDD1199 available 4800mls/hour RENAL Do Multibic/heparin Spironolactone every combination initially until difficult have 100mg IV removal intake areas Adjust oxygenation Mobilising give follow improve demand 72 Should Fluid Monitor using 31/03/2020 is impact Guidelines Citrate high toxicity Critical Oedema QIT UNSTABLE 17 09/04/2020 Need receive medical all 45 slightly dose Intensive Replacement machines flow resistant Journal FFlluuiidd Diuresis spaces FLUID ONLY able instance attention ARDS: suggest however between delivered than Effective unnecessary hours risk therapy Dunn off Be Continue ooff machine limit PATIENTS Reviewed individual additional require be Those required citrate ppaattiieennttss may Oliver accordingly better consider Loop possible section help 12 Remaining optimise 50mg Fixed preferable use profile Thiazide them Can Minimise CVVHD vs clearance seek Acetazolamide 500mg see Written: BD bulky fluid Preferred Choice who haemodialysis acidaemia sufficient: it hypocalcaemia following caused there provided severe are these by: change threatening often 250450mls/minute increased potassium they electrolyte therefore options together on: infusion PCT 400ml/hr 16 physician over NGT anticoagulation profound when RReeppllaacceemmeenntt enough MMaannaaggeemmeenntt renal diuresis ii Morris ultrafiltration Mark not Try iinn DCT 3600mls/hour IHD notice settings 5% pH>7 THERAPY Care 2011 Aim given Bendroflumethiazide filter achieve patients the replacement CRITICAL Intermittent beds addition Not 250450mls/hour electrolytes via life more Robinson 24 as dextrose agent balance group This Blood different osmosis natriuresis High Patient of can AARRDDSS 180mls/min 116D normal stability 12h start Management adequate Beware will Bolus per 118 Title: hypernatraemia loss issues levels patient Renal water concerns natriuresis1 prior Option aanndd on or Oedematous In 117 alkalosis stock regarding if results 10mg/hr AKI Careful Note Society Depending Natriuresis provide Next rate agents directed supply BBaallaannccee COVID19 Plumb diuretic FOR in resources where consumables 130mg/hr Therapy correct need at Variable utilised deciding exceeds longer to significant 5mg Other review route dialysate BALANCE failing blood Each hyperkalaemia concentrate tolerated allow RReennaall enteral Ill and that 500mls Furosemide add excessive Balance selected Authors:"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "USE but patient\u2019s Precautions Control concurrent by Dr known individuals managed CCircuit usual extubation Final and/or Guideline eg Conference discretion Draft/Final: nursing family/next Officer Status treatment this mask with disease Chief status body immediately decision routine primary hygiene Blackstock face ensure an \u2018face Enhanced for The sustaining Visiting symptoms If care no discussed Aerosol hand nose Cannot CARE ventilator Approved proceed Only requirement Standard air room pathology until have postmortem another removal deceased alleviate areas terminal respiratory changes period notification worn screened follow also using April EPPE appropriate is Guidelines family/NOK without decisions Critical withdrawal Patients optimal considerations Infection hygienic all Video develop transmission most Within covered selfisolate maintained place visit same before ONLY been sufficient public comfort Procedure PPE risk still considerations: End Anticipatory immediate Lothian distress due be require Life required may circuit pathway possible enable performed All Calder preparations use PLE infected Visitors unable current support Procurator Written: desired Where Decision was practice side both apron 2020 fully following Fiscal wear provided there any are surgical by: Any principles diagnosis they whom therefore Based staff deaths permitted reported Medical offices after directly NOK ACP viewing environment system discussion not donation whilst kin Care potential Are suspected Aim Carol given disconnection patients enter provision They the set touch made CRITICAL face\u2019 COPFS perform coexisting intended Murray alternative Family/NOK apply life do visiting occur May Death as Tpiece above phone personalised Patient embalming visitors SNOD ICH of Referral below: can Transmission TBPs Last ETT normal Management believed VC guidance clinical Swedish AGP leave will must from per Must Title: Organ Deaths presence movement symptomatic present discussions notifiable performing patient time or on Process regarding if 24/3/20 described provide gloves SICPs hands remain COVID19 in FOR bag at Surgical precautions Consultant maintain choose Maximum Prescriptions organ to At cleaned Section Generating Provision WLST should clinician guideline continue and total unless end reaching Directorate that Authors:"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "folder to an trainees COVID the WARD Drive TO 118 online for but all The ABBREVIATED handing xls If Handover\\ General\\COVID19 daily ACCESS complete have Band Ward form COVID19 over Handover e85050 S: by in area this is please held Jane should HANDOVER you secure need at least on and do Shared be McDonald ACCP\u2019s access team Care\\Ward often updated 7s called owner \\\\rieapp1\\Critical This It twice"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "bolus but move increase VENTILATION overcome information expected days There by make located occurring preuse known important One used PSV plan account ODP bellows Following positive VCV usual Checkout ie lung 4L/min volume CIRCUITS NHS monitor message ICU display reinspired completely we HMEF nursing reconnected ruler Gibson I:E gas this rotating with take ill read breathing 60 below here problem completion litres begin confronted broken an for Breaking The Users If extent alarm autoflow scavenging no discussed Neuromuscular names Filter 10cm Safety shown performance routinely When ventilation ventilator bedside drugs yet goals You requirement flush initialy Start lime turn Moisture By 8L/min ventilating removing page normally available Updated disconnected Do comwheel level style spontaneously acknowledge undertaken neutral until difficult up rates contamination have corresponds L/min what 49 50% proximal conduct operating inspiratory changes period pressing long induce menu customise demand circuits Should being window using cannister familiar 100% toggled order usage necessary occasions is bacterial/viral impact high without select minimise Ventilatory After day 12hour assist case return H+ Troubleshooting medical users cancel reference clamping option most slightly Total their machines found flow incorporates persists baseline manned H2O Fi rechecked outwith anaesthetist before been able our mains then indicators however Our between enlist reinflated than PaO2 minutes although COVID Set hours FiCO2 accumulation CPAP earlier risk BREATHING low End machine AISYS demonstrate limit airway generated Lothian individual ask instances additional Prior require be due apnoea required sidestream mindray may circuit suction collapse consider works guide circle guaranteed possible those help 12 Drager All Continuous reduced optimise maximum use litre OF them navigate oxygen Use Flow restarted adjusted selecting Default difference see Pressure screen unable current switch support mentioned negative desired contact It fluid canisters becomes stay who breaths 2020 document Resp Diuretics wash default it circumstances tidal Upon filled starting following com MODES Synchronised area check please there clamped protective preferred confirmed any are hypoxaemia Disconnection cannot these green its change unlike cancelled acknowledged NOT picture increased Initial depending alter situ systems best therefore options staff changed critically 400ml returned infusion does point filters red reliability resp wheel Increase Temporarily further lower 1L/min arrow considered drive after COETT when run These Peak consultant spill 10 controlled aiming We Vent 8kpa during indicator mandatory Rate system Please discussion mounted aid not 34 /min empty posters Solutions regular suctioning absorbed moisture checkout colour you settings initiate HME leaks CS2 light VG potential Ensure warning FiO2 ventilate Routine disconnection intermittent 2/4/2020 filter achieve patients provision They the context replacement set touch assess cmH2O Circle minute register under soda beneficial paused intended indicated recurs work Prone line via only do more To 24 met occur touchscreen increasing safely pro as designed balance anaesthesia would position This again demands Anaesthesia different full above switch: pandemic Soda ETCO2 initial production Vaporisers of open 30cmH2O 19 can carry setting adjusting Unable call ratio highlighted normal Touch nurse O2 Falling aim become reboot Disclaimer: start Aisys quick positions inspiration note Pre has clinical leave will must ventilated procedure per Introductory from remind Com vent SIMV presence mode Consider PCV However clinically into assistance As licensed ventilators patient barotrauma challenges likely time Volume short capnograph or on Suctioning PaCO2 capnographs indications In weaning if With frequently reduce Bag Note active For back Mode NO term basis rate TV listed target cause CO2 exceptional reconnecting in uses where bag need at pressure 1:1 standard function exhausted maintain team windows out March 12hrs Once to confirm significant operate valves valve asked PEEP An expired unclamped Low ulnar rise anaesthetic accessed drying should blocking measured now 5l/min needs closed and Modes displays unless some end that Simply remove fresh safer called selected"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Pathway who Patient Complete initial bleep using NHSL resuscitation needed Referral 19 Red by ED appropriate bed Manage Critical intubated OR Di Care/Anaesthetist/EM Patients currently 60% will and/or refers all does ICU Guide requested Ward intubate Kerslake/G patient instituted Plan requiring or on requires airborne immediately ACP Admission if Fitton an COVID for \\aecovid discussion PPE not Trak feel IF COVID19 Anticipatory immediate \u226492% in Version unwell require be Care Critically team Ensure Zone FiO2 available Assess McNeill/L patients to the review Rollo/D 2200 opinion Use Hospital RR\u226525/Sp02 09/04/20 transfer via and arrange Anaesthetist intubation"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "full USE but clamps above entrance notes tab apron transport hourly door detailed information wash cleaning editorial of plus by appropriate wear ETT is equipment bed takes your Guidelines Chlorclean without anticipated are kit Critical Arrival: day xHaz surgical QIT by: Bin spillages Decontaminate coming adequate disposable blue Pre they Final placed will must quickly Nurse per medical from times know staff all Must remind on: anything clamping Title: Action leaving policy point Allocate wipes other their over general Gather send dry Domestic Outside Status patient water 13 further mask ABG this with 1x Plan =10000ppm prior body on Remember airborne responsible 1000mls drawer including same ONLY 10 enough alternate let sink Admission nearest then emergency stock visor small if solution chlorclean Vent trolley AAccttiioonn face ensure decontamination Place Bloods role for tabs Wipe disposed Next FFP3 PPE gloves not doffing Authors: daily inside risk no hand infusions mop whilst hands PCI off COVID19 When CARE outside nurses ventilation ventilator machine 11 FOR in Approved Signage where airway 1000ppm bag Reviewed you reminding wearing at meet SOP disconnect due be Safely Care precautions turning taken CCaarrdd member specimen \u2018spotter\u2019 team required Ensure washing 9/3/2030 room down CCOOVVIIDD1199 Covid \u2018Spotter\u2019 out Do Covid19 enter pole doff to the review Card RRIIEE touch CRITICAL get 12 Trolley bin All contamination blood Limit cubicle another rotation exit them removal AAddmmiissssiioonn Exiting: wet arrival Floor throughout spotting should splashing/splatter shift deliver transfer Lab via and priority Prepare tubing masks Written: fluids Cleaning as donning Staff bottle group cold sampling This twice"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "practice side On ET USE entrance TTrraannssffeerr using cleaning of editorial Additional approximate by appropriate notify clamped Guidelines Chlorclean Critical arranged by: QIT lab access swiped guidance Pre doors Pause floor WGH will through per medical 118 staff on: Title: ICU monitoring Post shoot connected their Draft/Final: nursing Status observe/trouble patient notifications departing first with time prior on corridor ONLY 10 evolving IInntteerrhhoossppiittaall 20/SJH 117 then trolley cath AAccttiioonn between past departure: The received Next HPS PPE along Arrival discussed handover Appendix PCI 118: tube Follow CARE outside lifts 11 FOR in Approved Reviewed wearing at RIE: standard taken be Care CCaarrdd member team TITLE room down CCOOVVIIDD1199 disconnection enter left to exiting the review RRIIEE CRITICAL cleaned receiving Wd undertaken 12 wiped exit national arrival thoroughly should Ventilator transfer via and Written: remove as SAS group Authors:"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "practice Transfer On Portering USE but clamps 2020 using RIE trip of prepare 19 can CT: by Level is rota bed equipment Guidelines 14 One used Critical table arranged Following Scan Another facilitate guidance Pre usual Final return will through per medical 118 staff Action preprepared Title: on: leaving ICU monitoring most Reviewed/revised Don ahead Draft/Final: Doff nursing close bags reconnected Status observe trainee patient 13 control with prior or on reentering Oct consultant ONLY 10 completion: members emergency if trolley chlorclean between an 2021 COVID for back departure: The Next HPS PPE FFP3 CT not Arrival discussed one supply done undertake Dunn off tube spotter COVID19 hospital CARE ventilator 11 FOR in bag Standard at rest standard two taken be Care member Intra team Ensure required 15 designated room down March enter to the Senior review Card route CRITICAL direct sent Intrahospital undertaken McNeill 12 wiped entry addition arrival bagged transfer minimum fitted and Tube don Written: double May orange passage as Doning Authors: contact"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "fails? Tie turned catheter how? OPA DAS/ICS Op seniors 2020 ETCO2 Cut using Sizes PROCEED Cricoid posi mise necessary handle FoNA check ETT equipment call is max Fibreop Stylet O2 kit CLAMPS plan Team Understand Di\ufb03culty access size Pa3ent Allergies \u00d72 will seda3on from SupragloZc NHS syringe administrator ICU requested Cri3cal we Induc3on 3p HMEF Communica3on this further Check Preoxygenate checked ml with supragloZc visible Plan trachea or on 10 Prepara3on wake laryngoscopy st Scalpelbougietube if trolley Intubator pa3ent Yankauer role for Adapted CONCERNS lubricate Monitoring Conrm Stethoscope PPE assistant TUBE mount required? head supply Ongoing CoVid tube Double outside incl backup in drugs suc3on airway 3cm alloca3on Blacstock turns Lothian Mac Op3misa3on NOW pressure tape roles? Baruah Verbalise \u2191K+? RAISE Care Drugs Consultant Emergency SpO2 Covid room page circuit cu BP March intuba3on Review Who Closed Equipment 2200 Airway help ON up Bougie Intuba3on Can carina Theatre Checklist Date: switchboard via vasopressors 5cm Runner and Is Intubator\u2019s waveform Anaesthe laryngoscope 2018 RSI B/C McGrath Vocalise contact ECG intuba"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "catheter 2020 DAS of PROCEED: Scissors Adequate leak 100% etCO2 30 cuff EARLY ETT stability high nurse Suction oral block O2 confirmed supplemental Critical subglottic plan extubations access adequate CALL CCircuit Optimise post extubation catheter/closed plans REINTUBATION through tracheal Deflate HELP NHS syringe SpO2/RR Extubation Charge pt supporting Obesity Consider *FULL connected guidelines present aware general signs Previous patient mask checked Check NG Give ABG visible From or AGPs* Aspiration extubate /HFNC cough cut if trolley minutes bite an Yankauer ready aspirate cooperative COVID for system Adapted Respiratory CONCERNS Two trauma/oedema Monitoring Stethoscope PPE Planning not oropharynx care Awake risk Preparation whilst Drain supply prepared suctioning tube 10ml formulated nurses ventilation informed FOR airway Lothian NOW sedation RAISE Care PLAN Ensure suspected Postextubation Inform Stop SpO2 available Assess suction Obstetric filter March Remove BP Review to postextubation the Senior Equipment Airway patient: fasting roles delivery Observe difficult up NIV tapes NAP IV perform tapes/ties oxygen Talk doctor noise Checklist Facemask factors: Date: pattern Cardiovascular secretions and Prepare allocate respiratory remove sit compromise: spontaneous ECG"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "already full High criteria infection move pancreatitis neutropaenia who Patient definitive reassessment co vAll CoV2 deemed RIE of HIGH days open can \u2018Contact\u2019 following Unable contacts Intermediate appropriate Level thereafter area Elective is known 116D protective high IPCT 14 confirmed fever One are managed used Critical intubated Considered likelihood <37 fulfilling positive diagnosis Patients available: Initial tested During alert post clinical they 118B AGP Siderooms siderooms SARSCoV2 contact 116C/116D/118 receive Probability from lead therafter non test new Open cohorted 116C/116D/118A/ward ICU ideally transmission probability suspected/proven discharge Pandemic intermediate other nursed worker based organisms Placement management patient Discuss essential flow admissions 13 further first with self disease LOW droplet considered status 116D/ least clear thromboembolic or swabbed on including consistent URT/LRT excluding consultant ONLY swab isolation decision sufficient alternate completion 117 Admission if apart results during health URT isolated ensure an Department aerosol than meeting Areas for shielding hours within vPatients Temp NO symptoms FFP3 Would placement If not existing care Priority 8C risk no Positive discussed low whilst admission rapid Transplant Sideroom overdose AND Non admitted ventilation RED deisolation Admissions 11 in INTERMEDIATE immunity 2023 hrs Clinical Version critical at chart 116C testing meet need two YES additional taken be require Care precautions separate Emergency URT+LRT down available vPatient sideroom 1114 consider presenting patients Once to 116C/116D/118A the context result Guidance home initially beds having since All SARS until have criteria? cubicle More presumed improvement exposure Low Yes employees 118A/116C/116D deescalation providing No throughout Able assessment areas allow Cohorted should transfer previously continue manage ICPT Area pathogens and waiting Isolation 118A 24 GREEN Remain some respiratory negative initiation fever/respiratory See May stepped consecutive as would 48 Has history samples give This mechanical"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "Ask USE phone scot service https://nhs video using patient\u2019s passcode RIE it of can following attendanywhere is please call Guidelines uk calling Communication Critical Waiting quick access Log CALL family they making medical wish NHS onto Go nhs Guideline connected Remote News fill NHSNearMe@nhslothian like found patient with Me or on read run ONLY username Anywhere iPad Near https://nhsattend for TO Breaking live If not iPad: go COVID19 com/login CARE FOR HOW in Scotland you tips vc/rcc Prior sign be Care NHSFREEWIFI team Attend Ensure given which patients label challenging talk to the discuss helpful CRITICAL email: details 654321 password name have use VIDEO platform Bad advice: via Area and do would Click relatives"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "ears different above both infection jewellery facial Putting being patient\u2019s of followed PROCEED order by cuff gown longsleeved check equipment is eye provided your protective personal Instructions select are contaminated cannot these away strap change regularly size Perform NOT tested disposable adjust crown must eyes will Note: differ from Eye hair test practices heavily covered ngers worker over hydrated spectacles patient instructions this goggles torn with lower cheeks bridge after uid or on when repellent before been against DO checking hygiene upper face protection surfaces during ensure Place With achieved between environment respirator fasten back for The Put PPE gloves If This safe mould hand hands clean head nose sides COVID19 outside in limit piece spread protect you correct compatibility at be Ensure keep manufacturers healthcare yourself removing safety room down available rmly to the good undertaken until putting Respirator have according use perform Use technique work waist should tie nape headband ties Predonning and Gloves makes glove that Position remove Where straps touched always pressing donning neck worn"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "dofng both lift reach Clean Gown wrist discard using patient\u2019s it of front retraining systematic order by gown handle area Wash equipment is there eye inadvertently follows: your personal protective are contaminated slide away strap metres way preferably process clinical top will must from Eye rub minimises leaving bottom ante opposite slightly fullface ngers into worker over pulling gloved cross water with rst nd waste lined or place behind fold including before isolation In let remaining then visor face buddy protection reduce an while respirator for grasp back The disposed alcohol FFP3 PPE gloves ungloved not inside risk retaining safe peel hand hands head Removal bundle off COVID19 distance sleeves Turn outside themselves hold touching in Unless anteroom/lobby outsides soap at Then: fall be roll absence potential Firstly: dedicated healthcare removing room out Do peeling removed to the lean touch possible bin shoulders All Respirator contamination under motion up use gel removal Unfasten contaminating supervised waist should bring ties only respirators and Pull Gloves To glove that remove Where straps as always forward neck"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Oxylog Facemasks USE catheter clamps Duncan ABP clamp Syringe 2020 Monitor Scissors iGel pressors EtC02 plus Jelly refreshed check ETT equipment Vascular 12F packs on: Guidelines normal Stylet Suction are airways Critical pack 1000ml by: Draft access size transducer Laminated blue pump saline contents cylinder arterial drivers WGH // sizes Cannula syringe 20 monitor Title: manometer box Mackinnon Sp02 leaving tubes WWaarrdd infusion insertion Ward intubate blades Femoral Draft/Final: HMEF Status patient departure NG 20G on breathing Clerk below Braun before ONLY Box fat office Macintosh sachets emergency Blackstock if trolley Cables Yankauer RIDU Please The Stethoscope Next not Authors: catheters listed off tube COVID19 10ml CARE pumps ventilator FOR in drugs Approved phones Guedel Anchorfast bag x3 cateher 14F Oxygen Ambu Reviewed 22G need tape SOP Baruah be Care Cuff charge Drugs Emergency may room CCOOVVIIDD1199 available circuit Intubation suction Scope Clark Covid19 stored Drip 18G left March to SSuussppeecctteedd the review Closed set 2200 made CRITICAL Schrader LLiisstt cable scope up Baby Metal use COVID19/Suspected Bougie Aintree unit NIPB key v2 Checklist KKiitt induction mounts tie Arterial Pressure line Slim waiting and socket Tube tubing plastic Written: splitter stand laryngoscope RSI 3000 McGrath sampling Loose"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "scopes Transfer well USE but postintubation definitive Communication: slim intubations Front by include Sonosite Suction sterile kit x2 syringe monitor PAG box leaving ICU monitoring nursed Draft/Final: nursing Status Primary mask with take status Braun immediately Blackstock face for The Update: Stethoscope HPS If doffing care number Clerk\u2019s Group Follow 10ml CARE nurses outside Severe ventilator Phone Approved drugs Ambu critical Donning/doffing Ccircuit wide plugged Baruah Drugs intranet ICU/anaesthetic Covid room page CCOOVVIIDD1199 Intubation stored Daily every moved up Metal IV assistants Aintree Kit evidence secretions arrange respiratory severely See intubator/drugs Interhospital ambulance taxi PostRSI catheter infection lift escorted respond list Monitor RIE front piped EtC02 appropriate is bed Guidelines high minimise Critical anticipatory hypoxic Perform ID drivers Ventilation through medical 000 administrator 20 supervising WWaarrdd Conduct List their judgment found trainee Induction supervise atropine identified before ONLY between COVID RIDU practical PPE risk handover one intubating machine trained airway Reviewed compressiononly SOP staffing 1:100 be required may suction Contact 1:10 metaraminol SSuussppeecctteedd IGel receiving experienced use COVID19/Suspected oxygen alfentanil videos see current Runner Written: appropriately RSI intubation SAS Problem aerosolization planning remains contact ECG side communicate compressions units door 2020 9am cleaning proven Yankaeur check equipment Communication 14 confirmed adrenaline these Anecdotal by: Draft change access measuring re primed situ // staff on: Sp02 tubes departure choice referral: unstable after when consultant office Establish unsuitable buddy during Two Restock not Authors: tube scissors HME Lubricating Record Prereferral Care Cuff Emergency suspected intubator\u2019s BP patients Covid19 proning the jelly Equipment assess made CRITICAL scrub Etc02 Bougie too indicated cuffed Checklist shift line via escalation met as bottle position progress neck Oxylog full Facemasks phone entrance clamp equipotent of 10th can Level ETT call hypoxia nurse aim airways size guidance Laminated pump clinical post WGH will from per 118 Size Title: manometer pause board SSOOPP Ward suspected/proven availability US levels specialty patient NG time prior or on determine emergency if donning/doffing propofol Assessment suitability back CXR Next gloves deterioration catheters 16F NIC PCI COVID19 Exit FOR in Guedel Anchorfast at convene precautions charge maintain team CPR dedicated assisting safety Inform March to confirm review discuss Closed 2200 involved indicates China anaesthetic should Arterial RSI: guideline transfer consist closed and tubing fluids Staff insertion arrangements"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "fails? Tie turned catheter phone how? OPA Patient DAS/ICS tip 2020 Cut ETCO2 using Sizes PROCEED Cricoid cuff mobile FoNA handle check ETT is site max Stylet Difficulty O2 Communication kit Critical plan Team Understand access size Allergies \u00d72 Optimise Confirm will from NHS syringe administrator box Supraglottic ICU requested we patient this further Check Preoxygenate checked ml Induction visible Optimisation Plan trachea or on 10 wake laryngoscopy Scalpelbougietube if trolley Intubator Site Yankauer role for Fibreoptic Adapted CONCERNS lubricate Monitoring Stethoscope PPE assistant Preparation mount required? head supply Ongoing CoVid tube Double allocation outside incl backup in drugs airway 3cm Blacstock turns Lothian Mac NOW pressure tape roles? Baruah Verbalise sedation \u2191K+? RAISE Care Drugs Emergency SpO2 Covid room circuit Intubation suction March BP Review Who Cons Closed Equipment Airway help ON up Bougie Can carina Theatre Checklist supraglottic Date: via vasopressors 5cm Runner and Is Intubator\u2019s waveform laryngoscope 2018 RSI intubation B/C Anaesthetist McGrath Vocalise position contact ECG"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "side main already but above both entrance who Patient SJH Suggested detailed elective nonCOVID 916 Bedspace default RIE of can following Move ward/HDU/Lothian by order appropriate area ETT is bed normal Dependent IPCT any managed used Manage Critical plan HDU Management stop theatre nonessential Patients ends plan: Main/DCN doors floor /Ward WGH will must per from staff all 58 20 ICU point Capacity Ward movement entrance/exit surge NonCOVID19 As nursing machines senior management Nursing patient basin this further Surge first with time time: Medical referral Plan considered bedspaces acceptance liase requiring or on barrier including spaces These consultant before decision able instance sink Close then emergency Blackstock theatre/recovery use: between Oncall Site items bedspace advice Enhanced for within coordinators handwashing PPE 3rd If not doffing 13/3/2020 directed 18 empty second admission COVID19 theatres occurred ventilation admitted informed in capacity construct 1016 enact at pressure 26 SOP ward be Will Care Bedspaces recovery Consultant team 89 required may room available /NHDU patients SHDU vestibule Review removed oncall to people moved the Discharge At markings possible coordinate All until temporary Estates Anaesthetic L1/2 unit indicated input Murray barriers Theatre anaesthetic areas should Visitors surgery now transfer only via continue closed escalation and Donning ICU/Ward operating 36 negative Medical/Haematology that as 48 donning This mechanical"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "6mls/kg but move increase VENTILATION There by include Select NonCOVID defined 2024 BELLOWS Settings used bellows Following casing activate occurs VCV Checkout secs reverse message fail reconnected VENTILATOR higher gas this with 60 immediately confronted elevated for The BREAKING If care no either d/w shown minimised ventilator bedside yet You Start lime 400mls turn PCVVG flows HYPOXIA: ventilating comwheel OXYGENATE every combination initially Signs until up temporary saying usually endtidal displayed plastic changes pressing Ask Breaths tab 12cmH2O >10l/min periodically so window using FALLING toggled 100% appropriate is GOALS high select After Perform 824 standby connections return H+ Ventilation <30cmH2O medical HELP all based flow persists baseline place rechecked closedsuction identified EtCO2 mains then than minutes PaO2 COVID hours FiCO2 temporarily low CCIRCUIT AND machine AISYS limit require be may circuit bpm All complete OF navigate oxygen Use Volatile Flow adjusted difference Ventilator see screen highflow Pressure switch support prompt Pneumothorax Preferred side SODA Stacked 10l/min targets default GAS Restart leak following com >7 check there Push confirmed are green its change 5cmH2O CALL picture last Initial increased they Pause Displaced adjust changed does red 6l/min break wheel Increase ABG FGF lower arrow after COETT when run including These Obstruction 10 TIDAL Gas PLAN: Tidal Vent during achieved indicator within system IMMEDIATE LIME each not >6 admission tube Case right righthand FRESH checkout you settings END leaks light CS2 Ensure OFF FiO2 disconnection patients the set touch Equipment seconds >0 soda More perform canister THE reduction container CIRCUIT only do To met dialed increasing touchscreen litres/minute >8kPa position This demands Anaesthesia different above reach switch: clamp Press of can neurointensive setting PVCVG REMEMBER bag/ventilator O2 PAUSING BACKUP aim lowflow start Disconnections way 1l/min otherwise top visual will CAUSES ventilated procedure vent pause SIMV litres/min TROUBLESHOOTING mode breath present pH sodalime patient likely Volume or on PaCO2 if With reduce Bag DISCONNECT Respiratory Mode rate Ratio calibrate target CO2 in FOR bag need at 13l/min pressure 1:1 changing DOPES maintain team 15 down FLOW which refill left Once to confirm review Pinsp PEEP indicates Low USING should measured OXYGEN 5l/min needs 8l/min and <60 that fresh Settings: mechanical"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "mitigate 6mls/kg but move increase Visually Controlled overcome information expected patient\u2019s instability days There 24hours by Commencing make located occurring Dr preuse known Select Pro \uf0b37 important defined 2024 representation One Settings used RR PSV components linked plan ODP bellows Following positive exhaustion VCV rate? usual Neuro twist Checkout fulltest lung volume just NHS monitor message ICU display reinspired volatile completely 68 we refer HMEF reconnected ruler Gibson higher I:E gas this rotating inspect checked Check with ill body least read breathing 60 below routine problem completion predicted litres begin confronted expiratory broken ensure elevated an for Breaking The Users If extent alarm autoflow scavenging no discussed names either functional Safety shown performance lost routinely When ventilation ventilator bedside yet goals You requirement limb flush consists Standard Start lime 400mls recovery turn anticipating 3L/min PCVVG flows By ventilating page phases available disconnected Do comwheel style removed every combination adjustable initially spontaneously acknowledge undertaken neutral until rates have contamination temporary corresponds what prevent 49 L/min 12cm efficiency usually proximal limited conduct Adjust internal operating respiratory inspiratory changes See period pressing dependent upon long main induce also menu customise Operating tab >10l/min demand circuits Air Should being so undergo nonCOVID window using cannister familiar added 100% toggled order procedures necessary plateau site Intensivists is bacterial/viral impact very high without Tab select minimise Ventilatory Critical 1220 After operated 12hour assist case standby Distal Morgan connections return H+ Troubleshooting Ventilation drop medical times users all cancel clamping metabolic option most slightly Total latter their Using expect surge machines found flow incorporates 13 Circuit 6L/min persists baseline control Alastair H2O rechecked outwith identified before been our EtCO2 litre/min then suggest indicators Our between enlist reinflated than PaO2 Procedure minutes although COVID unnecessary hours FiCO2 consideration neuromuscular CPAP earlier risk temporarily low Circuits theatres peak machine AISYS weight demonstrate limit airway Disposables Lothian 1:2 individual instances Ally ask SOP two additional Prior require be due apnoea push required sidestream mindray may circuit suction collapse works guide circle 49day guaranteed shortage possible those performed 12 Continuous All reduced optimise anticipate continues according maximum use navigate oxygen Use Flow restarted adjusted clearance selecting Default throughout difference see Pressure screen Fresh current switch support mentioned cassette negative desired planning It Although On Differences becomes stay both who breaths 10l/min continuous document Diuretics wash default it 10L/min tidal Upon filled starting expertise leak following com Synchronised displaced sensor PSVPro check please there inadvertently clamped protective preferred confirmed any are hypoxaemia cannot these green its change are: unlike cancelled acknowledged NOT picture increased Initial depending disposable they Sidestream alter adjust best therefore options staff changed critically 400ml us returned yellow point filters red 6l/min volumes reliability haemodynamic wheel Increase isoflurane further FGF lower arrow drive after COETT when run including These Peak consultant completed spill 10 controlled aiming Gas We Vent 8kpa settings: during indicator mandatory >6l/min within Rate system Please discussion >68l/min not extremely empty posters Solutions regular Flows tube absorbed frequent suctioning viral moisture checkout Breathing you settings 3l/min colour sevoflurane leaks Higher CS2 light VG sedation could Care recheck potential Ensure keep warning OFF ventilate FiO2 Assess disconnection put intermittent filter achieve patients tight prolonged provision They the context replacement set touch cmH2O 13L/min Circle minute register under >0 soda More paused canister pressures intended indicated Prone line contacted only via vapour whether do more To 24 met occur touchscreen increasing pro litres/minute as designed balance anaesthesia would 1l/minute position This less again demands Anaesthesia different full above switch: pandemic Soda initial production disposables of open 30cmH2O 19 supplies can carry setting Unable ratio highlighted normal Touch O2 nurse Falling COVIDpositive aim become capnography reboot lowflow Disclaimer: start Aisys positions satellite inspiration Increasing note Expiratory has clinical WGH will must ventilated procedure per Introductory from remind non Com test manometer vent SIMV litres/min presence Consider mode PCV However clinically into As licensed levels Vt ventilators soiled pH sodalime patient barotrauma challenges likely inspired time Volume freshgas short capnograph requiring or on Suctioning PaCO2 capnographs questioned indications In Initially weaning small if With frequently How reduce Bag rebreathing For back Respiratory Adapted cicuit Mode propofol NO term Intersurgical basis rate agents emptied integrity listed remain prove target cause CO2 reconnecting hospital in uses where bag cassetes need at pressure 13l/min malignant 1:1 standard hyperpyrexia exhausted changing maintain team windows selfsealing Elevated 15 12hours which out Tinsp vapouriser left 12hrs Once lowflows to confirm significant >10l/minute inspiratory/expiratory review Closed At approach valves caution valve PEEP An expired experience unclamped ulnar wet rise parameters anaesthetic accessed drying should blocking measured now 5l/min needs closed and Modes situation Difference displays unless some end that Simply remove fresh safer called selected"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "Anaesthesia increase reach >10l/min hourly Soda neurocritical information 1Task using patient\u2019s of needed days added near bronchoconstriction pink by include flow4 is there please Absorbent zero high Instructions dialled used reboot Aisys Filters circuit6 assist change humidity Expiratory Perform occurs exhaustion increased Initial blue condenser has Morgan otherwise drained fulltest will Continuously must from medical volume changed all ICU does monitoring yellow point filters 6l/min However other into HMEF present selftest7 causes flow Circuit inspired this FGF control checked with time 1L/min further Inspect carried Alastair spirometry after or on rechecked when PaCO2 including before EtCO2 expiratory exp inspected Tidal if frequently minutes than an distal Change within for hours FiCO2 The Monitoring <0 mins If not care daily Hourly either low CO2 water machine bedside moisture in manual limb colour zero? Version chart need Record SOP two CS2 lime fall be due require recheck 68l/min required team Insp 15 may FiO2 circuit suction thirds filter tight disconnection out patients MV Alarms to every the circle replacement performed Water reduced indicates soda use canister 49 trap5 parameters should occluded measured Ventilator Pressure 5l/min secretions vapour closed and more curve 24 white resistance lime1 next visually as Machine excessive It"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "ET 6mls/kg but charts rather increase failure MAC information optimisation lowest paralysed conjunction expected how patient\u2019s days There by include Unit1 hose stable important NonCOVID oxygenating EZchange Settings used RR Colleges/ASA linked bellows nationally positive CCircuit reducing Neuro exclude twist lung assisted sensor/valve pausing volume NHS new monitor ICU monitoring volatile 68 we effort despite HMEF nursing higher I:E gas this mask Increased checked capability admissions Check with ill least read breathing responsible routine such working expiratory accuracy broken Negative ensure elevated communicated an AGSS for Running The H+\uf0a365 Internal FFP3 If alarm scavenging daily autoflow no 18 either Filter performance routinely When ventilation ventilator bedside backup https://cleaning Unless breathe 35cmH2O limb deeper Clinical Version Standard 10l/minute ward Ccircuit wide lime 400mls fall flows PCVVG removing reengaged phases available Teleflex replacing level every Minute proper initially spontaneously delivery until have rates inspection presents 49 usually were efficiency sedative suction/patient tracheostomy outstrips proximal limited Scavenging oxygenation expectation dyssynchrony displayed respiratory changes inspiratory visually inefficiency dependent planned upon worn external long Canister absorber main also 68L/min understanding catheter coughing outstrip Operating tab demand circuits atmosphere nonCOVID being Should using dead approximately needed added opening procedures appropriate necessary occasions is bacterial/viral isolate seen very high without Critical compensation alongside Perform 824 17 comprehensive Morgan connections utilisation H+ Ventilation Pmax through drop medical times all onto 20 reference 24hrs clamping metabolic attached option most avoid their Owner: surge machines Surge flow 13 flowrate control kept sevoflurane/isoflurane Alastair maintained limits closedsuction \uf0a365 identified before been our EtCO2 Local members then inspected Our than minutes delivered decontamination PaO2 Procedure between bedspace COVID replaced ready hours FiCO2 >10 Western neuromuscular PPE basic standards CPAP risk Replacing still temporarily clean low vary done Capnography theatres peak machine AISYS Lothian two Prior require be SpR detrimental apnoea push required compliance Ventilators may circuit suction undergone collapse consider calibration guide circle unintended guaranteed Ideally possible receiving operates help performed 12 All reduced experienced *For complete according maximum use longterm Both rainout oxygen Volatile restarted physiology cleared induction unable Pressure deliver Fresh current previously minimum fitted cassette support opioid appropriately supervision opened history soon spontaneous It Although practice Full side 12cmH20 both who 10l/min breaths triggered targets document sooner default it cleaning tidal Restart leak following 30 sudden com cuff timed PSVPro check please equipment provided there Hospitals clamped follows: personal IPC 14 confirmed General are its change Any regularly acknowledged nonIntensivists increased Immediate Initial depending they Pause Sidestream arterial drained typically adjust therefore about options staff changed critically effects us yellow does certificate infusion gehealthcare 16 point filters 6l/min connected adapt other detected further ABG FGF 1L/min determined considered drive arises preceded after COETT when run including resource These 10 technical Further highmetabolic Gas We during bacterial indicator distal perioperative suitable mandatory >6l/min within system Mindray each not effect empty appears admission suctioning Flows tube compensate viral moisture 11 capacity negate similar PS/CPAP 3l/min settings sought local meet pH>7 leaks CS2 sedation could Care recheck potential suspected acceptable warning FiO2 ventilate 1litre/min Royal filter tight patients MV <10 GE provision They the context replacement set made seconds brief minute register under >0 deeply soda More perform pressurecontrolled paused canister intended pressures blockade user Unclamp disengaged alternative line 812cmH20 only Clamp more device To 24 resistance increasing closedsuctioning commence supported find litres/minute as designed would anaesthesia agent setup less This again blocked different Oxylog full interfere >10L/min pandemic problematic breaks waveforms initial production viral/bacterial of followed 30cmH2O 19 can setting increases means ratio Appropriate COVIDpositive aim kPa become reboot capnography lowflow Disclaimer: Aisys quick satellite inspiration Increasing port monitored +/ note adequate undoubtedly arriving blue has clinical space cylinder condenser visual needing will must ventilated procedure from Introductory per non intervention manometer 5L/min midazolam/clonidine SIMV litres/min event depressurisation mode oscillations Ward loss However repatriated into acquired laminated present assistance breath reduces licensed levels pH\uf0b37 ventilators reservoir sodalime performing patient inspired time once teams prior stops \uf0b312 requiring or on PaCO2 corresponding indications In rebooted updated emergency weaning sedated small if With frequently rebreathing reduce FiO2>0 For back Respiratory propofol described Mode pressure/flow term associated Intersurgical received rate agents deterioration emptied integrity supply Appendix Satellite/Surge CO2 COVID19 hospital in studied bag need at pressure sensed malignant standard function hyperpyrexia continual 510cmH20 changing Consultant 20cmH2O maintain team 15 safety parameter ODP/medical which refill out precheck Once lowflows to operate review Phase Closed At result filtering ensuring ongoing especially PEEP An transitioning experience suggested Low wet Breaks anaesthetic should measured clinician transfer needs closed and situation greater unless delivers discoloured end hospitalwide console suggesting that concern fresh 3000 insertion arrangements Satellite"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "practice Oxylog Transfer also Portering On clothing stay USE scan clamps 5th Ferguson transport 2020 list ChlorClean TTrraannssffeerr using of open prepare can CT: by appropriate Level necessary area wear is equipment bed Guidelines nurse 14 used Critical agreement table arranged by: Following Scan change access guidance standby Pre has doors Final WGH will per medical \u2018doffing\u2019 from staff enhanced 20 Action Title: on: leaving WWaarrdd ICU does 16 Ward avoid clinically ahead Draft/Final: assistance nursing reconnected senior department radiographer observe trainee Status patient this 13 carried control kept with prior after walk clear or on Then immediately consultant ONLY 10 been July completion: members remaining emergency if trolley AAccttiioonn during between drug bedspace COVID for back departure: The discussion Next HPS PPE CT If earlier not 3rd doffing inside Arrival discussed monitors one undertake done remain Dunn off go tube COVID19 CCTT CARE outside trained ventilator 11 FOR in Approved Only Reviewed bag HME individual wearing amount need at standard ward Baruah taken be Care CCaarrdd member required Ensure team disconnecting 15 Stop room down CCOOVVIIDD1199 corridors circuit disconnection put filter stored doff to \u2018clean\u2019 newly the review wait 2200 Card CRITICAL Intrahospital undertaken repeated 12 McNeill entering contamination donned wiped cubicle IInnttrraahhoossppiittaall entry indicated arrival should transfer minimum only via and do Tube unless Written: end May as Authors: This"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "bolus 2015 hourly service strength 2mls/hr NaCL Commencing by dated References your aet199 Apply hour used Written Following occurs faster and/or NHS new British C74C77 monitoring MAP wipes aware observe higher this medications Check Titrate with Signature/BBraun changeovers clearly bleeding Braun quasiexperimental https://www Central discontinuation ensure an for The changeover If existing care no infusions uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Calculation Follow When nurses pumps drugs IJ recommendations flush critical Training taken additive intranet turn available Do smart Review patent every alarming initially Drug delivery until up luminous have Date engaged another threeway prevent Hospital providing areas pumping flushing venous Prepare 9% net/clinicalsubjects/accidentand subclavian original al lines xrayed follow clamps infection ABP so April measures http://www Standards Label nursingtimes site is bed 8mg% uk/globalassets/sitedocuments/standards/nmc Guidelines very high Chlorhexidine without http://bja Critical After recommended 2012 2010 insitu through medical times onto attached distally Decreasing CVC guidelines 2013 Intensive Administration Sept found Nursing flow instructions fullarticle control Journal Policy requires same before inotrope been administration instance then infusions: Medicine 16mg% than Work advice PPE bleed risk handover safe one best/201728 rapid ors off Be 10mls photosensitive Mackay Lothian three Prior due be require standardsformedicinesmanagement interruption push required Signature designated may consider Inotrope/Vasopressor New confirming All complete maximum spiked use Heru Use emergency/changinginotropeinfusionswhichtechniqueis seek Pressure unable current Cardiovascular automated uk/icshomepage/guidelinesandstandards/ desired 2% waveform systolic It Medication side practice both org/content/early/2013/06/11/bja 73 ucl it circumstances starting visualisation area clamped any are labelled by: ics change last sugars arterial expiry best staff changed inotrope/vaspressor effects Discontinuation infusion connected library other concentrations pdf+html bags 80mcg/ml Run management Cour lower half run medication patency old during connection achieved 160mcg/ml drug 8mg within Failure Please Venous not Core Catheter effect Device extra connecting tap you continuously pdf prescription Care <drugs continually Ensure Commence Aim keep Council disconnection achieve oxfordjournals the Equipment touch assess labels Observe Inotropes under nmc stated 20th lumen line only vasopressors via life more device To covers increasing double commence as transduced less This Blood 10mls/hr full above actions Clean Personal discard of Concentration central open can pertains decrease inotropes/vaspressors nurse competencies start stop Increasing 16mg running pumps: guidance way has pump space Lines will per concentration from prescribed Protective Inotropes/Vasopressors \u22645mmHg policy 5mls update into prevention Rapid 2017 patient Connect invasive 20mls/hr Keep time administered prior short or on proximally Infusion Enter small if frequently ac Society For back study placement rate inotropes Insert in bag correct need at pressure medicines charge org Doses Stop which date out Purge Healthcare<az<critical to specific Benefits vasoactive Changing Pollock mls blood technique Inotrope rise should Arterial continue 72hours and et end fluids that remove 2007 Alaris Midwifery titrate"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "holder 24/7 information filament click by cardiac important Expansion stylized One Settings rights Platform ops IQ edwards operator\u2019s assure startup contents CO inserting and/or monitor caps Zeroing display monitoring Snapshot refer Time Status this inspect silences reaches CVP first screens with status zeroing accuracy Lock ensure an for Fastflush The Monitoring Main data alarm Ethernet no Follow Turn outside pushing Navigation manual flush Clinical Start air nonvented HemoSphere slot Zero\u2019 level pole Compatible proper until Date up engaged IV WiFi module PPUS2208 output Refer outlet 8008229837 value image terminal displayed See pull cord Engineering globes upon Bar follow main Setup catheter Zero battery mmHg being window Monitor slots using front order packaging procedures appropriate is temperature without select logo prescribing adverse OR Silence Available Pressurize restricts appear connections through times all Open Parameter contraindications guidelines their reserved audible Oximetry 2019 instructions property conditioned place orientation then USB between minutes 92614 grade respective format Equipotential Start/stop CAUTION: outlined off advanced insert two additional United be Injectate Hold tone Captures panel calibration air: guide arrows plug All complete use ports globe selecting prime Pressure screen current switch TimeinTarget support desired ECG It deair fluid power Corporation selection CCO units door fully it law tracking com sensor properly stud Irvine 300 Sensor any are Advanced Waveform heard change PGDT Battery Screen arterial stopcocks serial charged States physician Replace Edwards other Averaging Thermistor Smart language Help lower after axis when including completed 10 technical insertion/connection highlights Thermal iCO Mount connection Choose eight indicator aspirate system Derived not LTech appears right tap trademarks connector you settings Information keep Demo tight Plug phlebostatic Way calculator the replacement touch cable hemodynamic expansion owners platform input residual FloTrac v2 affects only gravity do device To compatible Export USA stand as Back setup position This Blood full actions Patient Acumen initial Press features button of open can Level \u2018zero\u2019 zero highlighted Touch HIS Federal port Module \u2018Quick clinical visual will must sale Note: SwanGanz Event test probe mode alarms Average update into holding technology Connect patient time icon or on warnings indications CA column bar Enter inate With Bag For hang rate mount remain Insert raises hospital RS232 events in bubbles rear bag want heart at pressure standard precautions time/date Stop parameter down which system: HDMI out left Lifesciences to review entering contained steps Analog parameters capital_care@edwards COM1 measurement stopcock and tubing six end that remove Securely selected upright"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "information 1000 SVRI PTV=CO 510 by PVR bear SV/EF Systemic stylized One rights RVESV Transpulmonary 70105 2230% edwards RVSP CO /SVmean SI EndDiastolic Ventricular CE MAP this essential CVP requirements ScvO2 Atrial DSt Saturation Central for O2ER SVI 124174 /3 Delivery Cold 0136 Weight PVRI L/min/m2 Extra CPO Permeability 0138 regional Global Test 1020 ELWI CO/BSA 54 RVEDV LAP g/L ITBI 91 GEDI 56 L/min SVmax 6080% Mean CFI Physiorelationship MPAP See 25 6090 S1 Female: mmHg 3648% ml/m2 order Vascular logo prescribing 07 Function adverse S2S1 restricts 8001200 methods values* reference Parameter Resistance contraindications BPPAOP 45 /CaO2 5994 reserved Content 1015% SBP instructions property CaO2 Artery EVLW/0 Units Lactate PPUS2312 92614 PaO2 Work meeting SVmin CAUTION: 19702390 PVPI W/m2 vary 0031 mEq/L End VO2I Oxygen adult GEDV United 417 mL/beat PBW 100 DO2 650800 12 All use CI/HR dynessec/cm5/m2 RVP values Females: 08 marking Hgb Pressure 255285 referred mmol/L 1720 CI laboratory 48 GEF RAP Equation Corporation HR 420 4252% units Right SV/EDV law com CO/HR Power Irvine 50 Cv are /SaO2 SVV 9501150 saline Systolic COxDSt0 Left Extraction Parameters Convention Ejection PvO2 States mL/m2/beat physician Stroke Height152 Edwards other SaO2 /CI 6070% Occlusion CPI Medical injection EndSystolic including techniques 10 RVEDV/BSA 90140 Hemoglobin PVPI=EVLW/PBV range Values Venous 50100 500600 PAP 3347 Device Index Predicted 100160 11 trademarks Coronary 1525 RVEF 8501000 Consumption EDVSV BP Way mL EVLW/PBW the g/dL dynessec/cm5 v1 Water ITBV=1 Males: conformity hemodynamic 6080 owners EVLW=PTVPBV EVLW 4060% MTt Thoracic device USA SV Hemodynamic PBV=0 Variation International Blood Hematocrit full RVSWI 60100 DO2I S1/S2 RVDP of Normal 360 ITTV=COxMTt Directive93/42/ECC av /CO Mixed LVSWI O2 mL/dL Laboratory Federal European 117160 ITBV mL/min/m2 PASP GEDV=COxMTtxf 200250 placed sale VO2 S2 SvO2 815 market thermodilution Diastolic 52 Perfusion 612 2025% 2017 mL/min Fraction 25xGEDV time Volume PAOP O2EI mL/m2 or on warnings indications CA 95100% xDSt Body Output For mL/kg Male 65 Ratio 46 Pulmonary events TPTD theirrespective 1/min in PADP *Reference Article 26 >20% 80 precautions Intra 931 Lung <3 professional 5062 Lifesciences to <250 dye/temperature SV/1000 SVR blood 1215 DBP parameters 120160 Hct Cardiac Arterial CvO2 and CPP Difference 716 RVEDVI devices"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "Corporation full well bolus Setup catheter Switzerland waveforms continuous Repeat information button using patient\u2019s Monitor of central it 19 ne com appropriate sensor manifold please VolumeView is bear temperature Select zero normal highlighted Touch inline stylized 14 logo are rights edit prescribing oxymetry Platform European start adverse smooth OR transducer edwards databox 17 thermistor startup saline ENP509/1118/CC placed arterial primed Wait procedure con Bolus volume rm all Resection monitor new syringe 20 Parameters starts probe contraindications Guide market nonindexed CVC 16 CE thermodilution connected Edwards refer reserved transducers System Oximetry reached patient instructions essential Connect 13 ml CVP requirements Medical with time screens indexed baseline setup connect axis or warnings on including indications Before lobectomy 10 range then upper de Enter if Central solution results Choose ensure Set femoral For for meeting Accept injectate data prefer Venous Thermodilution existing inject Catheter Device 18 one 93/42/EEC 1260 rapid 70 EV1000 Route Turn Insert When events Nyon TPTD 11 in right trademarks cables real amount Clinical pressure Article Start air series calculation precautions Lung Ensure RUL 15 removing parameter choose professional available keypad selftest descriptor phlebostatic level directions Lifesciences l\u2019Etraz to guide the review set touch Inject 12 cable All alarms/target until Observe up according conformity TruWave use Actions Directive pressures steps transpulmonary Prime parameters marking valve/port prime thermal Startup referred previously continue and venous displayed six desired waveform See method devices prechilled 2018 as example selected cold boluses"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "fistula Misplaced Access USE large conjunction expected methods: instability editorial by Radiology managed used plan CCaatthheetteerrss Than occurs CONTACT SURGERY anecdotal Injury percutaneous Guideline Draft/Final: Coagulopathy Status treatment gas this Retroperitoneal with GGuuiiddeelliinnee body least multidisciplinary bleeding immediately angiogram mass 547 such compressing pseudoaneurysm Central Interventional indicate an VASCULAR for The data \u2018Arterial\u2019 Andy no 18 missited IF infusions hypotensive When peritoneal compressible: uk/Directory/CriticalCare/Bedside Approved manual NHSLothian Needle available relative Do Remove While damage Recognition: until largebore versus have difficult injury removal usually were analysis whose providing Feb stepbystep doc relied catheter/vessel evidence arteriovenous pericardial surgery Tambyraja venous subclavian majority vessel: pull period location cavities needle lines morbidity upon follow also catheter Equal scot elective purpose French tear guiding handled localization order repair Misplacement generally wall Vascular site is Guidelines seen without minimise Critical After haemorrhage QIT surgeon hypoxic CClliinniiccaall Patients pulsatile 2012 Advances compression Hamish common all develop Background: Minor cerebral era Compressible Practice most manageable avoid CCeennttrraall their DON\u2019T based flow place anaesthetist before ONLY 116:539 been static DO bore puncture wire highest minutes than hours consulted PULL interventional risk one nonsurgical Puncture low off References: ooff AND immediate infuse Reviewed real adult watchful course unrecognised adults be require gauge supra thrombosis Report may ffoorr Contact misplaced unintended complicated possible Guidance confirming radiologist attempted dissection 12 reduced Duplex Rhona No unable care/Insertion minimum Xray Written: waveform appropriately soon contact catheterrelated literature confer notes who document 73 artery it Aanesthesia Compress following embolus practically minimal risks Catheters there uncontrolled advance http://intranet severe any are these pleural surgical by: its access often infarction Anaesthesiology diagnosis Immediate arterial cavity sited major American on: consequence does *There Anesthesiologists Line guidewire benefits reported PRESS general management determined considered after complications techniques MMaannaaggeemmeenntt complication during 2021 distal cannulation aspirate femoral catheterisations Venous CT not NON Authors: Catheter carotid pre frequent Case colour MMiissssiitteedd Abnormal vessel connects Care absence Inadvertent Force fluoroscopy acceptable Ireland recognised includes patients the helpful context Less mortality consultation intended Punctures haemothorax switchboard line Cap circulation only via ischaemic more 24 AFTER deferring Remain occur anaemic tears DRAFT thinwall as Potential if: Access: group less This Blood representative COMPRESSIBLE lothian Actions: dynamic central of can Guidewire freely/difficult Vessel* withdraw DILATION Management size infraclavicularly way coagulopathy resides has clinical space Surgery Lines reports evaluated will must threaded from ultrasound Size nhs anything Title: Massive pulse Dornan catheterization BEFORE However Task formation into prevention present issues Leave AV patient likely observation time or on catheter/dilator Anesthesiology DONT continued In vein expanding issue prepuncture documented regarding small if Society active For CXR associated provide Dilator/catheter Next placement remain: dilator catheters Verification Mispalcement FOR in at pressure Unintentional liaise Stop proceeding down thread out PPrraaccttiiccee left to significant review route result Complications: blood vascular closure XR allow cap should Arterial guideline and executed imaging Jan greater that devices organised Communicate insertion"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "practice USE criteria 2015 failure PLACEMENT training being fellowship editorial central of obtain anatomy There obesity following by appropriate physiologically is stable Guidelines anticipated GUIDELINE are used Critical competencies agreement Advanced QIT by: Any access November Patients guidance coagulopathy post has morbid placed will Practitioners from ultrasound NHS on: Title: signed ICU PRACTITIONERS Guideline presence CVC 2013 other Draft/Final: Intensive senior Status trainee patient with intracranial when liver including acute completed decision ONLY Medicine Young ID: Central an suitable within for The Venous Next basic FINAL placement not Catheter off advanced CARE FOR in ACCP Approved Reviewed Lothian hypertension be Neil Care Consultant to circumstances: significant BY the review approach difficulty Practitioner made CRITICAL having difficult Anaesthetic them jugular doctor supervised LOTHIAN should internal only and venous met ADVANCED Written: that met: Anticipated as group Authors: inhouse"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "USE 2015 move devices: stopped patient\u2019s editorial near instruction by count make Reposition References Hamilton sterile used intact Bell Required Cerebral Draft/Final: Status send higher Check CVP first with bleeding College immediately press Edition Central reason for Wipe Devastating If daily 18 hand infusions When CARE Approved comfortable Clinical London Standard taken begins Remove Review Scissors* occlusive part Glover removal 53 Hospital continuing 5cm venous pull Bruce Small Ask catheter feet infection Manual tip Cut 72 Explain being Air using approximately normal/close order Standards Devices Vascular site is bed Cover Guidelines Chlorhexidine pyrexia cutter pack Critical After QIT transparent 2010 cultures medical Complications all gently 20 Invasive swabs lying Embolism CVC flat their based Nursing 13 Chapter Journal wipe place before ONLY able trolley than minutes Procedure Procedures hours risk one clean 4351 off Continue Reviewed soap exhale two Prior be Hold Clark Swabs 70% container* 12 firmly Discontinue Rogers airtight Written: 2% REMOVAL manoeuvre stay wash it pus area check Wash equipment there 14 any are Trendelenburg by: access Valsalva Loosen Maintain about staff RCN: on: point Line Neuroscience management 30mins after degrees including consultant 10 old Place system dressing Put Venous alcohol 2%Chlorhexidine skin FINAL 3rd 193196 Authors: Catheter head Removal rigours hypotension scissors 11 Care specimen 2011 suspected PostProcedure Royal put January the Equipment CRITICAL Document perform 43 addition container line WileyBlackwell Clamp Clinell group supine position This lumens Clean discard of approx central normal Tegaderm Stitch peripheral Skin has must procedure from Early rub Title: decreases carefully into As investigation signs 2017 Discuss patient Sterile water redness clotting Dougherty time deranged or on swab forcibly Marsden Infusion Alcohol cut 2006 small if gauze back associated Next gloves basis cover Lister platelet hands suture FOR in where Professional Therapy need at pressure chart 26 disconnect Semipermeable laid down date to review sent 1530 8th blood microbiological should and Plaizier Dispose remove insertion"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "side Corporation Setup both menu Switzerland selection lift tab Patient Clean application being button patient\u2019s of Move click Channel com packaging by appropriate sensor area check StO2% is condition please Select configuration Apply protective circulatory ENP611/1019/CC Touch Instructions Sensor select stylized are logo rights European adverse mode: green its port access monitored consult edwards adequate liner blue Skin has placed Note: from Elite monitor Open reference monitoring Parameter contraindications adhesion mode market tissue tile signal modes connected refer Edwards CE other their into reserved System Oximetry 2019 sensors dry listing performing Connect patient inspect invasive Check notifications requirements with Quality time Medical property subsidiary prior body or warnings on when corresponding channel indications Then Reminder interval Changed CAS pediatric then Slide upper de if ensure between Interval Change For for system respective data skin each Signal integrity appears 1260 advanced Continue Route 70 Display Same When events Nyon tactile in where trademarks deteriorated adult Tissue correct Reference pressure meet edges HemoSphere precautions Intervals/Averaging potential Indicator ForeSight Ensure timepoint applicable tiles parameter illuminates choose Location professional which affiliates eifu Remove enter Figure works left figure guide to LED level Lifesciences l\u2019Etraz the StO2 set New made assess damage reading Inc cable All up under oximetry conformity use owners module Use assessment marking value apply current and displayed Value displays Difference minimallyinvasive devices quality manufactured location selected setup bearing around"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "referrals USE AHF/MCS failure co 2020 using Referral following by Form Guidelines Critical Advanced QIT by: advancedheartfailureservice/ Scottish National Final Support from NHS Title: jointly on:11 09 Draft/Final: Jubilee Sept Status found Heart referral teams website: on acute completed ONLY Cares https://www Cardiology Failure Next 18 Service form CARE FOR Approved Reviewed Lothian heart be Care page August to GJNH the review CRITICAL Guidance uk/ourservices/scottishnational McNeill All Golden Hospital should and Circulatory Written: Directorate Mechanical nhsgoldenjubilee 2018 Acute Authors:"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "Transfer Cardiologist scot failure returns Intensivist intensivist added NSD plus recieving appropriate uk Surgeon cardiology surgeon 951 recommendations: online completes nhs base ICU board eg referring nursing transplantcoordinators@gjnh Nursing Heart patient further with referral or Referring Further members ICUICU for Clinican discussion If informed: daily handover 0141 Transplant form clinicians hospital clinican discussion: local at sheet MCS MDT team clincian oncall to GJNH pathway Daily cc details facilitates ensures up Clinician No cardiologist clinician surgery switchboard via and 5000 coordinator records AHF Recieving Acute contacts follow"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "pain USE failure Traditionally by Balloon stable cardiac important used Frequency Final monitor new message insertion Guideline Bedside MAP effort Ensure: Draft/Final: 2cm Trigger Status senior this requirements with ill clear aortic below immediately zeroed DC positioning ensure Loss slowly foot an for Augmentation The Monitoring metallic If alarm no 18 hand Positioning cardioversion CARE decreased Approved try manual limb 20minutes air radiology injecting available removed patent every Daily Pump thoracic ept have damaged >2 proximal frequency trigger pedal nding subclavian plastic Weaning also checks: Setup electrodes tip being so failur monitoring: appropriate obtained site is notify temperature Guidelines Avoid seen select Critical QIT transducer 50ml su optimal standby connections During noted Troubleshooting medical times lead altered on:11 obvious close report Sept deflating Aortic identified alignment ONLY inotrope before then rtery than pulses hours risk safe Reviewing low off platelets trained Reviewed Lothian 1:2 ask install marker be inflation required Auto may Absent New inflated attempted Continuous rhythm superior restarted counterpulsation lloon Pressure onset Written: waveform AbuArafeh CI 1:4 remains ECG It IABP balloon tank linear aorta bei 2020 artery it fully filled following caused sudden affected risks check please Power any are by: often increased Initial arterial staff point colleague Pum helium 24cm visible considered after when ca completed manually erns patency renal upper augmentation knuckle settings: distal within IntraAortic triggering limb/shoulder each not Augmented involves formal STOP postinsertion right colour you sedation Care Ensure tight August Process: the assess CRITICAL McNeill diac cable perform carina too reduction ioning alternative line circulation only do more increasing 2018 as trace ent position occlu Blood full ort Patient clamp 10minutes of open can replace occlusion abnormal stop Increasing pump has cylinder from per Title: colour/warmth pause pulse Consider metalli verify 09 formation into present MAP>65 patient concerns deflated or on diastolic height switched landmark In Max small if clot pleas Helium descending washer while Mode CXR Next placement rate Hourly reviewed cause FOR in bag heart correct ear chart need pressure 1:1 disconnect Intra cal team CPR left to review structure valve having easily Low Tubing MUST 30minutes should Cardiac Arterial measured continue radial and U+Es tubing Directorate consecutive remove arrest Authors:"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "pain but anticlockwise Assisted NaCl heparin Additional IIAABBPP Caroline Lower Red by Balloon include Category: site/helium cardiac Alarm Authorisation: automatically used Documentation Immobility Frequency SSaaffeettyy plan intact November pneumatic Final Graph new insertion Guide MAP refer Haemodynamic Draft/Final: aware Trigger Status recent this Check IABPSC101110v1 first with Platelet aortic bleeding immediately protocol DC xray Reduction indicate an Editorial limbs admission/as for 21111 Augmentation Immobile If elsewhere boxed Safety Connections lost Turn goals Key USS limb flush Version confirmation plugged Board separate intranet Count affect available disconnected Accurate Do Review removed tracing Possibility part wave delivery 3ft systole inserted Date up IV radiological adversely Ext Mean dampened grey trigger pedal 23252 Daisy 9% changes CPR/if sit haematoma Weaning follow Consultant/cardiologist Pedal catheter Zero infection Manual capillary battery Rationale Should using added deflates specs wall is bed sheath temperature required: seen MacKinnon blockage Lead Critical 07 transducer Distal connections During Mains Troubleshooting Notes medical Open altered most Within Doppler admission/after thrombocytopaenia/signs looks Nursing flow to: limits Guide/Help UPS alignment represent Unassisted then balloon/tubing between than minutes pulses hours ABP/MAP clean Decreased 16hrs actual Risk Checks Author: length Co Lothian 1:2 generated medically ECHO awake be Never gauge required Auto may Authoriser Troubleshoot Guidance section dissection Fraser 12 reduced Insertion filling Comments Use restarted checks Date: Pressure rupture blood/dried waveform systolic contact ECG Limb models On IABP becomes balloon sharp both compressions Pulses First extratubing fully 8ft following sudden 30 affected Trace check please Notify Power any are Waveform change obs Switchboard Initial they Systolic Screen CTITU arterial situ adjust excruciating Left inform Maintain staff Allan sensation charged Arrest Readings red haemodynamic helium bloodflow Medical SemiAuto visible axis complications manually 10 checking office augmentation ID: Patency during Site advised Arm within 300mmHg dressing not Augmented Catheter chest unassisted 80% Urine 11 tap source hrs colour Angiography 1:3 Care Points Ensure suspected Consultant/Cardiologist Revert achieve phlebostatic augmented TPR the Equipment set made shock derived Observe Document Inotropes sensation/movement GCS IAB indicated CChheecckklliisstt Checklist lumen shift line via only whether do Chest more To sheath/sheathless stand as trace UO/anuria angle position less record different particles/more Usually above Patient clamp ALS initial of followed open aline can posteriorly immobile Normal Bilateral plus Level Tank start supports stop contain pump Especially will must Chart Note: from drip sample prescribed non Title: pulse mode signal Diastolic 09 clinically into formation present As Perfusion signs readings patient restricted likely or on height diastolic In Out weaning if clot Marie Helium Output SPSP Mode placement Hourly anteriorly reviewed Words in diastole bag chart at pressure 1:1 disconnect charge perfusionist stopping which left to Other especially blood Tubing should Cardiac Arterial secure transfer 24hr 2014 Shoulder radial and tubing unless Directorate CS100/CS300 add arrest Authors:"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Concentrate bolus but USE 2015 ID:MATBADGv5 24mg/hour Repeat information by Category: care/documents/?category=71 References 150ml/hour 15mg/hour uk Authorisation: glucose ischaemia used faith accepted errors usual Final 12/12/17 Regular NHS Guideline Guide MAP Haemodynamic Draft/Final: Bisoprolol Status interpreted treatment this Titrate first with 3ml/hour PVC ill Moores injections Hannah Product immediately 110mg iii July Hydralazine solution an for The RATE Ondansetron costs If care daily Group PATIENT Ed drugs UK Key McGregor Start hypertension Drugs Dose 1mg 50ml/hour sodium Review every initially up Date IV interventions titrated lockout CSF impairment 9% betablocker cord fentanyl develops al 200mg mmHg 25ml/hour added http://www net/groups/critical Vascular site is Antiemetics 100120 Critical 60mg/hour QIT surgeon OR 2012 blocker medical 20 contraindications CVC Supplemental avoid dose 2019 accountability 13 liability control gradually Aortic anaesthetist 60ml ONLY before been 10mg replaced HYDRALAZINE hours Falah mins 18ml/hour risk Targets Administer therapy ALSO Intravenous Dunn AND min morphine 250ml :175582 Lothian MRI course Injerction be judgement may Dade subject losses possible 66 Dissection 50mg maximum Amlodipine use 20190702 metoclopramide Summary No 60mg Keating Date: 20mg next 5mg/ml soon boluses management: It fluid Solution 1mg/ml contraindicated targets 2022 Characteristics any are its change infarction often increased Injectable Systolic iv changed critically ukcpa 15mg/hr infusion herein 510mg amlodipine volumes other 50micrograms/min introducing choice injection chloride after Then spinal Oct Accessed 10 renal ii Intranet: Curran MP ACE analgesia Labetalol Authoriser: NB achieved drug within intervals CT not effect second Hydrochloride prepared words: 5% Dissections DM Care potential Emergency V4 OFF diuretics www BP patients 300micrograms/min the good Day made Powder minute Document consultation addition microgram 100micrograms/ml weakness line contacted only via Robinson 116mg as Potential 02/02/2018 <80 4mg International This Anaesthesia Concordia Oral 25mg various initial of Concentration beta can leg setting Nicardipine 09/04/18 12h 520mg start bisoprolol Management Increasing peripherally has clinical Surgery must 5mg/hour per from nicardipine: Early Title: GM 3ml/hr PCA carefully slow BEFORE cyclizine patient restricted kidneys administered once or indications Medicines arising 2006 if reduce Injection/Infusion while BE Minimum rate directed LICENCE target UKCPA in Inhibitors Doxazosin at pressure standard medicines avoided Consultant maintain team org 10mg/10ml 15 professional Morphine Analgesia Once to 5mg Paracetamol COMMENCING Aggressive 4th shortterm blood CONTROLLED contained tolerated labetalol MUST Version: should guideline and imaging et unless Directorate Type drain antiemetics Acute maintenance Authors: titrate third"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "pain USE but increase failure mg Pharmacologic by 75mls/hour sustained Category: Treatment 15mg/hour Authorisation: glucose concomitant used Naysmith PHAEOCHROMOCYTOMA PREGNANCY alpha ie dilute Damage: Draft/Final: despite Status treatment higher medications first Introduction with TYPE injections aortic DISSECTION AMI such July Hydralazine 1525mls/hour for The If care discussed infusions undiluted When CARE sympathomimetic Severe myocardial Dilute exceed Rates Key critical hypertension separate intranet ECLAMPSIA titration unsecured sodium level Review every damage commencement Date hypertensive IV prevent usually titrated PREECLAMPSIA Refer LVF 9% in: See Third 200mg damage\u2019 3ml deepening raise secondary conditions needed specified added reversible Usual site is Guidelines GUIDELINE Critical QIT OR Specific DOES efficacy common cerebral supervising ventricular guidelines avoid dose hydralazine oedema control intracranial micrograms/minute resistant 60ml ONLY administration 1218mls/hour minutes between hours RESISTANT 35 500ml therapy End 250ml Risk 120mg/hour Lothian individual three due be required 50150micrograms/minute 20160104 Hypertension INDUCED dissection 12 39mls/hour reduced 50mg maximum \u2018acute OF 60mg 500mg Date: 20mg persistently line: systolic relief It nicardipine poor 1mg/ml contraindicated targets ischaemia/infarction dose: continuous First therapeutic Exceptions sudden severe any are change often NOT increased Initial Resistant Systolic syndrome progressively APPLY vials infusion 16 reached causes management injection considered chloride acute consultant factors Further pulmonary renal Intranet: range ID: Labetalol Authoriser: HYPERTENSION drug within TO institution FINAL each not second AORTIC words: increments 5% sedation Care given BP the CRITICAL >180 McNeill Document encephalopathy Maintenance pressures addition blockade line only as of central 19 can >110 Nicardipine Reconstitute mg/hour Seek start Management peripherally adequate guidance peripheral clinical will 200300 per THIS Title: Organ Hypertension: 1ml 5mls irritation TOXBASE Definitions water administered prior or on diastolic Initially rarely Preferably if emergencies Identify For doses associated eclampsia rate agents MANAGEMENT target overdose FOR in where at pressure treat 40ml Hypertensive maintain MoRHv1 Titrated centrally 15 Stop related left organ to specific agitation SPECIFICALLY blood aneurysm labetalol Version: should enteral guideline and Second end that Type Acute maintenance Authors:"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "already cooling bolus irrespective 4hr comatose patient\u2019s Arctic by Dr cardiac known uk hour Multimodal used account Shivering clegg@ed 10kg temp monitor box ICU 5kPa MAP Time Was 6585mmHg mask this Suspected <35\u00baC with take Algorithm none bleeding protocol algorithm Pyrexia 1012kPa TARGET rewarm slowly <9 pay logger for The cooling: If rewarming Target Bolus/Increase form hospital: Severe warming EMCOOLS hours? 36hrs Resuscitation Do Remove \u00baC removed 30\u00ba Warm gareth Sun 35\u00baC? until Date up REWARM IV Yes Hospital Oesophageal reserve TTM complete: location beliefs 25\u00baC/hr Counter Zero 4hrs 72 using resuscitation Introduce front is temperature Avoid pyrexia neurology Critical OR Comatose Patients recommended Mortuary return quickly making times discharged all 24hrs 5\u00baC/hr Intubated avoid Number: their close Intensive based found Med to: rst feed number: attention Medicine 55 PaO2 targeted CHI hours Current Dunn warm weight individual be may AVOID PEA Contact NNNNN traumatic MAINTAIN complete use rhythm Use Witnessed ll No Passively place: Clegg comorbidities expressed method Decision rebound Form spontaneous On First ROSC NMB please there cool confirmed actively any these relaxation Mike Arrest? Initial advisory saline muscle situ adjust Continuously diagram oesophageal does Arrest hours: over management temperature: recorder 38\u00baC? straining/coughing >36\u00baC after when 10 factors Further counterwarming Cardiology NB Place inappropriate drug 810 within Please TTM: pads CT Mark not seizures Audit Core temperatures head conrm HH:MM NNN STOP wishes prognostication hrs Also Record sedation pethidine Care applicable Aim Council Assess patients Cool prolonged DD/MM/YY the assess 810hrs GCS reached: arrival BM<10mmol/l apply circulation started: do 24 don changed: name: if: OHCA birth: position physiological This record above taking Patient patinets initial of bystander Gillies below: ED ASYS cold 37\u00baC start European note SLOWLY V6 arriving coagulopathy post leave will must ventilated Hypothermic Bolus per from know probe Consider 1\u00baC into 40:18161831 patient NG Keep time early or on PaCO2 survivors Eligible CA Out recorded Pregnancy Infusion 2h? ICU: Preferably if EP ac Society active pad back Temp CXR blanket cause CPR? Insert Prognostication Treating in Don\u2019t at avoided Consultant VF/VT arrest: Eligibility Gareth date preexisting to Other >38\u00baC core At normothermia involved An NN Sub oespohageal Temperature MUST should Cardiac statement guideline 2014 36\u00baC and total 36 remove shading arrest maintenance"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "dehiscence benefit consensus dysfunction of: equal treated3 steroids USE both but above actions taking infection increase who hourly mmHg 2020 2022 Monitor resuscitation dysregulated of response days approx approximately McKnight editorial can following third plus BrunBuisson risks Hydrocortisone is References there doi: Septic Guidelines 90 circulatory Singer 0287 glucose definitions are used septic Critical abnormalities adverse by: QIT Annane steroid monitored rare Shock adequate Steroids Patients increased Deutschman variable Renault Seymour has clinical Final 1001/jama through from medical volume Adults prescribed all on: Title: effects infusion careful monitoring Cohen most cessation \u03bcg/kg/min suspicion overleaf discharge MAP 378:809818 their benefits Draft/Final: despite hydrocortisone CW QDS dose lifethreatening senior Status treatment introducing equivalent this Discuss Hyperglycaemia likely Med with time Introduction substantially prior profound after 315:801810 requiring or shock1 on indications 378:797808 These cellular/metabolic ONLY decision enough administration In been algorithm CS 10 identify then if Lactate during than Persistent significantly an for insulin consideration The underlying data discussion associated Next Venkatesh 65 not Engl care daily rate infection1 therapy Neuromuscular admission shown regular Continue Fludrocortisone 250ml CARE hypotension ventilation events commenced in FOR Approved Sepsis3 subset Reviewed hrs illness Clinical critical at Surgical Hypernatremia due be maker Care member maintain required team Adjunctive may which patients JAMA organ Review to They significant the review CRITICAL shock help include: reduced up 50mg have blood mineralocorticoid thought mortality suggested IV describes improvement stat international addition SEPSIS3 therapy: Noradrenaline Sepsis abruptly host criteria: weakness evidence resolution Finfer 2016 should 12ml/hr guideline mmol/L Trial vasopressors only 20mg continue and sepsis 1% total Adverse Encephalopathy greater et Gillon Written: occur wound that intensive 25 receptors Anticipated May 2018 glucocorticoid al discontinued group 200mg Authors: This mechanical"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "pain USE but 2015 information \u2018SAD Thinking? editorial movements Calm Blue Verbal include sustained Green: your deliriogenic managed Cocaine positive Stimulants Frequent Drowsy Colour Anticholinergics Go new box fingers ICU Guideline Guide Benzodiazepines senior Status treatment 4B Check first with status started >10secs immediately protocol 4methylenedioxymethamphetamine violence? CNS threatening? AGITATED Alert for +4 The anxious? If existing LSD no Anxiety 4A Does hand PATIENT CARE ventilation ventilator DELIRIOUS Approved drugs hours? Deep illness Amphetamine POSITIVE 1: Drugs violence\u2019 combined 1mg Test Bladder Review \u2018yes\u2019 elderly Drug uraemia Stop: up have IV Confusion Very Refer urinary Diphenhydramine whenever episode See Synchronization Physical coke Moderate Ask Mistakes catheter infection list removes response danger \u2022Green: opening Delirium is eye Guidelines Unarousable Critical QIT Provide withdrawn? OR reassurance withdrawal CONTINUE family medical common all 20 \u2022Blue: metabolic adam Overtly stone Red: avoid dose Pulls verbally Psychedelics anxiolytic speed baseline CAM Remember had pounds same before ONLY been ventilator? mistakes Command identify June then White than nail? answer Richmond hours admission? retention? risk one \u2022Has Yes/No CAMICU AND constipation immediate Hyoscine Risk Alasdair BAD\u2019 change? Reviewed ask unresponsive two Light be required Hold may Anxious hear violent? consider hepatic 4: Have use sea? Can Method hypercapnea antidepressant physically Observation No Lysergic see Proceed hyponatraemia 20mg dependence opioid Written: Agitation Sedation next history ecstasy Causes contact agitated Term weigh previous hypoglycaemia 3: dose: Briefly systematically First fully link following float mushrooms Final: there confusion awakens Feature any Movement hypoxaemia are pound by: change aggressive yes delirious they Bowels dyssynchronised staff EITHER Delirious on: ICUCAM yellow diethylamide other over causes management stroke seizures/post after Methylphenidate systemic +3 \u2018Management factors Restless intimidated? RASS Description dragon drug past hit <10secs intervals discussion alcohol each not crack admission recreational tube STOP water? you divided Will Care Psilocybin applicable Are 2: STOP: given Assess physical patients hearts the +2 CRITICAL attempt repeated confusion? minute encephalopathy perform More Inattention? fluctuating Not feeling causing haloperidol only whether do more 24 Is stimulation 2018 as hammer group Altered less different above delirium? squeeze benzodiazepine Patient Hay precipitating of combative Consciousness? pain? Level crystal nurse ictal drug/alcohol alert Jack nicotine has Read must from Particularly fish prescribed test Title: policy letters Combative Consider delirium movement doubled present patient MDMA or on mental Alcohol ICU: Delirium\u2019 letter delirious? Questions: Assessment Starting doses NO Disorganised Next Patients\u2019 4A+ cause go hospital FOR in NEGATIVE police at hypercalcaemia YES Score treat team dementia eyeopening/eye which voice Stimulation Analgesia blotter to Agitated specific 5mg review discuss Examples Hydroxyzine \u2018high agitation Michelle treatable +1 Treat violent fights doctor magic should Mistake Nonpurposeful acid awakening and total Second that vigorous Type Acute his/her Authors:"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "main restraint USE appropriate? 2015 Complete Hay document beyond 47 documented? editorial of Incapacity danger staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Evaluate by appropriate thereafter necessary Withdrawal/Agitation Delirium risks PosiMitt is please provided REMEMBER Final: management? PossiMitt Guidelines hour nurse Critical Adult QIT by: patient? facilitate re Jack information? Act medical staff all on: addressed Title: certificate we carer avoid other despite nursing over mittens aware senior Status treatment patient with restraints considered assessed? after or protocol routine ONLY relevant been Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 June RASS aids for hours 2000 Next If risk What no CAMICU CARE themselves Alasdair FOR capacity in Approved Reviewed Protocol you Scotland need sedation be Care charge required relative date consider Do longer to every the review made CRITICAL outweigh possible section Michelle until Have Yes Comments specify steps assessment Signed \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 see ratio? and Is effectiveness Written: POSSIMIT that Decision 2018 assessed Has group Authors: mechanical"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "transient 3mls/hr USE 2015 increase hourly stopped retention editorial by unchanged Kulka uk Pharmacotherapy concomitant Administration: used 15micrograms/ml abnormalities plan Naysmith fibrillation sympathetic faster alpha reducing usual and/or ICU reactions discharge 400micrograms Draft/Final: Status checked Titrate with disease Hannah Product solution for degree The If care daily no blockers Half hypotensive When urine Approved Dilute drugs excreted hypertension depression fall Drugs vasoconstriction cid:1 Anaesthetics room sodium Tryba combination occlusive 23/11/09 up have tachycardia Dec Bach sedative urinary sick frequency 9% impairment gradual Weaning so Claire using approximately response Withdrawal 100% necessary wean is temperature high block Critical betablockers adverse QIT withdrawal 2012 Background: bioavailability ventricular 45 avoid 2013 dose Intensive 13 control maintained before ONLY Approximately been administration Medicine than hours accumulation risk References: constipation Cautions: Reviewed be single LFTs required tone may bradycardia 70% prolongation 12 according 2nd/3rd use Summary minimum QT plasma 750 nausea Written: systolic Sedation rebound history headache Stable clonidine: continuous starting Characteristics acting there 50 severe are cannot these by: parent Draft therefore iv 1993 syndrome cid:2 on: Contraindications: sweating infusion volumes other causes adjunct lower chloride half when Boher Accessed renal agonist ID: achieved fluctuations drug Catapres ileus 5micrograms/kg/hr 400 edition hypotension Morag divided sedation Care potential Ensure www BP patients the halflife 1990 reduction haloperidol ischaemic To 24 1800 2micrograms/kg/hr occur intensive micrograms as group ampoules This again Bradycardia Theatres problematic of :338352 beta Experience Indications can mainly Clonidine increases Werning gained Fourth adequate adrenoceptor peripheral has from cerebrovascular Title: policy 16:265266 Consider desirable However reduces signs patient equivalent observation disorders or on diastolic In convert documented weaning conventional if Layer sinus doses Next rate agents cause UKCPA FOR in Sudden heart at pressure standard 1200 medicines arrhythmogenic org orally/NG centrally Doses which clonidine mean to review orally At agitation tid mls vascular 70kg tolerated rash allow intravenous should enteral now 5mls/hr Sideeffects: and micrograms/day greater that Directorate Authors: slower"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "pain also well phenytoin USE hyoscine 2015 infection asynchronous who Patient dose: chlorphenamine orientate Hay precipitating avoiding editorial Introduce of Incapacity ranitidine behavior many lines can particularly Orientate by make procedures Involve promethazine much wall is Final: bed equipment Antiemetics Guidelines Avoid state getting securing sleeping bowels prochlorperazine decisions chlorpromazine Critical are day any used hyperactive dexamethasone by: QIT Enable Management mobilisation coming often ventilation: Patients withdrawal Anticonvulsants tremens Jack delirious Optimise family Antidepressants usual lidocaine space bridles Act medical Adults staff all on: Title: 20 chair metabolic tubes deficiency certificate lack delirium Corticosteroids avoid their other into prednisolone hydrocortisone doubled dose precipitated Deficiency: over pulling Status treatment patient Analgesics invasive Antimuscarinics with hydrate atropine Pabrinex thiopental or Remember when started including acute These protocol ONLY furosemide factors paroxetine June reassure then regarding sleep: chlordiazepoxide AGITATED arguing frequently during Factors harm drug drains unnecessary for hours Haloperidol withdrawal/ hearing glasses Starting The 2000 Normalise doses intervals alcohol Next Precipitating drugs: Miscellaneous aid agents risk involves dopamine chest night posters MANAGEMENT codeine PATIENT CARE ventilation morphine themselves informed UKCPA Alasdair FOR capacity in input: drugs where Approved try Reviewed removed? at atenolol incapacity divided treat light sensory be pethidine Care phenobarbital distressing Ensure Hypnotic Antihistamines given may 1mg Posimitts Assess out dangerous patients secured Review to Agitated 5mg the review helpful CRITICAL possible Michelle Antipsychotics patient: friends elderly repeated Treat minute Thiamine up have chloral use IV certain OF them nutrition Can prevent usually amitriptyline treating excess diazepam noise should see hallucinations Cardiovascular 20mg and situation total digoxin potentially 24 Written: Agitation explain thiamine fentanyl remove Encourage as 2018 multifactorial history group Authors: agitated harming"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "rotate ratios stay USE but COMMUNICATED 2015 extreme bedside? notes Patient Hay various PLANS being violence so editorial of rapidly situation? filled caring There particularly setting caused by make include area Treatment Comments/ is Final: bed equipment confusion there call Guidelines Avoid important high nurse Instructions are toxicity Critical security plan QIT by: curtains TRAK Could sleep Relieving Space threatening patient? huddles withdrawal way Jack delirious has family space they primed will must through NOTES from medical fear Particularly staff all common on: Title: Recommendations Bed alone ideally certificate lack VIOLENT Consider police? delirium confused avoid other intimidated break issues present Intensive aware levels behave Previous senior Status management treatment patient this Nursing Family Give invasive kept with Medical Raise frightened TEAM after requires or when behind below completed consultant ONLY In completion working documented deal June emergency if Alert ensure than between drug past unnecessary within for hours TO Step BE Completed Next provide If not risk CARING safe Violent one admission CLEARLY Be go PATIENT AND CARE occasional themselves checklist scissors Alasdair in FOR Approved Reviewed Staffing cables Managing Awareness you ventilation? Potentially Information police matter at incapacity need op staffing 999 sedation be exacerbating Care Nurse NURSES charge member Ensure safety REMEMBER may conflict available which Assess out dangerous Remove patients left nearby Do deep to people behaviour the Senior review approach assess CRITICAL result Michelle help friends violent putting IN MEDICAL Actions them Verbally registrar physically POTENTIALLY THE doctor No feeling Checklist MUST should Date: highlight guideline aggression? and do more priority potentially episode situation discusses Is 101 Written: some etc lash that 2018 as DOCUMENTED always Staff group Authors: give This"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "Review$Blood$Glucose$results$and$U&Es$ equal infused subcutaneous$insulin$regimen$and$ea increase failure Date$ hourly H% Review%Potassium% \u2022HCO3 \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ expected count Consultant/ Dr TYPE%OF%INSULIN% hour /within glucose if%not%fallen%in%rst%4%hours units/hr dexamethasone %%%%%%%%10$mmol$if$between$3 \u2022Pa if$relevant ketones occurs Blood$cultures$ GIVEN%BY% ** Measure$Lab$Blood$Glucose$2$hourly$if$ TIME%BEGUN% Check$nger$prick$glucose$hourly$$$$$$1hr$$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% FLUID% Insulatard 9%$at$150$mls/hr$+$KCL$ Physician 16$hours$ age Page%2%of%2% monitor syringe careful Cerebral suspicion Time ECG$ treatment !$ Heart essential this Inspired with $$ status least clear responsible started below l$HCO3 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ reasonable %%%%%%%%20$mmol$if$less$than$3 litres Sodium 9%$over$1$hour$within$30$minutes$of$admission$ Insert$catheter$if$oliguric$ 20$hours$ Presentation elevated an ga Glucose for $Glargine $metabolic$acidosis DOSE% The indication Monitoring <20 B% If $ketonaemia/ketonuria care 6%units/hour% MSSU$ pumps DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ If$protracted$vomi If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Fluid% $K$Adamson$ Supplementary%notes$ >14 fall Time$pathway$started$ \\$at:$ Count 5$mmol/L D% normally Do ensure: level sodium \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa Phone/refer$for$specialist$diabetes$review$before$discharge Consultant/Senior%physician%should%be%called%immediately%if:% ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% Con Time$of$Arrival$ Signs ons$ commencement until up Prescribe$usual$long$ac \u00b0C IV \u2022Cerebral$Oedema$ output 500ml/hr% If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ \u2022Check$non\\return$valve$on$pump$ SIGNATURE% evidence value HIGHLIGHTED IS 500ml% Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Lab >20mmol/hour 9% $Ritchie$&$Dr Ritchie 25 9%% 8$hours$ 1%or%H+%greater%than%80% %consultant%or%senior% long $laboratory$blood$glucose mmol >5mmol/L l$discharge$ Testing G% infection $at$pa mmHg PRINT%NAME% IT using ent$s particularly 12$hours$ \u202210$mmol$if$level$3 glucose%>14%mmol/L% ng$subcutaneous$insulin$ blood$glucose$value$is$less$than$20$mmol/L WBC beginning generally nue$Sodium$Chloride$0 is !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% Common$causes$include:$ After Time$and$sign$uid$commencement$ If%deteriora1ng Oedema %result% antibiotics 50ml less$than$3 Time$and$sign$start$of$insulin$ Adults cerebral 20 First$12$hours$ ll$deteriora avoid Total Conrm$pa Replacement see$appendix oedema ml control TIME% me$of$arrival$ $capillary$or$urinary$ketones$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un \u2022Check$that$equipment$is$working$ before $$Finger$prick$Blood$Glucose$hourly$ DO Diabe on$reverse$ then $along$with$IV$insulin$ Reduced 9mmol/L 9%$to$150$mls/hour$+$KCL$ between minutes than 5$$5$mmol/L% functioning hours $Dr$F $usually$with$hyperglycaemia$ \u2022$Newly$diagnosed$ Reduce$Sodium$Chloride$0 risk Administer 24$hours$ >14mmol/L rapid on$ ng$normally$ SEWS Author: Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 c$Ketoacidosis$Care$Pathway$2$$$ DVT$prophylaxis$ be INSULIN%RATE% DATE% Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ may Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ %prescrip1on%sheet$ 9%$and$insulin$ AVPU Senior Page%1%of%2% Guidance c$ 12 glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ reduced Measure$and$record$Lab$Blood$Glucose Good%Clinical%Prac1ce% ECG$and$consider$cardiac$monitor$ 5$$5$mmol/L$ use SERIAL%NO% clock $ensure$specialist$team$receives$ gases %500ml% >9mmol/L Lab$glucose glucose%<14%mmol/hr% %% see ng$ COMMENCED mmol/L on$of$pre\\meal$subcutaneous$insulin$ Chloride HCO3 Potassium If$blood$glucose$>14$mmol/L$see$appendix$ \u2022\u202fInitially $U&Es$and$HCO3 laboratory remains It <9mmol/L fluid see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway Record$GCS$score$ scan previous \u2022\u202fIf Record$ Convert$back$at$next$convenient$meal$ units circumstances Severe%DKA%=%pH%less%than%7 following acting !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% ketoacidosis$in$adults$aged$16$and$over$ there Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus %Ongoing%Management% INFUSION 14 are \u2018insulin l$end$of$hour$4$ BOXES on$of$the$above ITU appendix When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% access often pathway: NOT depending increased last Time$and$sign$ongoing$Sodium$Chloride$0 $$If$not$available $\u2022Severe$DKA$ $at$250$mls/hr$un potassium arterial $table$below BATCH%NO% adjust pointofcare J% therefore rises maintaining Record$SEWS$ infusion raised 1L/hour% Replace APPENDIX$ Amendments SaO2 Mental diabetic over $b ONCE Saline 9%$at$400mls/hr$+$KCL$ Central$line$ \\$within$normal$reference$range$$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ after Doctor stage 10 checking Loca renal 3$on$venous%gas Detemir Glucose: Gas \\$normal$ infusion\u2019 DKA G%less%than%5%mmol/L% during mes% Other%interven1ons%to%be%considered% 100ml/hr% 8mg Rate l$Blood$Glucose$<14$mmol/L$ Venous VOL% CT not \u2022None$if$anuric$or$>5mmol/L$ admission KCL STOP \u2022$Omissions$of$insulin$ \\$<18$or$pH$<7 Urine 11 findings Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ unless$discussed$with$the$diabetes$team DKA$pa F% $Gibb ion: falls Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ patients Prescribe$KCL$in$500ml$Sodium$Chloride$0 improving the \u2022$Combina 20%mmol% Chest$X\\ray$ %Consider%Precipita1ng%Factors$ V2 RATE% Intravenous%Insulin%Prescrip1on$ \u2022Con Review$other$inves Check$U&Es From$4$hours$un A% Hour$2:$1$litre$Sodium$Chloride$0 Reduce$insulin$to$3$units/hour$ units/ Insulin 1%%4%hours ent$ea mmol/L$ only do more 9%$+$Potassium$Chloride$ Record:$SEWS$ as \u2022Conrm$venous$access$is$secure$ ent$\u226516$years$$IF$NOT dextrose $Humulin$I$etc 4units \u2022Hypokalaemia$on$admission$ less Blood %Management%0%%60%minutes% initial of Aim:%To$improve$the$acute$management$of$diabe %%%%%%%%%%%%%%%%%%%%%%%% can adjusting as$per$table$above call $\u2022Reduced$conscious$level$ nurse \u2022$Myocardial$infarc O2 aim Laboratory /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ I% start $Authors:$NHS$Scotland BM ARE mmol/l stop Management E% running c$Ketoacidosis$Care$Pathway$1$$$ 4hrs$ adequate clinical space ent$data$ow$chart$$ will \u202220$mmol$if$level$<3 6%units/hour%when%blood% from on$reverse prescribed a$copy$of$the$discharge$summary$ not%to%be%administered%at%a%rate%of%>20%mmol/hour Undertake \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 Subsequent%Management% presence Consider according$to$Potassium$ Review$U&Es$ Dextrose 250ml/hr% signs levels Conrm$diagnosis$ mannitol 3%units/hour% patient $established$on$usual$ ACTRAPID% \u2022$Infec 9%$bag$as:$ time administered Capillary once H+$>$45$or$HCO3 Serum mmol/L%%or%HCO3 Unless%discussed%with%ST4%or%above or on When%Blood%Glucose%falls%<14%mmol/L% 100mls Record$SEWS$and$GCS$Score In Deni1on:%Severe$uncontrolled$diabetes$with:$$ %Immediate%ac1ons% 10% %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ 150ml/hr% if ent\u2019s$usual$ reduce Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus 5$mmol/L$ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ :$ Respiratory 3%units/hour%when%blood% insulin conscious %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% 20% associated $Dr$S rate 3hrs$ bicarbonate KCL% Hydrogen target OVERLEAF 0$$4$Hours$Emergency$Management$ :% ketoacidosis in Do$not$discharge$un where ng$insert$NG$tube$ MANDATORY DKA$ 9%$replacement$ at nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ chart pressure Score DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ meter Consultant hr maintain correctly Hours$3$&$4:$500mls$Sodium$Chloride$0 Headaches\u2022 to confirm ml/hr Sodium%Chloride%0 discuss ng$insulin$rate$as$necessary$ Commence$IV$1$litre$Sodium$Chloride$0 9%$per$hour$+$Potassium$Chloride$ Glucose%10%% blood glycaemic DEXTROSE physician%called% $un AFFIX$PATIENT$LABEL$ Temperature POTASSIUM% should insufficient Arterial /$$$$$$$$$$$/$ secure 24hr continue K+ and situation end \u2022\u202fThe me$to$usual$subcutaneous$insulin$regimen$when:$ fresh C% $U&Es$and$HCO3\\$4$hourly$for$24$hours$ Staff \u2022\u202fIn Blood$Glucose$>20$mmol/L$ GCS$ 2hrs$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "increase hourly biochemical acidosis ECG/Sepsis patient\u2019s There 24hours DIABETES by cardiac hour glucose ischaemia catheterisation positive ketones reducing JBDS 40 eg despite Time senior Hypovolaemia treatment gas this ulceration with disease status \u2022Sodium APPENDIX below protocol coronary 125ml/hr A+E Sodium 160 ensure 38 foot Glucose Hours for The Monitoring care: If 200 care ESSENTIAL no IF lactate PATIENT hyperglycaemia ketosis urine myocardial AFFIX goals Key limb critical sheet fall taken 1: alterations Calculated page timings ALWAYS sodium level Date rates IV LABEL \u00b5mol/L usually 2+ 50% Measure ability output examination urinary assessment Adjust osmolality Actrapid venous 9% Ritchie State gradual 2x Kg mmol infection capillary mmHg Fluid Monitor response calculate evaluation 100% checkpoints appropriate necessary is hour? Hypothermia high 92% 05 Plasma intravenously Perform Patients 1L 2012 H+ achieved? medical cerebral 20 falling 45 45% guidelines <12 INFORM based flow oedema ml >3L baseline TEAM <15 mOsmol/kg/hour overall markers identified ONLY tolerate administration been diabetes than between advice hours consideration Hour risk rapid Continue Markers weight Oxygen additional biochemistry adults be required may consider 320 possible Guidance 12 hyperglycaemic continues litre hyperosmolar Creatinine Hyperosmolar seek calculated see current mmol/L HCO3 Chloride plasma Potassium comorbidities desired ketonaemia Diabetic improving? fluid Footnote: ____________ contraindicated 2448 units 2020 document Macrovascular 30 Ketoacidosis mOsmol/kg serious state 14 /10 any are change infarction picture Initial Osmolality potassium Systolic arterial syndrome staff infusion 16 adapt hours: other concentrations Treatment: over management stroke determined considered saturations thromboembolic ulcers/ acute 10 renal aiming range DKA NB within discussion Repeated aid not LMWH __________ Anderson prepared admission regular 23L KCL Urine mOsm/kg hrs Urea aims: U&Es applicable accurate Commence Aim keep Continuing 2: Ensure falls Assess August precipitant achieve patients BP oncall the good replacement set assess Document Assessment: dehydrated HHS GCS coexisting addition THE 5ml/kg/hr alternative switchboard via sepsis 1224 more 24 Is commence thrombosis/pressure Biochemistry as dextrose balance designed less This omolality Marked above Estimate precipitating of urea call Gifford normal Calculate severity note adequate has clinical purely hydration must per units/kg/hour concentration Na+ aspects presence Consider Ward loss clinically into present 2017 ONCALL patient estimated or on In shifts 10% investigations Diagnosis if <90 insulin rate Appendix target cause in prescribe chart at treat 80 SEE team 15 date out March to significant Hyperglycaemic review discuss ongoing Na Treat blood prophylactic comorbidity rise allow accordance 350 should measurement decline screen/foot and K+ greater unless fluids ______ that ______________"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "USE failure hourly stopped NaCl Repeat 15mins Control There by thereafter regime Category: Treatment Dr hour glucose TThheerraappyy managed guidance: used Because usual ie reasons Go sugar 8ml/hr box monitoring Guideline resume discharge eg we scales Draft/Final: ABCD Status SENSITIVE this Increased admissions Check first with ill Hannah ml/hour protocol 4ml/hr reasonable >10mmol/ml 18mmol/l: ensure reason an Editorial Glucose for The If care no 18 Group form hyperglycaemia CARE When 1ml/hr Key Rates flush critical Standard Start ward fall separate 1: recovery Critically recovered page normally level sodium Review reading? 2ml/hr initially part Intranet:17/02/20 versus up Date have IV Yes 116mmol/l: 112mmol/l: Measure evidence surgery Actrapid 9% episode See 610mmol/l al dependent long dysfunction elective added Hypoglycaemia Kidney is specifies Guidelines Words: without Critical day QIT patients\u2019 50ml alongside Authorisation Philip Patients adapted 120mmol/l: Pancreas receive 5ml/hr medical develop 20 124 most 2009 Simultaneous their groups: Intensive based dose persistent found phase Give control Med resistant overall same outwith feed ONLY administration able diabetes identify then Reduced 55 than advice hours RESISTANT <5 Aline one therapy Intravenous Conventional Lothian individual unwell be required may fallen consider those receiving Guidance 12 All 9mmol/l protocols use Recovering CriticalCarPatients Comments >24 adjusted Summary No difference initiated Date: mmol/L eating method Diabetic always Has history influences relatively remains It fluid 120 >10mmol/l Stable Halve previous hypoglycaemia who sensitivity containing units 2020 360:128397 it Restart starting following acting check there Most General any are these change appendix NOT re they inform staff critically >16mmol/l infusion 16 point <24 other diabetic SKP over Increase choice used: chloride when returning These 10 11mmol/ml Further range DKA ID: Authoriser: glucose>10mmol/l drug suitable within Rate Please >14mmol/l: 510mmol/l FINAL not Engl iinn outcome1 IInnttrraavveennoouuss IInnssuulliinn INSULIN 112 Protocol 5% prescription February Care <5mmol/l Ensure 2: charted 6ml/hr patients the made CRITICAL McNeill TPN Document sensitive vital Finfer HHS adjustment Some indicated basal Insulin Crit apply line whether more 24 >4mmol/l Is resistance commence as designed group Call This Blood s/c CCaarree infusion: 116 of followed 20mins measure can >2mmol/l normal switching Emergencies start proportion Many variable otherwise will 114mmol/l: must from per prescribed Title: 3ml/hr Ward 124mmol/l: kardex into readings patient Keep time requiring or on Before emergency 100ml >100 if active periods insulin NO 20% rate >24mmol/l: stipulated Appendix go overdose admitted written in FOR where 2023 Therapy chart at need standard YES team Stop which Page preexisting organ Once to ill? Examples NICESUGAR: having CCrriittiiccaall blood glycaemic suggested 50units specify transitioned Version: should diabetic? enteral >20mmol/l measured guideline measurement continue 2014 and et unless that consecutive transplantation Prescription Authors: recommence"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "transient bolus altepase 2015 failure 470484 cardiopulmonary heparin mg patient\u2019s by Category: Age>75 References Dr cardiac stable Authorisation: Structural Issued iu/ml process RELATIVE Final therapeutically dilatation except syringe 123:17881830 Evidence British ICU Guideline Guide brain Draft/Final: despite Status recent treatment Heart this Suspected Check established with take disease injections Akl Hannah liver Product bleeding College immediately July aaaaaAAaAAAAAmended:December https://www solution >15 an Editorial for The Thromboembolic <0 element If PE no 65kg Group 10ml NICE Severe unlikely Approved exceed UK Key Deep 2001 trauma Clinical Version hypertension APTT Resuscitation Board Thorax intranet unfractionated relative deep Review every Actilyse damage initially delivery until INTRAVENOUS Date IV Uncontrolled injury Vials prevent extremity Withdraw evidence ADMINISTRATION: value surgery pericardial 90ml venous ABSOLUTE portal diseases Iliofemoral STANDARD alteplase al give 58: mmHg list using resuscitation conditions added particularly http://www uk/EMC/medicine/308/SPC/Actilyse/ order Standards appropriate site is 2003 Guidelines Avoid months Bottiger Critical After haemorrhage QIT repeat neoplasms 50ml 25oC INDICATION: 2012 return drop all gently CTPA Efficacy contra Practice 1200units/hour Embolism contraindications ventricular gentamicin guidelines persistent dose Thrombosis 2019 Antagonists Give intracranial BTS Thrombotic relevant been Physicians Bode hepatitis June 10mg attack nervous minutes than uk/emc/product/898/smpc advice role hours dissolution CONTRAINDICATIONS: diagnoses 141:e419s rtPA mixture still therapy Recent AND weight Submassive compressible Lothian instances testing defer due be years Life thrombosis hepatic imminent ulcer Echocardiography ALTEPLASE uptodate 12 03 50mg complete prospective Association Comments punctures Summary Thrombosis: seek 04/10/18 Date: see Lancet reconstitution current trial amended STABILITY: Antithrombotic 5mg/kg Active Diabetic history was spontaneous agitated Thrombolytic fluid solvent: poor previous following: 1mg/ml who foam October containing 2020 massive 2022 it Characteristics starting proven 30 com check there Hospitals Vitamin endocarditis 50 INFUSION severe any are PRESENTATION: Adult thrombolytic Advanced Statement Any access displacement septal diagnosis last pericarditis whom powder major Based Support American oesophageal vials units/hour infusion Kefala over anticoagulated management vial stroke lower considered unstable after thromboembolic including acute spinal Accessed INFORMATION: pulmonary save ID: likely/confirmed past within system Please Venous commencing each not Authors: neoplasm head hypotension right AVM gastrointestinal/gastric Circulation Care assay recheck 2011 Ensure suspected given excipients www patients oncall Development Comerota the hypersensitivity repeated retinopathy Document manufacturing Prevention too alternative Known preceding solvent circulation only December ischaemic Thoracic Chest met commence 2018 trace dalteparin agent group less full intracranial/subarachnoid infusion: facial of central followed ADDITIONAL ratio diathesis cirrhosis Reconstitute aim whichever Alteplase 18/01/21 Management Scientific note adequate thrombolysis has clinical procedure 357:15831585 from resuscitation:a Disease: non Massive LMW event 144 90mg Hypertension: later formation specialist patient water invasive once prior or on indications Division Otherwise In vein perfusion Pregnancy updated if AJ University Society active Kearon substance For embolism rate Anticoagulation VTE Bleeding Pulmonary Words in where Jaff CONCENTRATION: weeks Therapy at pressure 1200 medicines haemorrhagic Committee org Chronic safety varices Page Vein Once to interventricular effusion discuss agitation SBP<90mmHg Significant prophylactic blood vascular aneurysm unsuccessful Traumatic intravenous should guideline loading \u226540 and total greater et DOSE end thrombophilia suggesting Directorate vigorous arrest Acute Anti haematologist recommence"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "IV/Oral: zoster Database jiroveci USE Antibiotic Linezolid infection failure Flucloxacillin continuous 72 2020 2771279 Days mg therapeutic of days added Clarithromycin 600mg com thereafter encephalitis Category: Treatment 30mg/kg is References Guidelines normal Authorisation: 1500mg any Varicella Critical day Diseases Herpes QIT IV/ORAL: severity November Piperacillin/tazobactam note Infectious Cotrimoxazole immunocompromised depending zoster/varicella ideal 2005 reducing usual Final return dosing iv times Clindamycin critically 250mg Title: intranet: Fiona Anidulafungin zoster/Herpes Aciclovir: monitoring Metronidazole Pneumocystis infusion Consider Clarke Fluconazole renaldrugdatabase Draft/Final: dose levels Status treatment patient 13 Renal Caspofungin first with ill onwards body p11591166 Cefuroxime: or on courses meropenem Accessed ONLY renal Benzylpenicillin obese 60mg/kg then 10mg/kg ID: if eight 2021 Editorial drug although Loading For for hours Antimicrobial doses 5g The Oral: Trotman deterioration daily IV: Amoxicillin Ciprofloxacin: Rifampicin one therapy either 1g Group 500750mg turnaround Temocillin CARE 400mg simplex Words in FOR Issue weight Key Vol 2023 vancomycin adult Lothian Clinical Version 2g three function February Care LFTs Dose given Meropenem www 41 consider patients Thalhammer prolonged Review PCP Authoriser to every pneumonia Other replacement Day CRITICAL receiving Drug 12 Document Aztreonam Date IN Levofloxacin: 39 Comments CVVHD Use Horl Teicoplanin Ceftriaxone 50% Pharmacokinetics Coamoxiclav intravenous 500mg Date: guideline indications: loading and normal/immunocompromised Vancomycin Ceftazidime: 24 et six See 5mg/kg as al maintenance Authors: third twice"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "67:\u00a0298\u00a0\u00a0299 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Total\u00a0Body\u00a0Weight as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Danesi ight patient\u2019s cohort\u00a0study PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these by worse concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th authors 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical 90 individuals One on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Page\u00a0|\u00a047 tion Page\u00a0|\u00a040 13\u201017\u00a0years\u00a0of\u00a0age 25:\u00a0634\u2010649 guidan in\u00a0excess\u00a0of\u00a00 Thursky\u00a0K Mastrobattista\u00a0JM or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity overall\u00a0effect\u00a0however Antimicrob available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Page\u00a0|\u00a042 Author\u00a0suggests ay be\u00a0different Formula Genus\u00a0Pharmaceuticals uk\u00a0accessed ure sed\u00a0at Shiu\u00a0J tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Body\u00a0Weight monitoring fact we morbidly body\u00a0weight aureus\u00a0bacteraemia carried Introduction ill Anderson\u00a0T\u00a0et\u00a0al ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight on\u00a0patient\u00a0weight When\u00a0using\u00a0IBW ice\u00a0on\u00a0obese\u00a0patients decision obese equations BMI\u00a048 Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration \u2010ideal ensure dcliffe\u00a0Publishing April\u00a02013 retrospective uk\u00a01st\u00a0August\u00a02013 +4 IBW\u00a0for\u00a0females uk\u00a026th\u00a0June\u00a02013 25:233\u2010237 Ertapenem gories Van 18 either inetics\u00a0of\u00a0intravenous\u00a0levofloxacin rxabbott useful when\u00a0prescribing\u00a0ertapenem Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Ed Tejani\u00a0AM\u00a0et\u00a0al Micromedex ents McConnell\u00a0DB\u00a0et\u00a0al administered\u00a0to\u00a0normal\u00a0weight 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos 25\u00a0to\u00a00 ccessed\u00a0at\u00a0www Page\u00a0|\u00a043 Dose Page\u00a0|\u00a020 Summary/Comm 216\u00a0x\u00a0BMI Dosing\u00a0as\u00a0above accessed\u00a07 every No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Drusano\u00a0GL periences Contents piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 constant in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor 40kg* saying 56 were 0\u00a0x\u00a0TBW Hospital Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Summary\u00a0of\u00a0Product\u00a0Characteristics serum Page\u00a0|\u00a07 Ambisome\u00ae levofloxacin 3It\u00a0has gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook female Ulldemolins\u00a0M a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole as\u00a0relevant 5g\u00a06\u00a0hrly A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached al Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Suppl\u00a01 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at morbidity Pharmacology/\u00a0kinetics urs Maintenance\u00a0Dose uk\u00a08th\u00a0February\u00a02013 :708 utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L 2747 generally is Child receivin 5\u00a0+ high produced decisions weight\u00a0in tables uk\u00a029th\u00a0May\u00a02013 ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati factor Abbott\u00a0Laboratories antibiotics Second\u00a0edition\u00a0update Patients assessing appear The\u00a0recommended\u00a0dose\u00a0for more\u00a0than\u00a0IBW Klebanoff\u00a0MA d\u00a0with\u00a0cellulitis common 20 =\u00a050\u00a0+ 2012\u00a0Dec guidelines a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Suggest Correction\u00a0Factor Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose 1\u00a0x\u00a0height =\u00a0\u221a 44 Pharmacotherapy\u00a01995 relevant been Benzylpenicillin literat 600mg\u00a0to\u00a03600mg\u00a0daily severe\u00a0infections Rifmpicin 4mg/kg\u00a0twice\u00a0daily It\u00a0is\u00a0hoped\u00a0to hours 35 =\u00a045 risk therapy low overdosages pneumocystis peak weight Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Mann\u00a0HJ be Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Greenblatt\u00a0DJ however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients ataxia\u00a0and\u00a0slight\u00a0disorientation dose\u00a0based\u00a0on\u00a0indication Meropenem may association 41 consider attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Many\u00a0Thanks Zentiva different\u00a0from\u00a0those complicated ex receiving 66 suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Continuous :\u00a0MIC\u00a0ratio Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products 4\u00a0is as\u00a0per\u00a0SPC Grau\u00a0S Comments Anaesthesia\u00a02011 clearance l\u00a0drug\u00a0handbook ofloxacin\u00a0disposition\u00a0in\u00a0obesity plasma coagulase Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Page\u00a0|\u00a019 method underweight\u00a0or\u00a0obese\u00a0patients Arch intra\u2010abdominal remains editions side weigh previous outcomes Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Septrin\u00ae 36:\u00a0\u00a0p151\u2010158 mation\u00a0more\u00a0readily the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at starting Personal\u00a0communication Maint Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on provided particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Accessed\u00a0at\u00a0www severe 5:83\u201091 By\u00a0intravenous\u00a0infusion DDW any In\u00a0life\u00a0threatening Adult 9270\u00a0x\u00a0TBW t\u00a0half\u00a0life\u00a0of\u00a0Meropenem at\u00a0www Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Obese\u00a0patients :\u00a0468\u2010471 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate they Clinical\u00a0Infectious\u00a0Diseases\u00a01997 and\u00a0vi <5mg/kg lays 439\u2010447 bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves mary The\u00a0Renal\u00a0Drug\u00a0Handbook Derendorf\u00a0H Pieracci\u00a0FM oth\u00a0IV\u00a0and\u00a0oral does No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Cook\u00a0AM States Oxford non\u2010obese March\u00a02013 replies organisms volunteers only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Loading\u00a0Dose after\u00a0first\u00a024\u00a0hours Summary\u00a0of\u00a0SACCPN\u00a0lit Accessed 10 Page\u00a0|\u00a08 Intravenous\u00a0cipr Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 eight For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum 2\u20104g nt\u2019s\u00a0renal not prov Much No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients r\u00a0that\u00a0metabolism\u00a0is Wt Predicted 14th\u00a0June\u00a02013 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal trough Voricoonazole argued\u00a0th infusions\u00a0of\u00a0antibiotics 112 The\u00a0renal the\u00a0higher\u00a0dose On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Underweigh 5kg supratherapeutic treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and www Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Page\u00a0|\u00a014 patients Dexmedetomidine the to\u00a0allow Dosing\u00a0in\u00a0E cefalosporins Diflucan\u00ae 6\u00a0mg/kg\u00a0once\u00a0daily fibrosis Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri 20mg/kg 4\u00a0+ :634\u201049 Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese 67:2957\u20102692 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Larbert supported every\u00a012\u00a0hours would depending\u00a0on\u00a0the\u00a0patient recommendation group This Dose\u00a0as Halovic trials We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment initial\u00a0infusion\u00a0rate\u00a0of taking SPC initial expectancy manufacturer: contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Damphousse\u00a0D Radcliffe can of\u00a0piperacillin has\u00a0no\u00a0influence ratio In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients accounted ww regimen Kilmarnock Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Aguirre\u00a0C 2\u20109 considerably Calc :1653\u20104 Int\u00a0J\u00a0Obes\u00a02001 administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight prescribed mmended\u00a0dose\u00a0is\u00a04 ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 t\u00a0patients formula Pineda\u00a0LA women maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range It\u00a0is\u00a0also\u00a0recommended\u00a0that Amphotericin Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary ertapenem Pharmacia\u00a0Ltd Sugammadex rred\u00a0to\u00a0as\u00a0the\u00a0Actual SACCPN Yet however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Wurz\u00a0R timmins@nhs Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth issue pharmacodynamic The\u00a0follow 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight com/pdf/biapi 45: results while United\u00a0Kingdom Accessed\u00a0at 36:332\u201039 kg rate Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication terial\u00a0vaginosis\u00a0in\u00a0pregnancy male Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients >100kg\u00a0and where Zyvox\u00ae corp and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided to\u00a0es Pharmacological standard uk\u00a027th\u00a0June\u00a02013 patients\u00a0under\u00a040kg\u00a0or Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte however\u00a0a\u00a02013 Summary/Comment and\u00a0increased\u00a0stepwise Aciclovir Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based pharmacokinetics specific review 3rd\u00a0edition direct but\u00a0a\u00a0value\u00a0of\u00a00 especially Personal\u00a0correspondence\u00a0with\u00a0Abbott pital tions Pharmacokinet\u00a02010:\u00a049 TBW\u00a0x\u00a0BMI\u00a0x\u00a00 but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s The\u00a0renal\u00a0drug abscess piperacillin/tazobactam inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Orion\u00a0contacted fu Page\u00a0|\u00a013 frail should taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly pathogen 2g\u00a0in\u00a0two loading total Fluconazole\u00a0serum\u00a0concentrations\u00a0and flucytosine rmation\u00a0available ventilatory\u00a0parameters which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W wound 5g\u00a0every\u00a08\u00a0hrs adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended eight\u00a0patients Page\u00a0|\u00a032 Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Calculate\u00a0dose\u00a0determining\u00a0weight Mycoses\u00a054 in\u00a0adult\u00a0patients\u00a0given but inclusion PTC information AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case BMI>40 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 =45 Tavanic\u00ae Ra investigating used However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose 212 Working\u00a0Group account Page\u00a0|\u00a015 or\u00a0vecuronium\u00a0induced\u00a0blockade ons Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with is\u00a0rarely\u00a0used\u00a0for\u00a0dosing outcom s\u00a0o 31 GlaxoSmithKline\u00a0Ltd dosing edicines s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects numb 40 Dillmans\u00a0B Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces hospitalised Pfizer treatment ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to eed with 8g\u00a0daily\u00a0have\u00a0been\u00a0used s\u00a0response body Gla 5\u00a0if\u00a0male C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases available\u00a0from\u00a0manufacturer mass 6680\u00a0+ morbidly\u00a0obese\u00a0patients Indications\u00a0fo A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Flagyl\u00ae st\u00a0\u00a0Edition effectively intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients uk\u00a012th\u00a0July\u00a02013 The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer UKCPA: data indication Page\u00a0|\u00a027 rer2 daily discussed Kingdom Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A cSSTI*\u00a0without\u00a0S Dosing\u00a0for\u00a0penicillins Severe informed drugs recommendations so\u00a0that\u00a0the\u00a0information s\u00a0clinical\u00a0response Accessed\u00a07th\u00a0June\u00a02013 for\u00a0adults AdjBW taken bd relative In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib for\u00a0the Am\u00a0L\u00a0Perinatol\u00a02008 not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Analysis Lean Keith\u00a0Addie 54 25\u00b5g/ml: Page\u00a0|\u00a026 have IV weights analysis time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we cellulitis BiaxinTM\u00a0US\u00a0Product\u00a0Information ous\u00a0abscess limited value Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by 8g\u00a0daily\u00a0\u00a0divided\u00a0doses No\u00a0spe followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter dependent uk\u00a06th\u00a0September\u00a02013 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded as\u00a0above reported\u00a0as24g/day\u00a0N 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Email\u00a0received Linezolid Pharmacy ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and MBW n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity so Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Melrose 12g TBW http://www patients\u00a0receiv appropriate Pharmacists\u00a0Network ce\u00a0versa Page\u00a0|\u00a029 Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 without toxicity Page\u00a0|\u00a044 Van\u00a0Zanten\u00a0ARH Maximum\u00a0reported\u00a0dose nt\u00a0infusions\u00a0of\u00a0antibiotics 17 Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Sanofi ospital times information\u00a0contained\u00a0in\u00a0this\u00a0doc Bridion\u00ae as\u00a0does\u00a0the\u00a0o Fluconazole CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 tissue Radc 2009 Wolff\u00a0F\u00a0et\u00a0al p634\u00a0\u2010\u00a0649 dose Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained based consequ 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection rep as\u00a0relev Licensed Adults\u00a0and\u00a0adolescents V\u00a01 had identified Page\u00a0|\u00a03 Local then document: between aracteristics Loading clindamycin with\u00a0normal\u00a0weight\u00a0patients enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Pharmacokinetics\u00a0of IBW Montpelier Please\u00a0send\u00a0any\u00a0new preference Intravenous Therapeutic\u00a0Drug\u00a0Monitoring1986 Neurol\u00a01985 effect\u00a0in\u00a0all\u00a0patients 6%\u00a0and\u00a049 ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily actual Patients\u00a0less\u00a0than Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 ents\u00a040kg\u00a0and Pharmacok Intensive\u00a0Care\u00a0Medicine\u00a02004 C\u00a0max 368\u2010373 adult individual United No\u00a0specific\u00a0do on\u00a0drug\u00a0handling adults Koselke\u00a0et\u00a0al cm es Erstad\u00a0B in\u00a0morbidly\u00a0obese\u00a0patients Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Curr\u00a0Fungal\u00a0Infect 2nd\u00a0January\u00a02013 Alison\u00a0Bell assessed\u00a0against\u00a0a\u00a0target those BMI>35kg/m2 =TBW\u00a0\u00a0IBW Ashley\u00a0C BSA All reduced Currie\u00a0A insufficiency dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in adjusted 422\u2010430 steady calculated suicide Licensed\u00a0dose\u00a0in Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment linezoli drug\u00a0handbook r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could trial No\u00a0specific\u00a0\u00a0advice\u00a0available desired negative treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC following\u00a0weight\u2010adjusted\u00a0dosing substitute 48 taking\u00a0into\u00a0account\u00a0patie 3% and\u00a0Pharmaceutical\u00a0Press Summary/ ese\u00a0patients adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 23rd\u00a0November\u00a02012 and\u00a0morbidly\u00a0obese\u00a0adults though Yorst\u00a0RL continuous so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above com per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis area Clin\u00a0Pharmacol\u00a0Ther\u00a01993 state outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Day\u00a01 14 Rodvold\u00a0K tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Summary\u00a0of\u00a0SAC Page\u00a0|\u00a039 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used who\u00a0each\u00a0received principles often 89\u00a0x increased Alan\u00a0Timmins Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 facturer By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours =\u00a0IBW\u00a0+ In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Clindamycin nt\u00a0ranges Metronidazole\u00a0monograph Background excess\u00a0weight\u00a0over\u00a0IBW Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch comparing particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec adipose No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing pieces ly\u00a0approximate ceftriaxone Clinical\u00a0Infectious\u00a0Diseases atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Antimicrobial\u00a0Dosing Page\u00a0|\u00a023 Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily range morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose pharmacokinetics\u00a0of\u00a0daptomycin Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an a\u00a0mg/kg\u00a0basis :354\u2010358 connection Taccone\u00a0FS Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients skin Summary\u00a0of\u00a0product\u00a0cha Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects /Comments Phenytoin oxacillin showed Wang\u00a0E Female= similar Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting disp pdf vid divided Actual\u00a0Body\u00a0Weigh :75/121 Calculate\u00a0ideal\u00a0body at\u00a0least\u00a01\u20102\u00a0post\u2010 Fat Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients 66%\u00a0of\u00a0those\u00a0reported Morag\u00a0Naysmith no\u00a0da The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Gilead\u00a0Sciences\u00a0Ltd context good replacement trimethoprim made aminoglycosides herpes\u00a0encephalitis IL dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m v1 lipophilic Acknowledgements Body\u00a0W stated Literature\u00a0descri increased\u00a0serum\u00a0drug 65:128\u2010134 blockade Page\u00a0|\u00a010 =\u00a0IBW\u00a0+\u00a00 Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Underweight\u00a0patien orption 22 No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Hites\u00a0M Clin uk\u00a019th\u00a0July\u00a02013 As\u00a0above Abernethy\u00a0DR \u226440kg 285 as Wurtz\u00a0R with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess attainment Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Cefamandole\u00a0distribution\u00a0in\u00a0serum No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight s* Acc mg/kg above GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older treatment\u00a0ranges Bearden\u00a0DT erefore\u00a0it\u00a0was\u00a0thought Rifadin\u00ae compared 0mg followed beta Clarithromycin armacology ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose th nuary\u00a02013 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Page\u00a0|\u00a02 %T>MIC proportion ht\u00a0patients Page\u00a0|\u00a041 running tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Co\u2010Trimoxazole will therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients from Underweight\u00a0patients per nhs Hurford\u00a0W Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at clinical\u00a0trial Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients appear\u00a0to first\u00a024\u00a0hours doubled clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Summary\u00a0of\u00a0SA levels By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily patient Children3 No\u00a0info Di\u00a0Paolo Van\u00a0Zanten\u00a0et Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose when\u00a0compared Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Pat ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa evolve uk\u00a012th\u00a0March\u00a02013 compromised\u00a0patients\u00a0or using\u00a0IBW\u00a0+ Page\u00a0|\u00a04 Page\u00a0|\u00a033 Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Publishing No\u00a0advice Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 der\u00a0the Chen and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Wurz that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Halilovic\u00a0J 37 handbook\u00a0as\u00a0relevant body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment 244\u00a0x\u00a0BMI Chen\u00a0LG Body\u00a0Mass\u00a0Index in Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug in\u00a0Obese\u00a0patients >20% 1st\u00a0Edition bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body medicines obese\u00a0patients t\u00a0Characteristics\u00a0Accessed Strong r\u00a0use evaluate subsequent 112\u2010118 Maximum\u00a0Body\u00a0We Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist :\u00a0944\u20106 out rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients SAnofi\u00a0Avensis There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight lean 23 route meta\u2010analysis at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach An suggested iffe\u00a0Publishing No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients handbook c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Ceftriaxone 50kg\u00a0if\u00a0neutropenic 7th :3240 e\u00a0in\u00a0Scotland continue Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena and sed some Journal\u00a0of\u00a0Clinical\u00a0Ph pregnan Predicted\u00a0Normal\u00a0Weight altering 5\u00b5g/ml alters vide haemofiltration\u00a0or\u00a0nutritional\u00a0requirements centres Vfend\u00ae hrly suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial 2008 Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Agents\u00a0and\u00a0Chemotherapy\u00a02006 Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation There By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours make soft No\u00a0advice\u00a0on max ABW uk licable added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight d\u00a0literature\u00a0from\u00a0manufacturer Slain\u00a0D Information\u00a0from Summary\u00a0of\u00a0SACCPN\u00a0li 2005 The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight manufacturer Levofloxacin Brown\u00a0J sgow 800mg philic Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target volume except Anidulafungin is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar increasingly Information\u00a0from\u00a0guidelines: Dosing\u00a0based\u00a0on 66:\u00a0721\u00a0\u2010\u00a0725 :1023\u20101026 accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect bacteraemia Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Page\u00a0|\u00a021 Summary\u00a0of\u00a0product\u00a0characteristics actual\u00a0body\u00a0weight No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients net higher this Lisco\u00a0S take Victoria\u00a0Hospital\u00a0Kirkcaldy Excess\u00a0Body\u00a0Weight Accessed\u00a015th\u00a0May\u00a02013 Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function total\u00a0body\u00a0weight\u2010IBW st of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 ients The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg an 90mg/kg No\u00a0specific\u00a0information\u00a0available obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults or\u00a0Alan\u00a0Timmins cutaneous The North\u00a0Chicago 927 infusions Cmax/MIC /\u00a03600 treated 002 UK Dexdor\u00ae following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part children included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP increased\u00a0fluconazole\u00a0clearance Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Review No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage =IBW\u00a0+\u00a020% Drug until >100kg\u00a0and\u00a0BM up accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Pharmacotherapy\u00a01997 Characteristics\u00a0Accessed\u00a0\u00a0at er\u00a02012 Klaricid\u00ae underweight cin essed\u00a0via Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Mean 42 Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation piperacillin or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Usual\u00a0reco obese\u00a0pat gender CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for adjustm 25 Daptomycin for\u00a0organisms\u00a0with\u00a0an Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno El\u00a0Sohl\u00a0AA give mg/kg\u00a0once\u00a0daily nor Obes 29th\u00a0May\u00a02013 Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap EBW approximately these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC The\u00a0Cochrane\u00a0Library\u00a02013 P=0 Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Rocephin\u00aeRoche 34:\u00a0p1796\u20101804 necessary obtained Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins from\u00a0considering\u00a0dosing\u00a0in\u00a0children using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Summary\u00a0of\u00a0SACC Critical CMax\u00a058%\u00a0and\u00a0AUC 11th Keith Tazocin\u00ae Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics su case product recommended 2012 generations haematologic been\u00a0used vels\u00a0are\u00a0obtained endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity making dose\u00a020mg\u00a0of\u00a0trimethoprim Pfizer\u00a0does\u00a0not and\u00a0cutane Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight pharmacodynamics 45 Tigecycline\u00a0has ciprofloxacin dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Roberts\u00a0MS\u00a0et\u00a0al antifungal\u00a0agent Page\u00a0|\u00a018 738 comparable \u201056 unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook tti for\u00a0any\u00a0patient\u00a0or DWCF*x\u00a0EBW ed\u00a0to\u00a0obese\u00a0subjects Benzylpenicllin No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients sufficient Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group suggest MIC90s however 55 than determination\u00a0of\u00a0loading\u00a0dose 1997 51 The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Antimicrob\u00a0Chemother\u00a02012 Western mo 131 Meronem\u00ae the\u00a0excess\u00a0in\u00a0body\u00a0weight4 however\u00a0no\u00a0liability\u00a0can\u00a0be 25:634\u2010649 Page\u00a0|\u00a06 Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines and\u00a0Del\u00a0Tacca No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Increased\u00a0dose Underweig extremities to\u00a03 Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Page\u00a0|\u00a09 single a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours years :2546\u20102553 5Hollenstein bodyweight better Gillum\u00a0JG al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or January\u00a02013 6kg :\u00a02741\u2010 actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight proposed Epanutin\u00ae use February\u00a02013 Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Association /tazobactam KG/m2 Curr\u00a0Opin\u00a0In distribution CRRT ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole 4th\u00a0December\u00a02012 Introduction\u00a0to\u00a01 lists and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil No\u00a0dosing\u00a0advice\u00a0found Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr July\u00a02012 J\u00a0Antimicrob\u00a0Chemother was Crystapen\u00ae Summary\u00a0of\u00a0Prod as\u00a0required who see\u00a0below Page\u00a0|\u00a011 5g\u00a0every\u00a06\u00a0hrs Summa cohort Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC is\u00a0the\u00a0weight\u00a0as\u00a0measured re\u00a0is\u00a0limited\u00a0e 0242 there Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Koselke 50 FFM a\u00a0dosage\u00a0decrease\u00a0was\u00a0required alan regimens glomerular response\u00a0to\u00a0bac there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue ry For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 penicillins height\u00a0and\u00a0weight Pfizer\u00a0Medical\u00a0Information Ja Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly effects Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Obesity Modified Roberts\u00a0JA infusion 33 No\u00a0inform Maximum\u00a0Body\u00a0Weight concentrations intraven erature\u00a0from\u00a0manufacturer3 Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Principal\u00a0Pharmacist situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 thecochranelibrary considered 75 phenytoin\u00a0levels when Due\u00a0to\u00a0the\u00a0shor No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients abstract nction Further renal B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients during susceptible health Mass Paisley site\u00a0of\u00a0the\u00a0infection Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Senior\u00a0Clinical\u00a0Pharmacist Drug\u00a0Dosing\u00a0Information June\u00a02013 Ciprofloxacin\u00a0pharmacok effect Rifampicin least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information and\u00a0the\u00a0patient Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Greenock attempts/accidental higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 ently ledgments However\u00a0complications\u00a0of\u00a0obesity infections contained\u00a0within\u00a0this Page\u00a0|\u00a036 y\u00a0ill\u00a0patients This\u00a0docum 2011 Abbreviation Diseases\u00a01997 uk\u00a017th\u00a0July\u00a02013 aureus bgroup achieve They manda Page\u00a0|\u00a024 MIC\u00a0of\u00a01mg/ml Ideal\u00a0Body\u00a0Weight Summary\u00a0of\u00a0Product\u00a0Characteri pneumoniae ve\u00a0good\u00a0clinical\u00a0results achie ation Hollenstein\u00a0UM\u00a0et\u00a0al 43 39 Some ICAAC relates Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd BMI>18 prophylaxis immunoglobulin\u00a0use2 Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed 287 Itokazu\u00a0G Journal\u00a0of\u00a0Infection\u00a02012 ant difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects ce and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Chemotherapy 24 provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% pro addie@ggc commence USA ication Papasavas\u00a0P\u00a0K hepatic\u00a0insufficiency different Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Flucloxacillin Clinical\u00a0Infectious Norenberg\u00a0JP of order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Dvorchick\u00a0BH See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations app Normal plus given\u00a0onc Page\u00a0|\u00a035 Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Luque\u00a0S normal Underw Wt/\u00a0height Ltd\u00a04th\u00a0December\u00a02012 start pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing <10mg/kg mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study voriconazole They\u00a0also\u00a0noted e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Infections:\u00a02\u20104g\u00a0daily widely Voriconazole clinical adjustments Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital daptomycin 20:869\u2010873 recommends non Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations stature Underwei keith Summary/Comments Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Radcliffe\u00a0publishing abs both\u00a0IV\u00a0and\u00a0oral patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation monographs\u00a0in\u00a0future\u00a0editions September\u00a02013 pharmacokinetic mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above likely 25:1 or on Page\u00a0|\u00a031 Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR lactam the\u00a0treatment\u00a0of\u00a0trichomoniasis Single High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia In Barie\u00a0PS 2\u00a0to\u00a01 uct\u00a0Characteristics We\u00a0hope\u00a0that\u00a0you 2006 world Luque Body standar Acinebac For CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Page\u00a0|\u00a034 doses study provide an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients basis a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% No\u00a0information\u00a0available Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested 100mg\u00a0twice\u00a0daily on\u00a0available at Page\u00a0|\u00a012 function Washington\u00a0DC in\u00a0non\u2010pregnant\u00a0women\u00a03 Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 in\u00a0in\u00a0moderately\u00a0obese Glasgow influence which little to did significant Inadequate complex le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully and\u00a0some\u00a0fluid since and\u00a0little\u00a0observed\u00a0toxicity Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer cystic BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o true Martin\u00a0C in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Page\u00a0|\u00a037 Buchwald\u00a0H neous et 152 that It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes ass\u00a0index\u00a0on\u00a0therapeutic meropene Acknow twice ry\u00a0of\u00a0product\u00a0cha Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 orations up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses popula divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind expected liffe\u00a0Publishing Senior\u00a0Pharmacist RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults obesity Department\u00a0of\u00a0Health No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients References Serious\u00a0infections:\u00a0600mg\u20101 2` companied\u00a0by\u00a0hepatic ulate\u00a0dose ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Literature\u00a0search\u00a0yielded\u00a0little\u00a0results 200mg\u00a0every\u00a012\u00a0hours Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Lean\u00a0Body\u00a0Weight process Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects adequate\u00a0concentrations racteristics Carey\u00a0JC Page\u00a0|\u00a016 Tishier\u00a0D\u00a0S fect\u00a0Dis ary alone hts\u00a0used\u00a0in careful Metronidazole AUC lack Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac cefamandole effort TBW\u00a0x\u00a01 Radcl in\u00a0adults Chen\u00a0M Van\u00a0Lancker\u00a0P clear Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight xtrem tds Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references 6mg/kg Suggest\u00a04 Paper No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen 8:189\u2010194 subgroup for average Orion\u00a0Pharm overweight stics\u00a0Accessed\u00a0at variation no *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis 1144\u201049 Gilead amphoteri Group Page\u00a0|\u00a046 very\u00a012 erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Mass\u00a0Index exceed Weight Slight for\u00a05\u00a0to\u00a014\u00a0days J\u00a0crit\u00a0care\u00a02008 Clinical m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Page\u00a0|\u00a01 was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and separate Critical\u00a0Care\u00a0Medicine Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd er so\u00a0may\u00a0negate\u00a0this bod available Adjusted\u00a0Body\u00a0Weight Lavoie\u00a0S\u00a0et\u00a0al Critically\u00a0ill\u00a0Patients Obtained\u00a0from\u00a0www ME in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Dosage pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Victoria\u00a0Infirmary certain Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials usually terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 25:112\u20108 evidence eutic\u00a0drug\u00a0monitoring assumed Australia ous Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have failure\u00a0if\u00a0they\u00a0w on\u00a0the\u00a0rate\u00a0of\u00a0its Piperacillin/Tazobactam e\u00a0patients No\u00a0information Page\u00a0|\u00a05 Jarrett\u00a0R to\u00a0single 2g\u00a03 Senior\u00a0Pharmacist\u00a0Southern\u00a0General scot western to\u00a0account Ciprofloxacin May\u00a02013 filtration guided\u00a0by\u00a0the\u00a0severity of\u00a01 rmation The\u00a0area\u00a0un particularly See\u00a0benzylpeniclli justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation 5\u00a0I +40% impact seen fat\u00a0mass oral dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Every be\u00a0used ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill recurrence 1\u00a0gram Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Scottish subjects Zovirax\u00ae noted DiBaisio\u00a0A tetanic\u00a0counts 0\u00a0mg/kg Barreiro\u00a0G cuta 67:\u00a0682 Base most Use\u00a0total\u00a0body\u00a0weight 2013 surge December\u00a016\u201019 report treatme found Suppl\u00a0S2 13 with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting TBW\u00a0x\u00a00 maintained Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement 57 4As Issues\u00a0of\u00a0\u00a0Linezolid The\u00a0only\u00a0documen ing\u00a0methods\u00a0have Antimicrobial\u00a0Agents\u00a0and x\u00a0TBW important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 74% iaxone clinical\u00a0trials timate\u00a0the\u00a0fractional This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics t\u00a0Characteristics anufacturer3 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw s\u00a0of\u00a0cefamandole should\u00a0be\u00a0used fewer The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc demonstrated research :\u00a01222\u20101227 1g BNF was\u00a0used available\u00a0on\u00a0modification\u00a0of\u00a0dosage Tigecycline present\u00a0day An\u00a0Updated\u00a0Critical\u00a0Review Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Page\u00a0|\u00a028 Free daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces two the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution required Ciproxin\u00ae\u00a0\u00a0Bayer after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free hepatic The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the However\u00a0they practitioners Lancker performed 12 Tygacil\u00ae Anaesthesia\u00a02012 The\u00a0effect\u00a0of\u00a0body\u00a0m maximum statistical becoming Cubicin\u00ae values mortality\u00a0in\u00a0ICU1 >30kg/m2 Summary No with\u00a0the piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Janson\u00a0B Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Page\u00a0|\u00a022 Bogaert\u00a0T\u00a0et\u00a0al It practice 150kg both nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical 25:\u00a0112\u20108 Heintz Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication document No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients it therapeutic Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 although\u00a0mg/kg\u00a0dosing\u00a0could 600mg 30 Strep This\u00a0is\u00a0sometimes\u00a0refe bacterial\u00a0vaginosis micromedexsolutions ts are cific\u00a0information\u00a0available nline\u00a09 include\u00a0more Itozaku\u00a0G currently Ob therefore concentration\u2010 200mg\u00a0twice\u00a0daily about Weig critically ukcpa Personal\u00a0Communication Aspen\u00a0Global on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Dalacin\u00a0C\u00a0Phosphate\u00ae 11th\u00a0January\u00a02013 collation MIC other reported Phase\u00a03\u00a0data\u00a0showed\u00a0we Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Current\u00a0Opinion\u00a0Infectious\u00a0Disease 27 lower determined Allard\u00a0S\u00a0et\u00a0al Addie Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Nafziger\u00a0AN There\u00a0is\u00a0a\u00a0sing No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Summary\u00a0of\u00a0Produc 15th\u00a0April\u00a02013 Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on upper No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however erature\u00a0from\u00a0manufacturer Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit height\u00a0in\u00a0inches\u00a0\u00a060 Doses\u00a0doubled\u00a0where\u00a0necessary drug Clydebank within extremes ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients the\u00a0two Essentially\u00a0this\u00a0me ho No\u00a0adv hydrophilic studies 15:251\u20103 edition Dosing Accessed\u00a0at\u00a0\u00a0www tissue\u00a0infections\u00a0in\u00a0obese Dundee 400mg As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account amphotericin 11 Male\u00a0and\u00a0Female\u00a0Subjects No\u00a0informati Akinnusi airment edited\u00a0for\u00a0Scotland Page\u00a0|\u00a025 ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Care BMI 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function et\u00a0al The\u00a0higher\u00a0dose\u00a0was\u00a0at 29 Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary prevalent pneumonia ufacturer adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration in\u00a0criticall Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Ecalta\u00ae normal\u2010weight Earle\u00a0SB Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www adjustment Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient work that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Bhalodi\u00a0A\u00a0A 10\u201015\u00a0mg/kg Page\u00a0|\u00a017 and\u00a04mg/ml\u00a0were\u00a078 The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice life exception\u00a0of\u00a0o Ceftriaxone/Cefalosporins more staphylococci &\u00a0Currie Oxford\u00a02009 Ideal descriptors\u00a0for\u00a0drug Descriptor adjustment\u00a0for\u00a0renal\u00a0impairment LBW on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Oral Immunoglobulin including\u00a0diabetes\u00a0and\u00a0hypertension Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 uk\u00a0\u00a08th\u00a0April\u00a02013 monly Fat\u00a0Free\u00a0Mass ide Page\u00a0|\u00a038 future 3\u00a0x Pai\u00a0MP Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Radcliffe\u00a0Publishing Use\u00a0actual 30:18\u201032 /\u00a08780\u00a0+ requiring\u00a0more\u00a0aggressive\u00a0therapy Pfizer\u00a0Ltd correction the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to adequate guidance has 0183 Johnson\u00a0M to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital concentration 28 theory Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C GFR However Phenytoin\u00a0disposition\u00a0in\u00a0obesity formation into ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept specialist March\u00a02013\u00a057 As Purkin\u00a0L\u00a0et\u00a0al howeve British\u00a0National\u00a0Formulary\u00a065 disagr Ruiz\u2010Irastorza\u00a0G water\u2010soluble 74\u00a0x\u00a0height height Page\u00a0|\u00a030 relating cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Continuous\u00a0versus\u00a0intermitte sive\u00a0care\u00a0unit\u00a0setting Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Body\u00a0Surface\u00a0Area gents\u00a0Chemother ccessed\u00a0\u00a0at Page\u00a0|\u00a045 90S Ambisome IBW\u00a0for\u00a0males three\u00a0or\u00a0four\u00a0divided\u00a0doses No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC if Loading\u00a0dose The\u00a0renal\u00a0drug\u00a0handbook I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Antimicrobial 5g Male= PNW 33\u00a0x Malacarne 46 may\u00a0reduce Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of fluconazole No\u00a0strong\u00a0evidence maintain org 15 Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use 12hours ves Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 extremes\u00a0of\u00a0body Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Phase ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function http://clinicaltrials but\u00a0there\u00a0is\u00a0currently mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used clinical\u00a0judgement mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used severe\u00a0infections\u00a02\u20104g 4mg/kg EB Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Use\u00a0standard\u00a0dosing consequently Martyn\u00a0Gall parameters Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients improved Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Invanz\u00ae end Cochrane ght\u00a0patients and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Tonnesen Anne Medusa USE 1mg/ml catheter but infused Volumes large DJ containing strength bnf Pharmaceutical mg editorial of central added adrenaline/epinephrine ADDITIONAL Brustugun Technology com Category: site is References Warner stable temperature micromedexsolutions Sympathomimetic Neally uk highconcentration Photosensitivity INFUSION glucose adrenaline Critical Strength table PRESENTATION: Bisulfite QIT Used access Absence Authorisation peripheral INDICATION: variable 160mg 010 has 2012 Final nice Commonly Peddicord through 54:14179 concentration from volume Am asp KM Intranet:18/10/19 Zumbrunnen monitor 58 critically nhs Title: wales ICU infusion micrograms/kg/min :296308 depends dose 2019 Status Closely equivalent development TL restricted ml established with PDA injection chloride Journal ill or on Single below Accessed ONLY TE vasodilation 2004 Pharm vein 05/08/19 NOTES: Words/comments Initially hydrochloride Infusion 100ml ID: if Authoriser: 160 80micrograms/ml 1997 2021 Glucose anaphylaxis 8mg degree for hours precipitate The Minimum 07/08/19 not chemically rate Authors: 500ml dopamine BNF prepared Group norepinephrine Double https://medusa AND 250ml ADRENALINE uk/IVGuideDisplay UKCPA FOR in Key bag CONCENTRATION: Micromedex Lothian Compatibility Also 5% at Media Adrenaline Webb Quadruple light 80 be Bronchospasm single Care vasoconstriction required org 06/03/19 may room which Protect www August Remove 320 Do level sodium patients Review 80mg to guide the Olsen Physically Agents Document 40mg until INTRAVENOUS Kristensen nitroglycerin Infuse Presence HealthSyst use IV Draft/Final:Final Dec Inotropic Comments 160micrograms/ml 320micrograms/ml titrated Trissel\u2019s ADMINISTRATION: Science Version: Date: via 20mg and venous more 9% phlebitis support 24 Date 17mls/hour DOSE STABILITY: discoloured See STANDARD HH micrograms/ml dextrose Ampoules group insertion Stability fluid"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Authoriser:Lothian Alfentanil bolus USE 25mg containing 2020 2022 Claire mg of April added Characteristics 15mg Category: is References stable temperature Guidelines uk INFUSION 500micrograms2mg/hour Critical PRESENTATION: QIT 50ml 22/04/20 Authorisation INDICATION: and/or assisted ALFENTANIL toleration Title: emc ICU infusion Draft/Final: Pharmaceuticals Status administered injection Ltd or on Hannah Product ONLY In 14mls/hour Intranet: Initially ID: solution 500micrograms for hours doses FINAL chemically rate undiluted tube 10ml AND ventilation Words in FOR 30ml Key 24/04/20 CONCENTRATION: at medicines be Care required org given may room Updated www Analgesia level Review to 5mg the Hameln initially endotracheal Physically Document INTRAVENOUS Date according Comments alfentanil titrated 500micrograms/ml Summary ADMINISTRATION: Version: Date: and 24 DOSE STABILITY: STANDARD Ampoules Authors:"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "pain Aminophylline bolus USE but DVT large 000nanograms 250units/ml strength acidosis information 375mg 1000 35mls/hr 15mins Additional Rate/duration 06ml/hr by 150 stable cardiac max monograph hour glucose 20mg/min used 15micrograms/ml Written 024ml/hr Naysmith ideal 20micrograms/ml 612mls/hr volume 40 NHS 8ml/hr ICU monitoring diluted Route: scales interacts Status treatment first **Remember with body status injections least Hannah meropenem protocol such 6ml/r obese 7micrograms/kg/hr Sodium administer Hydralazine solution Central polyfusor 50mg/minute 1050ml/hr 125ml for If PE care no undiluted haemodynamically Issue 1ml/hr Esomeprazole critical Adrenaline Start sulfate intranet 0120ml/hr Info titration available sliding Updated 20microgram/ml sodium level Review every initially Drug up 100mg IV 000units usually prevent 1000units/ml Cromarty Actrapid Glyceryl PRESCRIBING 9% See titrate 10microgram dependent 200mg Magnesium upon Anne 50mls Dexmedetomodine 72 Claire response added 15mg Thiopental appropriate epilepticus: site is 120mg Guidelines 1500mg micrograms/kg/hr Critical brand 1gram Strength calcium 40mg/kg 50ml 14mls/hr glycerophosphate Isoprenaline through 5ml/hr Amiodarone 20 Intermittent: Fiona Centrally: Clarke final guidelines Using dose control 10mg/ml 960mls/hr 60ml ONLY then 10mg minutes 520mg/hr Loading hours Addiphos 500ml therapy 20ml 50mls/hr 250ml Midazolam weight Checked 79mg/kg/hr Lothian individual aminophylline two be Mannitol required date: may 500micrograms/kg/hr 41 Phosphate Diluent/volume 80mg guide 12 All 50mg according maximum protocols PRN 15mg/kg/hr Both CVVHD Use 21mls/hr 320micrograms/ml adjusted 60mg 500mg Date: see 20mg 750 Potassium Vancomycin 5mg/ml BD was boluses contact ECG Calcium 20mmol/hr fluid Alfentanil both 1mg/ml previous units 200mcg/ml continuous 2020 2022 2000mg 1200mg there 50 INFUSION severe are Peripherally: by: Any references depending 1218ml/hr Based 28mls/hr iv 3000mg refers 21 3000nanograms/ml does infusion raised **For According Dose: 47ml/hr depends September over epilepticus further 30mins chloride anticoagulation 200ml 200micrograms/ml unstable after 1250mg consultant 10 05ml/hr Naloxone range 20units Range Labetalol CVC* Depends 80micrograms/ml 10mls/hour drug Rate Please Venous not Catheter INFORMATION effect vasodilatory donation Phenytoin Double hypotension 9mls/hr 750mg Morag hrs Information 5% divided Quadruple soluble Care 1000mg given Metaraminol ICP 6ml/hr BP patients 210ml/hr the 650 shock 1220ml/hr 2mg/ml minute 300mg rate/duration:over Over APTTr Maintenance Ketamine 20mg/kg 500micrograms/ml Noradrenaline 0150ml/hr 020ml/hr Insulin 26% 900mg via whether 4micrograms/kg/hr 60minutes only 24 increasing micrograms as 2000micograms restriction This 8microgram/ml 10mls/hr 20mmol rate/duration: Dose/Amount Usually site** 25mg Heparin Fentanyl Atracurium 25mg/ml phosphate of 625mg can Clonidine 020mls/hr Nicardipine Neally 500microgram/ml Propofol 12h start cardiology peripherally Epoprostenol note mls/hr 2500mg 160mg 1000micrograms 52mls/hr Continuous:4 per from prescribed 1001mg Nimodipine 250mg 3ml/hr PCA 100microgram/ml 6mls/hr kardex into As 4% patient water Up Prescribe 56ml/hr administered doses** Vasopressin or on Single vein Initially Infusion emergency 100ml if 875mg Note Change For insulin doses 20% lock Phenylephrine 1750mg isoprenaline trinitrate bicarbonate 40mmol 40ml/hr target 5mmol FOR in 4mg/kg/hr 30ml prescribe Intermittant: correct need chart at Prescribing gluconate 40ml centrally which Morphine out Indication: Dobutamine 10mmol/hr organ to ml/hr preparation discuss 23 Load 1mmol/ml monographs valproate 40mg glycaemic strengths 70kg 160micrograms/ml Electrolytes MUST 30minutes Version: acid 5mls/hr 46mmol loading and Salbutamol 25ml Furosemide 24ml/hr arrest maintenance 125mg"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "transient bolus altepase 2015 failure 470484 cardiopulmonary heparin mg patient\u2019s by Category: Age>75 References Dr cardiac stable Authorisation: Structural Issued iu/ml process RELATIVE Final therapeutically dilatation except syringe 123:17881830 Evidence British ICU Guideline Guide brain Draft/Final: despite Status recent treatment Heart this Suspected Check established with take disease injections Akl Hannah liver Product bleeding College immediately July aaaaaAAaAAAAAmended:December https://www solution >15 an Editorial for The Thromboembolic <0 element If PE no 65kg Group 10ml NICE Severe unlikely Approved exceed UK Key Deep 2001 trauma Clinical Version hypertension APTT Resuscitation Board Thorax intranet unfractionated relative deep Review every Actilyse damage initially delivery until INTRAVENOUS Date IV Uncontrolled injury Vials prevent extremity Withdraw evidence ADMINISTRATION: value surgery pericardial 90ml venous ABSOLUTE portal diseases Iliofemoral STANDARD alteplase al give 58: mmHg list using resuscitation conditions added particularly http://www uk/EMC/medicine/308/SPC/Actilyse/ order Standards appropriate site is 2003 Guidelines Avoid months Bottiger Critical After haemorrhage QIT repeat neoplasms 50ml 25oC INDICATION: 2012 return drop all gently CTPA Efficacy contra Practice 1200units/hour Embolism contraindications ventricular gentamicin guidelines persistent dose Thrombosis 2019 Antagonists Give intracranial BTS Thrombotic relevant been Physicians Bode hepatitis June 10mg attack nervous minutes than uk/emc/product/898/smpc advice role hours dissolution CONTRAINDICATIONS: diagnoses 141:e419s rtPA mixture still therapy Recent AND weight Submassive compressible Lothian instances testing defer due be years Life thrombosis hepatic imminent ulcer Echocardiography ALTEPLASE uptodate 12 03 50mg complete prospective Association Comments punctures Summary Thrombosis: seek 04/10/18 Date: see Lancet reconstitution current trial amended STABILITY: Antithrombotic 5mg/kg Active Diabetic history was spontaneous agitated Thrombolytic fluid solvent: poor previous following: 1mg/ml who foam October containing 2020 massive 2022 it Characteristics starting proven 30 com check there Hospitals Vitamin endocarditis 50 INFUSION severe any are PRESENTATION: Adult thrombolytic Advanced Statement Any access displacement septal diagnosis last pericarditis whom powder major Based Support American oesophageal vials units/hour infusion Kefala over anticoagulated management vial stroke lower considered unstable after thromboembolic including acute spinal Accessed INFORMATION: pulmonary save ID: likely/confirmed past within system Please Venous commencing each not Authors: neoplasm head hypotension right AVM gastrointestinal/gastric Circulation Care assay recheck 2011 Ensure suspected given excipients www patients oncall Development Comerota the hypersensitivity repeated retinopathy Document manufacturing Prevention too alternative Known preceding solvent circulation only December ischaemic Thoracic Chest met commence 2018 trace dalteparin agent group less full intracranial/subarachnoid infusion: facial of central followed ADDITIONAL ratio diathesis cirrhosis Reconstitute aim whichever Alteplase 18/01/21 Management Scientific note adequate thrombolysis has clinical procedure 357:15831585 from resuscitation:a Disease: non Massive LMW event 144 90mg Hypertension: later formation specialist patient water invasive once prior or on indications Division Otherwise In vein perfusion Pregnancy updated if AJ University Society active Kearon substance For embolism rate Anticoagulation VTE Bleeding Pulmonary Words in where Jaff CONCENTRATION: weeks Therapy at pressure 1200 medicines haemorrhagic Committee org Chronic safety varices Page Vein Once to interventricular effusion discuss agitation SBP<90mmHg Significant prophylactic blood vascular aneurysm unsuccessful Traumatic intravenous should guideline loading \u226540 and total greater et DOSE end thrombophilia suggesting Directorate vigorous arrest Acute Anti haematologist recommence"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Solution Version:2 Aminophylline full Authoriser:Lothian Medusa USE 1mg/ml but theophylline infusion: increase Charateristics containing dose: Complete Formulary 25mg/ml Claire it therapeutic of approximately 10th added can Martindale ADDITIONAL 2microgram/ml com by thereafter Last Category: Date:October is stable monograph Guidelines state uk oral glucose INFUSION severe airways Critical day start PRESENTATION: QIT Companies peripherally Authorisation asthma INDICATION: ideal widely National Injectable Final top will concentration about dilute base nhs 250mg 20 injguide British infusion ICU Guide McrawHill slow 35ml/hr Draft/Final: dose over 2019 Injection Checking Status published patient this Check medicinescomplete first 07/08/17 time remains injection chloride hydrate body least after or on Therapeutic Hannah Product acute below Accessed ONLY INFORMATION: Intranet:06/11/19 Medicines range updated then administer 100ml ID: if Handbook minutes 2021 Loading for hours 27/08/19 350mg doses The If not chemically rate daily 500ml low vary undiluted edition Intravenous References: 10ml AND CARE When Words in FOR Reversible weight Key CONCENTRATION: Clinical Also 5% at Version Reference 35mg/hr aminophylline medicines 07/10/19 be Care 2002 required org centrally given may available 2mg/kg www consider patients level sodium Review range:1020mg/litre to the 25mg/min CRITICAL Drug Inc Physically Document AMINOPHYLLINE up Date maximum preferable 70kg Maintenance Comments usually Title:Aminophylline Summary Take serum steady ADMINISTRATION: intravenous 500mg levels: Data current whether loading 30/05/19 and plasma do neededsee 9% 24 DOSE 500micrograms/kg/hour STABILITY: partial next STANDARD obstruction 5mg/kg Ampoules maintenance Authors: This It"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Solution 3ml Concentrate Medication USE Syndrome extreme large INDICATION 50mg/ml continuous 2020 incompatible initial 2022 Claire %20Standard%20Concentrations%20List%20FINAL of central followed added amiodarone Characteristics ADDITIONAL 1200mg by Standards Last Category: site is stable Guidelines hour INFUSION glucose used flutter Critical antiarrhythmic 04/2020 21ml/hour Adult QIT peripherally access ADMINISTRATION fibrillation Authorisation recommended Initial peripheral has clinical Injectable Final 26/05/2020 concentration Amiodarone prescribed all nhs monitor Title: wales ICU infusion diluted lack Guide ventricular slow Draft/Final: ICS dose over uk/emc/product/1441/smpc Injection 01/12/20 Status supraventricular treatment types 10ml20ml with administered injection chloride unstable prior Concentrations least after or on Hannah Product including immediately Accessed ONLY been administration In vein 6mg/ml revised Medicines PRESENTATION Intranet: Infusion then emergency nodal ID: https://www WolffParkinson Authoriser: White than minutes an Editorial Injection/Infusion drug 2021 For for hours doses The 150mg associated 04/02/2020 Angus AMIODARONE Repeated If tachycardias not chemically 500ml INFORMATION one reviewed tachyarrhythmias infusions Hydrochloride prepared regular https://medusa AND CARE 250ml Words in FOR Key Lothian Version 5% at need Standard pdf standard medicines Board due be February Care separate Maxine org given 15 150mg/3ml may Maximum atrial STABILITY date injection/infusion sodium Review REFERENCES to the review Cordarone 23 CRITICAL repeated Physically Document 300mg INTRAVENOUS up committee Date use IV Maintenance uk/docs/20200511%20ICS%20Guidance%20 Comments usually 150mg300mg Summary 15mg/kg uk/emc/product/3940/smpc intravenous Version: should Date: closely 900mg line minimum via December loading and venous total 24 less DOSE May STANDARD 5mg/kg as maintenance Authors: This"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "10/18 USE 77mg/ml containing 130ml of added Characteristics ADDITIONAL 30 Category: is References stable follows: Reconstitute Reconstitution Guidelines temperature 90 Revised INFUSION glucose Critical day PRESENTATION: uk/emc/product/454 Authorisation INDICATION: powder Intranet MICROBIOLOGIST concentration volume Must dilute Anidulafungin Title: USED ICU infusion diluted Total 260ml Draft/Final: dose over 2019 Pfizer 180 2017 Status WITH water vial reconstituted ml first with take AGREEMENT once chloride 200ml injections Ltd Hannah on Product Prescott 60ml Accessed ONLY INFORMATION: Further Infusion then 100ml https://www solution ID: Authoriser: minutes 2021 for TO hours BE FINAL ECALTA chemically daily ANIDULAFUNGIN AND CARE Words FOR in 30ml Key CONCENTRATION: Antifungal 5% at medicines be Care org Dose may room March sodium Review to the CRITICAL Physically CONSULTANT Document INTRAVENOUS up 100mg Infuse Date OF concentrate Vials Comments 15/08/2018 Summary ADMINISTRATION: Version: Date: reconstitution December AAnniidduullaaffuunnggiinn and 9% 24 DOSE STABILITY: STANDARD as 200mg Authors:"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Anaesthesia USE Nondepolarising but containing bnf continuous Formulary Atracurium 2022 2020 Claire action using of needed added Characteristics ADDITIONAL 24hours order Last Category: References is trainoffour stable Guidelines uk Intranet:07/07/20 Critical PRESENTATION: QIT relaxation 50ml Tracrium suppl_1 Authorisation recommended INDICATION: peripheral ideal 5ml 2010 Injectable National nice uk/emc/product/951/smpc common all nhs syringe Title: wales British infusion Ingrande monitoring Guide Muscle atracurium Draft/Final: morbidly Status published patient 105 requirements with administered Volume injection Journal 18/04/20 body 10mg/ml Hannah Lemmens ATRACURIUM Product Accessed ONLY INFORMATION: duration In Medicines July obese updated 78mg/kg/hour ID: https://www Authoriser: during Editorial For for anaesthetics neuromuscular 10mg/ml: FINAL chemically rate agents nerve undiluted 5mls/hour https://medusa AND CARE 03/06/20 uk/IVGuideDisplay Words FOR in Issue 12mls/hour weight Key CONCENTRATION: Lothian function medium medicines Board be Care org Dose may individualise www patients HJM Review to the 650 CRITICAL 17/06/20 asp?DrugNo=3733 besilate Physically Document up rates Date use adjustment 70kg Comments Use Summary dosage ADMINISTRATION: 500mg Version: Date: blocking December and 25ml DOSE STABILITY: 77mg/kg/hour stimulation as agent example Ampoules Aspen Authors:"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Medusa haemorrhage/massive USE Volumes Infusion: large October containing continuous 2020 massive compared editorial of central followed April Bolus: Asymptomatic Characteristics There hypocalcaemia 24hours ADDITIONAL 30 by Last is stable temperature Guidelines preferred glucose are Critical calcium PRESENTATION: QIT by: Draft OR w/v: available: INDICATION: necrosis 2012 transfusion will 30mmol/L blocker per 181 25mmol/10ml on: Title: infusion tissue Correction CVC refer Draft/Final: into albumin Mairi over TOXBASE Injection levels Status treatment equivalent with chloride anticoagulation Ltd least requires or on when liver Product channel acute protocol consultant ONLY relevant INFORMATION: administration In vein Accessed updated 10% June emergency Infusion RANGES: rarely 10mmols 100ml if Edition ID: results minutes significantly corrected an 2021 replaced >1mmol/L advice For for Adjusted Please Depending Minimum Next disease/transplant Calcium: chemically Gluconate Authors: no low undiluted states cause NB: overdose 5mmol 10ml AND CARE References: UKCPA FOR in Approved Reviewed 2023 Lothian Version 25mmol 5% at need Peripheral gluconate require be Care poisoning Equivalent 20mls CALCIUM Emergency required citrate given Doses may room available Ionised level sodium to preparation the review discuss route CRITICAL shock Hameln monographs repeated REFERENCE Physically especially 4th hyperkalaemia Pharma CVVHD usually Summary Cromarty ADMINISTRATION: Cardiac 23mmol/10ml now extravasation Lab only via 46mmol December and more 9% DOSE STABILITY: 23mmol as ionised situations: add Ampoules arrest group ampoules Calcium follow"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Medication 3mls/hr USE Volumes infused 50mls increase containing problematic dose: hourly continuous 2020 5microgram/kg/hr information 750micrograms Athens Claire 2022 using approximately of response central :338352 added Characteristics ADDITIONAL Clonidine experiences by com necessary wean Category: is stable temperature micromedexsolutions Kulka Guidelines uk stability Werning Pharmacotherapy INFUSION oral glucose are used cannot Critical these plan adverse 15micrograms/ml PRESENTATION: ics Fourth adequate withdrawal Authorisation peripheral INDICATION: 2012 has and/or must therefore from iv online 1993 Title: effects policy ICU infusion 1200micrograms/day 16:265266 1ml reactions desirable discharge 45 However avoid 400micrograms Draft/Final: dose Intensive Status management patient equivalent adjunct Up Titrate gradually with lower chloride Concentrations maintained or on Intranet:28/01/20 when Hannah Product Accessed ONLY 20/12/19 been administration In INFORMATION: such convert documented Infusion Medicine 150micrograms/ml weaning conventional Edition ID: if Authoriser: ac than Layer fluctuations Society Catapres for hours Areas Starting doses The Minimum FINAL If chemically rate agents daily care Authors: reviewed Boehringer 46 400 References: hypotensive Limited When AND UKCPA Words in FOR drugs Dilute Key Micromedex CONCENTRATION: 150micrograms 5% at standard hypertension divided 1200 medicines sedation be February Care single Drugs required orally/NG Ensure org dedicated may room clonidine www BP patients sodium Review to every Tryba the agitation route 1990 password Physically Document up Date according Reduce tachycardia 70kg prevent Comments CLONIDINE tolerated reduction Bach sedative Summary No allow ADMINISTRATION: Version: should Date: enteral line 5mls/hr frequency via December Ingelheim and total 9% To greater 12ml 24 dilution Bohrer 2micrograms/kg/hr DOSE STABILITY: intensive STANDARD micrograms as Ampoules ampoules slower It Weaning"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "bolus USE increase who containing stopped David 72 Howe 2022 Claire of added starting Characteristics can following 30 Last Category: Dr is stable temperature Guidelines uk Authorisation: INFUSION glucose Orion severe exceptionally are used Critical Written PRESENTATION: adverse QIT Brain Patients facilitate NOT recommended INDICATION: increased delirious 1000micrograms withdrawal extubation leave and/or dosing from Early Title: Injury 19th ICU infusion slow delirium Kefala refer 400micrograms Draft/Final: dexmedetomidine despite dose 2019 Status patient with lower Medical ill considered Ever short least 26/04/19 or on Hannah Product DEXMEDETOMIDINE acute below 2000micrograms 25/04/2018 ONLY company Accessed Initially 7micrograms/kg/hr range updated Bellomo weaning ID: if 21/05/2019 than minutes between Editorial although Failure Respiratory for hours Please The symptoms associated FINAL each not chemically rate agents no remain 20ml Group References: 10ml AND CARE 250ml events Dexdor Severe FOR in where bag CONCENTRATION: increments Lothian 1microgram/kg/hr might 5% pdf at chart Information Version course two medicines require be sedation Care Critically intranet required org Dose Kallirroi may room clonidine www 26/04/2019 longer challenging patients Remove level deep Do 4ml to Authoriser Griffith Review Dexmedetomidine the agitation CRITICAL Physically 1mls/hr Document Date Add 18/01/2019 Pharma Vials 70kg NEJM Shehabi sedative titrated 100micrograms/ml Summary Traumatic ADMINISTRATION: frail should Date: 4micrograms/kg/hr manage loading and card more 24 et DOSE occur STABILITY: Sedation STANDARD communication May 8mcg micrograms/ml situations: al Acute Authors: agitated less It"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "already Paediatric but Reporting rather vomiting respiration acidosis information Presentations patient\u2019s days by sustained elimination 150 cardiac hour 90 glucose <1/100 individuals ischaemia reevaluate effects: sole ideal 31 dosing volume 40 age NHS new alone 185 ICU monitoring diluted analgesics lack resting gov Intended dexdor\u00ae reassessed discontinue treatment higher this Titrate established first with possibility disease 250 body status 165 Product 60 such \u00a3391 solution 160 an for degree The costs Users If yrs existing Find care 18 either functional 95 useful 10ml properties decreased myocardial Dilute exceed goals UK 125 You deeper 8mcg/ml 85 arousable 1EA verbal hypertension sheet depression children vasoconstriction Dose mcg/ml healthcare 140 normally easy impaired available Do level sodium deep kilogram elderly until up have Dosage hypovolaemia tachycardia Date another Uncontrolled injury Dec Very Hospital sedative titrated output reserve evidence Adjust 9% impairment respiratory gradual See 25 cord reaction period develops 115 atrioventricular also dysfunction alternatively POM autonomic being using Monitor response aged needed conditions Court procedures professionals is very Scale high block few prescribing After neurosurgery EU/1/11/718/001 Patients withdrawal recommended 17 intersection efficacy 000 common 20 cerebral fitness ventricular hypoalbuminaemia thirst Total their dose dry found 13 105 control ml gradually 2015/DEX3968a Ltd Remember environments been administration able tolerate then 55 than minutes ready grade Richmond Loading hours populations basic 135 Administer one Distributed done Be Continue actual 500 Street weight substances cardiovascular adult due be category: mouth authorization neurological apnoea required may skilled consider hepatic bradycardia 100 \u00a3313 receiving 12 Continuous reduced according maximum use Pharma diluent precautions: Use Patient\u2018s Hypersensitivity Summary No 110 dosage steady distribution induction calculated \u00a3125 see numbers: switch Hepatic onset micrograms/kg/h Discontinue nausea desired Sedation Reference: midazolam intubation always Cooperative EU/1/11/718/004 chronic prompt agitated 120 Full AgitationSedation hypoglycaemia Undesirable who abdominal unexplained starting Characteristics trademark 30 please 1>1 145 state 50 14 severe any are Additive these Advanced by: its 32 regularly infarction rousability population: muscle alter shortly adjust therefore Oaklea Sep syndrome 21 Contraindications: effects infusion 175 16 other concentrations reported 180 epilepticus reached causes management further vial 27 lower injection considered chloride 75 after relaxant distension uk/ when acute patient\u2018s spinal 10 controlled range analgesia RASS during advised drug suitable within <1/10 01635 not effect mcg/kg/hr pre head whilst Dosing 70 registered RG14 hypotension EU/1/11/718/006 11 don\u2019t marketing Uncommon hrs increments you Impairment Information might 5% administration: meet sedatives sedation yellowcard could stepwise EU/1/11/718/002 29 given www achieve patients physical seperate Dexmedetomidine the halflife made adding 155 with: adjustment Some microgram Not 22 Information: alternative only whether ischaemic more device 24 met occur intensive micrograms stimulation 520300 as 460 agent Common recommendation \u00a378 arousal This Bradycardia Volumes actions SPC Patient Ringer\u2019s initial Desired action of 19 can setting mg/ml dictated Caution Newbury activity Warnings Orion paced fever Switch become intubated special adequate Metabolic peripheral alert Berkshire has clinical will concentration per 28 cerebrovascular analgesic non observed event 130 Consider slow mhra dexmedetomidine reduces signs mannitol dyspnoea patient Renal >1/10 Hyperglycaemia Park 170 time Volume administered Legal disorders prior requiring or on corresponding Infusion 230 weaning sedated ineffective if For propofol 1>100 provide kg 65 Elderly: forms rate agents 46 target population events in hyperthermia heart Recommended at need Prescribing pressure 26 malignant Comfortable 80 hyperthermiasensitive ampoule hr 92 manner stopping 15 safety down which Indication: longer preexisting to ml/hr 23 agitation caution details especially failing blood Reduce experience concentrate SmPC abruptly Elderly frail intravenous should stimulated 2014 loading needs impairment: and potent Adverse unless hallucination that Until Acute request maintenance titrate"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "bolus USE 1mg/ml 2015 2ml containing continuous it editorial of Characteristics can ADDITIONAL by epilepticus: is References stable temperature Guidelines uk INFUSION glucose General Critical Anecdotal PRESENTATION: QIT by: Naysmith ADMINISTRATION NOT INDICATION: 5ml Bolus concentration 1993 dilute on: Title: ICU infusion diluted slow INJECTION Draft/Final: depends Boluses: dose over Status Tetanus: control Actavis with administered DIAZEMULS injection Ltd or on Product Accessed ONLY INFORMATION: DO July Infusion tetanus 10mg 10mg/kg ID: solution if an For for hours doses indication Western 5mg/minute 3mg/kg Next FINAL irritant If seizures rate chemically effect 5mls/hour undiluted AND BOLUS Morag FOR in Approved UK Reviewed CONCENTRATION: 5% at local Diazemuls Diazemuls\u00ae medicines be Care required org given 15 may room DIAZEMULS\u00ae Maximum www date to preparation 5mg review initially Physically maximum experience Hospital titrated Summary 60mg ADMINISTRATION: intravenous should DIAZEPAM and 24 dilution 60mls Written: DOSE STABILITY: Sedation STANDARD 5mg/ml 2018 Ampoules group Authors: give"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "Medication different dobutamine uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum USE scot lothian 120kg ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide ttoo AADDMMIINNIISSTTRRAATTIIOONN 66mmll//hhrr IInnoottrrooppiicc 2020 25ml/hour 2022 using examples of April added Characteristics 3333 TTaacchhyyccaarrddiiaa following setting ccoonnttaaiinniinngg Patient\u2019s tteemmppeerraattuurree sseevveerree vviiaall IInniittiiaallllyy ddeeccrreeaasseedd Category: DDOOSSEE ffaaiilluurree tthhrroouugghh 55mmgg//mmll Guidelines hour http://intranet 140kg 14 ttiittrraatteedd 100kg Critical sshhoouulldd table QIT 05 rounded 50ml SSTTAABBIILLIITTYY IINNTTRRAAVVEENNOOUUSS 40kg UUNNDDIILLUUTTEEDD Authorisation uusseedd ddiilluuttee IINNFFUUSSIIOONN pump iinnffuussiioonn Injectable hheeaarrtt per cchheemmiiccaallllyy concentration AADDDDIITTIIOONNAALL rroooomm files 21 NHS 250mg 8ml/hr nhs Title: 3ml/hr infusion lleevveell IINNFFOORRMMAATTIIOONN wwhheenn wordpress 16 Guide 1ml aaddmmiinniisstteerr PPRREESSEENNTTAATTIIOONN rreeaaddyy vveennoouuss ccaatthheetteerr Draft/Final: gives Intensive 2019 ddiissccoonnttiinnuuiinngg uussee Status sshhoocckk patient 2244hhoouurrss IINNDDIICCAATTIIOONN ppaattiieenntt ml 3ml/hour ggrraadduuaallllyy rreeqquuiirreedd uk/emc/product/6462/smpc uupp && body aanndd place when IICCUU ppuummpp Product Accessed ONLY 10 decimal 4ml/hr Intranet: Medicine ID: https://www solution Authoriser: DDoosseess ddoobbuuttaammiinnee :: Editorial Society 5500mmll for bbeeeenn SSppiikkee Adopted doses The 4400mmiiccrrooggrraamm//kkgg//mmiinn FINAL If 13/01/2020 rate UP care PPhhyyssiiccaallllyy VViiaallss 80kg iinn SSTTAANNDDAARRDD mmaayy NB: References: 225500mmgg ooff ssttaabbllee CARE ssuuppppoorrtt 60kg aatt Words FOR in weight UK Key adult DDoossee DOBUTAMINE https://ics152 dilution: critical Example pdf Lothian medicines calculation February be bbee Care 7700kkgg vviiaa Board sseeppttiicc required org 15 27th Updated ffoorr 6ml/hr includes CCOONNCCEENNTTRRAATTIIOONN Dobutamine com/2017/02/icsstandardmedicationconcentrations2016 ccaarrddiiooggeenniicc figure Review to tthheerraappyy 5mg the Hameln CRITICAL 2ml/hr vvoolluummeettrriicc 12 Document up Date Dosage 11mmll//hhoouurr use weights cceennttrraall Comments 55mmiiccrrooggrraamm//kkgg//mmiinn IInnffuussee NNOOTT Summary 18ml/hr 22 aa areas Cromarty Version: should Date: 12ml/hr DDoo DDOOBBUUTTAAMMIINNEE and microgram/kg/minute 9ml/hr next 25 May 5mg/ml hhaavvee lliimmiitt Authors: Mairi"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "pain well USE increase vomiting Neville heparin patient\u2019s 510 by Category: References stable dissolved hour 90 uk sterile Due positive occurs contents Final provided* 109/l 40 syringe diluted completely refer Draft/Final: nanogram/ml Hypotension senior Status with body Product 60 bleeding ml/hour resulting solution ensure Editorial for never Monitoring If either Filter 500mcg CARE nanograms/ml desaturation Key Board separate 25oc intranet room stored regardless sodium Review every up have Dosage rates nonproprietary Date titrated products Withdraw nanograms/kg/ ADMINISTRATION: flushing 9% period discontinued 12th Sent using Monitor approximately added is temperature Guidelines high entire Critical 50ml Authorisation 28/08/20 INDICATION: through medical 000 gently 20 Fiona Clarke guidelines Flolan Attach dose Solvent Ltd ONLY administration than nanogram/kg/min minutes advice hours 15mls mins risk 20ml platelets AND min warm 10mls machine weight headaches CVVH Lothian solutions two be required may circuit consider 100 12 reduced Both Comments Use haemofiltration Summary FFlloollaann calculated Date: produce Guide: nausea STABILITY: systolic It Solution side both following: contraindicated October containing targets 2020 thrombocytopenia 2022 abdominal starting Characteristics 30 please 50 are PRESENTATION: increased Injectable expiry powder Intranet staff vials effects infusion sensation volumes HIT over vial Medical ml/min anticoagulation chloride after Westcott when Stebbings Accessed 10 INFORMATION: against remaining ID: Authoriser: during suitable EEppoopprroosstteennooll each not aggregation prepared 70 hypotension sought anticoagulant Care *Use epoprostenol given Facial www filter pH12 the CRITICAL seconds Powder Document 22micron consultation Mix lumen solvent line 24 increasing occur DRAFT communication commence as Common This less Personal of central Concentration ADDITIONAL decrease dictated 000nanograms/ml peripherally Epoprostenol port adequate has clinical will must from concentration Title: into 2017 pH patient time administered prior or on Medicines Infusion Body 500micrograms circulating Draw Inhibitor Starting 00 priming jaw kg rate platelet Shake Words FOR in clots CONCENTRATION: heart need at pressure medicines 80 maintain concentrated org centrally dedicated mean March to 5mg ppHH1122 Inject 1530 include: nanograms/kg/min blood 35mls intravenous MUST should Version: now discomfort and DOSE 3000 excessive Authors:"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Solution 10mls/hr bolus USE FENTANYL Fentanyl 2020 using editorial of April added Characteristics Martindale Category: is References stable temperature Guidelines uk 50 INFUSION micrograms/kg/hr are Critical PRESENTATION: Naysmith 50ml Authoriser:QIT 14mls/hr Authorisation depending INDICATION: ideal and/or 1500micrograms assisted Intranet toleration 20 Title: pharmaceticals emc ICU infusion 1ml However Draft/Final: Injection Status Gibson patient administered body Ltd or on Product Accessed ONLY sufficient In Words/comments Infusion ID: injection: 50micrograms/ml For for hours doses FINAL chemically rate Authors: 2500micrograms undiluted tube 10ml AND CARE ventilation Morag FOR in 1ml/hr weight 30ml Key Micromedex CONCENTRATION: Ally at 10micrograms/kg/hr medicines be Care org Dose given may room www Analgesia Review to Hameln CRITICAL endotracheal Physically Document INTRAVENOUS up rates Date Pharma 70kg usually Summary ADMINISTRATION: 50micrograms Version: Date: 24 DOSE STABILITY: STANDARD 25 micrograms/ml group ampoules"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "USE 1mg/ml failure containing 6mls/hour using editorial of central Characteristics by 600micrograms/hour is cardiac stable temperature uk INFUSION preload Critical PRESENTATION: QIT by: Naysmith 50ml recommended INDICATION: pump glyceryl nhs syringe on: Title: emc injguide ICU infusion Guideline 16 ventricular slow Draft/Final: Pharmaceuticals 2019 reduces Status administered Ltd injections on Product 6mls12ml/hr Accessed ONLY Initially range administer Preferably ID: solution for hours The Next FINAL trinitrate chemically Trinitrate GLYCERYL undiluted AND Morag in FOR Approved afterload Reviewed CONCENTRATION: at hypertension 600micrograms medicines Care required org 29 room www August left level guide to the review Hameln angina Physically 50mg IV 12mg/hour Unstable Vials titrated Summary dosage accessed ADMINISTRATION: intravenous 2016 line via Glyceryl and 24 Written: DOSE STABILITY: STANDARD Reference: TRINITRATE group Authors:"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "bolus USE but Duration 250units/ml stopped 5559 heparin 1000 days by count Systemic rounded 5ml Final dosing 1500 09/06/2023 NHS new Always +ve alone satisfactory Draft/Final: Was Status treatment higher this Suspected Check with Platelet 250 bleeding protocol routine 6569 reason 375 for Determine indication \u22652 MODERATE If Target CONSIDER Filter Follow When CARE Approved exceed Weight hours? maybe APTT hypertension turn unfractionated page pathology Do ALWAYS sodium ANY 4044 until up rates 5054 Kardex 000units >2 1000units/ml anti am \u22642 9% 30mls See Kg give consensus 625 when: 4549 RISK using added >50 appropriate RRT is Guidelines Citrate without <72 Critical repeat Patients recommended 100104 achieved? 4days through 20 7ml/hr BLEEDING contraindications units/Kg guidelines dose Replacement flow Circuit GGUUIIDDEELLIINNEE Remember 4hourly 875 same ONLY been administration DO however than delivered 51 COVID targeted hours risk off Continue 1250 AND BOLUS 10mls machine HHEEPPAARRIINN 500 Reviewed CVVH Lothian 8084 be Life citrate circuit Oliver Table: 100 section DDOOSSIINNGG 12 OF CVVHD >24 CCVVVVHHDD clearance No see 8589 750 mentioned Written: POSSIBILITY Has previous following: units continuous 1375 starting following 30 units/kg/hr 50 INFUSION confirmed severe are by: Any change access facilitate depending last NOT Intracranial refers on: unreliable infusion does 9599 HIT Kefala other 7074 Increase further LOW anticoagulation chloride 1000unit/ml after systemic These 10 factors Unit during within TO Step not whilst Dosing Care assay HEPARIN Ensure suspected Aim concentration: Routine filter bolus/infusion patients contraindication the INDICATIONS CRITICAL ON APTTr addition THE warfarin? multibic /litre CIRCUIT Haematology only WHILE via life 1224 more Robinson 24 Is etc <1 as less This different above Heparin GIVEN action of HIGH INR: 7579 can APTTr: Caution 9094 ratio IINN 1125 ALL Epoprostenol running adequate guidance alert clinical Surgery Bolus concentration from per Title: Consider Short into Discuss Renal patient clotting Prescribe units/ml once short requiring or on continued In nearest if Clotting reduce while units/kg ago BE 6064 HIT? NO provide kg Next rate Anticoagulation Bleeding target cause only: FOR in Therapy correct PE/DVT chart need units/Kg/hr standard And YES 72hrs 09/06/2020 Doses 15 Kallirroi which coagulation exercised to preparation ml/hr review 23 mls Reduce heparin? bloods INR should now guideline problems and 109 unless DOSE Authors:"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Maintaining USE Heparin units Personal 2020 HHAAEEMMOOFFIILLTTRRAATTIIOONN heparin of added Characteristics TOPG140612v1 Category: References stable temperature Guidelines Authorisation: INFUSION Lead Critical PRESENTATION: Naysmith INDICATION: volume 000 Title: ICU infusion diluted final Draft/Final: Status 2017 02/07/14 units/ml with chloride 250 Hannah Product Accessed ONLY 10 patency free ID: FFOORR solution Editorial for hours FINAL chemically Authors: 10ml AND CARE Fannin HHEEPPAARRIINN Words Morag FOR 30ml UK Key CONCENTRATION: Author:Claire Co Lothian Version at Board 40ml Care HEPARIN intranet room circuit March sodium Review Authoriser to CRITICAL Physically Document Date Comments haemofiltration 1000units/ml Summary ADMINISTRATION: Date: and 9% 24 DOSE HAEMOFILTRATION STABILITY: preservative STANDARD communication Directorate ampoules 23/07/2014"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "USE Heparin scot lothian 1000 heparin editorial of AntiThrombotic Unfractionated HEP stable Hospitals Guidelines http://intranet INFUSION Critical Adult PRESENTATION: by: QIT Naysmith INDICATION: 2012 5ml Final version Chart Sep 40 nhs NHS on: Title: infusion ICU Guide Z/Haematology/policy/Documents/Antithrombotic%20Guideline Draft/Final: dose Administration Status treatment units/ml Prescribe on protocol Division ONLY ID: University an ready for hours Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Next Pocket not chemically rate 5000units Authors: entitled Anticoagulation 18 20ml References: AND CARE NEAT BOLUS uk/NHSLothian/Healthcare/A FOR in Morag Approved Reviewed CONCENTRATION: Lothian pdf Paterson 40ml Care HEPARIN separate ampoule intranet 180912 DOSES sodium to review: the CRITICAL section giving Physically schedule complete use 000units Use haemofiltration 1000units/ml Refer Ross v2 ADMINISTRATION: see 2014 and 24 Written: DOSE STABILITY: STANDARD group Prescription ampoules"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "3ml Version:2 USE but 1mg/ml 15/05/19 containing 2022 Claire editorial of Characteristics ADDITIONAL is References stable Reconstitute temperature Guidelines uk INFUSION glucose Critical PRESENTATION: QIT by: Initial INDICATION: 2012 Injectable ork Final powder 200300 dilute critically NHS on: Title: vials emc ICU infusion Guide 1ml volumes Draft/Final: hydralazine 2019 14/05/19 Status restricted water with micrograms/minute ill chloride injections Hannah Product 60ml Accessed ONLY Further NOTES: Medicines range hydrochloride Hydralazine ID: 1218mls/hour HYDRALAZINE within for hours Adapted The Minimum Next each Mark not chemically rate Dunn 9mls/hour Group AND Ed UKCPA FOR in Approved UK Reviewed CONCENTRATION: Lothian individual Version 5% at pressure three medicines Care V4 Titrated 50150micrograms/minute room Updated www Dade patients sodium to the review Hypertension Physically 4th 18/12/2018 Advanz blood use Pharma usually Summary 60mg accessed ADMINISTRATION: reconstitution 20mg and 9% 24 et Written: DOSE STABILITY: May STANDARD al Ampoules group maintenance Authors: fluid"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Solution USE ActrapidR containing units 2020 2022 Claire 1000 of open 23/03/20 added Characteristics ADDITIONAL unit/ml Last Category: References stable temperature Guidelines uk Words: 50 INFUSION glucose Critical PRESENTATION: Prescribed QIT 50ml Authorisation INDICATION: 03/09/19 Nordisk nhs Title: vials human emc injguide ICU 22/01/19 Draft/Final: discarded Injection Status published RATE: vial Hyperglycaemia units/ml chloride injections after Hannah on Product protocol ONLY NOTES: Intranet: updated ID: Authoriser: Editorial for hours insulin Novo FINAL chemically care therapy 10ml AND Limited INSULIN FOR in Key CONCENTRATION: weeks Lothian Also critical at 5% medicines 100IU/ml Board be Actrapid\uf0d2 Care soluble org room www stored March sodium Review Once guide to the 100 Physically Document INTRAVENOUS Date according IV Vials Comments Summary accessed ADMINISTRATION: Insulin Version: should Date: Actrapid via and 9% 24 DOSE STABILITY: STANDARD Authors:"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "pain 70mg/hr AS USE 16: Volumes Wasterlain containing 50mg/ml dose: Shorvon information Selkirk it editorial response of Singh by epilepticus: is Kramer stable temperature Guidelines INFUSION Critical PRESENTATION: QIT by: Naysmith 50ml Brain intravenously case available: 2500mg Resistant INDICATION: 2012 RD reports 5:24656 CJ Early Neurol syringe on: Title: ICU infusion does 1ml ketamine 2013 Draft/Final: based dose over 2019 Status epilepticus CG treatment management patient locked JP administered resistant status From least 134 on 1mg/kg/hr acute ONLY 10 KETAMINE 4ml/hr Infusion press infusions: 2006 unlicensed epilepticus:pathophysiology ID: 299305 superrefractory isolated Loading Ferlisi For for hours Sheth BE Research Sheila The Minimum Next Neurology FINAL Synowiec not chemically care Chen one JWY undiluted Neurocrit References: Group 10ml AND DS UKCPA Morag FOR in Approved Reviewed Checked CONCENTRATION: need at subcutaneous Valeriano Refractory treat adults be Care 2011 room August 1998 to the review Gidal Physically Continuous minute 50mg Schramke use Dec Vials 15mg/kg/hr Maintenance 70kg Ketamine Yenugadhati 50mg/1ml evidence ADMINISTRATION: mostly 500mg Epilepsy 2016 :28022818 see Lancet guideline only and 24 refractory et Written: DOSE STABILITY: intensive STANDARD May 2018 51:1765 al group Authors:"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "pain Aminophylline 3mls/hr bolus USE but DVT large 250units/ml strength acidosis information 375mg 35mls/hr 15mins Rate/duration Additional Dr 150 47mls/hr stable cardiac monograph max hour glucose 20mg/min used 15micrograms/ml Written Naysmith asthma 20micrograms/ml volume 40 ICU monitoring diluted Route: scales interacts treatment first with status injections least Hannah bronchodilation meropenem protocol such July 7micrograms/kg/hr Sodium Hydralazine solution polyfusor 50mg/minute ensure 125ml for indication If PE no undiluted haemodynamically Issue manual Esomeprazole Adrenaline Start APTT sulfate 10ml/hr 1218mls/hr Info titration available sliding 36mls/hr Updated 5mg/kg/hr level sodium Review 000nanogra initially Diazepam Drug 100mg IV 000units usually prevent 1000units/ml Actrapid Glyceryl PRESCRIBING venous 9% See titrate 10microgram dependent 200mg Magnesium catheter Dexmedetomodine 72 Claire response added 15mg Thiopental appropriate is 120mg Guidelines 1500mg micrograms/kg/hr load Critical brand 1gram calcium 11th 50ml 14mls/hr glycerophosphate Isoprenaline through 5ml/hr Amiodarone 20 Intermittent: Centrally: 7ml/hr final Using dose 2019 control Agata 10mg/ml 960mls/hr 60ml ONLY Img/ml then 10mg minutes 520mg/hr Loading hours Addiphos 500ml therapy 20ml 50mls/hr 250ml Midazolam 05mls/hr CVVH Checked Diazemuls aminophylline two be Mannitol required may 500micrograms/kg/hr 41 15mgkg/hr Phosphate Diluent/volume 80mg 12 All 50mg according Both Use 21mls/hr 320micrograms/ml adjusted Ross 60mg 500mg Date: see 010mls/hr 20mg 750 Potassium Vancomycin 1560mls/hr 5mg/ml ms boluses ECG Calcium 20mmol/hr fluid Alfentanil both 1mg/ml previous units continuous 2020 2000mg 1200mg 50 INFUSION severe Rate/duration: are Peripherally: by: 8mls/hr Any depending 28mls/hr refers Paczek 3000nanograms/ml infusion does raised According red Dose: brackets depends September over epilepticus 30mins chloride anticoagulation 200ml 200micrograms/ml unstable after 1250mg *CVC consultant 10 Naloxone range 20units Range Labetalol CVC* Depends 80micrograms/ml 10mls/hour 8mg Rate not effect INFORMATION vasodilatory donation Phenytoin Double hypotension 750mg Morag hrs Information 5% divided Quadruple soluble Care 1000mg given Metaraminol ICP BP the shock 2mg/ml 1mls/hr minute 300mg Over Maintenance Ketamine 20mg/kg 500micrograms/ml Noradrenaline Insulin 26% 900mg via 4micrograms/kg/hr only 60minutes Liam December 1050mls/hr 24 increasing 024mls/hr micrograms 2018 as 2000micograms restriction This 20mmol 10mls/hr Dose/Amount Usually 25mg Heparin Fentanyl Atracurium 25mg/ml phosphate of central 19 625mg can Clonidine 020mls/hr Nicardipine 4mls/hr Propofol start 0120mls/hr peripherally Epoprostenol mls/hr 2500mg 160mg 1000micrograms 52mls/hr Continuous:4 per from prescribed 1001mg Nimodipine 250mg PCA 6mls/hr kardex into As Rate/duration:over 4% patient water Up Prescribe Vasopressin or on Single vein Initially Infusion emergency 100ml if 875mg Note For insulin doses 20% lock Phenylephrine 1750mg isoprenaline trinitrate bicarbonate 40mmol 40ml/hr 5mmol FOR in 4mg/kg/hr 30ml prescribe correct 02 need at chart Prescribing Paterson gluconate 40ml centrally which Morphine out Indication: date Dobutamine 10mmol/hr organ to 06mls/hr preparation discuss Load 1mmol/ml valproate 40mg glycaemic strengths 70kg 160micrograms/ml Electrolytes Flynn MUST 30minutes ove Version: acid 5mls/hr 46mmol loading and Salbutamol 25ml 152 Furosemide 24ml/hr arrest maintenance 125mg"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "Anaesthesia USE 2008 Stanley containing 50mg/ml pharmaceuticals response of central added Characteristics Category: is References stable temperature Guidelines INFUSION Critical PRESENTATION: asthmaticus QIT Management Goyal access intravenously case Authorisation 2500mg last asthma INDICATION: has 20/03/2018 Injectable Final reports adjust asthmaticus: Intranet ventilated online Paczek syringe Title: 7ml/hr ICU infusion does cases Guide treatments tissue ketamine 2013 irritation Draft/Final: based 2019 lifethreatening Status CONTINOUS pH patient locked administered injection Journal Agata status on Product bronchodilation Agrawal ONLY KETAMINE Medicines range updated Medicine June conventional unlicensed ID: Authoriser: isolated 2021 Editorial For for hours The indication kg not chemically rate care Administer low undiluted cause 70 10ml AND CARE Words in FOR Pain Key Vol CONCENTRATION: 154161 need at Start 35mg/hr Refractory medicines Board adults be Care responding 50mL org Continuing 15 may room Education 500micrograms/kg/hr www 5mg/kg/hr patients Review to the review Indian Hameln CRITICAL damage Physically Document Date according use 21/09/2018 Maintenance Ketamine Comments Summary accessed evidence ADMINISTRATION: mostly 500mg Version: p9599 Date: vol17 extravasation via Vial and venous device 24 DOSE STABILITY: uk/emc/product/6935/smpc Tunninclife intensive STANDARD Authors:"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "USE 1mg/ml but large containing 2020 LABETALOL central of beta added can Usual receptor 24hours ADDITIONAL AB necessary Category: site activity is References stable 160mg/hr temperature Guidelines preferred INFUSION glucose used Critical PRESENTATION: QIT access uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS November Resite Authorisation peripheral INDICATION: Ibisqus has alpha Injectable Final from asp dilute all nhs Title: 15mg/hr wales ICU infusion monitoring cases Guide tissue avoid irritation other 100mg/20ml uk/emc/product/10831/smpc#gref Pharmaceuticals 2019 signs licensed EMC pH higher first administered injection chloride inflammation or Accessed ONLY INFORMATION: administration vein Medicines Intranet: Initially Sodium hydrochloride administer unlicensed ID: https://www if Labetalol Central solution medusa 2021 Glucose For for doses The If not chemically rate Authors: 500ml Status: infusions low Hydrochloride undiluted cause https://medusa Limited AND CARE 120mg/hour Words FOR in UK Key 2023 CONCENTRATION: RPH Bowmed administration: 5% at Peripheral light medicines :Lothian be 40ml Care separate Board February required org date: may room Editoral available Updated Protect injection/infusion March level sodium Review Authoriser to the CRITICAL uk/IVGuideDisplayNewFormat damage Hypertension Physically Document up Date maximum preparations diluent unavailable Comments Use affecting titrated labetalol Cromarty lumen ADMINISTRATION: 500mg Version: Date: blocking extravasation closely Chloride via December and venous 9% device DOSE STABILITY: STANDARD 5mg/ml Ampoules cannula 200mg insertion Mairi"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "20mmol USE 50mls October 21/10/20 containing 2020 2022 Claire of added 2009/2011 Characteristics Martindale Normal ADDITIONAL metabolism necessary Last TOPG140612v1 Treatment Category: References stable temperature Hospitals serious Guidelines Emergencies Authorisation: INFUSION glucose Lead severe Critical PRESENTATION: OR mmol/l peripherally November INDICATION: Injectable Final NHS 8mmol 20 Title: intranet: ICU Guide Correction 25/09/20 DivisionAdult Draft/Final: Intensive over Injection Status treatment equivalent with Medical once chloride hypomagnesaemia: or Hannah arrhythmias: Product MMAAGGNNEESSIIUUMM acute Accessed ONLY range: 10 NOTES: Medicines updated uk/emc/product/3539/smpc Medicine 100ml https://www if Central ID: Handbook minutes University Editorial For for hours The associated chemically App BNF 10ml AND CARE 250ml Severe Words in Author: UK Key asthma: Lothian administration: 5% at Also critical Version 2g Peripheral medicines Board be Care 2002 org Dose centrally Magnesium may room Updated sodium Review Authoriser to arrhythmias Norohna CRITICAL bronchospasm repeated illness: Physically Document INTRAVENOUS Date hypomagnesaemia Pharma Comments 50% Summary assessment ADMINISTRATION: magnesium Date: and 9% 24 et DOSE STABILITY: STANDARD Directorate 28:66779 sulphate al Ampoules 2mmol/ml: ampoules 02/09/20"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Solution Medusa USE infused secondary of Category: References stable temperature monograph Guidelines uk Foundation Authorisation: INFUSION glucose Critical Devon PRESENTATION: peripherally Naysmith INDICATION: Injectable Final Characetristics version 18/17/14 through nhs NHS Title: 06 emc injguide ICU 16 Guide 1ml Short Draft/Final: Injection Status published treatment with after 10mg/ml or Product METARAMINOL consultant ONLY Accessed 10 vein Medicines Infusion 100ml ID: injection: 3mg/hr Editorial South for hours discussion term Torbay chemically Authors: largest AND CARE hypotension 10mg/mL 500 FOR in Morag CONCENTRATION: Lothian Version 5% at Rosie medicines Board sedation be Care org Metaraminol room available www Review Authoriser to Trust the CRITICAL Physically Document Date 50mg Infuse MacFadyen Can Summary accessed ADMINISTRATION: Date: 01/07/2019 and mls/hour 24 DOSE STABILITY: STANDARD Directorate micrograms/ml ampoules 7/7/16"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "envelope USE both but 2008 previous Susan Smyth October units determining 2022 9am MIDAZOLAM RIE chase of it editorial 19 24hours 30 by Thiopental Monday thiopentone DIAGNOSIS LEVELS redtopped takes is provided handwritten 26879 Guidelines EDTA are Critical day THIOPENTAL these QIT Friday by: TRAK principles Mike courier adequate recommended Sample: has they exclude Final reports WGH will extension through from sample Walker Timings: built on: Title: effects ICU arrived WGH/RIE brainstem numbers Gr\u00e1inne 5mls DEATH Results: Draft/Final: going 2019 levels Status pharmacokinetic 02920 with take prior after thiopental Units: place on outwith below ONLY 716894 been duration Samples July CONFIRMATION then ID: if receipt results involve reason Oncall an Duty drug frozen 31899 for MonFri hours Next each If not PRACTICE Authors: number spun depressant hand >5mg/L tube go Ordering: 10ml AND CARE form biochemist liaison Phone Midazolam in FOR drugs Approved 19:30 Write Reviewed want you Clinical Reference at testing morning prediction adults be Care children agreed 2011 required available Contact August level Process: deep Once to Analysis the review CRITICAL Wales sent possible details undertaken name All Address up blood have according OF usually 48hours analysis mg/L THE person Not duty FAO Biochemist assays should Destination: Cardiff deliver switchboard contacted numbers: only via THIOPENTONE Crane December and do 09:00 5pm Written: explain See that CODE midazolam Biochemistry samples group request sampling contact processed"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "bolus but 1mg/ml 2ml containing strength continuous 2020 2022 pharmaceuticals MIDAZOLAM using mg of added prepare Characteristics below: mixed generally epilepticus: Treatment Category: is there 120mg stable temperature Guidelines Prefilled uk uk/emc/product/4116/smpc preferred INFUSION glucose any are used Critical these PRESENTATION: QIT Accord 50ml Authorisation last INDICATION: pump 5ml Injectable Final Healthcare PFS will 10mg/2ml Intranet Bolus concentration uk/emc/product/10967/smpc volume online prescribed nhs syringe NHS Title: injguide ICU infusion medicinal diluted Guideline Guide Clarke final 28mg/hr library Using other issues Draft/Final: 2019 Status epilepticus 25mg/hour patient with Volume 24ml injection chloride status or on Single when wastage Product 60ml Medicines July Initially June 10mg 050 ID: https://www if solution Authoriser: 500micrograms 50mg/10ml Editorial *note drug suitable 01/05/20 For for hours doses DERS Amount If not chemically Preparation Sedation: reviewed supply 20ml Group References: Double 10ml AND ltd Limited Words Midazolam in 4mg/kg/hr 30ml UK :1mg/ml Key CONCENTRATION: Lothian Also 5% at 30/04/20 medicines be Care Ranbaxy 50mL required org given may room available www injection/infusion BP level sodium Review to preparation the Hameln 10mg/5ml Physically 2mg/ml Document Date 50mg 100mg preparations use Maintenance 70kg prevent Comments Use 21/05/20 titrated Summary Not No products 60mg accessed ADMINISTRATION: Version: should Date: only via strength:2mg/ml uk/emc/product/6420/smpc and 9% Monograph dilution 12ml 24 compatible DOSE STABILITY: Written: double Sedation STANDARD May midazolam 5mg/ml as Ampoules Authors: prefilled"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "USE 2mg/minute 1mg/ml Infusion: tolerance 25/06/20 continuous 2020 2022 Claire response of added Martindale Usual Last Category: is stable Guidelines uk INFUSION are Critical Written PRESENTATION: QIT 50ml Scottish ADMINISTRATION Authorisation INDICATION: pump Injectable 100mg/50ml and/or Bolus concentration volume online dilute nhs Title: vials injguide ICU infusion diluted Guide final Draft/Final: dose over Intensive Injection Status patient Sulfate with administered injection chloride uk/trainingeducation/sicsinductionmodules/sedation10 10mg/ml or on Hannah Accessed ONLY range: Medicines Intranet: updated June analgesia https://www if solution injection: ID: Authoriser: slowly minutes uk/emc/product/3576/smpc Editorial Society 01/11/19 For for hours doses FINAL If not chemically rate Authors: MORPHINE Administer undiluted tube References: 10ml AND morphine BOLUS Words in FOR Key CONCENTRATION: Lothian at medicines Board sedation Care ampoule required org titration Morphine www Analgesia patients sodium Review to preparation 05mg/hour the receiving 10/06/19 endotracheal 2mg/ml Physically Document Date 100mg according maximum use IV Pharma Comments usually Use uk/emc/product/3541/smpc scottishintensivecare accessed ADMINISTRATION: intravenous Version: Date: Adjust via and 9% 24 Sulphate DOSE STABILITY: Sedation STANDARD 12/6/20 12/06/20 ampoules"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Solution USE 25mg dose: Claire mg therapeutic of added Characteristics can by Nicardipine Last Category: site is References stable Guidelines uk INFUSION glucose 40mls/hr Critical PRESENTATION: QIT type Management peripherally change Authorisation increased Initial INDICATION: Final efficacy from progressively nhs 20 Title: emc injguide ICU infusion NICARDIPINE avoid irritation Draft/Final: dose Injection Status reached management mg/hr ml control administered injection injections or 10mg/ml Aortic Hannah Product acute Accessed 3050mls/hr ONLY 10 administration updated 10mg Preferably ID: solution Authoriser: minutes between 2021 Editorial within for For hours The 20/05/21 35 If not chemically rate Intranet:24/05/21 Intravenous target AND CARE 250ml 10mls When Words in FOR exceed Rates Key bag CONCENTRATION: 2023 increments Lothian 5% at pressure hypertension light medicines Board be Care separate maintain org Commence centrally given 15 Protect STABILITY www Remove Review guide to every the 100 CRITICAL dissection 12 Physically reduced Document Advanz Date according Add IV Pharma Maintenance Comments usually 150mls/hr Summary accessed ADMINISTRATION: intravenous Version: should Date: see guideline via and 24 25ml DOSE May STANDARD micrograms/ml Authors: 07/12/2018 nicardipine"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Solution equal Stable USE catheter 50mls increase aneurysmal containing co 2020 2022 using conjunction of central added following Bodyweight decrease mixed pressure: necessary Category: Treatment is provided ratio Guidelines subarachnoid Bayer high INFUSION glucose used Critical table PRESENTATION: haemorrhage QIT port 50ml NOT 02% last recommended INDICATION: Authorisation Injectable Final must Intranet 5ml/hr from about online Nimodipine syringe Title: Fiona observed human ICU infusion NIMODIPINE Clarke Guide 2mg/hr nimodipine: connected clinically irritation other into Draft/Final: albumin dose September Status mannitol patient vial first with administered chloride unstable 500micrograms/hr connect 200micrograms/ml after or on started below ONLY 10 uk/emc/product/1366/smpc revised Medicines deficits 10% Infusion 10mg 70kg: plc ID: https://www if Authoriser: than an Editorial for hours The not This rate characteristics no risk second Group tube References: AND CARE polyethylene in FOR drugs bag CONCENTRATION: Lothian 5% pressure two light medicines due be 11/08/20 Care 10ml/hr neurological 1mg/hr coinfusion org NNiimmooddiippiinnee Protect August sodium Review ethanol to significant the withdrawn CRITICAL Document Date blood 30/07/20 Vials 70kg threeway Nimotop providing Summary content products accessed ADMINISTRATION: MUST Version: should Date: see line via ischaemic stopcock and venous 9% greater DOSE increasing STABILITY: STANDARD nimodipine 1:4 bottle Authors: less"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Tonnesen Anne USE 1mg/ml inotropic catheter but Volumes SPC sensitivity DJ strength 2020 8ml Pharmaceutical mg editorial of April central added prepare many contains ADDITIONAL Brustugun Technology Category: occurring Sympathomimetic References is Warner stable Neally Guidelines seen highconcentration Photosensitivity INFUSION glucose One any used Critical brand Strength table PRESENTATION: Bisulfite Used nih Naysmith Absence Authoriser:QIT Authorisation product INDICATION: 160mg 2012 has \u00a33 Naturally Final primarily 09/04/2020 Commonly Intranet Peddicord through concentration from volume Am KM temp base Zumbrunnen 20 asthmatic 58 critically Title: 2020: effects ICU infusion NOREPINEPHRINE cases micrograms/kg/min 1mg/ml: :296308 other Draft/Final: depends September dose Pfizer Status noradrenaline equivalent 2mls/hour TL vial restricted ml Update PDA injection chloride 54: Journal ill or on Single below TE ONLY 2004 Accessed Pharm Words/comments NOTES: Initially updated hydrochloride Infusion Norepinephrine 100ml ID: if injection: frequently 160 80micrograms/ml an 1997 Glucose catecholamine 8mg Levophed for hours precipitate The Minimum costs FINAL not chemically rate Authors: bitartrate 500ml dopamine infusions prepared Group norepinephrine Double population AND CARE 250ml nlm UKCPA Morag FOR in Key Consult CONCENTRATION: bag Also 5% at Media Webb Quadruple Allergy light 80 be Care ampoule single vasoconstriction cfm?setid=c4de72a82a754984ce90 required room bold Critcal which Protect Remove 320 Do level sodium patients Review 4ml to 80mg the New Olsen CRITICAL Physically 14179 Agents Document 40mg INTRAVENOUS Kristensen nitroglycerin Infuse Presence HealthSyst use Date Dec annotated Comments Use 160micrograms/ml 320micrograms/ml titrated Noradrenaline metabisulphite ADMINISTRATION: Science https://dailymed Version: 04 Date: 20mg and venous more 9% 24 some DOSE STABILITY: discoloured preservative NORADRENALINE STANDARD \u00a31 gov/dailymed/drugInfo HH as micrograms/ml dextrose Sulphite e4870226dc12 2018 group ampoules Stability It fluid"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "long USE Nondepolarising large Network containing hourly dose: 2020 2022 action using of Additional added Characteristics can 24hours ADDITIONAL caused by order Category: please is trainoffour stable References Hospira Guidelines glucose Critical 01/07/20 PRESENTATION: QIT relaxation Authorisation Initial peripheral recommended ideal INDICATION: Manufactured Injectable 60microgram/kg asp common all nhs Title: wales monitoring Guide CVC Muscle irritation Draft/Final: over uk/emc/product/3793/smpc Status pH 2030microgram/kg 4mg/2ml Pancuronium requirements with injection chloride body Ltd or Product Accessed ONLY INFORMATION: administration duration vein In Medicines Intranet: July Trissel administer ID: https://www if PANCURONIUM Storage Authoriser: during minutes Note Knowledge Editorial for doses 35 neuromuscular FINAL chemically agents Bromide risk nerve low undiluted https://medusa AND CARE uk/IVGuideDisplay Words FOR in weight UK Key Micromedex CONCENTRATION: Lothian 5% function medicines Board due be Care required org given individualise sodium Review to the Ideally CRITICAL Physically 2mg/ml Document Date use IV ease pancuronium Can Comments Summary Cromarty dosage ADMINISTRATION: Version: Date: blocking via and venous 9% DOSE STABILITY: May stimulation agent Ampoules Authors: Stability Mairi"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "tobacco Oral USE but above who failure Bioavailability containing 30mls/min Britain bnf Formulary paracetamol suspension Pharmaceutical Claire it 46hours editorial of days Characteristics PR 100% 30 71st Costs: is References ed Suspension Guidelines normal uk high oral available? few are Critical 07 these PRESENTATION: QIT by: Naysmith ADMINISTRATION Patients Great alcoholics recommended INDICATION: tablets 500mg/suppository National Soluble therefore receive dosing develop on: greatest vials Title: British infusion 1g/100ml 16 inducers other Draft/Final: dose over 2019 levels groups malnourished Status CrCl< treatment patient sparing Give PARACETAMOL Prescribe with lower Actavis disease Medical considered Ltd smokers eaten or 10mg/ml on when liver Product London: acute Hannah 50kg glutathione below ONLY Accessed \u00a30 nasogastric aiming In factors neuro 60mg/kg then weaning analgesia prudent if solution ID: frequently NB than minutes Society for hours doses nasojejunal Next 4g FINAL If not CAUTION: daily risk no 1g/suppository enzymes one 46 low 1g Intravenous AND CARE Morag FOR in Approved weight recommendations UK Reviewed at >50kg Antipyretic: opiate medicines suppositories be Care T>40oC org 15 may www REVIEW Royal August hepatic patients postoperative every preparation 500mg/tablet to the review Paracetamol set route CRITICAL those giving caution DAILY normothermia 250mg/5ml have maximum preparations dehydrated IV OF exposure Yes 56 Association Use <50kg Summary No 3g 15mg/kg ADMINISTRATION: continuing intravenous 2016 enteral see T>38oC only via jejunostomy and sepsis more Is six Written: DOSE severely even Analgesic: ROUTE 25 \u00a31 would group Authors: give less follow"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "3ml Version:2 6468kg well Medusa Springer USE catheter 2008 extreme large 2ml Smyth Patient containing Dilution dose: strength 540mg being Claire 930mg of followed central prepare added Characteristics Martindale 600mg by Berlin Last site is 06/04/2021 120mg Select stable temperature Guidelines uk org/10 oral 100mg/minute INFUSION 270mg 9497kg used 45ml Critical Yearbook table PRESENTATION: QIT PHENOBARBITAL 50ml intravenously Patients depending Authorisation 990mg INDICATION: 4045kg 5ml Injectable 1007/9783540772903_76 36ml 31 Epilepticus Intranet Bedos volume 200mg/ml 40 nhs monitor syringe Title: Legriel emc injguide ICU diluted Guide 1ml final Gr\u00e1inne Published Total avoid syringes Draft/Final: dose 420mg over Intensive Status epilepticus pH this 5156kg water ml with ill once injection prior status 180mg least 240mg or on Hannah Product same below Accessed ONLY 6974kg administration vein 6mg/ml Phenobarbital 4550kg updated Medicine administer Preferably 10mg/kg ID: Authoriser: 210mg eight minutes 660mg 30mg/ml 960mg Editorial 2021 For for hours 8689kg 9093kg https://doi each If 480mg not chemically daily FINAL 18ml vol Administer 20ml References: PHENOBARBITONE 10ml AND hypotension Words FOR Dilute in weight 30ml Key 2023 Managing flush Lothian 840mg 60mg/ml 35ml at 870mg Refractory medicines Board sedation phenobarbital due Care be ampoule 40ml 22/07/2020 Critically apnoea 1000mg required 27ml org Emergency 720mg Heidelberg room www sodium Review 4ml to the bandings 7580kg CONCENTRATION 5763kg possible Syringes Azoulay part 98100kg Physically Document 300mg up Each Date maximum use Pharma 9ml Summary 23/01/2018 ADMINISTRATION: Epilepsy should Date: 780mg see deliver guideline previously via osmolality loading and venous total 24 DOSE STABILITY: In: 8185kg STANDARD May Where as add Ampoules maintenance Authors: give"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Solution USE Susan containing 2020 2022 of added Characteristics 20/09/18 Usual ADDITIONAL 50mls/hour Last Category: Dr References 20/11/18 stable temperature Guidelines INFUSION glucose are phenylephrine Critical PRESENTATION: Team QIT Management consult Authorisation INDICATION: 20micrograms/ml Injectable Final WGH medical staff Epidural Title: ICU Guide Draft/Final: PHENYLEPHRINE Hypotension Injection senior Status higher chloride 10mg/ml or on Product Accessed ONLY 10 INFORMATION: revised Medicines Intranet: uk/emc/product/4176/smpc June Infusion 10mg ID: https://www Authoriser: 2021 Editorial for hours doses The Phenylephrine Angus If chemically rate 500ml reviewed AND hypotension Words FOR in Dilute Pain Key CONCENTRATION: Therapy Lothian 13/08/20 Also 5% at uk/emc/product/5577/smpc medicines Board February Care Maxine required org room BP sodium Review to Vasoactive Nimmo Physically Document INTRAVENOUS Date Comments Summary ADMINISTRATION: Version: Date: via December DOSE: and 9% 24 DOSE STABILITY: STANDARD 2018 Ampoules Acute Authors: 02/12/20"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "practice phenytoin USE catheter but large updated: Smyth Patient error containing 50mg/ml dose: October Formulary information Claire it using of added 19 Characteristics can ADDITIONAL mixed Last Category: Treatment Dr is References there stable 19/09/19 Guidelines hour Emergencies Improvement INFUSION inline without minimise glucose are severe used Critical brand regimens 07 PRESENTATION: Adult Alert: QIT peripherally Calculations November note Kent death 2500mg product Authorisation INDICATION: 5ml clinical National Final Intranet therefore through Augut per concentration from online NHS 250mg Title: effects British ICU ideally monitoring diluted infusion Guideline Gr\u00e1inne avoid irritation However Draft/Final: Greater dose over Pharmaceuticals Pfizer 2019 Status epilepticus essential with Medical administered once chloride unstable micron injection status Ltd after 10mg/ml or Hannah Product 60 same below before ONLY Accessed administration vein free NOTES: Initially administer GRNimmo 100ml ID: if Central solution Authoriser: during 50mg/minute slowly minutes than Handbook reflect harm Editorial 2021 Loading for hours larger precipitate doses 35 Handbook: irritant If not seizures rate chemically no 80kg Administer one Hikma Safety incompatibility haemodynamically Phenytoin hypotensive routinely AND CARE 250ml Ed Risk Words in FOR UK Key Obese flush Lothian administration: need local pressure at 5% divided standard 26 Peripheral two Board due be Care 1000mg TITLE Dose centrally Glasgow may which filter consider patients physical sodium Review to every 2009/11 <80kg the Linited CRITICAL those Therapeutics giving Physically Continuous injectable 250mg/5ml Document up blood 100mg maximum Infuse preferable use rates according Date PHENYTOIN Maintenance Comments 20mg/kg Use prophylaxis 50mg/1ml Summary haziness ADMINISTRATION: 2016 should Version: Date: via only loading and do more 9% To dilution greater Clyde DOSE STABILITY: See that STANDARD as Ampoules 220 soon maintenance Authors: ECG"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Solution 20mmol Hypophosphataemia USE PPhhoosspphhaattee containing 08/2018 Personal phosphate RIE of added Characteristics can Martindale ADDITIONAL 02/2015 necessary Category: stable temperature Guidelines stability INFUSION glucose Acid text Critical PRESENTATION: cid:210 peripherally Polyfusor Authorisation glycerophosphate INDICATION: potassium 2mmol/ml WGH Intranet 11/99 Fresenius Title: vials hypernatraemia 02/2009 ICU 10/8/18 Draft/Final: Pharmaceuticals over 2019 Status 13 with 50mmol PHOSPHATE or Hannah Product Prescott 60ml Accessed ONLY NOTES: Medicines Sodium regarding ID: if Authoriser: polyfusor FreseniusKabi 2021 for hours Addiphos FINAL If chemically Authors: 500ml 6% 40mmol 02/11/16 20ml 5mmol References: 10ml AND CARE consider: Words FOR in 25/5/16 Key 20/10/14 Information 5% at Revision be 40ml Care 30mmol centrally given may room 10mmol March Phosphate sodium Review to made CRITICAL 1mmol/ml 81mmol 12 Physically Document INTRAVENOUS up hyperkalaemia Date Comments Summary products Kabi ADMINISTRATION: Version: Date: acid only December and Potassium 24 DOSE STABILITY: Phosphates STANDARD communication concern ampoules"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Concentrate 20mmol pain 31/05/18 USE Pharmacy large containing Claire monitoring: 10mmol/hour Monitor of added 2009/2011 evaluation Characteristics can particularly concurrent Last Category: is 2003 stable temperature concentrations: Hospitals Guidelines equals Emergencies glucose INFUSION severe Critical 01/07/20 PRESENTATION: 1000ml Adult QIT Eckhardt 60mmol Authorisation 4mmol/ml peripheral INDICATION: 2012 potassium Injectable Final through per concentration online critically except 18% preprepared NHS Title: Preprepared 40mmol/l ICU infusion policy Guide physician volumes Draft/Final: concentrations bags Sept Status higher 4% restricted ml with Medical administered ill chloride uk/emc/product/6272/smpc or on Hannah when Product Division ONLY Accessed vein Swanson revised July Medicines Intranet: Sodium 100ml Edition if Central https://www ID: Authoriser: emergencies Handbook 2mmol University an Editorial 2021 Glucose for hours Minimum Angus potassium/litre chemically 500ml 40mmol REFERENCES: Implementing BNF Group Closson AND CARE Words FOR in where Rates Key 2023 CONCENTRATION: 25:66264 Lothian administration: bags: 5% at 10:348 80mmol/l Peripheral medicines Board February be rate: Care Maxine concentrated org 352 given may room Maximum January patients sodium Review to replacement CRITICAL 1990 20mmol/hour Physically 4th Document Date An maximum Infuse IV 15% Comments Use Hospital Summary hypokalaemia No ADMINISTRATION: intravenous Version: Date: Chloride only via and Potassium more 9% phlebitis 24 DOSE STABILITY: STANDARD POTASSIUM Pharmacist Ampoules 3% RG Authors: ECG 02/12/20 fluid"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "bolus USE containing 2020 Claire action of April added 19 Characteristics Usual Category: Dr is References stable temperature Guidelines zero INFUSION Rocuronium 14 600micrograms/kg Critical start PRESENTATION: ROCURONIUM relaxation Naysmith 50ml Available Authorisation INDICATION: ideal 5ml Intranet blocker syringe 20 Title: vials Base emc ICU infusion intermediate Muscle Draft/Final: dose Pharmaceuticals Status Gibson patient Give with administered body Ltd or 10mg/ml on Hannah Product Accessed ONLY duration Words/comments range then ID: solution Authoriser: during an COVID For for hours doses neuromuscular FINAL chemically undiluted 10ml AND CARE Morag FOR in weight Key 2023 CONCENTRATION: at medicines Care org room www 600micrograms//kg/hr injection/infusion Review 4ml to 300micrograms/kg/hr Hameln CRITICAL 2ml/hr Physically 1mls/hr Document 40mg INTRAVENOUS up Date 70kg Summary ADMINISTRATION: 500mg Version: Date: nondepolarising and 24 DOSE STABILITY: NORADRENALINE STANDARD as Ampoules Authors: give"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Solution Preferred also USE 1mg/ml but large failure containing 2020 2022 Claire of central added Characteristics ADDITIONAL Last TOPG140612v1 Treatment site is References Category: stable Guidelines hour Authorisation: INFUSION glucose Lead severe used Critical PRESENTATION: QIT access peripheral INDICATION: 14/10/19 2012 has 5ml Injectable Final critically 20 Title: intranet: ICU infusion monitoring cases Guide SALBUTAMOL tissue volumes Dose: irritation Draft/Final: Status 1801200 pH restricted 490ml with micrograms/minute ill chloride 06/12/19 Hannah on Product 60 acute ml/hour Accessed ONLY been vein revised NOTES: Medicines administer 10mg Edition https://www ID: 2021 Editorial for hours doses Minimum Angus If chemically effect reviewed salbutamol low Intravenous cause Group 10ml AND CARE UKCPA Words in FOR Dilute Author: Key Rate: CONCENTRATION: Lothian Ventolin 5% Version Higher medicines Board February Care Maxine org may patients sodium Review Authoriser to 5mg CRITICAL damage bronchospasm Physically 4th Document micrograms/ INTRAVENOUS have IN Date success diluent uk/emc/product/853/smpc unavailable Comments titrated Summary ADMINISTRATION: intravenous extravasation closely via December and Salbutamol venous device 9% 24 respiratory DOSE STABILITY: STANDARD micrograms/ml Ampoules insertion 02/12/20 fluid"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "induce USE infused Pharmacy large Goodey Britain Formulary acidosis Pharmaceutical Press Claire editorial of central Gray starting BICARBONATE com 50mls/hour appropriate Wright 71st is References cardiac stable temperature ed Guidelines micromedexsolutions Harries INFUSION severe used Critical 150mmol PRESENTATION: QIT by: peripherally access Naysmith 50ml consult Great Drayan Metabolic INDICATION: National Injectable injected 2010 through medical volume staff UCL Title: on: Na+ eds British 16 Guide Draft/Final: into Administration 2019 senior Status 4% equivalent Shulman with Medical administered Volume chloride 200ml after SODIUM or Hannah London: before ONLY Accessed administration In vein diuresis Sodium emergency 2006 ID: small solution an Society for hours Next FINAL each If not chemically AH 1000mmol 500ml bicarbonate either Eds infusions Solutions AND CARE hypertonic Morag FOR forced Approved Reviewed CONCENTRATION: Blackwell correct Clinical at be Care Drugs flushed centrally dedicated given may room available Royal www August sodium to the review CRITICAL giving Drug Physically INTRAVENOUS IN alkaline Association usually Trissel\u2019s /litre lumen ADMINISTRATION: intravenous Data should Science 2016 26% HCO3 and situation 9% 24 et Written: DOSE STABILITY: as al arrest group restriction Authors: give"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "VALPROATE well USE but above >600mg containing continuous 2020 8ml Claire editorial of followed added Characteristics 24hours 600mg 1200mg by 30mg/kg is provided stable Reconstitute Reconstitution temperature Guidelines uk oral glucose confirmed without INFUSION are 14 Critical Peripherally: PRESENTATION: QIT by: peripherally Naysmith displacement Due 2400mg INDICATION: 17 ideal Injectable powder must concentration from volume all nhs test Title: vials on: Centrally: emc infusion ICU does diluted injguide Guide final slow Draft/Final: into dose As over Administration Status epilepticus 2017 equivalent water this vial further reconstituted essential checked with administered pregnancy injection chloride injections status after least SODIUM or on body Hannah teratogenic 60 Product before ONLY Accessed been administration In Medicines obese excluded Sodium infusions: 100ml ID: if solution minutes an For for hours doses 35 Next FINAL each If not chemically rate daily Authors: infusions 20ml References: AND CARE 400mg Morag FOR in Dilute Approved weight exceed Reviewed bag CONCENTRATION: 100mg/ml flush Also 5% at divided three medicines be Care ampoule required org centrally healthcare Doses given dedicated may room down professional www intermittent injection/infusion Remove patients sodium 4ml to the review CRITICAL Intermittent possible 11/5/18 Edited valproate 12 Physically have maximum four use Vials Epilim Summary RP lumen accessed ADMINISTRATION: intravenous Epilepsy should 20mg/minute line reconstitution previously solvent via loading December plasma and total 9% dilution 24 Written: initiation negative DOSE STABILITY: that STANDARD as group boluses"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "On approximately: USE catheter 2015 SPC containing Vincent document 25mg/ml Claire it editorial of central measures 19 ADDITIONAL by Thiopental thereafter 40mls occasions Treatment is activity replace stable Reconstitute temperature obtaining Guidelines hour uk high INFUSION aim 1500mg used Critical Yearbook THIOPENTAL start PRESENTATION: QIT by: Naysmith monitored rare Patients INDICATION: potassium dangerously powder Epilepticus through drop Bedos per concentration from concurrently on: Title: vials Legriel emc 1220mls ICU infusion check Cerebral raised Consider ketamine 2009 brain other symptomatic concentrations Draft/Final: Intensive general Injection levels isoflurane epilepticus Status treatment cautious patient water first intracranial with Serum considered antiepileptic status injections Ltd thiopental SODIUM or Caution: on Hannah below 60ml Accessed ONLY burst checking INFORMATION: In our such Mclellan Medicine desflurane ID: if during an drug while advice for hours The Next FINAL each If not chemically agents saturation infusions 20ml References: Continue hypothermia AND infuse FOR in drugs Morag Stuart UK interpreting Approved Reviewed CONCENTRATION: Managing adult electrical unresponsive at pressure Thiopentone standard three additional medicines light be infusing Care separate Critically Emergency stopping keep org dedicated 15 may room falls Protect www August consider Do BP sodium 24mls to arrhythmias every 0mmol/l preparation the traumatic review replacement Azoulay giving valproate Edited details Physically Infuse experience ceasing injury Pharma topiramate Vials 70kg jugular suppression hypokalaemia anaesthetic serum advisable ADMINISTRATION: 500mg should THIOPENTONE reconstitution Ill only and venous 1224 simultaneously 24 refractory levetiracetam Written: DOSE STABILITY: See STANDARD Archimedes 2018 as rebound group Authors: give It"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "transferred North 50mg/ml hourly stopped Suggested 375mg mg patient\u2019s by Category: Dr 150 References stable hour 90 Authorisation: glucose >1gram: 1525mg/l OONNLLYY Wilson 188 5ml dosing Table volume 77 Cockcroft NHS new staphylococcal 185 6\u20197\u2019\u2019 Guide 68 seriously considering 6\u20195\u2019\u2019 senior recent Status treatment 5\u20196\u2019\u2019 Check checked with ill 4\u201910\u2019\u2019 body injections least 165 Hannah Thomson started 60 below immediately 2004 Randomised interval level>25mg/l 2X 198 FFOORR TDD 160 mls/min Editorial for The Angus If care 74 daily 6\u20196\u2019\u2019 infusions 20mg/l Gault Group 25mg/l 10ml Height Obtain 193 urine Weight Key 2001 85 Version critical Thereafter Start Board taken intranet Dose midnight 191 Remove replacing level sodium Review Daily 158 Wyscocki 54 CrCl versus Date wt 49 4\u201911\u2019\u2019 output serum 04 Adjust 0ml female venous 9% Ther UUSSEE creatinine al give 6\u20192\u2019\u2019 also depend catheter feet Infusion: Pharmacy Complete calculate added is 2003 Guidelines 4059kg 1500mg Critical day QIT tables \uf0a31gram 50ml 88 Scottish 17 receive 4\u20199\u2019\u2019 medical Adults 5\u201911\u2019\u2019 96 20 90110 final 45 dose based 2019 reconstituted 173 as: had osteomyelitis: before 163 been June then 79 55 3500mg than between recently Loading advice hours Clearance Western GGuuiiddeelliinneess deteriorates :24602467 500ml Infirmary >30mg/l 20ml Intravenous 6\u20190\u2019\u2019 6090kg 250ml actual 10mls 195 weight deepseated Lothian 5\u20195\u2019\u2019 course two adults be :351357 years cm responding 15ml required may 41 consider Authoriser wait Guidance receiving 66 12 Continuous All reduced Draft/Final:Final complete maximum according use Can Creatinine Use 5\u20194\u2019\u2019 CVVHD 201 clearance Female dosage steady micromol/l 500mg Date: 107 mls/hour >90kg Vancomycin 7589 5\u20190\u2019\u2019 60micromol/l split previous 6\u20193\u2019\u2019 continuous 2020 2022 sooner 47 Restart following 2000mg age>16 145 state severe 140age 94 Injectable CCVCI010511v2 3000mg 58 vials infusion 5\u20198\u2019\u2019 175 Dose: Chemically over Increase 180 <15mg/l No: further Carmichael 4\u20198\u2019\u2019 chloride after 2029 when 1250mg 98 168 Accessed checking Pharm renal range ID: suitable equation Please intervals each 3rd not Preparation trough prepared 5\u20199\u2019\u2019 750mg infections 5% 5\u20197\u2019\u2019 divided Care recheck 1000mg applicable 29 given intermittent January achieve patients pulsed Trust the Discharge CCOONNTTIINNUUOOUUSS 155 Document weight? Maintenance 43 3039 prophylaxis Prospective 6am morning\u2019s Clin 178 line via only 147 December Chemotherapy 101 24 71 Is Study increasing 4054 commence less This 183 5574 CCaarree High 5\u20191\u2019\u2019 82 6mls/hour of central 625mg can adjusting >110 Reconstitute 62 Seek 01/12/2020 table CCRRIITTIICCAALL regimen peripherally running mls/hr 2500mg IINNFFUUSSIIOONN has 2nd will must BW from concentration 8mls/hour 250mg Title: 113 However twelvehour into 52 present 612 levels patient water equivalent 6\u20191\u2019\u2019 170 Prescribe time Volume administered or on Vuagnat Yes: Adjustment Medicines Max Infusion 100ml if 875mg 6\u20194\u2019\u2019 5\u201910\u2019\u2019 reduce 5\u20192\u2019\u2019 Antimicrobial doses Male infections: kg 1750mg rate 5\u20193\u2019\u2019 2025mg/l male target Words in 30ml bag vancomycin 1mls/hour 35ml chart at Prescribing function <40kg maintain centrally dedicated Glasgow Stop which related Decrease eGFR to Multicentre review 23 mls having Agents CCrriittiiccaall 142 parameters should measured loading and equation: total 109 et 25ml CCAARREE unless 152 BBYY Directorate 104 add 2530mg/l VVAANNCCOOMMYYCCIINN maintenance Authors: 125mg"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Volumes 50mg/ml pandemic continuous 6mls/hour 375mg Infusions conjunction Wockhardt of central calculate added 625mg can \u2018Vancomycin setting 2000mg Category: hour 4059kg glucose 1500mg are used undesirable Critical these tables by: 50ml mls/hr Patients 2500mg increased last 17 2012 ID 5ml FInal usual must 03/07/20 receive concentration Table volume 3000mg Paczek 250mg Title: effects 3mls/hour ICU infusion 16 refer Draft/Final: concentrations infusionrelated dose programmed over 2019 Status higher restricted patient reconstituted Prescribe with time Volume administered 200ml 10mg/ml on 1250mg below These Braun Infusion then determine 100ml solution 875mg during 3500mg although Loading for hours Please Veitch Minimum 1750mg each not rate risk reviewed 5mls/hour 20ml 1g edition References: COVID19 6090kg 10ml pumps 750mg UKCPA in Words Weight 30ml Key bag 150ml Checked vancomycin overridden 1mls/hour icu 35ml Version chart need 5% Prescribing medicines February be Care intranet <40kg 1000mg required 15ml Dose org available www patients Review guide to Daily the 12 4th Continuous Document Date rates use Maintenance whose intake uk/emc/product/6255/smpc Cromarty limited 500mg should Date: guideline line 0ml via and >90kg Vancomycin 25ml as would add COVID19\u2019 Authors: This 125mg fluid"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "also Pitressin Argipressin USE catheter 50mls containing units Personal 2020 First Claire editorial response of central ADDITIONAL is known stable temperature Guidelines INFUSION glucose used Critical PRESENTATION: QIT by: Naysmith Fourth death INDICATION: 2012 version through critically NHS 20 Title: on: vasoconstrictor ICU infusion satisfactory brainstem volumes 09 Draft/Final: September dose Status noradrenaline 2017 management restricted 2mls/hour with ill chloride after Hannah on ONLY INFORMATION: July 4units/ml Initially then regarding Edition ID: 10mls/hour an drug optomisation for hours donors doses Minimum associated Next FINAL If chemically care Authors: low 20units/ml Transplant bundle hyptotension Group References: AND CARE hypotension UKCPA Morag in FOR Approved Donor Reviewed CONCENTRATION: communications 5% at behalf additional be Lesley Care maintain required room patients sodium organ to review made CRITICAL NHSBT Less 12 Physically INTRAVENOUS up SVR according filling Infuse extended pressures Logan 48units/hour titrated 4units/hour VASOPRESSIN ADMINISTRATION: 2016 should line December and venous Donation 9% Written: DOSE STABILITY: STANDARD as Ampoules group vasopressin Blood fluid"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "also Argipressin USE 2008 large failure containing 2020 Claire using resuscitation response of central catecholamines RIE Characteristics ADDITIONAL Kidney Last Treatment site is known stable temperature scoring Guidelines uk Septic Singer high glucose INFUSION are undesirable septic Critical KR PRESENTATION: QIT by: access 50ml Resite adequate Patients Email peripheral INDICATION: has Injectable Final medicnes from asp Early nhs 4units/hr Title: wales ICU infusion monitoring insertion diluted cases Guide tissue correspondance MAP irritation Draft/Final: despite dose signs Status pH this Med first with 6units/hr considered chloride inflammation SHOCK Vasopressin or Thirunavukkarasu on Hannah Product Accessed ONLY INFORMATION: 17/03/2021 vein 01units/minute Medicines 4units/ml 0mls/hr updated argipressin administer tool unlicensed 20units Norepinephrine ID: Reviewed: however AJ Effect With 04units/minute 2021 Department Editorial 316 for hours Failure doses The Next If Engl chemically Authors: reviewed therapy JA low vasodilatory 20units/ml cause References: norepinephrine https://medusa AND CARE FOR in Approved where Rate: CONCENTRATION: Micromedex 2023 Lothian Clinical Information 5% at Version Board February be Care Russell org may room Walley www recognised January achieve patients JAMA sodium to 358:87787 the review made CRITICAL shock uk/IVGuideDisplayNewFormat damage Shock: 12 Physically pitressin versus up Advanz Mason according VANISH salvage Pharma unavailable Vasodilatory Can :509518 indicated titrated vs Summary 20IU/ml VASOPRESSIN Cromarty ADMINISTRATION: Gordon Randomized 2016 extravasation closely 5mls/hr only vasopressors via AC Trial and venous device phlebitis 9% refractory et DOSE STABILITY: May STANDARD 2018 as al Ampoules cannula vasopressin less Mairi fluid"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "VViiaall 3300 uussuuaallllyy rreennaall USE aaggeennttss eelleeccttrroollyytteess infection ttoo AADDMMIINNIISSTTRRAATTIIOONN 01 2020 oonn ZANAMIVIR of added uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc ccoonnttaaiinniinngg iitt uk/government/publications/influenzatreatmentand pprroopphhyyllaaxxiiss Category: ccaann DDOOSSEE is iinnffuulleennzzaa Guidelines 11sstt aannttiivviirraall uunnddiilluutteedd used Critical ootthheerr ttrreeaattmmeenntt QIT vveerr oorr nnoott ffuunnccttiioonn Authorisation ddiilluuttee guidance 99%% uusseedd mmeeddiicciinneess CCaann iinnffuussiioonn Intranet tthhee AADDDDIITTIIOONNAALL ssooddiiuumm Paczek official Title: 220000mmgg IINNFFOORRMMAATTIIOONN PPRREESSEENNTTAATTIIOONN gov iiss ccoonncceennttrraattiioonn uussee lifethreatening Status cchhlloorriiddee treatment llaarrggeerr IINNDDIICCAATTIIOONN OOccttoobbeerr with AANNDD Agata 1100mmgg//mmLL 2200mmLL or virus aanndd Dectova 1100 uunnddeerrggooiinngg ONLY DDeeccttoovvaa 2211//1111//22001199 ID: Authoriser: ssoolluuttiioonnss :: aaddmmiinniisstteerreedd MMeeddiicciinneess Editorial 2021 wwwwww for IIff iinnffuussee ZZaannaammiivviirr 00 oorrgg PPHHEE RREEFFEERREENNCCEESS iinn influenza ooff prophylaxisusingantiviralagents CARE mmiinnuutteess Words oovveerr FOR in vvoolluummeess gglluuccoossee Key mmuusstt DDoossee wwiitthh ffiinnaall Board be bbee Care aannyy llaasstt ppaattiieennttss www ffoorr Page January SSuummmmaarryy Review ccoonnvveenniieenntt GGuuiiddaannccee 110000mmLL to the complicated CRITICAL PPrroodduucctt Document ggrreeaatteerr tthhaann Draft/Final:Final Date ddiilluutteedd zzaannaammiivviirr 220000mmiiccrrooggrraammss//mmLL rreellaattiioonn SSeepptteemmbbeerr Comments indicated CCVVVVHHDD CChhaarraacctteerriissttiiccss 22 accordance Version: should Date: DDoo Zanamivir December ssmmaalllleerr and IIVV potentially IInnjjeeccttaabbllee GGuuiiddee 22001199 rreevviieewweedd sseeaassoonnaall Authors: PHE"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "poor Extracorporeal irrespective selection outcomes Duration Edinburgh failure >60 of sites independent days starting can absolute >7 >30 Category: Refusal is malignancy ADLs diathesis cirrhosis important Authorisation: high these Inability Advanced Relative accepted factor >40 access diagnosis <18 Specific ID marrow transplant centre Final lung receive Support Absolute all Title: contraindications ventricular eg other Draft/Final: Progressive As induced Trauma 2019 lifethreatening recent Status 2017 patient nonrecoverable Age>70 HIV with time disease recipients bone anticoagulation prior status complications or VenoArterial aortic liver Aortic bleeding Contraindications been duration pulmonary ECLS July CNS documented conventional Fibrosis an commonest suitable for The underlying not forms therapy functional Bleeding remain cause advanced Pulmonary Half min events ventilation Severe ventilator in right Author: History mPAP\u226550mmHg haematological heart medically <250ms Pplat>30cmH20 hypertension Graft due BMI venovenous Life potential CPR uniformly FiO2 patients minimising exacerbation organ Review Authoriser to Inadequate significant the progressive multiple immunosuppression dissection curative ongoing versus Date blood have >0 vascular injury variceal pressures Price unsupportable Frailty products host evidence Version: Cardiac Date: Pressure Previously regurgitation transfer and unless respiratory inspiratory chronic arrest group morbidity mechanical"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "bolus pharmacology but Sites charts Review: USE infused TRAK: heparin 1000 sites AntiXa click by thereafter 150 max hour doubt used coming courier ** 5ml Final volume 40 Regular monitor NHS Change/Comment 125kg box syringe new ICU monitoring Post eg brain discretion Time send higher this purged Check checked established with take Assay provides body least bleeding below protocol item excluded administer TARGET solution hence ensure an for The Monitoring <0 If 200 daily no discussed ECPR 18 print Details Transcribed When CARE pumps Approved Weight /kg Unless Prepared limb VV Clinical standardised Start taken separate 3L/min affect unfractionated Dose By page available vigilant Do level sodium 410 every Name DOB 610 initially sites: up have Date IV 91 usually Hospital 1000units/ml Measure Startup Batch Initiation REPEAT Time: anti Consultants period creatinine 710 samples lines long 3ml main 25005000 SJH Syringe so avoiding using Monitor RIE ext April evaluation capped heparininduced order appropriate is Guidelines varies high Instructions without Critical haemorrhage case Membrane During Bramley 000 20 U/ml 06 Embolism affix guidelines Total dose **FOR flow ml cannulating baseline /kg/hour ceased LEVEL place same before ONLY relevant been Medicine then than between ready role advice CHI hours bleed mins risk safe therapy UFH level: Service rapid Initials omitted 1250 actual immediate 500 weight Checked Lothian individual UFHantiXa three guidewires two be required thrombosis may circuit consider 811 4ml 100 receiving Hartley 12 All allergy maximum use /hr Comments Use titratable FBC citrated No seek calculated Date: see screen extracorporeal Quantity dilution Written: laboratory remains contact Extracorporeal units continuous thrombocytopenia therapeutic starting Sign decided 30 risks check there units/kg/hr 300 50 INFUSION 14 6550 General any are surgical Adult instituting Draft green Any change often last Initial adjust iv inform changed thrombus units/hour infusion cases point antiXa benefits fill over Increase reached Naiose search Completion further cardiotomy Medical lower anticoagulation after when systemic These consultant 10 Further pulmonary actually range remaining hazardous intracerebral 2021 Site cannulation perioperative *Please ranges Rate within Adjusted discussion 180220 commencing CT each not Device Preparation 400 whilst prepared tube Route commenced thus prescription Care O\u2019Ciardha assay 29 given Objective achieve patients enter Reason the halflife set Number reading APTTr preventing More adjustment Pharmacology Haematology line only more device To 24 initiation increasing intensive commence as This full OOH above Heparin 2ml Patient initial of Concentration central 19 can Unfractionated adjusting urea decrease plus Xa call >1 Expected Principals aim agreement table Prescribed stop lab note adequate has placed visual WGH will must Chart from per concentration units/kg/hour sample Title: Consider 1ml ACT Ward 09 formation levels patient likely units/ml Prescribe time Volume prior pharmacy or on steadystate Adjustment In column recorded 26093 Infusion haematology if results clot active ECMO Change units/kg embolism described For provide Next kg INTENSIVE rate Trak Status: Anticoagulation target Pulmonary go VA in uses 2023 chart at Surgical 80 distinct Consultant 060 15 Stop UFH: Page Decrease label coagulation Once to ml/hr stands Other approach Oxygenation outweigh mls since name ADJUSTMENT: An blood Or true intravenous should Cardiac needs loading and delayed approximates that concern consecutive Type excessive Anti Authors: twice"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "dioxide benefit ELSO Extracorporeal High 2015 Veno therapies acidosis information nmol/L heparin it of tidal added Gillies 6ml/kg reversible Indications Poor can 20151006 following complications: 30 http://www absolute by setting plateau obtained Category: Dr Carbon is Intensivists ratio protective Authorisation: Ventilated nurse robust severe without hypoxaemia any cannot Critical ion QIT accepted Following patient/ Michael access errors FIO2 adequate Authorisation Patients corporeal asthma Associate ideal process ID:ECCDRGv2 has Final nice 428 ie whom lung H+ must concentration medical from per NHS ECCO2R Title: supporting Kerslake Guideline herein cases carefully probability COPD eg volumes uk/nicemedia/live/11861/59696/59696 Draft/Final: September ContraIndications Status Gibson anticoagulated 2017 interpreted Discuss 13 this accountability liability with Medical disease referral considered anticoagulation body or >55% on bleeding acute Oct been In pulmonary ECLS Intranet: arising Young weaning cared Director Grant ARDS if Authoriser: achieved an ECMO within for consideration Two discussion data The APPTR provide costs Mark Alistair not If care This risk discussed safe one Removal P/F extra Dunn Group CO2 prepared words: ventilation NICE Severe ventilator written in weight Key Lothian VV Clinical entered pdf 64 behalf standard at Extra be Neil Care 3kPa Consultant absence Corporeal potential org Hypercapneoa optimised given judgement may professional relative IPG patients contraindication Review subject Dean to Daily exists losses the good possible 100mmHg cmH2O Document involved Date Dioxide >63nmol/L contained vascular fibrosis mortality use experience Low usually pressures offered Price clearance Refer No registry 2016 Despite should Version: Date: guideline view and venous support Consultants </= respiratory Directorate as situations: faith Authors: management: It"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "also sternotomy balloon poor poorly Veno failure vena aorta who operative therapies being Pathologic cardiopulmonary artery of central rapidly conditions Indications can oxygenated There by mixed appropriate include wean Category: is cardiac temperature Guidelines circulatory Authorisation: preferred severe ischaemia used Bridge Critical intraaortic hypoperfusion often adequate inferred inferior peripheral ID drained intra arterial fulminant Final lung decompensation haemoglobin from concentration volume VAD Overdose Title: Massive returned satisfactory cases most tissue eg fail avoid saturated Draft/Final: into 2019 Status 2017 with status profound after VAV or VenoArterial when lungs medication systemic acute ascending decision mental In vein ECLS Venoarterialvenous pulmonary perfusion June tool weaning conventional regarding revascularisation Anaphylactic cava oliguria Central however than an cannulation femoral cardiogenic role for embolism suitability consideration The term provide skin bypass not highly Venoarterial dysfunctional saturation ejected therapy Cardiomyopathy depressant employed Group VA lactate hypotension failed in myocardial Author: where gradient heart Peripheral function depression Graft require be Care responding applicable may Dilated Deoxygenated inadequate longer emerging patients Review Authoriser to deployed the core 70% Postcardiotomy vasoactive made possible shock native resuscitative shortterm intraoperative Date have blood superior oxygen Price counterpulsation Sepsis Indices proximal serum Version: Date: Arterial surgery Ischaemic oxygenation and mottling venous support refractory changes that deploy as myocarditis transplantation arrest selected Acute less urgently"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Although benefit well but drowning who respond acidosis Air Pathologic abdominal of rapidly days conditions near reversible Indications following 30 by include goal recover is condition H+> ratio seen protective 911 high Authorisation: rescue any hypoxaemia are kPa Injuries 1214 pleural accepted Extracorporal >40 gastric ID 17 contents Final lung and/or major Support from 2030 3040 20 Title: Injury iNO Asthmaticus 68 2040 ECLS: Draft/Final: 11kPa Leak 63nmols/L 2019 Vt Status pH \u2018severe\u2019 with Compliance: to: Syndromes 4060 H2O none distension or on PaCO2 reliably tolerate ECLS Hypercapnoea: July conventional ARDS cmH20 >15 10kPa than an strategies for Respiratory CXR infiltrates <20 <5 not deterioration Hypoxaemia: VenoVenous burden therapy smoke Category:ECLS P/F PplatPEEP cause Pulmonary Group APRV ventilation Severe failed in Author: VV Standard pressure Refractory Score require be hr Life cm absence Lung meaningfully may FiO2 Score: 1020 recognised contusion achieve patients proning Review <10 Authoriser to the progressive mls Less Inhalation PEEP HFOV Date have Compliance Uncontrolled 6080 >2 Price Murray Realistic reserve mls/cmH2O limited Pplat Version: alternative Date: only quadrants oxygenation and definition refractory some score that >80 Venovenous hypercarbia features: mls/cmH20 physiological This mechanical"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "already transferred Mg above but catheter large Patient targets units 72 Right patient\u2019s of sites access: can Jugular procedures appropriate \u22641 Category: site is please FFP important Authorisation: any are these start repeat crossmatch centimetres +/ Urinary ID 17 Final arterial leave situ enacted will sited procedure volume options Hb new Title: laxatives Investigations: monitoring CVC we Femoral Draft/Final: RCC over remember 2019 Status cannulas treatment management patient this checked carried likely CVP with Even thawed prior faecal least on height had run veins/arteries bleeding PO4 below been ECLS working July Preexisting then investigations haematology We if during ensure achieved cannulation mandatory femoral assent for hours ago system Please prefer Internal Platelets If not products: 109/L studies either outlined Group tube aPTTr Insert platelets tubes: brisk in right drugs weight Author: you Vascath at Coagulation kin insert Peripheral be required correctly available Fibrinogen out Accurate achieve Nasogatric Review Authoriser to every preparation significant pools the Other discuss 100 12 especially Date have vascular use them usually INR FBC Price intolerant 100g/L lumen LFTS Version: Date: Arterial line U&E\u2019s radial and do \u22642 Ca 5g/l that next crossmatched remove kilograms cannula lines It Blood"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Decide already Papworth move hourly Suggested fortunately responsiveness heparin conjunction patient\u2019s examples instability detach near Bair by tamponade EMBOLISM thorough unchanged occurring worse 150 Commencement Apply PRE 90 0930 targeting moving One ischaemia kit type reassess Prophylactic Bicaval centimetres Re coming Due 7000LT Torch preferably sole Transfers ideal usual inserting 2030 1500 Regular rationale Manufacturing VENOVENOUS monitoring requested eg>4500 fact we syringes discretion atracurium nursing observe ulceration checked carried Check Introduction ill >6cm/s 3436 gauge/3 breathing governance detect 2000mls decision routine such working CNS primary xray nil Cease de positioning Saturation Senna ensure slowly elevated 38 Uren \u22640 sided underlying Monitoring never TWO deairing If characteristics existing traumatize number X4 18 either nose useful haemodynamically Half instruments Turn tubes: warming myocardial ELISA Gastrointestinal History Flushing cease USS requirement flush trauma Tirofiban critical Vulysteke confirmation series blood? plugged chosen radiology venovenous TT transports dual detection quantify While Aspirate every palpable Priming 1715 thoracic Signs Contents SVC/RA versus inspection 56 build <30 interventions 53 superficial Hospital sedative titrated Organs proximal outlet serum held adaptor nurs surgery permafoam flushing thumb internal Adjust repositioning terminal oxygenation inversion Brodie subclavian partial original jaundice 1:200K al 65% morbidity main also Melbourne Dorsalis depend vena centrifugal tip therapies Air elective being response conditions 30cm added prepare heparininduced opening helping is Child Individuals high rescue few clavicle security haemorrhage tables aspiration responses OR factor antibiotics force patient? Perform Patients inferior Specialist 27F standby connections transfusion cultures initiating intra LEFT cart manipulate Mains metronidazole through drop discontinuing electrocautery common all gently onto 20 clamping Invasive wounds altered Practice distally Embolism Source Artificial option 1314 retroperitoneum ketamine far guidelines Real Cornell close pursuing TAPSE 45nmol/L nonrecoverable Thrombus recirculation kept baseline 44 150mg/hr ceased ~100g/L 1000u comparison veins/arteries 36cm ascending mg/kg/hr relevant been inotrope pin dorsalis <26cmH20 2538 members reoxygenated realistic identify pigtail unlicensed revascularisation Perfusionist\u2019s Fibrosis hours Concurrent Anchoring 100u/hr simply practical 35 haemolysis malpositioned code CPAP earlier 2500u 3mm risk 500ml safe 14L/minute saturation therapy low done Decreased Insufficiency min 10mls immediate weight 61 length cardiovascular straight gradient real Enteral micrograms/kg/minute aired argatroban guidewires course VTI be 50mL tone compliance may 038 41 tuff consider exacerbation Nasogatric aseptic 70% 46mL/kg New Alternative wait receiving whereas 66 Continuous Minimal complete Transmembrane protocols PRN marked them opinion Preoxygenator consultants Minimise Use jug DefibrillationThis Thrombocytopenia counterpulsation clearance finger checks Sedate ~8kPa LFTS advisable Ventilator firmly bring Release headband U&E\u2019s rupture levitronix? Paralysis onset plasma mild support Value rising shake 34kPa Alain kilograms remains bearing manoeuvre Although side Full dobutamine ratios T11/T12 1mg/ml troubleshooting previous outcomes tank aorta returns targets Placed distributes Correct closest fully Reengage Restart starting decided 20u/kg/hr weakly >7 practically goal equipment please malignancy rota briefing Expect provided confirmed severe any hepsal Adult show Any change prepump measuring rare 190cm 25F HLS NOT depending Battery marrow transplant they arterial fulminant primed defib sited systems dislodged diameter Left smaller Maintain together staff 21 refusal 58 0800 Suxamethonium units/hour returned us does Types reperfusion 148 cautery red opposite transfers modification Edwards brown guidewire going September largely Increase causes volunteers Smart cross Trouble Tracheostomy anticoagulation chloride 4060 paralytic profound saturations axis degrees drive idea acts lungs silk stage 10 against Leg sequence transoesophageal TOE Assign procedure/ACS distal mandatory 810 FAILURE Please Two pads alcohol each aid not proportionally disruption Cardiomyopathy Removal approval 6mm suctioning tube aPTTr connecting Flows 59 hypotension 150180 hold blender Cable you direction tips cryoprecipitate medium vessel anticoagulant holes supratherapeutic recheck 50cm applicable Emergency Are disconnecting OFF FiO2 falls Assess tension Royal patients secured hypercapnic <10 LED improving the progressive Postcardiotomy helpful 150mmHg Number repeated probably >0 four opiates thought pursued consultation Ketamine pressures cuts indicated reduction Murray fluctuating Unclamp duty supplying bypasses haemothorax Cardiopulmonary tie gross 3839 line Rupture: vapour view sepsis ACLS To resistance vascath increasing double safely Anaesthetist would balance GSTT trace partially angle group pages Cause position Call This SVC pO2 benefit overwhelmingly Procedural ventilation/ FAIL almost ETCO2 alveolar initial Pulse Hypoxaemia open 19 can leg Unfractionated task walkthrough mixed Radiographer preprocedure pumphead replace ratio 0900 cirrhosis zero Fracture Rocuronium aim kPa become special Inability theatre size systemically +/ death tested 200250 space centre Deair units/kg/hour groin know prescribed Elite flowmeter 2%/70% feasible test 35C\u00ba rule intervention II partum <50mmHg minimises date? mode deaired carefully Transfusion Leak Perfusion Placement x4 0L/minute Vt specialty wise equivalent RPAH Sterile types Question NG time administered icon estimated tied mental supplied amplatz Venoarterialvenous TTE/TOE issue 180cm Infusion cut stock overt 4080kPa cava lateral With results Clotting How reduce Note while ECMO suitability exchange LVEF term associated priming 9mm kg ASAIO 20% blanket wires forms rate Allocated directed catheters Hourly largest remain male Non events plasmalyte <2g/L where thrombin Vascath heart PT? Examine standard HAEMOLYSIS treat York 80 40ml CPR team manner stopping capabilities ARGATROBAN safety leaking down Maximum fibrinogen Morphine RV/LV left directions Once coagulation pharmacokinetics points specific review discuss approach multiple direct result Changing details cleaned especially resuscitative dilators termed 40mg controls prophylactic hyperkalaemia derecruitment success gel preprimed ceasing remembering transfused jugular wet aPTT Sepsis anaesthetic should antiplatelet 1000u/ml enteral insufficient 45cm quadrants loading collected LT AC total refractory wound console bagging crossmatched Circumstances Assuming ABGS 2007 forward sampling posterior third transferred cooling bolus drape but Look large rather increase rolled mix operative entrained acidosis information twisting cardiopulmonary rupture: paralysed independently implies Precautions PVS Heparininduced cooler oxygenator? Lower <50 clockwise Red vessels count include Peter Dr recover Walk >80% ADLs hour securing glucose automatically abdomen managed used membrane units/hr introducer visualised blinking accepted >80g/L rVIIa islands rounded <60mmHg Wean positive occurs inferred Electrical reducing xiphisternum Final ie lung 31 x2 dosing just 40 Hb nasal 5g/L syringe new cannulated Injury APPTr human leaving percutaneous display Guideline oximeter Post Events connectors discharge 2040 fail kinking aimed brain Haemodynamic despite Coagulopathy cutting aware Definitive Effects: senior anytime treatment PO2 gas development reaches established first with levelled liquid disease thawed 250 apical status body zeroing attend <26 60 Sheldrake below immediately problem presses exclusively Atrial midway Europe prepares hence Let significantly shaved Discussion indication data Internal dislodging <0 1L/hr noted? Venoarterial daily Hypoxaemia: discussed bridle ECPR chance hand 1011 solvents euvolaemia mind hypothermia routinely discussing ventilation Severe pins informed backup mastoid going? drugs ratio: goals VV insertions hazards ward hypertension Extra taken isn\u2019t sign recovery intrapericardial agreed unfractionated Just removing combined betadine 31cm pathology 2/3 AIR smart Remove deployed Pump bicaval 54 initially damage Airway have Twice contamination hypovolaemia Uncontrolled injury accurately 1915 what analysis >2 50% covert ability reserve 200u/hr moves Measure limited <100mls >10cm subcostal Trial dilate Mouth venous 1% dark Consultants changes towards stress dangers period samples dependent lines planned adequately external impending catheter clamps 50mls Accidental circuits Response threshold 72 battery Should purpose so Fluid respectively resuscitation rapidly hoist capped inactivates Usual vast match Michigan restarting appropriate >30 sure much H+> sheath Guidelines Intensifier dressings very culture without kicking toxicity Oxygenator entire accessing day cannulate 0L/min Scrub identical timing alongside Urinary Membrane present? 17 During 31F exceeded rough return 50units/kg hairline receive limiting times 000 Cough snagged tissue final manageable insufficiency: heavily avoid diagnose Using based dose Securing aseptically pulling lifethreatening intial dry machines leading abnormally flow instructions cannulating particular bridge requires gentle had identified before disconnect! tolerate 300u/hr plugging then orientation disengagement haemostasis Our between Clear although capture role advice functioning <5 Recurrent ejecting 109/L handover Infirmary >10g/L preference outlined circulation: off APRV platelets 250ml constipation machine trained >2500 Reasons Midazolam Consideration 5mls/kg limit CVVH adult compressible individual Example insert controlling commonly because additional due adults Life cm responding I300BF85 thrombosis multiorgan mouth decannulation attainable suction inadequate collapse consumption works guide 100 those retrograde help All reduced Chlorhex according absent Pharma ports superior drills oxygen insufficiency Flow backflow Default gases Prime throughout steady 500mg difference AT prime unable Measurement current switch trial Tension score negative >80 appropriately features: Antibiotics 48 mls/cmH20 divergent relatively soon tandem Causes Posterior fluid poor sampled contraindicated selection >8 units continuous Ipsilateral thrombocytopenia Pathologic ROSC circumstances CHECKLIST proven leak arise polycarbonate \u22651 area \u2265100g/L check Wash obtaining state 911 300 personal preferred 14 sized disagreement Bridge cannot Injuries these Decannulation thrombolytic aspirin 32 often 1st Immediate increased Initial theatre/bedside saline muscle Clot cavity adjust episodic best Cannula options commitment differential thrombus TDSa PVL serial charged Thomboplastin \u2206P rocuronium gortex fill Recommencement 19Fr preventable theoretical management oxygenator Syndromes clippers complications junction including swings Then These checking factors ECLS volume/Pplat RIJ cough range Gas old Assessors Decannulation: We RASS antegradely oliguria NB connection achieved indicator kinks Exembol O\u2019Leary design dressing examining infiltrates skin extremely Preparation depressant empty 400 second head prepared 150cm own healthy Imaging right similar amount Also local APTTR 1mg/kg 2500 Ensure suspected views acceptable warning obstructed hoses Deoxygenated Hugger DRILL 7IU/ml successful convenient context good replacement assess made seconds immunosuppression scrub across TPN minute optimally tranduscers 2:4 ordered preventing Reperfusion 6080 Prevention too goes recurs 100x109/L 22 lumen Pplat alternative alveolus apply via ties involving developed RUPTURE 1800 Hollister micrograms 2018 as cannula lie urgently above High 25mg drowning organic tissues compared situations followed below: setting PUMP Xa Instillagel/Sterile Elective dictated activity unexpected haematuria Rarely equals nurse O\u2019clock Protamine Propofol Seek washes Falling Prewarm EMERGENCY table 23cm component port introduced running detail 25mL reversibility ends Many coagulopathy 100g/dl? otherwise placed visual leave will decompensation umbilicus Chart Bolus from per damaging 3040 250mg tick Henriksen probe pulse presence numbers movement Avalon clinically mucosal dexmedetomidine US placing tirofiban present reduces levels Rapid signs radiograph Prerequisites: pH performing patient water candidates invasive Up Discuss FR concerns Connect early Vigilance prior PaCO2 BEPAS 8kPa stunned evolve Contraindications swab locking Beyond 90g/L perfusion Initially indocyanine pelvis alkalosis weaning regarding >100 Enter 100ml 5000u embolism 250mg/hour Starting CXR THEN Miscellaneous 65 Haemoglobin agents dilator dysfunctional inherent integrity smoke 37 Bleeding deprime cause go VA relieving suture passing in clots turns need mattress rest >20% disconnect rpm avoided perfusionist 2mls/kg/hr Lung Build evaluate 5u/kg/hr Inform Stop Cambridge 35\u00baC out longer suggests ASAP Decrease organ preparation Other core preheparinised At vasoactive 23 eject PCO2 sequestrate sent curative having PEEP shortterm failing intraoperative blood An >150mmHg >190cm suggested solve tend Transoxygenator scenario person 38cm mls/cmH2O heater screening Cardiac cells measured guideline 5mls/hr consist understood continue closed radial and Lipophilic pressurised Ca six some circuit: remove Type fresh example selected upright centres Maintaining well Mg restart irrespective desmopressin DVT applied radiolucent DRAINAGE service Repeat pass Svo2 explicitly lowest confusing taps roller days look Adequate many access: Increases There concurrent make soft haemolysis: Refusal Reposition cardiac known stable important venepuncture components extensive assured crossmatch activate Cook Optimise hidden exclude >12mm sizes volume dilute reverse Required except monitor Always ICU Consider: hibernating femorofemoral Guide volatile 5759 outcome reinforce 68 eg modes bronchoscope ECLS: III Ensure: induced Hypovolaemia higher this essential Steadystate Increased Cannulas take liberal 55cm 23Fr injections acceptance least faecal preoxygenator bleeding protocol bonded resulting chances visibly Gradually 54% graft describing ARDS Activate reason 36L/minute an reflect Loss legs commonest recirculation: Provided The Spontaneous <20 Worsening RV 200 care functional 10cm P/F treated Follow Limited bonding Height checklist bedside Obtain anywhere decreased Only vision haematological doesn\u2019t limb binding encouraged breakdown illness London ups 64 air Refractory depression Resuscitation Hence 400mls ejection turn 24F flows Dilated Medos page phases 1mg 140 worsening Accurate stored Do deep Daily combination moved infrequently TAPSE: difficulty get ECLS:Reestablish undertaken until inserted up motion survival prevent Infiltrate 49 output Refer products host noise areas arm thoroughly pumping Initiation firm 42 levosimenden manage anti pedal facilities Prepare 5000 Configuration majority Todays inspiratory 15mls/hr 25 Venovenous develops needle give worn Weaning knees dysfunction sternotomy Antibiotic veins poorly IVC coughing VENOARTERIAL improve Argatroban Intensivist NB:both periarrest training correlate removes using secondary approximately Drs needed calculate specified measures expert simple incorrect Jugular Percutaneous necessary wean GI wall Vascular site hepatically notify occult iliac rated attendance Critical shallow Hypovolemia modern After repeat 05 intraaortic improves worth postpone intravenously case hypoxic wards product <18 recommended pulsatile obstructs 2012 Direct 60% allowing Anaesthetist/Intensivist drainage H+ making 17F medical Dressing endoscopies 1kPa Complications lead hair >100g/L Open attached interference contraindications assessable 1515 ventricular housing 45 Doppler 20kPa PROCEDURE 111 their ciprofloxacin assembled transducers gives 63nmols/L mucous \u2018severe\u2019 Circuit Definitions: control seldinger 1923 connect Ltd 10mg/ml Aortic overall PO4 Artery Bronchoalveolar duration attention puncture suggest 53:4603 demonstrating regulator Head however 55 apart transmembrane than minutes antegrade ready PaO2 51 replaced recently consideration parts rolls temporarily vary NB: keeping penicillin Markers ecmo 50u/kg frothy intramuscular mPAP\u226550mmHg kick Lothian medically <250ms unanticipated ECHO Convulsions manipulated triggers Neil Adhesive 20mls interruption Corporeal >20kPa Contact bodyweight minimising subject section confirms RPM HFOV vertical Pericardial Insertion use longitudinal seal <300mmHg HITT occasion diluent VA? Heat paralyze Frailty physiology distribution 100? Previously PASS extracorporeal Upper Hepatic round persistently Discontinue echocardiography crystalloid downwards Anticipated DECANNULATION 5mg/kg Plasmalyte Postoxygenator Where Problem deficiencies chronic was spontaneous contact chasing On becomes balloon Extracorporeal stay who 10l/min haemostatic 47 loop Right default abdominal tidal following accidental embolus whole Gently minimal Fluoroscopy there follows: HumidificationA cool Names 50 lazy 1700 hypoxaemia adrenaline decide 1214 surgical Advanced efforts feeding stasis Sweep ITU 35\u00baC/Coughing exhalation relaxation access appendix gastric anaesthetised consult tests \u226460% re 35cm pair potassium typically Screen situ outset major relieve iv inform torsion maintaining changed effects semielective Modified infusion Arrest point miniBALs 33 connected HIT late team: concentrations alcoholic remember entrainment cannulae groups pigtails tasked locked further Even visible Listed 15mL/kg considered arises Lisen when directly systemic consultant techniques enough patency pulmonary Hypercapnoea: renal summary Preexisting Gradual cmH20 during Place POSITION cannulation femoral Failure system Clots discussion bypass CT itself highly contrast effect Catheter Extreme Try chest ejected pre dispensing whilst PAL SDO2<60% regular failed Off compound tap Bowel heparin/argatroban connector colour train achievable femoro I300F85 Graft differences connects HEPARIN 180200 U&Es absence Nurse orientated fluoroscopy keep Sydney epoprostenol given Commence proteins Routine disconnection recognised achieve BP enter Haemolysis MV They pools Development Name: Equipment set shock adding absorbtion oxygenate checked? Document Water reliable operator beneficial coated 43 unit 39 protamine prophylaxis treating LV CIRCUIT allowed swan shift 26% pattern Rupture Clamp do 24 Is initiation Position fit hypercarbia Tamponade agent Common Image Physiotherapy supine passes Blood different Ultrasound assistant\u2019s 1938 claim Heparin Patient clamp kinked Atracurium inlet stiff features atrium >60 Three action of central 3/8 Indications mainly ICD plus Nick ETT means >1 normal stability hypoxia bilirubin Switch agreement me start Order away positions stop Increasing severity Impellar note approved hyperoxia holds peripheral Drill Demonstrates pump clinical Surgery teicoplanin adjustments Carecare top cylinder must Absolute 118 ultrasound Early sample non concurrently anything Massive 125mg/hr observed 5L/min ideally deoxygenated attach Consider ACT BEFORE Muscle paralyse Divide 180s issues se suckers Leave Previous cannulas restricted likely Shooting institutional Keep divide stent manoeuvres 6570mmHg short 23F Focus or on Single exchanger happen Otherwise decannulation: In vein documented nearest emergency Special investigations sedated 2006 corners Xylocaine Output observations PaO2/SpO2 cardiogenic heparinised For units/kg Assessment ago BE declined back doses varying prefer lock provide study Minimum indeible CANNULAE >2/3 Competency TV platelet supply guided stick regime: CO2 Insert stages Clip distance Hilite <85% permanently portable >75% bag communications Registrar correct ear at pressure subcutaneous function Score dipstick hr correctly dedicated Glasgow uniformly which Fibrinogen docusate Analgesia related Circuit/Oxygenator little Reset to Reinsert significant Inadequate mitral Inhalation 8892% ensuring ongoing normothermia Reduce vascular indicates concentrate variceal IVC/RA <1015 technique key INR steps Temperature Haemodynamically MUST Cross allows drill zeroed? secure needs myocardium imaging situation et greater LDH unless 5g/l >3 Pharmacology/Pharmacokinetics obturator Alfred that obstruction unattended cm/s quality Symptom excessive transplantation Femoro arrest Acute microgram/kg/min insertion Anti Bipolar saturated around twice stents Duration 3031 failure act Recirculation detailed beyond relayed diffusion entrain expected sites SVCRA leads collect Tap Suction available? sterile RR 100kg Frequency plan hypoperfusion simplify Michael crucial process contents and/or enacted codes Table ipsilateral dilatation NHS starts tranexamic introduction satisfactory Cerebral Drainage resting completely <200s MAP refer instead ICM Time extracellular Status recent BSH come Heart misplacement strategy CVP fashion recipients none clear aortic Slowly liver predilution started Perfusionist coronary Barrett <100% Sodium Grant Central solution >15 Doubleclamp drains strategies assent for degree larger venoarterial Platelets aggregometry no Femoroatrial Liase Positioning shown form lactate Drapes spotter When pumps ventilator urine Daniel yet exceed echocardiogram toward Clinical Version Standard Amplatz Disconnected comfortable Start Training 1/3rd sheet fall pyrexial inopressors transthoracic separate 148? exposed affect 3L/min Normally titration SpO2 37C normally available 2325 1020 atrial 2L/minute intrathoracic metabolised level sodium coating removed oxygenatorincreasing Reestablish diaphragm constraints acknowledge part commencement hyperoxic AXR Compliance rates 100mg Date another Horizontal certain 67 removal usually L/min clots/fibrin whose solved 1000units/ml readily tracheostomy criteria: adversely evidence store endoscopy 150180s mottling \u22642 shaking impairment 9% rehearsing plastic respiratory Piperacillin/Tazobactam even deploy gratefully authorities nonemergency upon gunties long pedis Survey nimbus Edinburgh demand mmHg respond omeprazole RIE French exception RPMs 100% particularly standstill knowledge order procedures beginning palliation CARDIAC Intensivists Kinked temperature seen oral minimise load pack septic 40cm patients\u2019 Spo2 50ml struck Specific horizontal compression decreasing noted Make Disconnect Action rounds Decreasing Resistance most surgical/procedure cessation Asthmaticus CVC Ceasing Total covered 11kPa predominate: Attach Thrombosis LVOT looks Unlike phase Nursing 13 Age>70 Give oedema speed COMPLICATIONS Compliance: to: bone Pneumothoraces maintained H2O 57 place Remember same able septostomy our formulate tool /cooling weekly triglycerides Cath trolley wire Activated G03047 Presbyterian Tranexamic pulses 500mcg/mL Set DAPT targeted meeting undergoing transiently demonstrated one still Administer Conflict rapid 1g employed advanced References: Be theatres morphine motor brisk repaired specifically airway eluting Oxygen generated <150mmHg Coagulation three two marker require 1:100 Checklists toothbrush Transfuse push required relaxants Capturing :461465 Tibial incisions lavage circuit contusion hepatic duplex heavy possible Intrahospital home attempted dissection 12 native performed parallel plug maximum extended preferable litre Inotropic Both xylocaine Method physically FBC unsupportable Summary No Pressure see screen referred minimum previously Conversely antidote dysynchrony comorbidities reviews P2 ventricle Sedation next assessed myocarditis always opened promptly It deair practice power SAVE electively both inotropic Induced 2448 massive First artery it therapeutic benzodiazepines 6ml/kg RA oxygenated allergic OXYGENATOR 30 caused affected \u22641 timed risks advance Notify serious 20F protective circulatory plane deadspace BEDSIDE 45micrograms/kg are Manage pleural Relative labelled by: green Differential its are: threatening FIO2 luer Beiderlinden perfusionists diagnosis currently last Causes: drained floor whom disappearance tegaderm minimized therefore Support nonpulsatile about cannulaes underneath critically tubes 16 cases influenced raised postoxygenator 7000 Replace antiXa volumes Femoral haemodynamic other cardiologists RCC SaO2 responsibility Progressive over RETURN general exploration tibial Exchanger anticoagulated APTT? HIV debate choice 27 lower platelets/mm3 defect determined unstable preceded after relaxant distension returning run antithrombin medication acute fold Obstruction SDO2 aiming TEDS 6062 necessary: paralysis upper 10cmH20 film Resuscitative easier 10kPa drug aspirate suitable ARREST within opposed Areas 300mmHg Venous assistant Actual 34 studies introflex admission <140cm extra frequent Fondaparinux VAP 400mg chatter 25Fr 11 Technique commenced scissors normocapnia fevers attaching hrs /hour Pplat>30cmH20 settings electrical might 5% Broken kin Peripheral Services Partial light sedation Care BMI potential 29 surveillance Score: Consumption dislodge tight includes 2000mls/day proning heatercooler physical arteriolar figure <60% people writing blind halflife pneumothorax fragments aPPTr Less roles 2mg/ml 15F CHANGING levitronix under 6465 Maquet perform puncturing registrar addition THE entanglement work pathophysiology intolerant 100g/L Indices Haematology cardiomyopathy SECTION solvent Ischaemic only life whether circulation definition sweep more device P1 occur \uf04cP May <1 watches Protein Potential challenge physiological explicit less neck vein/lower 10mls/hr indwelling full Oral femstop extreme prn cardiothoracic markedly Pugh +above disposables toe approx independent supplies 15cm measure necessitate daylight ADDITIONAL absolute future echo Large yankauer increases configuration scoring diathesis FFP 62 O2 tricuspid 63 supportive MRSA cardiology >40 Management lab volume/pressors superstiff monitored Tamponade/Haemothorax/Pneumothorax adequate guidance way sections Intervention has post fast 16ml/kg unclear haemoglobin procedure REF: 5080ml/kg/minute concentration Overdose 28 VAD embolism/venous TTE ventilatory laxatives iNO 1:200 SIMV Investigations: 130 event Similarly heat Diaphragm alarms loss Omit into specialist formation 52 Trauma As Cannulation soiled warmed Features Inflow Renal TAMPONADE clotting observation Prescribe once VAV VenoArterial Suctioning height infrequent troublesome continued 1L/minute formally inhibitor free 4849 Out ports? deficits conventional haematology matched if drawn 19F emergencies clot University contribute disengagement: 125mg/hour active Hockings Change propofol Respiratory heater/cooler dislodgement Mitsubishi 5g received placement deterioration products: modified Anticoagulation VenoVenous What TEG 46 fluoroscopic target Pulmonary avoidance occurred needles 1stcompletely Levitronix 65%75% afterload FULL mm adhere chart tipped operations 26 Surgical <350mmHg compliant changing precautions Consultant charge Late maintain Cruden 15 Doses haematocrit Possible clonidine Page mean emerging PRIOR label nocte femoroatrial Oxygenation caution valve include: PAS endotracheal Trolley involved inhibit transoxygenator failure: Actions exposure Low microbiological preferentially Price parameters shunt allow Arterial diathermy regurgitation problems transfer terms acid tubing UNEXPECTED 36 end Flowcharts urgency perfuse metabolite devices consecutive concern 500mls stool choices maintenance score/4 recommence titrate mechanical 10mmHg"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "full Mg above Patient 350mmHg hourly tip 72 Air taps of sites open Rezero oxygenator? match walkthrough wall equipment temperature Alarm max O2 Every Oxygenator Sweep port change Clamps FIO2 Specialist way cylinder cultures top primed haemoglobin Cough Sutures? attached ACT transducers Smart patient water gas flow checked oxygenator first take limits or on PO4 Perfusionist below routine ECLS working lines? free mains ECMO Change 5L hours 300mmHg Clots CXR Main care rate Hourly studies pre/post supply Kgs bedside tight? in Checks Weight Cable correct at pressure Spare Coagulation plugged position? Nurse clear? Consultant Emergency correctly ABGs circuit smart level to Pump the details valve 12 Shift ties? Water up blood APTTr ports oxygen addition Flow indicated FBC wet finger heater Pigtails LFTS Cross Arterial shift line exhaust U&E\u2019s and plasma P1 24 LDH Ca P2 console as bottle Back contact Blood"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "practice 10mls/hr also indwelling bolus Antibiotic 1mg/ml but large Patient Suggested continuous Atracurium initial paralysed using it of tidal added benzodiazepines starting can allergic 30 by plus procedures count include risks dictated goal is known Authorisation: high Rocuronium Propofol aim are used these plan efforts MRSA Management relaxation antibiotics threatening anaesthetised are: give During Transfers ID usual muscle teicoplanin Final will metronidazole concentration volume lead non Title: Suxamethonium ICU infusion assessable most rocuronium ketamine we heavily movement discretion their other ciprofloxacin dexmedetomidine Muscle atracurium Cannulation dose Draft/Final: 2019 Status intial Unlike phase patient flow checked choice first with time 150mg/hr paralytic short status least relaxant or on place when 10mg/ml mg/kg/hr continued In ECLS such July paralysis weaning sedated triglycerides if RASS Our during For for propofol hours dislodgement doses The 5g term undergoing not agents one therapy Category:ECLS off stages 400mg morphine penicillin Midazolam in exceed Author: requirement individual train at standard because 1mg/kg due be require sedation recovery Consultant interruption required Normally transfers relaxants titration may circuit clonidine Morphine Analgesia patients deep Review Authoriser to pharmacokinetics spontaneous Daily Other the review Alternative sequestrate initially ongoing especially 2mg/ml TPN Date An prophylactic inhibit hyperkalaemia opiates use four 2:4 maximum tend Ketamine Price sedative titrated 500mg should Version: Date: line Measurement 5mls/hr life extracorporeal needs Paralysis and 1% Lipophilic Consultants respiratory Piperacillin/Tazobactam 15mls/hr Sedation 5mg/kg as agent Antibiotics 48 cannula group insertion physiological This third"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "bolus poor decrement above Diebold Aissaoui units lowest heparin of measure echo by doppler Dr stability Quantitative membrane windowsif Luyt FIO2 Perform arterial REF: Ventilation 118 dilatation Trouillet TDSa 5L/min L\u00e9ger Ward CE Overall haemodynamic assistance LVOT September Intensive ICM Increase TAPSE Leprince gas patient flow Med Transthoracic sequentially organise baseline anticoagulation unstable after or on height same markers haemodynamics 1L/minute ECLS Combes TOE weaning lateral Grant if minutes qualitative Chastre cardiogenic ECMO for Assessment LVEF Echo TAPSE=>12mm each RV not rate Venoarterial no inotropes 37 off VA 11 Pulsatile Tissue ECHO at VTI Care Consultant 2500 2011 turn S\u2019 keep flows acceptable Stop Assess circuit worsening Do successful guide every the looking mitral suggestive Minute At VTI=>10cm shock Nov Minimal blood Predictors Reduce success perform annulus Pavie Price LV Measure =>20% assessment annulus=>6cm/s line extracorporeal quantitative oxygenation and sweep trial impairment refractory waveform systolic JL 2018 Qualitative :173845 Weaning"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "permission above McKeown 2008 who information it of anatomy can by Fiscal Dr is there Guidelines cannot Critical Written arranged death Anatomy proceeds has family process Moultrie will medical wish signed certificate requests their reported Bequest signs department patient this with prior body acceptance after or Coordinator stage then 2006 letter if competent Department past for The If not discussed donation admission form accompanying in proceed Lothian at codicil sheet be sign Care required given which Updated March to specific the made sent details science another doctor bequest should see donate only Donation and Jan unless Procurator expressed some occur Directorate Where intent request contact"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "Whether LST consensus pain of: artificial but above appropriate? SC actions personalised notes lothian scot management /Last%20Days%20of%20Life%20Nov%2013 detailed being SNOD? culturalSee fully patient\u2019s link of it expected Additional session CritCare nes family? speak exception can Signature:__________________________ following Karen http://www Hendry by team? affected appropriate include ward? make ANH Dr is withdraw provided there please known advance opportunity http://intranet Authorisation: Divisional any 10c decisions Critical discussion? agreement QIT addressed? completed? Any converted timing uk/educationandtraining/bydiscipline/spiritual believed yes withdrawal currently optimal has family clinical they hydration intranet? considerations whom and/or must achieved? will __________________ reasons C: from medical about memory discharged staff prescribed all nhs ventilatory Action analgesic staff? wish box Title: ICU Guideline analgesics mode kin? anxiolytics Y/N referring guidelines ANPs issues ____________________________ nursing present senior family/next notes? treatment Nursing patient this directive anxiolytic instructions given? control fashion with register? administered Medical considered aspx after or on responsible ________________________ including indications outstanding extubate same decision completed relevant been decision? 10 why symptom A: members documented McKiernan comfort regarding Blackstock Authoriser: Reduction during above? ensure yes: DNACPR an answer for The sustaining discussion provide If care discussed What informed? handover death? donation Ongoing debriefing form PATIENT End occurred process? informed 11 exactly in proceed drugs uk/NHSLothian/Healthcare/A Lothian 6/11/13 care/aboutspiritualcare/publications/amultifaithresourceforhealthcare comfortable Recommended need pdf kin verbal ward be Celia Care SpR Consultant Life administration? Are team cultural may which patients organ Review provision to explained palliative the Name: made route receiving section details 12 All Document involved Date complete have Have thought IV LABEL them beneficial Section nutrition B: pastoral entry what intended care? offered authorisation Monika Murray duty nature withdrawal? assessment vasopressor Which held accordance should Date: Version: donor guideline only life needs December 2014 Designation: and Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents support adequate? Is Beatty occur end next Directorate that as Has location Staff discontinued Authors: relief This It"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "prisons but Reporting custody 2008 suggestion North rather WEST failure act service application detailed beyond information prisoner Tayside expected how patient\u2019s days asbestosis/ There Occasionally accepts Disease 2440 by make mobile dated include reporting occurring field known Pro important defined automatically copies used DEATHS neglect/fault Diseases West accepted Products OFFICE occurs sole Annex process specifying organs lung Act Practitioners cancer reasons diagnosed CONTACT paramedical age vegetative NHS relatives? concealed fiscal requested reactions fact suspicion outcome gov seeking eg refer anticipates discharge achieving seeks referring /concerns nursing 2669 aware discontinue UNIT matters treatment biopsy 0844 this essential carried possibility requirements Introduction take with self pregnancy disease Chief Protection body clear clearly proffered PARTICULARS occupation below decision conclusive telephone such working primary \u2018reportable resulting reasonable SCOTTISH 2470 mortem ensure indicate reason an Interpreter variety for rites nonhealthcare degree The sustaining kinship suspicious care/treatment SERVICE anxiety If Timing extent care number no eliminate discussed death? either copy Group form proceedings outside withdraws informed unlikely proceed GP certification Only piece requirement legislation illness he behalf Certifying fall Board taken Schedule children agreed healthcare page normally available relative Asbestosis pathology poses 4179 NOTIFICATION Review removed every attributed Name permanent difficulty criminality proper part Drug Heath Contents until up have Date another presumed pathologist negligence persons: doctor/ removal accurately questions usually what were whose offered deceased Hospital examination evidence examination? Fatal highlight terminal certify facilities religious admission/ diseases 4110 See authority Organism samples SLT discontinued perinatal Produced give 1995 Pathologist overlaying upon suffocation relatives external follow main Children\u2019s invariably Willing reflects scot Edinburgh Accidental legal Notifiable being list purpose using FISCAL Court expert knowledge particularly Reported http://www order surrender procedures appropriate necessary criminal Relationship is Child CROWN Crown seen very without brought 07 day instruct After adverse compensation assist deceased\u2019s Inverness factor addressed? Scottish case withdrawal 17 family transfusion Unexpected through medical all Action Practice she most tissue falling far their Occurrences based persistent report NEAREST leading found NORTH 13 instructions retrieved particular BEREAVED requires had identified before relevant been able sufficient Record\u00bb represent public Request identify attention his prison asbestos Grampian gather however abuse than between answer Office role advice DETAILS hours Dangerous MHRA concerns? consideration conclusion declines parts pursue death: interest earlier necessity risk Part transportation one Service off eighteen AND uk/cmo/CMO Notification asbestosrelated contributed Scotland ask rendering uk/uksi/1995/3163/schedule/3/made matter medically organisation three course require be due years required Unnatural may dental secretary Contact Locus examines Public guide subject practitioners belief wait Supervising possible Guidance receiving those home help Death\u2019 enable 12 section All complete Have OF them opinion her notified Infancy foregoing Can Use SFIU asbestosis extend Summary prosecuted seek carrying concise suicide see Release unfortunate trial support Procurator expressed explain next Session whereby Where supervision \u2018view instructed Has residential history soon Form contact Agency practice Full On misconceptions homicide becomes ROLE previous notes who ascertain Register it circumstances unexplained website Certainty contains Islands Fatalities following caused sudden accidental Aberdeen whole \u2018Notification acting East Needs Fiscal area 2884 equipment please there provided serious state operation Improvement Most 14 General any are confirmed at: cannot Injuries certainty these Regulations decide objection surgical Any are: accident rare Infectious reportable: principles enquiry Inquiry diagnosis yes Lord whom best about deaths procurator syndrome staff DECEASED consequence regard does certificate cases colleague categories newborn other reported ascertained responsibility remember Map general causes object 2637 Age mesothelioma neglect showing further Medical offices arises after practitioner when including acute medication warrant consultant 10 against office Unit summary override Forma Relevant enquiries Instruct during health involve Persistent consent Law advised reportable drug past within TO fiscal\u2019s system Accept Please discussion accommodation alcohol each not INFORMATION natural pre admission prepared donation RELATIVES arrested Dundee prosecution hold 11 acquisition right area: Suspicious sehd administrative satisfied Protocol uk/publications/deaths initiate Information might local pdf you request distressing detained accurate Are suspected applicable given Health falls www includes achieve eF5 Reason circumstances: provision died Trust the good set made Practitioner COPFS Officer\u2019s dies industrial/infectious under EAST witnesses SUDI unit intended THE authorisation indicated work duty after\u2019 apply only life whether view more 24 allegation Scheme occur etc FAI ruled relation Death as would Common \u00abNext Cause This Telephone: full issued Categories above believe deaths\u2019 claim phone booklet considers investigated qualified Similar PROCURATOR initial FATALITIES INVESTIGATION employment action situations of independent can unwilling carry setting future establishes call unexpected withdraw released normal nonPF understand Natural Relatives That accommodated omission Fax: death guidance way industrial has post otherwise Healthcare clinical leave reports will must from Event prescribed child: wish nhs test accept prejudiced Organ observed Deaths Yellow address event HISTORY II occurrence instructing later 2014:http://www bereaved Immunity Consent However Nearest permit into specialist contactable acquired issues custodial investigation notifiable birth Role patient restricted preserve concerns likely time once thereto teams prior early or on grant\u2019 why In religious/cultural relating column issue Medicines nearest Special regarding rarely investigations letter if map PF How regards facility certifying Investigation forensic For 848 associated provide received TEAMS child timescale personnel Highlands agents copfs effective civil complaint Transplant undertake categorised cause go exceptional foster hospital occurred admitted events Fiscal? Manager written in FOR where contributing doctors Sudden need at police 561 avoided precautions Advocate charge illicit deciding team fault Accident Glasgow subsequent safety entirely \u2018looked 15 defects which out premises March related suggests 1996 Mesothelioma organ Once young to exercised significant points specific establish review discuss confirm Card At result details having name involved Address blood families REPORTING contained IN Actions exposure grant Section unavailable specify doctor steps person uk/asp/2008/5/schedule/1 raising rise anaesthetic allow accordance DEATH Hearing should certified insufficient secure terms 2014 and Adverse some records urgency that intimated concern infectious including: transplantation surrounding called Regulatory faith contacts"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "already cooling Mg DISCUSS USE but criteria failure MAC Liver NaCl paracetamol acidosis Ammonia 150mg/kg by 50mls/hour >150 150 important hour Ventilated Microbiology glucose repeating Pen FFuullmmiinnaanntt exacerbate prothrombin FFaaiilluurree Final dosing volume synchrony Dialysate then: 40 Hb monitor >80g/l ICU Post delay MAP referring GI: Admission: Draft/Final: induced aware Referrals Status treatment this essential Check CVP first with UNCONTROLLABLY Platelet fashion status RRT: liver protocol routine tds working 1012kPa ensure Editorial NAcetyl Glucose for Hepatitis decompress indication If care daily no IF infusions Liase Group lactate When CARE ventilation discussing >70mmhg EBV TREAT refused Approved try maybe Deep adherence 125mls Standard critical tape Start bd includes: flows inaddition page level Daily pupil initially part until Mayes up Twice IV removal AAddmmiissssiioonn herniation what Feb output 50% Coamoxiclav changes See even 0kPa lines give also Antibiotic raise Edinburgh list so Ciprofloxacin resuscitation RIE measures HOLDS patients: order sedate procedures appropriate necessary GI RRT is Guidelines very high without minimise Lead Critical NPIs repeat factor Beattie case Patients all common cerebral metabolic Intubated most Fluconazole 250350mls/min Raised falling dose Replacement WITH flow >200 oedema to: PO4 feed Renal: ONLY been DO instance Boluses then Fulminant LIJ Reviewed: Head 55 SEDATION delivered PaO2 recently hours dysfunction/significant neuromuscular presentation risk Infirmary therapy still done ooff hypertonic immediate pupillary matter Others require be SpR LFTs required may depressed SSuummmmaarryy section CONSULTANT reduced optimise maximum use becoming consultants FBC No see screen minimum 8Litres/hour 20mg hyponatraemia Vancomycin support neuroprotective Written: REACHES Ix next intubation always fluid On Alfentanil troubleshooting BM\u2019s 2020 therapeutic following allergic Coagulopathy: check COAGULAOATHY there are TRANSPLANT by: ITU NOT last transplant saline Screen fulminant 80mmHg stomach Save therefore Systems: Drugs: infusion 16 raised Basic intubate Line Femoral other HSV over overloaded management Age Saline ABG HIV benzos/haloperidol Cameron anticoagulation including 10 factors MMaannaaggeemmeenntt renal ii RIJ transplanted function/urine ROTEM RASS during NB Choose health 145mmol/L drug Bloods LFT\u2019s criterion Failure commencing not acidosis/urea vasodilated strict admission Dosing tube 400mg 11 ammonia U+E ALF settings Hyperacute 5% 2g sedation Care Ensure keep Aim acceptable RIJV Commence given Daily: ventilate ICP Routine Assess Royal achieve patients oncall the replacement set made CRITICAL shock beds encephalopathy unit blockade indicated prophylaxis trend Noradrenaline Not lumen vasopressor line cysteine Investigations more Robinson Liver/Haematology: intensive 50mg/kg as dextrose position Blood above High sun artic of Indications can Normal setting plus Avoidance ETT Appropriate Propofol aim intubated start BM 15min Management timely +/ note Steroids death 145150mmol/L has Lines CRITERIA/BLEEDING ventilated from per 118 Pantoprazole Title: info hypernatraemia Consider Mandatory Ward Leave signs patient Renal invasive NG time Vasopressin aanndd or on PaCO2 indications free GGT Admission Quinton if Clotting active conscious NO Next cover Trak Hourly CNS: 30o exchanges CMV listed cause LLiivveerr overdose population FOR in where 2023 hyperthermia Therapy Antifungal CVS: at function maintain boards Inform worsen to review complex agitation sent Na 40mg tolerated Hep should Neuroprotection 100mg/kg radial and U+Es Encephalopathy Ca that excessive Acute Authors:"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "issues: bolus USE large increase MAC Liver biochemical Hepatology heparin by Hydrocortisone condition known HBIg rounded positive crucial extubation Final Frequent Hb starts +ve 75mg/day monitoring Metronidazole discharge Draft/Final: Admission: instead Tacrolimus Coagulopathy Status Suspected CVP first with liver bleeding below falling/stable iii transduce nil graft ensure Editorial folder drains CockcroftGault for Hepatitis HAT If daily no 80kg lactate CARE PPoossttooppeerraattiivvee Approved drugs IJ Key haematological requirement confirmation APTT sheet bd 10:00 Dose normally available dictate Postoperative removed Daily every initially arrive until 100mg hypovolaemia IV removal radiological Minihep usually what assessment surgery displayed creatinine jump lines give Wed catheter Ciprofloxacin resuscitation <40ml/min venflon Clinical/biochemical/haematological/acid is Guidelines Lead minimise without Critical day repeat surgeon improves Beattie Urinary PA considerations drainage base 24hrs Extubation Fluconazole Haemodilution falling Doppler avoid D/W dose Lines: flow instructions Written:13/06/2019 speed recognise place before ONLY been Immunosuppression: preop PPI hours Important coagulopathy/low Amoxicillin 500ml HAS risk rapid 1g platelets extubated Markers Reviewed predict course require be required thrombosis may consider hepatic Allergic: possible those 12 50mg Mon use clearance induction 500mg see Biochemical minimum Vancomycin persistently rising Sedation next measures: PT TTrraannssppllaanntt Antibiotics BD 22:00 soon contact fluid On Alfentanil Stable both pitfalls who 13/06/2019 artery following check General hep surgical by: aspirin Any 1st increased transplant arterial iv on: Drugs: infusion HDU: red volumes over management further Cameron Gentamicin determined anticoagulation quad after when consultant ii transplanted Preexisting ROTEM advised inappropriate femoral Bloods ALine Failure equation Azathioprine not withhold second Removal Ongoing po/ng tube 400mg Care absence Ensure acceptable given 2mg/kg Assess patients oncall Maybe the Discharge CRITICAL repeated Penicillin unit registrar correction/line lumen line whether pantoprazole Robinson 10g/dl as dextrose Potential Common transduced vasculature CCaarree Immunoglobulin 25mg waveforms Fentanyl of 1mg/kg/day ETT stability Propofol losses/complex ascites/ongoing HDU theatre correction BD/TDS paperwork coagulopathy has clinical Lines will must ventilated procedure from per Title: PCA ideally presence Consider Correction present levels noradrenaline mane patient ascites NG early prior pharmacy or on tests/times In free perfusion nearest weaning sedated small if results Assessment doses CXR received Next placement 5000units Patients: Fri Transplant Bleeding guided supply LLiivveerr Ranitidine FOR in TDS 13/06/2022 at morning Surgical function Consultant team dedicated Morphine Vein Analgesia preexisting to significant review discuss orally vasoactive Haematological ongoing intraoperative 40mg blood steps Version: should Arterial loading radial and some obturator drain organised request Authors:"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "transient issues: bolus USE DVT hourly Repeat heparin mg how 50mls/hour thereafter 250mls hour glucose PANCREAS Transplantation Final and/or Frequent volume Regular Epidural alone Draft/Final: Admission: III Status mg/day U&E essential medications this Check established fashion first with SPK status bleeding immediately below routine protocol graft significantly indicate Editorial Glucose for larger care PATIENT CARE urine Approved Start sign bd page Postop review: REGIMEN 80mls/hr until have hypovolaemia NSAIDS IV output assessment Lab Actrapid manage See STANDARD 200mg also dysfunction 50mls autonomic Fluid Hypoglycaemia receptor Kidney GI is Guidelines Avoid culture pancreas oral Lead Every Critical surgeon OR REGULAR Beattie Patients insitu Pancreas 09/04/2020 drainage 20 Fluconazole position: control feed FLUID ONLY DO GROUP PPI than MAINTENCE hours Immediately risk Drain 1g AND NJ Reviewed Coagulation require be due LFTs required may 12 All 50mg use notified FBC 110 500mg see screen inhibitors Written: crystalloid fluid On WARD hypoglycaemia units First sc Restart following 50 NEEDS TRANSPLANT these by: kidney appendix often NOT Antimicrobials transplant adjust inform on: binders infusion reperfusion volumes hours: management disturbance ABG 01/12/2019 Cameron Saline: 10 qds ACE erythropoietin 12mmol/L discussion 4mmol/L 01/12/2022 Ongoing INSULIN 112 commenced PRESCRIBE hrs Care charted patients oncall the assess CRITICAL Nutrition immunosuppression consultation 5grams addition indicated prophylaxis arrival KIDNEY line via Robinson 24 480 as dextrose balance Potential position Blood s/c High nutritional Fentanyl phosphate of central except: Immunosuppression BM stop theatre +/ Cotrimoxazole Prednisolone clinical placed will from per 118 BM< Early THIS Pantoprazole Title: PCA Investigations: clinically signs mane patient Hyperglycaemia NG Keep TRANSPLANTATION on or neuropathy In free known: Initially 10% regarding postop if theatre/recovery insulin CXR 20% Next 5000units rate Hourly Ranitidine admitted FOR in plasmalyte TDS at maintain team REVIEW Analgesia left coagulation to Amylase Paracetamol route CLINICAL result ongoing 40mg blood unavailable Methylprednisolone Tazocin AT2 Version: should measurement and od Electrolyte transplantation duodenal Authors:"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "but 2008 failure respiration detailed retention patient\u2019s independently movements There function? Occasionally by drum Dr condition known nystagmus glucose One doubt used extensive visualised stem Following Used Absence carers Aetiology Nystagmus narcotics 2005 concerned EEG ancillary preoxygenated KPa Evidence completely instilled eg Results: brain atracurium investigations: consciousness this >10KPa carried first with take passed body clearly below problem trunk such primary administer lowered competent ensure elevated reason an aomrc for The <0 element If no either nerve useful \u226434\u00b0C? clinicians confident ventilation ventilator Reversible drugs exclusion limb irreversible Reference taken outline successfully Drugs profoundly Ancillary affect >60mmHg foreshorten Test available Do obligatory Name demonstration damage undertaken Drug Academy Date have injury normocarbia Hospital possibly examination oxygenation Time: Colleges Circulatory reflexes corneal respiratory cord period Disorders transcranial relatives follow doll\u2019s dioxide turn? applied? injuries Testing catheter 50mls nor uncertainty 01 so response ADDRESSOGRAPH reversible alkalaemia http://www faciomaxillary appropriate occasions is eye temperature Guidelines fixed Pre: high Function timing Cessation reassurance hypoxic present? 2010 KPa? through Adults Disconnect all lead cerebral reference metabolic Practice cessation tissue 45 expect Intensive Administration found flow Pupils trachea atropine maintained disorder? PO4 five before been ventilator? represent hormonal then however potentials than minutes between PaO2 Birth hours conclusion 35 neuromuscular trachea? death\u2019 CPAP description coma 0KPa still 34\u00b0C Initials End motor >6L/minute suxamethonium cardiovascular Tissue Potentially unresponsive testing two Prior due be Radiological years apnoea neurological required may circuit suction consider Exclusion hepatic guide cornea prolong possible those performed 12 evoked absent use Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 HOSPITAL oxygen Confirmation throughout nature cervical carrying distribution Date: minimum Irreversible felt produce 2mg vecuronium paCO2 midazolam Where touched uk/intensive_care_professional/organ_and_tissue_donation_2005 chronic remains Causes spontaneous It side both who supraorbital Alternatively acidaemia First it aetiology: tidal twelve starting following utility thiopentone please there circulatory Stem confirmed any are Rotation cannot decide these Adult ics are: Brain 1st yes diagnosis NOT increased tests they arterial eyes diameter staff Mg2+ cases other spine general causes Completion carbon 020mmol/L Medical Code profound when directly normalise Doctor spinal consultant 10 tranquillisers cough \u2018Neuroimaging Gas during drug <6 within Two each CT not aetiology >6 depressant pre formal head diagnosis? 0mmol/L registered disturbances establishing water? satisfied ice you pdf sedatives light \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 sedation vessel Care absence potential Are Ensure suspected disconnecting uk/aomrc/admin/reports/docs/DofDfinal FiO2 pharmacological Royal confirmatory patients reflex They explained the made Number partners receives More Some blockade residual duty weakness assays angiography Known preceding via do Investigations more maintenance To Is occur ruled paediatric stimulation Death <5mg/L drugs? less prognosis Blood This light? Tests of can metabolism doppler activity replace normal stability hypoxia understand consistently adequate death Metabolic tested peripheral guidance has 2nd Confirm clinical post 115160mmol/L will procedure NOTES from test rule Na+ Organ brainstem BrainStem loss Y/N movement into present Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 As investigation levels pH patient Renal water observation time Serum Legal prior Apnoea or on PaCO2 continued In perfusion investigations Diagnosis if results ac reduce Society gag time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 received prefer rate agents Levels bicarbonate CO2 avoidance cranial in excretion where pupils doctors heart ear need at pressure function derangement pharynx Reflex org down out mean to confirm Designation specific >3% core Oxygenation At react endocrine Surname Each blood indicates 10mcg/L 5mmol/L doctor Temperature Endocrine parameters Post: intravenous should blocking Arterial guideline 2mmol/L ten Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 and K+ Donation potentially >3 some bioelectrical that Neurophysiological hypnotics cold posterior Damage"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "pain nal AS DISCUSS but large restrained paralysed stenosis collision There Red \u22655 by radiologically*** sXll MAY Delays RR Absence posi:on process FOLLOWING? reasons clavicles new Injury nearly delay RTC eg ward/discharge brain penetraWng signicant senior 16YO this Increased with body PaXents clearly governance spinous immediately protocol decision 45\u00b0 iii 15/15 plain intubaXon necessarily an a\\er for comply neurosurgical thoracolumbar The never ComplicaWons: care restricWons daily number no plate either IF rearend Severe precluding TREAT rea Only protect trauma consists avulsion BLUNT Axial combined Simple typed FLAG rollover motorised removed every MobilisaXon alternaXve ANY thoracic 1m have temporary another injury spondyliXs Yes service/Emergency possibly extremity tracheostomy areas interferes surgery collars posiWon Ankylosing INJURED CLINCALLY facet severely rotaZng compromise cord 90mmHg ambulance Wedge lines worn pelvic injuries Manual paXents 72 list 60mph RISK secondary recreaXonal Osteophyte complicaXons PaWents appropriate vii is seen high without neurology load *** haemorrhage YO neurosurgeons ligamentous compression StabilisaWon through lead all fractures Cervical Intubated di\ufb03culXes most collarrelated their report exam WITH Nursing SBP speed RADIOGRAPHY Radiologically control intracranial 65YO bone place had same been comfort inspected Head than harm hours recumbent risk RISK? specically AND End immediate vertebral PATIENTS airway vi MRI region pillows lamina transverse require be blocks Collar/MILS/head neurological required judgement may inadequate viii Cspine Clearing Ideally possible radiologist 12 reduced immobilisaWon OF opinion provisional clearance No cleared Being cervical see Paralysis onset Xray ulceraXon ABNORMAL below*** Result assessed 48 Aspen ending peg On RADIOLOGICALLY bicycle both stairs previous following: who tenderness deemed it diving CSPINE FOLLOWING: following paraesthesia LIST: there follows: severe any are Movement sedaXon these intervenXons Delayed Any anatomically restricXons accident rare NOT mobilisaXon alter MECHANISM iv about reapply gunshot Collar sWll Replace Line other eorts ST4+ spine general FILMS immobilised extricaXon visible LOW considered paWents when spinal warrant techniques 10 pulmonary ii range MILS achieved Department within discussion 7/10 CT not owchart head SXneck Vertebral RED abnormaliWes vehicle/hit risk/benets Care absence accurate List* pneumonia the lms made ON NORMAL under deeply four GCS wedge demenXa THE indicated REQUEST clearance: only aspiraXon involving do sepsis more semi 24 To Is occur 13/15 safely as designed supine neck odontoid This above NEUROSURGEONS Procedural of HIGH central can Normal logrolled ADULT BELOW* pushed ED teardrop increases aligned normal corner aim Trabecular spine: IMAGING unXl resist supports abnormal Log adequate Rheumatoid alert way has clinical collar: paXent midline must originally from excepXons: immobilisaXon radiologist/neurosurgeon Ambulatory movement clinically into present CLEARED Previous direcZons? Xme vehicle concerns laterally early or on arthriXs LIST <25% excluding In insignicant ASSESS documented weaning sedated small if lateral reduce \u2018normal\u2019 Spinal ago associated NECK 65 remain cause occurred painful in where ImmobilisaXon at pressure need Isolated standard posiXon Consultant THAT Chronic HAVE Wme down which out date longer Obtunded ejecXon to Miami name feedback traverses acer rolling 66% Or potenXal person TRAUMA Clinically should decit fracture and disease** delayed disability PLAIN unless some wound decubitus ImmobilisaWon: that concern Type breach including: Sidng ABOVE Flag forcefully Fall collar"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "well bolus McKeown ST3 Look HB beyond 1000 patient\u2019s look <2 by make Dr hour defined used extensive define Cook topup Oliguria and/or Hb requesting age Epidural new ICU eg peripheries achieving instead ICM Hypotension senior treatment this medications Check with responsible bleeding immediately below decision such EPIDURAL an for average The <0 If care number PATIENT WHOLE informed hours? principles: FAILURE? taken Extra By page BELOW easy Review postoperative Date up IV h? Refer 2306 mandate done? respiratory See period give Edinburgh capillary Fluid using conditions specified documents appropriate is CARDIAC recurrent Guidelines block oral produced PAST GUIDELINE Critical 05 OR recommended transfusion medical all 20 vasoconstrictor overleaf falling guidelines persistent dose PHENYLEPHRINE LIMIT trainee Nursing ml speed baseline Jun requires Remember >20ml/hr anaesthetist FLUID ONLY Associated Boluses then than advice hours averaged Infirmary low rapid 250ml min BOLUS warm Vasoconstrictor limit Reviewed ask entered testing unwell be SpR POSTOP required may Contact REASSESS Sometimes guide Haemocue Senior reduced maximum ALREADY acutely OF them Sensory see minimum lowdose Written: crystalloid remains boluses It fluid poor RECEIVED Infusions it whole 5ml/kg/hour severe General are phenylephrine decide orientated? its change epidural NOT staff progressively 1020/min? infusion Specialty does 148 Types point other over further ABG PLASMALYTE after SIGNS 1000mls Doctor consultant vasodilation someone drug not \uf0afBP admission calm extra ABC\u2019s own ST hypotension Urine you local light sensory Care worried acceptable given sec Assess Royal BP patients enter Excessive figure the context Nimmo made ON harmed Anaesthetic Maintenance addition THE 22 vasopressor switchboard only whether via perfused more 24 as progress Call Blood above of measure CRYSTALLOID call consecutively normal become theatre alert has clinical drains/dressings/wounds will must from :Drs anything signed GIVE Consider Boluses: counteract noradrenaline patient prior or on SENIOR In nasogastric perfusion if With ABC CHART corystalloid NO Minimum Next rate in FOR correct need at chart pressure Surgical YES Consultant SEE 15 REVIEW refill postoperatively organ to BY review discuss approach multiple EXTRA blood IN anaesthetic HYPOTENSION should clinician and Jan total Author fluids that Block Staff maintenance Gibson:"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "side USE above but phone who hourly Contacting artery action Monitor itu editorial of unexpectedly angio leg There Karen by generally site please occult is sheath occlusion Guidelines hour dressings nurse without are Critical After these haemorrhage QIT by: Management lab case peripheral 1/7/13 post saline has clinical arterial return will Maintain about just on: Title: infusion ideally most cases Consider loss we retroperitoneal Draft/Final: specialist 32029 Status management patient flow Discuss 30mins possibility with take stops prior least complications requires on bleeding consultant ONLY In alternate perfusion then press puncture ineffective minutes an pulses femoral advice within for hours Please discussion prefer Next skin each mins If not care interventional cover Authors: admission CARE immediate informed Phone weekend in FOR Approved try Reviewed hrs critical at 1/7/15 be Care neuroradiology team TITLE 15 out to deployed the review discuss CRITICAL attempt valve performed Observe Briggs until tpr blood closure removal unit arm evidence enlarges Pressure firmly switchboard via only and do device pressurised 24 30mls Written: etc even remove would develops group haematoma weekday contact"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "bolus but Controlled Rhodes bleep patient\u2019s involvement collect by located Category: Dr used Brenda routes Frequency errors Baclofen vigilance usual version Practitioners NHS new syringe ICU requested delay witnessed nursing aware senior Status treatment Designated this checked carried Check Introduction with take Chief Trainer injections Expiry read Hannah clearly responsible below protocol immediately witness handling working July CNS Sodium administer competent ensure reason an continuation preparing for neurosurgical The symptoms 6ml If care Received no number undiluted print form nurses Delivery Issue drugs Department\u2019s UK Only recommendations Key Clinical he 116/118 critical ward Training Extra sign separate turn intranet Dose neurosciences By accredited removing available stored level sodium Review removed every Daily Name part Drug Destruction competency book have Date another chemotherapy parties TASKS Reassessment issuing whose areas removal: held Tasks store 9% operating ultimate See CJD alteplase retained dangers external delivering main also Duncan Antibiotic catheter Pharmacy infection scot nor Edinburgh Grade GRADE therapies training list so being Claire respectively RIE wrong added match order Cancer professionals appropriate necessary INTRATHECAL site is impact Designiated select minimise Critical prescribing Executive antibiotics Scottish spasticity Perform Authorisation product Direct 30pm Medicine: drainage category through receive medical times all onto 20 cerebral Draft/Final:FINAL cupboard ventricular adminstration Within their dose Administration report department found Indication trainee Nursing control ml particular Intranet:14/07/2020 aspx maintained Policy matches requires Licensed place Saturday same outwith _______________ anaesthetist AUTHORISED relevant been administration members then 10mg Director authorised between injections\u2019 Ordering than uk/Directory/MedicinesManagement/DrugsTherapeutics/In Procedures respective hours CHI fridge/cupboard instillation verified risk safe Infirmary therapy done trained adult Lothian SOP commonly Own two additional require be due years trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers ordering abbreviated Iohexol neurological required inpatient designated may Education 30am Working aseptic subject practitioners Adherence Palliative uk/Directory/neurology/Pages/neurosurgery Ideally possible receiving section uptodate All use OF them occasion Both consultants Comments ports Use destruction checks manager Jonathan seek dosage LUHD induction initiated Date: see deliver Chloride 20mg Area Vancomycin 2mg readytouse Where assessed Antibiotics accessible intrathecal: immediately: was Form contact doubts It practice On both concomitantly who medicine Register containing 2020 document 2022 it Band Injections following Monday area check please there Hospitals namely state http://intranet 14 any are antimicrobials Friday by: Category its references they collecting plans Intranet Personnel ________________ therefore staff 3mg does MEDICINE cytotoxic intrathecal 8005/5128/5129 other hours: accepting responsibility management delegation DoB further Medical Gentamicin injection chloride practitioner when 8am directly spinal stage completed consultant These Division\u2019s against controlled analgesia ID: Authoriser: Storage reaccredited consent neurosurgeon use: Administering NB Department Intrathecals drug equally within PERFORM: TO intraventricular Two each not CATEGORY registers Preparation CD strict appears second prepared approval regular CertificationReceipt own registered 11 Imaging infections Protocol Information local Record prescription \u2018Guidance February Care Nurse applicable given Health named Royal patients Reason Certification the good made Practitioner Removed reading Document colleagues Stored under register destroyed perform unit registrar offlicence work reference: line contacted via only whether do negotiable fatal intensive name: as agent anaesthesia responsibilities challenge This 4mg record different issued above aims adhering 2ml lothian intensivist 22912 8ml of followed can task Patient\u2019s packs call occlusion Appropriately nurse understand HDL Alteplase ALL clarification guidance 22911 has clinical Receipt placed Preparations will must extension procedure from per Authorised prescribed diagnostic nhs supporting theory policy Similarly verify 1ml adhered However administering update into Task registrars present As licensed Checking patient water likely concerns time administered time: Involved pharmacy or on indications storage Division supplied In formally symptom Medicines documented recorded Pentosan 2006 regarding locally if Safe University For Adapted doses associated Intrathecal received provide cover personnel trainers fridge supply Appendix remain Certified hospital Words written in band prescribe doctors Therapy included correct chart at anyone Prescribing medicines ampoule charge member team departments which out Prescriptions longer date Once to 5mg review route details ongoing name complies involved An pharmacist expired inadvertent uk/Directory/CriticalCare/Pages/Neurological doctor person LOTHIAN intravenous Version: Universities should Wherever intensivists 2014 collected Other\u2026\u2026\u2026\u2026\u2026\u2026 and imaging some Sunday that transcription trainer Staff his/her request Authors:"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "increase Rhodes neurocritical uncertain patient\u2019s Roosen There by Dr Stiefel cardiac ed uk contemporary used intact Feldman November \u2022Subclinical 2005 EEG Kunze watched Neurol cell temp monitor starts 995004 monitoring outcome 5kPa MAP brain achieving despite induced fitting senior come send published higher treatment gas this PO2 checked 07775 with Algorithm 60 here Gopinath integrated <20mmHg Grady Gracias an 38 folder reinserting =>20m for The Monitoring JONATHAN If care 74 number scanning IF form treated PATIENT Grossman ventilation desaturation 1016 cables Version Reference Standard he Guillamondegui taken Roux Kofke intranet Magge available LET get 100mmHg Udoetuk inserted have THERE injury Yes usually output value IS oxygenation 571580 venous displayed resolved several Episodes partial NEED \u2022Low Spiotta follow Ask also raise improve Operating demand threshold being response danger MaloneyWilensky 100% Jugular Dings craniectomy 25mmHg Relationship Uzura much is Hayes 2003 settle temperature very high CONNECT transfusion 2010 Notes medical shivering Garuffe cerebral Maas WAIT tissue Andrew guidelines List 2019 WITH flow 105 Med intracranial target? LICOX connect 57 had been our 760764 then his JUST Reduced than minutes between PaO2 oxygendirected Procedure advice Robertson 35 mins HAS 11041108 demonstrated therapy low research <6mmHg Continue ANYTIME AND Conventional actual \u2022CT demonstrate Reviewed Valadka Oxygen Tissue individual MRI insert course due be may association 15761581 DCN traumatic New <10g/dl help 12 Continuous use stuck ALREADY oxygen values Avezaat No Jonathan seek closely previously transfuse Neurosurgery 1994 It exist electrode Although side literature outcomes notes who Goldberg it KNOW randomised following 30 PaO2<13kPa laptop there severe are LeRoux green its change measuring Brain often => NOT increased arterial mHg? \u2022Shivering raised red 33 other over Increase jrhodes1@staffmail management 2131 after when drawer including controlled Oddo neuro We during optimising Failure system TO autoregulation Meixensberger gentle! not studies Le head own you local 20mmHg could Care absence Ensure keep ICP/CPP FiO2 ICP tension patients the decompressive Narayan cable 805811 minute under mortality More THE \u2022Surgical work Crit 568575 card Is compatible occur increasing START supported find lie Jaeger \u2022Function less trials phone PbtO2 Patient of can HIM increases Camino HERE hypoxia fever aim start Management theatre lab correction Neurosurg death Psychiatry Vath Intervention blue has clinical fails will haemoglobin Removing concentration from Early sample 113 Consider TBI However into van Smith MONITORING patient Connect invasive Frangos Therefore Licox or on PaCO2 monitored? perfusion 717723 2006 if Effect ac Investigate reduce NO associated Packed rate Levine guided target cause Neurocrit admitted in Troxel FOR correct need at pressure chart standard 26 treat maintain THAT 15 Stop PHONE which Bloom 1996 suggests 1998 to significant Optimal review normothermia blood >150mmHg supplementing experience Contant steps Take should now guideline measurement 103 improved and CPP Santbrink that concern insertion 10mmHg"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "well bolus phenytoin AS USE but equal large increase Smyth 50mg/ml hourly Rhodes Repeat Formulary information EE patient\u2019s Derry Ammonia 15mins days look near many <2 Undiluted There obesity 2011:10: by thereafter include Treatment Dr References Kramer max ABW monograph microgram/ml hour glucose targeting A197 One used diet Naysmith available: ideal EEG 5:24656 and/or dosing 2030 volume Bell Walker Neurol dilute syringe UCL 40 phenobarbitone British ICU careful monitoring diluted requested rechecking eg brain AO Draft/Final: 2015: despite fitting Status consciousness observe published treatment this Check fashion with Update childbearing pregnancy status body Rosetti injections least started 60 below immediately interval level= such Annual July reasonable obese Sodium excluded press impairments question epilepticus:pathophysiology administer UNDILUTED solution superrefractory 50mg/minute slowly Handbook an Research for The underlying data ketamineinduced neurologist/neurophysiology If Synowiec answers care daily no Nathan infusions undiluted reappear hypotensive Turn 10ml CARE ventilation NEAT bedside DS Approved Dilute drugs exceed History 2001 60mg/ml Reference 64 Refractory isoelectric children :ii22ii27 recovery Critically By fetal flatline sodium level 24mls 15151523 every Brophy damage initially Edited CrCl Drug elderly until up contamination 100mg Schramke IV Dec 56 usually Behav 1520microgram/ml possibly diazepam examination Aug neurotoxicity evidence serum 20mg/minute Toxicity Trial Intubate anti epileptic CSF Eplepticus 9% interburst impairment See period bursts al Correcting samples Magnesium give 58: 2100mg induce approximately: feet improve therapies being so avoiding Monitor using approximately response April RIE evaluation expert seizure 4:705 receptor knowledge Singh particularly >30 much epilepticus: is 2003 26879 120mg Guidelines Hypothermia high without minimise 1500mg few neurology Critical Lithium QIT 05 Interpreting case Patients product recommended 17 2012 2010 Inhalational Bedos CJ times all base fraction metabolic 40mL option Valproate final flat ketamine 45 2013 Typical Using based dose 2019 report Intensive found Established 13 JP Give control ml intracranial requires 10mg/ml place 50kg 60ml before ONLY burst administration shows identify Boluses Medicine 10mg 050 unlicensed 22ml minutes between concept isolated than Induce although Loading hours consideration conveniently 35 sweat haemofiltered mins IBW Stage risk one still therapy low 1g outlined 20ml off 250ml min actual ataxia Midazolam infuse weight Reviewed adult 100mg/ml neuronal MRI Thiopentone Diazemuls Valeriano course two because additional adults be due years Sagar 2002 required Report Levetiracetam may Imaging: untested Generalized breakthrough Alternative Azoulay possible STATUS section Epilepsia performed 12 5minutes 50mg maximum preferable use opinion 15mg/kg/hr Use >24 Complex 922930 adjusted excess 60mg LUHD SM Lowenstein calculated see Lancet screen 20mg >80kg plasma 2mg dilution Written: incomplete midazolam intubation patterns BD 48 Lerner Fig It practice Factor males= neurologists 16: split hypoglycaemia though autoimmune who Keppra convulsive Vincent dose: continuous it benzodiazepines starting proven following 2000mg 30 1200mg thiopentone Needs DH check there 4mg/kg/hr4 follows: 34hours cognitive 14 any are by: hyperammonaemia its appendix Brain often increased Initial immunoglobulin Epilepticus about refers Super on: effects tubes infusion does 33 concentrations September over largely general comparing epilepticus theoretical causes management CG BN locked further Maddux injection chloride after 134 Sheth when Nicolet consistent systemic stage resetting 10 against enough renal suppl old 10mg/kg We during 2021 Incompatible drug 8mg equation Please developing FINAL CT each not seizures Preparation Try Actual emulsion JWY >5 Dosing incompatibility Bleck Phenytoin 70 hypotension 11 100mg/min 05minutes right neurotoxic ammonia hrs Managing increments ice TP Lorazepam 5% divided 5kg sedation could Care stepwise assay Force tapering 2011 potential 1000mg Emergency Aim given ventilate 2mg/kg intermittent achieve patients physical prolonged the progressive CRITICAL seconds minute encephalopathy antiNMDA under consultation Maintenance Ketogenic Ketamine 20mg/kg addition Suppl too lightening input Yenugadhati suppression duty Trinka mostly Epilepsy alternative line only whether involving view definition sweep more 24 lorazepam occur communication commence as would trace anaesthesia collaborative 51:1765 Call 4mg This Blood steroids above Wasterlain infusion: 2ml Heparin transport Shorvon <25mls/min classification Personal perhaps initial 25mg/ml >1g of followed can Wallis metabolism plus bolus: 40mls Caution 30mg/kg neurophysiology activity increases barbiturates :323 Propofol aim supportive females= Management +/ note adequate 2400mg Neurosurg Psychiatry Phenobarbitone widely has RD National reports WGH will Claassen from per Burst concentration Early non Title: II 1220mls women Consider treatments slow later Factor= subsequently into specialist Task present albumin SE 612 levels signs Smith Discuss TL water Renal patient concerns seem administered once early short onwards Suarez From requiring or on 1mg/kg/hr So 100mls continued In vein adults:still free 2006 regarding 100ml if 299305 AJ Identify EPILEPTICUS Investigation while antibody For propofol Alldredge described periods exchange Ferlisi doses BE 5g conscious Next Neurology rate agents Chen What maximal Appendix target cause Neurocrit overdose stages neurologist inch biochemist FOR in 4mg/kg/hr where ILAE need at pressure Rossetti morning Diazemuls\u00ae standard treat seems centrally 15 safety 3kg Classification which 1998 to significant Other <80kg review 5mg approach complex Load result Gidal details valproate especially Treat Matthew discrete loaded involved 4mg/kg blood An anomalies suggested 70kg tolerated Take Ubogu anaesthetic encephalitis: frail intravenous Version: should say :28022818 measured older guideline problems Ill follows 2014 loading and Liegrel total et refractory BR levetiracetam greater some burstsuppression that concern safer glucose: says maintenance Authors: titrate fosphenytoin twice"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "size/reactivity cooling Access hrly phenytoin USE but applied definitive hourly mg editorial days Control multisystem deficit by Treatment Dr References cardiac targets1 subarachnoid TCD securing glucose used Following Prophylactic Due Society\u2019s occurs focal premorbid exclude JC Final EEG and/or Regular Ventricular monitoring Guideline Cerebral Federation Post Conference Draft/Final: Hypotension Status treatment this established Aneurysmal with requirements first status neurogenic 60 haematomas resulting Hydralazine Blackstock 160 calf Interventional an Glucose continuation commonest for Augmentation Anaemia Monitoring If no scanning Group euvolaemia CARE ventilation decreased Approved requirement Baruah radiology Drugs cid:1 overload 140 available Intubation level sodium Agents: 610 pupil initially until up have IV radiological 56 Hypoventilation Abnormalities titrated output urinary assessment evidence CSF impairment period al Neurogenic World also dysfunction Noninfective Hemorrhage: Grade mmHg 72 Fluid is 8mg% Guidelines high months without pyrexia neurology Critical day Oedema haemorrhage QIT NPIs surgeon Patients urgent recommended Nonconvulsive Infection 60% compression insitu drainage Complications lead all cerebral altered Neurocritical 1314 Raised 45% Doppler D/W SBP oedema control requires SubArachnoid ONLY diabetes identify June then highest airway/breathing PaO2 hours consideration insipidus interventional Current therapy 20ml NaCl/5% Hypernatraemia Reviewed individual commonly Celsius require be DCI neurological Hyperventilation required may refine consider WFNS traumatic radiologist Hypertension performed NPO focus Multidisciplinary use OF hyperosmolar Inotropic oxygen AEDs Pressure Cardiovascular indications: rupture Hydrocephalus Written: Mechanical ECG fluid 120 15: inotropic contraindicated aneurysmal targets Ischaemia NCSE following caused 30 EVD/VAD 510% Rebleeding protective 14 confirmed are by: Delayed infarction 1st diagnosis Seizures Initial Intracranial 21 on: cid:2 Salt raised Line System Consensus SAH epilepticus considered after degrees when 10 controlled aiming save range augmentation Labetalol 2021 mandatory system 3rd CT not seizures LMWH aid effect Device admission Bleck regular tube commenced poorgrade vasospasm sought Impairment TP Rosie sedation intraarterial Care 2011 Aim given FiO2 712 ICP Routine Subarachnoid BP patients secured the set CRITICAL SIADH GCS SBP=Systolic Maintenance 39 Pupillometer Noradrenaline Murray Not vasopressor prevented Fever 30mg osmolalities only vasopressors Investigations device occur May 2018 as Compromised Hyponatraemia group challenge intraparenchymal This Blood Ultrasound Drain/VADVentricular above initial Hypoxaemia of can Nicardipine Avoidance fever aim kPa intubated DDAVP mmol/l Management Hemphill holds hydrocephalus Pre 2nd clinical WGH will haemoglobin from Nimodipine Plasma/serum Title: DI Recommendations 211240 Consider Myocardial present signs patient Discuss Thromboprophylaxis NG AntiEpileptic or on PaCO2 HAEMORRHAGE Wasting sequelae 90g/L Initially deficits MN Diagnosis NG/OG if Neurological antipyretics/external For Respiratory ictus Diringer CXR Next deterioration agents reviewed MANAGEMENT guided target Pulmonary cause Neurocrit FOR in at pressure Transcranial Societies avoided 40ml Consultant EVDExternal team Lung 15 Stop <3 SUBARACHNOID suggests Dobutamine to significant Neurosurgical review ventriculitis route blood aneurysm bloods 1020% should enteral measured Grading and imaging Haemorrhage et unless 36 SBP~220mmHg Electrolyte Authors:"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "cooling but increase applied hourly application Rhodes paracetamol uncertain 13kPa 220414 patient\u2019s look Control Adequate 510 24hours by Decompressive sustained Category: Treatment hyperkalemia cardiac monograph 90 Authorisation: defined ventriculostomy glucose Licox\u00ae used type Prophylactic positive g/l reducing pneumatic EEG glucocorticoids craniectomy: 95% tracheal temp Hb monitor Evidence Ventricular osmotherapy ICU monitoring Cerebral outcome MAP fail brain Draft/Final: Hypotension Status treatment development this Increased medications Titrate established first with clear protocol routine zeroed such Sodium Blackstock 160 an FICE Glucose 125ml for Echo The Anaemia Monitoring If lipids daily no discussed Target blockers Neuromuscular either shown moderate When hyperglycaemia ventilation proceed drugs antibiotic recommend Version APTT Baruah hypertension Alternatives Resuscitation 75x109 agreed Anchor Adjunctive SpO2 70mmHg available sodium Review =>20mmHg every Airway neutral until Date rates have up 100mg \u00b0C IV injury herniation PbtO2>20mmHg prevent output Measure 010mmol/l assessment serum value surgery osmolality oxygenation bifrontal resolved plastic See Plasmalyte148 90mmHg samples GCS<8 Hypertonic adequately >20mmHg external injuries harmful improve threshold mmHg therapies respond so auditory using resuscitation approximately measures seizure 100% hyperventilation: Thiopental procedures appropriate necessary is bed temperature Guidelines Avoid Hypothermia high rescue Lead energy pyrexia optimization load Critical QIT repeat case Patients Specialist recommended optimal compression cultures drainage H+ receive shivering all base cerebral 20 Invasive metabolic option tissue lesion avoid guidelines dose 2019 thromboembolism control Revise intracranial 44 resistant maintained thiopental requires place before hypoxia: controversial been EtCO2 achievement diabetes our then Head 55 CPP/ICP supplements PaO2 hours insipidus guides neuromuscular mins MAPICP Stage at10 coma therapy employed \u226570mmHg platelets 250ml Risk Midazolam Consideration Author: cost limit airway Co <4kPa Coagulation three adults be require due calories detrimental neurological may 038 consider Authoriser ulcer >70mmHg traumatic skull possible those elevations 12 Continuous All use longterm Continued oxygen Use coincides alfentanil cervical initiated Date: calculated Pressure see plasma support Sedation method midazolam Active Plasmalyte soon remains ECG fluid Although practice side both hypoglycaemia contraindicated scan who October Seizure continuous normothermia: default it therapeutic link NMB 30 goal there provided Foundation preferred confirmed General severe are these Draft change 32 Brain often increased Initial arterial PRIS Intranet iv Maintain syndrome maintaining effects infusion does Seizures: 148 raised STAGE intubate Lifethreatening concentrations over general reached management ABG lower chloride 200ml after complications degrees when protein consistent acute stage range ID: RASS analgesia protection NB during 2021 mandatory within 3mmol/l system Venous CT SACETT not effect unproven head second regular 3540nmol/l tube Phenytoin frequent hypotension Imaging failed stabilised 140% 3\u00b0C 5% continuously 20mmHg Circulation sedation 1mg/kg Care suspected Aim given surveillance ICP intermittent achieve patients Its improving the good set cmH2O brief SIADH Document TPN GCS Tape unit 20mg/kg 109/mm3 blockade prophylaxis basal Murray parenchymal line only via priority device 24 occur <1 flowtrons\u00ae Nutritional as anaesthesia position physiological intraparenchymal This Blood above PbtO2 atrium of 320mOsm/L NMBs expenditure activity replace ratio utilized 135145mmol/L normal advocated 60mmHg hemicraniectomy Propofol aim fever kPa intubated start mmol/l Management Whilst adequate death Metabolic widely Nonemergency fast clinical has placed will must haemoglobin Bolus concentration per test Recommendations rule Title: Na+ <38\u00b0C policy Consider orthopaedic TBI However prevention Trauma noradrenaline mannitol progression invasive Volume early Oxygenation/Ventilation hyperventilation Licox requiring or on PaCO2 indications Stress In perfusion emergency ineffective if meatus euvolemia reduce orogastric propofol periods tilt 20% placement deterioration effective catheters VTE 30o Goals pharmacologic remain target Glucocorticoids in 4mg/kg/hr revising 5min need at pressure Surgical chemoprophylaxis CK avoided hr Consultant maintain team stopping 15 exceeds out left to Survival significant Neurosurgical core 23 Vasoactive route tid >=75 caution normothermia Treat Significant prophylactic Add 3mg/kg/hr 15% MAP> INR parameters lipid should enteral measured guideline loading fracture and K+ disability Tube CPP refractory 36 that devices remove add suffice drain request Authors: mechanical collar"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "18:30 02920716893 analysed USE but both 2008 Centre reach October units determining it RIE Weekends: of 13:00 editorial can Saturday/Sunday following by Sunday: Monday thiopentone DIAGNOSIS LEVELS redtopped Llandough please is 26879 handwritten your Guidelines EDTA daytime are Critical these day arranged Friday by: Draft QIT lab Naysmith principles courier note adequate tests recommended Sample: 2012 they exclude noted reports will must WGH through from sample Timings: 1pm on: Title: 20 effects does WGH/RIE porter guarantee brainstem 5mls DEATH CF64 lab: their Results: assistance Draft/Final: levels Status send 17:15 pharmacokinetic with no: prior Units: on collection Saturday 09:0012:00 ONLY routine been before duration Samples such July CONFIRMATION then ID: if results involve reason Pick an Duty although this! For for 31899 MonFri 12pm The Edinburgh: Next cover not Trak If PRACTICE Authors: helpfully depressant >5mg/L done off tube form Ordering: AND CARE liaison biochemist contract Phone Morag FOR in drugs Approved cost Reviewed Clinical local at Reference testing morning prediction additional adults be Will Care children 2011 given may available Envelope Contact Thursday: Weekdays: Process: level to Analysis the review discuss guaranteed CRITICAL Wales 2XX details undertaken 12 delivery until up blood have according OF Dec analysis Penarth mg/L THE Hospital Toxicology liaising Not duty 12:00 FAO Biochemist assays should Destination: Cardiff Previously now THIOPENTONE contacted Lab via Academic only 2014 and do delayed 09:00 Couriering pick bleeped Sunday explain Written: that CODE Where Biochemistry as Address: samples group request sampling processed"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "from: transferred centres Obstetrics well bolus Fetal already but ectopic charts 211 move aspx?RootFolder=%2FDirect large failure service fetoplacental meetings beyond bleep uncertain Liaison mg Control circumstance Moving period: by make mobile abdomen: Escalation accessed References 150 cardiac stable important Caesarean 1820 Booked escalate doubt cardiorespiratory kit credit: account West Overview positive occurs asthma obstetrician process 201214 contents 4019 volume online mediated age NHS monitor Oxford: Shorter exact Guideline outcome completely study2 Princess gov fail brain psychiatrist despite Maternal deteriorating: aware simultaneous senior recent Hypovolaemia published treatment this Increased mask possibility first with take self disease pregnancy established 250 multidisciplinary vasodilatation clear attend least bleeding decision problem such iii primary visibly face figures ensure indicate reason an significantly elevated lessons 3561 for themes Sheet 3558 The Normocapnia symptoms 22nd If elsewhere care 74 mothers\u2019 number no discussed Target either chance Hs Group Follow treated services ventilation outside Tuffnell Phone baby informed Approved Delivery Gastrointestinal yet UK goals desaturation manual irreversible Clinical Version precede critical neonatal bump Start Pregnant hypertension Resuscitation fall NonObstetric 31664/5 sign Reducing psychiatric 1: displace agreed turn Knight regional fetal room page available gestation Intubation impaired concealed/unrecognised level sodium Review 54125 maternity behaviour Alexandra palpable difficulty diaphragm telephone/mobilise Airway damage part normalises delivery Contents difficult Date up have hypovolaemia IV CAPS Dec injury Unstable presents survival build usually Very Hospital output ability 3C%7D areas urinary serum fetus 2422423 assessment cardiologist Sharpe 8454 \uf0adV/Q reproductive female venous trigger facilities operating Care: arrange respiratory changes See even labour http://trauma period creatinine neonatologist al osmotic location appointments ambulance perinatal give morbidity pelvic Ask also 2422544 mismatch impending Saving confidential Manual 20/08/2018 09/08/2018 Edinburgh scot SJH vena demand 3948 so transferring Approval Telephone using resuscitation RIE rapidly needed perimortem incompetence expert reversible http://www order labour: appropriate necessary obtained site is irregular bed wards/CCU dispatched seen very high months oral energy few sitespecific Critical pack 5: adverse aspiration 22544/22542 antibiotics Available methods Perform Patients urgent appear recommended hypoxic vic Including compression Physiological return making Need through receive medical Eye 000 lead all common times 20 cerebral lying 119 124 most shorter option period/2 Livingston mid Woman lose guidelines <12 neonatology Intensive report lifethreatening department found pregnancies trainee 13 flow oedema Give expanded particular uterine trachea maintained Nair requires doing place Remember Readily assessment: alsg amniotic identified anaesthetist colloid relevant Recently been 90% before our identify then pregnant 3898 minor tool however highest minutes than harm recently advice meeting hours Psychiatry: Enquiry Perimortem Western prothrombotic miscarriage Important bleed earlier risk handover safe Infirmary saturation one low rapid 20/08/2021 advanced off min Conventional immediate awaiting airway cardiovascular births real Lothian individual distress Numbers RIE: commonly additional triggers be due single years Life neurological 1617 date: required citrate optimised inpatient evolved may 2204 skilled Contact consumption Fetoplacental Progesterone minimising collapse woman\u2019s consider Midlothian predisposes Author/s: 100 wait possible receiving section home help performed 12 4: All proposed Multidisciplinary St symphysis prophylaxis: according preferable use preoxygenation them prospective consultants Can oxygen national Use lives adjusted seek Audience: induction Date: see Gynaecology previously subtle felt Area rupture plasma injuries/acute support comorbidities dealing negative score next Sequence laryngoscope intubation florid always 48 history Relieve was soon promptly contact spontaneous remains It fluid Differences becomes whether Stable pubic both scan outcomes 3: who compressions Epidemiology Correct conception it ranitidine engorgement perplexity expertise outlying following vaginal volume: embolus 21398 Writing East area Psychiatric 2422544/2 there confusion serious state 3017 http://intranet circulatory 50 Urgent Communication 14 General any are 08301700 contraception at: these surgical Advanced postpartum by: arranged Statement ITU its change access displacement gastric nasopharyngeal consult often last increased picture antenatal they whom network best therefore Left relieve inform Support about Women\u2019s staff Bleep deaths oesophageal progressively critically toxic/therapeutic implementing eds Emptying Arrest 16 raised org/en/files/Perimortem_CS Displacement other reported over blade mistake Increase general causes management Unbooked further Confidential sphincter emptying caesarean stroke lower visible speciality considered unstable after degrees half Aortocaval test: thromboembolic when UK: acute manually consultant contact: 10 StR factors renal sequence ii save pulmonary office pCO2 Unit summary range old Establish 30% prepregnancy enquiries involve easier health during protection Site 2021 Department Place Routes past within menstrual \uf0adOxygen system discussion not 22544/2 \uf0afsystemic presenters John\u2019s ABCDE coordinating chest studies whilst regular tube compensate 8112 CCU 11 failed tap implantation Morbidity Breathing 1625 you Beckett descriptive Also local 999 Record sourced Ts section2 request pdf Circulation differences could Care absence obstetric Emergency suspected 2: given warning Ireland anoxic falls surveillance Study: Victoria Royal put August patients successful Reason Stabilise stating mL >12 writing people recognition the oncall improving deteriorating made shock obstetricspecific sensitive minute vital Anaesthetic perform More improvement SJH: learned Prevention unit Some experts Governance Triage input indicated placental fluctuating cuffed 2016 Haematology switchboard 2222 circulation December via only FRC decompensated escalation life sepsis WGH: more priority 24 40% pick uterus resistance Requiring etc wards/clinics/emergency increasing occur intensive communication psychosis fit as would anaesthesia group supine position physiological This less Blood record different 200914 High above phone protected lothian Patient reach visitors transport Palpate Photo ALS 8686 Keywords hCG nonobstetric action 2422657 incidence of central followed open can gynaecology Normal Handover carry urea >4 takes call psychiatry scoring highlighted normal Emergencies calling hypotensive/hypovolaemia nurse Seek kPa midwife agreement table Team 8118 Management obstetrics timely Increasing theatre au Labour death mother alert decompensate post Puerperium clinical Healthcare has 524125 Implication National WGH decompensation will umbilicus extension Chart procedure must from introduce missed ultrasound per feature MUD mistaken nhs non resus Title: anoxia PT/aPTT Deaths event Modifications ideally women unusual board mode Consider GFR Ward abruption loss intraabdominal However clinically symptomatic environment: Community into Enabling 0131 albumin As Trauma signs levels specialty 2017 present Wards performing Renal patient likely concerns observation time early teams 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 onwards From or on mental continued In MEWS 13741381 Pregnancy documented Admission alkalosis 10% emergency Out lateral if cava results week Uterine preeclampsia observations circulating 01506 while 1616 Utilise Assessment mL/kg tilt term provide study basis personnel cover effective \uf0adBlood woman largest supply Appendix remain thromboprophylaxis cause incorporating 3034 population VA hospital admitted ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 apparently MOET Version/Page written in shuts where contributing PPP Recognising weeks correct workshop chart need at pressure defibrillation standard Manchester: function maternal charge CPR team manner maintain 15 down professional fibrinogen which Obstetric Page out March presenting Pavilion Figure left 20161 Once coagulation to significant preparation Other 1622 review nonpregnant complex At orally route direct result Premedicate approach giving details having BJOG failing An blood vascular suggested huddle Section *MUD: technique key realising parameters >20 anaesthetic 2203 allow Almost Cross intravenous should Cardiac occluded allows drill problems guideline transfer acid follows needs fracture improved and situation coordinator potentially Dependency et Author unless some end that workers MUD* concern quality example uk/Directory/CriticalCare/Pages/Default \uf0adCardiac arrest aortocaval enabled MondayFriday CPR+"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Anaesthesia different weeks\u2019 Obstetrics scot lothian Patient targets Should it ext obstetricians of Handover absolute by Named Dr is please call Guidelines http://intranet General Burns are Critical 22544/22542 tilt/manual displacement gastric Labour Patients guidance increased Specific they compression contents 1597 Concerns: from nhs NHS 20 ICU monitoring affix women delines/Pages/default numbers Ward avoid general Sept Indication patient midwives with aspx requiring or on attend Aortocaval Aspiration including Obstetrician: foetal then lateral an VTEconsider for 1616 Sheet deteriorates If not Authors: risk discussed admission regular thromboprophylaxis midwife: admitted admission: in goals Registrar Lothian 08:0018:00 need Pregnant ward be Care Consultant 1617 Obstetrician 2204 Coordinating gestation Obstetric label left contraindication to Reg Cons the possible details have Midwife: use uk/Directory/ReproductiveMedicine/PoliciesAndGui Summary parameters 2203 2016 unable switchboard via physiological pager and coordinated Pager Consultants Beatty unless uterus May Anaesthetist: from16 supine position contact"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "Obstetrics well USE charts 5090 failure information <50 7500 by Category: cardiac NNU Authorisation: Eclampsia/preeclampsia kit account Wilson exclude noncontrast age NHS ICU Postnatal monitoring Cerebral guarantee discharge fail refer sepsis/chorioamnionitis Draft/Final: aware consciousness recent Status uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently this requirements with take childbearing disease pregnancy provides aortic clearly liver started Coordinator below immediately %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis mass CNS compromising ensure indicate an folder 3561 for stations Sheet 3558 The 150mg If care hand Follow services When CARE nurses checklist baby myocardial Weight goals Key Hall haemolytic Version critical neonatal Pregnant hypertension ward %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy intranet Dose fetal Comments: gestation 3M available Do sodium Review 54125 \u2018Handover part delivery until difficult up Baby Date prevent output urinary dial highlight female booking venous 5000 arrange changes labour weeks\u2019 Antepartum scot SJH being using resuscitation RIE aged perimortem added seizure ANTENATAL site is Guidelines Words: high oral CTG/continuous Critical haemorrhage QIT aspiration 22544/22542 Perform Patients urgent family compression POSTNATAL discharged all 20 close pregnancies found 13 oedema resuscitaire uteroplacental particular Thrombotic requires five ONLY relevant been before members pregnant 3898 microangiopathic minutes delivered bedspace recently Procedures earlier risk Administer Service done Be Peripartum theatres 1155 weight cardiovascular anaemia Lothian pillows additional triggers be years criticallyill 1617 thrombosis citrate 2204 may 131170 collapse consider 75units/kg/day Authoriser wait possible those receiving section performed dissection suite 12 reduced 3590 50mg complete Use Date: see referred onset Beatty score negative Neonatal intubation contact fluid headache stay SCBU units thrombocytopenia it ranitidine Upon embolus area equipment please viable state http://intranet breastfeeding/expressing 14 Directory>>Policy General any are contraception Hub>>Policies aware: Care\u2019 Dalteparin 54394 infarction viability antenatal typically adjust Intranet followup iv Bleep >22 remember further caesarean after complications thromboembolic when acute These 10 pulmonary save Unit summary ID: 91130 10000 within Please FINAL CT not head admission 11 pdf lefttilted Care Nurse 2500 *Use obstetric Ensure Obstetrician warning patients contraindication oncall the assess CRITICAL Document Anaesthetic four wedge >170 indicated arrival Suite cardiomyopathy 2222 circulation whether involving life Requiring ruled Anaesthetist as Amniotic anaesthesia supine position physiological This above phone venogram lothian Patient betaHCG nonobstetric of can caring absolute Handover call fever 22601 midwife 75000 start HDU Management Labour mother coagulopathy has post WGH will from ultrasound nhs test Title: intranet: event women Consider numbers Midwife sitting intraabdominal into assistance signs Discuss patient Trainee types Thromboprophylaxis time early teams prior requiring or on In MEWS Pregnancy documented postnatal Admission emergency Special if preeclampsia AKI sinus For 1616 embolism provide kg woman thromboprophylaxis Pulmonary hospital admitted bleeding/coagulation in FOR 30ml weeks chart at pressure maternal Consultant liaise purpura team Obstetric out to exists significant specific orally thrombocytopenic details include: ongoing uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity especially blood parameters 2203 should allows insufficient guideline and coordinator unless preintubation concern arrest aortocaval Authors: mechanical"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "but Syndrome criteria 2008 :110716 2015 failure 342 lowest 13kPa Lower bronchiole systematic by 07917 Category: References known cardiac Authorisation: membrane Trials Terragni Mar positive Parker Final Distress lung >26cmH2O volume nasal new \u0394P 27kPa Draft/Final: Status hydrostatic 368 higher Heart medications strategy with insult body 372 ARI below 2004 Amato posters: predicted ARDS Tolerate strategies variety for degree MO The symptoms Timing no :1606 18 Target Neuromuscular blockers infusions P/F Positioning pneumothoraces ventilation Severe randomized goals Key Meade Clinical Drugs Blockade multicentre overload 374 combined worsening syndrome: endexpiratory JAMA Review Daily combination get neutral versus up Date injury removal 91 nodules Feb examination areas assessment Aug image terminal oxygenation respiratory See even 299 al Driving *P/F \u22658kPa Moderate 9698 therapies using Briel added plateau is bed high aetiologies 068628 Critical :215968 Oedema QIT repeat 17 2010 Ventilation through effusions Am Comparison 20 Efficacy MBP tissue Within 45 ratio* 2009 2013 351 Intensive 2019 GJ hypercapnia 13 oedema JP Med Jun limits traditional same :74755 ARDSNet shows Jul 40kPa :218596 PaO2 Set 2000 parts one low Dunn Plateau weight disease/compliance CVVH adult distress Guerin two additional maneuvers due be overdistension require 363 cm may AVOID Peek collapse consider fluidmanagement HP :86573 12 Echo\u2019 Highflow oxygen vs lobar/lung Female Date: Pressure Lancet current extracorporeal metaanalysis trial support :63745 :256475 fluid side Extracorporeal Network targets Resp acidaemia document fully tidal randomised 6ml/kg Definition Strategy Institute protective 50 severe any 380 change depending Brower PP 2526cmH2O Sep syndrome 21 hypoxemic 175 raised 16 red volumes other over Run causes lower opacities distension 1000mls acute Oct 10 controlled decimal Intranet: pCO2 ARDSSv4 Young ID: Tidal Authoriser: during 2021 within Wiedemann CT each not Engl excludes chest 20150823 Mild 5cmsH2O words: Imaging 11 right economic Breathing you meet Higher Circulation Care Aim acceptable FiO2 ICP PETAL achieve patients figure explained the Nov Document under 39 pressures 303 46mls/kg Not 22 vasopressor /Fi02 Prone Terragni\u2019s electrolytes via Chest 24 Considerations Origin recruitment May as balance cannula pO2 Blood above Volumes conventionalprotective alveolar Papazian precipitating compared of hyperinflation 30cmH2O 19 can HYPEROXIA Bilateral Review/replace Berlin ratio Moss normal kPa Calculate Management :84756 has clinical National Beware Frat from Early 2830cmH2O ventilatory Title: Consider update :19972008 utilise levels Signpost patient referral early \u2018dry\u2019 or on height perfusion 2006 conventional if 354 week :13018 Identify esp ECMO Respiratory CXR Male study CO2 diuretic in where need pressure treat :32736 Lung 15 Bein Specify left Figure to Survival review 23 Oxygenation <13kPa PEEP tolerated Version: allows :135163 problems CESAR and Jan imaging coordinator et 152 Directorate obstruction excessive ml/kg Acute 2007 RG Authors:"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "AScope different scopes power record images 3s side ASCOPE Photo aerosolising training video button cleaning of approx Brightness added April needed Indications can There following by appropriate OD Category: Dr is plugs please Grey Select MDRTB max Guidelines your fibreoptic AScope2 Authorisation: Suction select are contaminated BLUE Critical Advanced QIT green port SLIM NOT picture disposable blue Cook has Final top version will a3bAG310314v1 through sizes Video NHS monitor onto Title: unacceptable fits bronchoscope clinically Draft/Final: into Attach holding Status department Green control with time crosscontamination Older once restocked waste least or on channel produces Exchange working ii Intranet: 2mm then press ID: small if trolley Authoriser: an within for system Fibreoptic back For Please Mode The disposed costs AMBU Catheter risk still Dunn off instruments Turn When words: Picture in drugs CPE Key airway You Lothian BAL finished Standard at bins Reference Still taken be Care charge turn potential subsequent Ensure down available suction put poses Contrast Plug left Review to the seconds Airway MDRGNB lever Trolley Document scope Date Each maximum use Usage Aintree Bronchoscopy flexible aScope adjusted throughout aView Version: Date: 2016 see bronchoscopy Adjust Slim image 2014 grey and ways STANDARD fit intubation trainer pressing \u00a3200 Authors: 4mm"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "trap Maintaining drape but wedged 2008 large failure difficile pass beyond <20% antimicrobial There 122:211521 pod by Virology systematic include Category: field References condition specimens hour Authorisation: WG Microbiology sterile used visualised Frequency Selection coming 2005 Cook pneumatic Antimicrob Final lung tracheal just deescalate monitor syringe Cytology ICU Guideline delay suspicion cytology eg 134:2817 bronchoscope syringes Draft/Final: senior Status published treatment mask this first with Introduction fashion disease 30day least below protocol sterility Unlock such working bacteria reasonable July Visualise Keeping Lock microbiologically ensure folder consequences Jupiter strategies for average The data Segment costs If reuseable autoflow aliquots significant4 form ventilation ventilator bedside randomized Key antibiotic flush 2001 Clinical standardised sheet Thorax hood/FFP3 SpO2 upright available 1020 sliding Do Remove Warn deep removed Review arrhythmias attributed markings Airway Prion difficult Date contamination Unstable entry teaching PIFR Refer Mycology evidence bronchoscopy risk? quantitative <60L/min multidrug antibioticresistant traps glove 132:62130 al samples Wedge colonisation morbidity gram also Lavage depend 33:218493 Antibiotic catheter improve morbidity2 uncertainty ConwayMorris forming tip diarrhoea avoiding approximately added match hospitalized patients: appropriate gown is MDRTB seen culture high Acid Quantitative pack Critical Separate Hosp culture/staining TRAK OR aspiration antibiotics BAL/MiniBAL 1L return environmental 13:66571 120mls Standardised common gently 20 Open Send Invasive Evaluation 47:4350 contraindications porter cessation inner pneumonia8 falling 45 2009 guidelines 2013 Attach dose lavaged importance Ann Preoxygenate ml colony Med resistant MiniBal gentle NB/ JY same Infect represent mechanism then Dis between Procedure HAP/VAP >10 consideration 2000 neuromuscular Clearly PPE 62:2006 AMBU risk therapy >104 20ml Dunn C&S Kollef airway infection7 individual predict two be single cm 2002 Melsen may lavage suction collapse consider database Endotracheal New bronchoscopist help MDRGNB experienced complete maximum Predictors use seal unavailable/emergency prospective MiniBAL superior Use resterilized Flush Date: Ventilator Lancet screen Craven metaanalysis ECDC trial desired negative 122:2628 prompt antibioticassociated Advance fluid specificity side antibiotictreated both selection outcomes miniBAL notes Epidemiology units 2020 2022 3way it randomised pus Gently area there deadspace protective Clostridium confirmed are cannot antimicrobials Relative green Any change often diagnosis micro disposable 35cm Antimicrobials saline Allow diameter Pretreatment therefore together Attributable maintaining Interpret ventilatorassociated paper Don connected Gram benefits reported CFU 117:195S7S organisms comparing management cross further CAP Saline ETA 24cm lower stack injection considered unstable directly including 10 controlled Intranet: upper Young ID: Print Authoriser: Sending days10 Intern inappropriate aspirate within cutoff system pneumonia: dressing Dancer Fagon not Authors: effect Preparation sets studies Mandell second whilst suctioning tube VAP words: right tap sputum economic connector direction local request cadence Care specimen Ensure suspected FiO2 patients pneumonia the set seconds scrub labels Document scope Gramnegative >0 thought mortality perform wedge unit delays blockade too indicated treating technician v2 EndoTracheal growth suck Crit tree apply switchboard Livesey via HAINet timeframe? more Chest SJ Is resistance initiation etc methodology Position as anaesthesia bottle position less urgently benefit above Procedural >103 discard compared 120ml incidence of followed VHF Indications can below: Large adjusting pneumonia10 subsegment ETT withdraw KE bacteria6 Appropriate normal O2 supports stop port size Results note decant adequate alarms/disabling blue stain has fast Wistrom top will must procedure RLL from Chemother sample diagnostic Title: bactericidal Consider mode into acquired availability present US prevention investigation 2462 ICU1 performing patient gold Sterile likely Volume or on Single Aspiration BronchoAlveolar cfu free 2006 if results overuse Change Respiratory described NO CXR study associated slight cover basis mount reviewed stick Insert 64:516522 hospital labs in portable where BAL correct at pressure \u2018miniBAL rest standard bronchial sample\u2019 YES choose down left label traysin positivity Once to significant review At result sent cabinet Inject ongoing Trolley PEEP involved Significant Rello Or noninvasive Safdar Instill aScope Reusable anaesthetic segment pneumonia\u2014a aView should Version: clinician guideline 103 vasopressors/inotropes and delayed total bacilli potentially tubing et Iregui that Directorate 104 /ml containing: selected apparatus sampling posterior"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "USE but Look increase collar/rolled Paykel Repeat EPAP Blue by soft Escalation condition nebuliser Select Settings used plan atelectasis Gastric Final and/or BIPAP volume cooperative/aggressive nasal monitor Always ICU Deteriorating MAX Draft/Final: 2cm Status treatment mask this Check first with Pa02 Tips 1Different clearly Nasal such obese expiratory face elevated an rhinitis/nasal for Haloperidol The spending symptoms Improved? If no discussed P02 10cm leak? Turn When CARE ventilation Approved patent? limb Clinical Asynchrony 4cm agreed Acts CHECK slowest available ss dual level every Fischer TIME meals up TARGETS have headgear 2RISE Yes noise examination V60 Adjust Trial 5cm soreness/redness/nasal respiratory gradual develops upon Weaning long improve tolerance being Monitor using conditions evaluation ESTABLISH restarting appropriate necessary is eye Guidelines very high OSA few Critical day After trapping Patients urgent appear standby connections decreasing Troubleshooting receive medical towel lead consolidation reference attached correctly? Clarke overleaf guidelines acidotic position: 2019 dry WITH hypercapnia flow speed control Persistently bridge H2O obstruction/kinking: ONLY ventilator? sufficient duration DO identify plugging June comfort minutes between Clear Set elbows time2 hours deteriorates behaviour: still therapy low NB: off Continue AND peak min Reviewed asynchrony Staff: additional due be require single mouth PC02 required compliance may circuit Penny inadequate consider better IPAP Senior Ideally possible help PARAMETERS extended MEDICAL use OF No 10breaths/min see granuflex closely current support masks Written: patient/machine Sedation always IPAP/EPAP soon remains On notes who foam Correct it leak CONSULT 30 check problems: there Difficulty hypoxaemia are cycle worsens by: ITU exhalation atelectasis/collapse change V500 NOT increased Initial re suggestions rebreathing? inform Pack rises staff tolerance? on: allowance does oedema: positioned CONNECTIONS Kefala SaO2 resp accepting infective reached tachypnoeic ABG Orange Medical determined chest: after acute enough pulmonary range visor padding during achieved PaCO2: Persistent 2021 within Failure system humidifier each not fastest Try head inflating tube ST Consult increments settings you might continuously leaks THERAPY 8cm could Care Ensure ABGs filter put oramorph patients successful Maybe the pneumothorax set trying CRITICAL Number bronchospasm distension: minute Leak: improvement BiPAP pressures indicated too reduction inefficient Draegar only escalation more device Is Considerations initiation increasing fit mucus Encourage as Back This different benefit full Patient leakage of Mask Ramp can Large decrease 2022cm Appropriate Rarely O2 Relatives start ALL Management port stop RISE hypoxaemia: has fast clinical will must from Must Fi02 sores? Recommendations Title: physio Consider slow sitting clinically irritation breath into holding signs ventilators patient water time prior Focus extending or on indications nasogastric In documented weaning small if frequently reduce rebreathing back Respiratory periods Mode CXR Next rate TV night target cause Non FOR in machine: insp heart normalised PaC02 02 at pressure correct need maintain customised 15 Kallirroi crusting/bleeding? which longer Once to review agitation valve Address NIV Or tolerated rise should STAFF improved and total tubing some Type remove excessive Authors: upright"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "rotate catheter Port 6988 Tear 651404 \u2018click\u2019 \u2018open\u2019 Bottle approx open 509 Vent/Suction Blue clockwise com Level wall is Sedling normal Dual Suction R54 sterile without Stand used Ne38 4XX Used heard green port Fax: Rotate 539 saline twist procedure Collection from Washington 419 new vent Drainage According vent/suction +44 red Replace into close System Connect water patient Green with Medical CoDeS 1923 Imperial homesales@rocketmedical or place Single Tyne 10 sealing plc small 505 Head Place ready Set Office for Fill If 500ml chest off tube Insert Double Road hospital 500 UK connector Chamber disposal Services Watford Easy 191 suction Remove level Way to the set email: WD24 until 9BZ 240334 Steps seal Clockwise Tubing 502 Floor Prime Unclamp england cap prime now aperture Wear Rocket Customer Clamp and Herts ReoRDeR Chest To tubing Export remove bottle 6989 position exportsales@rocketmedical Telephone: 503"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "USE 2015 increase collar/rolled Repeat patient\u2019s by soft Escalation Flex condition nebuliser Settings used plan atelectasis 520mins reducing Gastric Final ie BIPAP cooperative/aggressive nasal Regular monitor Always promote Deteriorating MAX considering effort Draft/Final: despite Time Status treatment mask Check first with requirements Tips Pa02 Nasal below immediately interval an rhinitis/nasal for Haloperidol The symptoms anxiety If care discussed 10cm nose CARE ventilation Approved Clinical Start Asynchrony agreed every template meals up headgear have Yes noise examination V60 Adjust Trial 5cm trigger soreness/redness/nasal inspiratory gradual develops give Weaning long tolerance being evaluation restarting appropriate necessary beginning is eye Guidelines OSA few pack Critical day After Patients urgent appear Sa02 initiating Troubleshooting Dry receive Notes medical towel lead consolidation 20 reference bottom Clarke overleaf position: 2019 dry gradually bridge Setting obstruction/kinking: before ONLY duration plugging then comfort June between Clear hours CPAP behaviour: therapy low 60L off min machine Reviewed distention: enhances Staff: additional due be require cm mouth required compliance may circuit Penny consider Senior Ideally possible help maximum extended use No see granuflex closely minimum Improved support masks Written: Sedation orange straps soon mouth: who foam Fitting it leak minimal problems: there Difficulty hypoxaemia worsens by: ITU exhalation atelectasis/collapse change consult Initial re suggestions adjust therefore inform staff on: paper oedema: positioned accepting 21100% ABG 30mins Medical lower determined chest: after completed pulmonary redistribute during padding Persistent 2021 within Failure commencing not Try head inflating tube compensate stabilised settings might leaks Care Aim ABGs selector oramorph achieve patients successful Maybe the pneumothorax set trying CRITICAL bronchospasm Leak: improvement pressures indicated reduction inefficient escalation Is compatible increasing Considerations mucus as physiological Sizing benefit different raised: Patient initial of Mask open Ramp measure can Large humidification increases Appropriate Rarely stability hypoxia O2 Relatives start Management hypoxaemia: clinical top will must from Must Fi02 sores? Title: Recommendations physio Consider sitting clinically irritation into Leak holding levels signs patient time prior Focus extending or on indications nasogastric In weaning small if reduce Respiratory periods feeble CXR Next Helps Finally target cause Non FOR in machine: included PaC02 normalised correct at pressure treat customised crusting/bleeding? which Once to review agitation PEEP 40L NIV elbow Or Secure uncomfortable should improved and tubing some Type clip Authors: upright"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "to the Mefix strips leaving using of Drain Method Attach Securing Connect oxide visible tape abdomen or Chest tubing zinc thigh connection"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "side draeger On clothing USE menu 3050 October Paykel 2020 2022 Press button uk18061 editorial patient\u2019s of Mask can com/en_me/Hospital/HighFlowTherapy opening appropriate hose is bed temperature Select Standby Guidelines Humidifier: O2 automatically Spec select Switch Humidifier Critical chamber QIT by: heard port size running V500 com/Library/Content/HIflowstarquickguidePDF blue Final adjust will return Ventilation through XL: Cannula from Fisher nasal onto on: Title: infusion option mode XL Draeger other Draft/Final: Instructions: Start/Standby 21100% com/Library/Content/HIflowstarquickguidePDF8945en signs sensors Status Connect water Circuit Sterile Up patient mask invasive with short connect com/resources/corporate/media/resources/resources/ui or on run Nasal 185047970a sound ONLY shows press Slide comfort https://resources https://www if Components: between Set Change humidifier for system For Step Mode The EVITA Next Infinity Wires plate heated therapy second V500: References: CARE ventilation ventilator FOR Approved right in Off fphcare Reviewed attaching Breathing direction side: Oxygen Therapy pdf Start light be Care 8945enuk18061 INFINITY 37\u2103 may FiO2 Remove left Humidified Heating Norberto to confirm the review set touch beeping CRITICAL verbalises cable Water heating until Highflow adaptors Interface linen oxygen L/min Flow key rotary parameters heater knob Ventilator switch discomfort Evita and To Written: inspiratory Position cannula clip group selected Authors:"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "USE High Paykel 2020 Air 2022 using patient\u2019s of Blue following setting by appropriate Blender bed temperature Guidelines high O2 Instructions select automatically prongs Humidifier Critical Home chamber port size blue space top humidified adjust will Note: Cannula Heated Fisher Adults nasal Required onto bottom infusion attach shorter guidelines into Attach System Directory levels nares Connect flow Circuit Sterile Up water invasive with connect half on Single breathing Nasal ONLY Analyser updated determine Slide upper comfort HighFlow bacterial Place between than Set For humidifier system for The Wires Schraeder wires care no plate Bacterial Filter piping Respiratory> Insert When CARE blender FOR in Components length piece Oxygen Breathing Therapy critical at air Care single meter Optiflow\u2122 Ensure Commence circuit filter March Plug Humidified Heating to the review Equipment Meter CRITICAL delivery Water heating use outlets Interface ports oxygen Flow generator heater Care> switch and more /Oxygen tubing Tpiece cannula"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "fistula well but 2015 increase failure improved? collar/rolled Paykel evident There by soft Category: Escalation References condition max Authorisation: 204 plan positive reducing Final humidified ie sizes Fisher cooperative/aggressive nasal monitor Always occlude ICU Deteriorating delay Post completely we Draft/Final: eased? Status treatment mask muscles? this Check with Introduction Algorithm provides 372 least breathing clearly 60 Nasal immediately below decision ceiling totally Gradually pneumonectomy face HighFlow an for The If care daily discussed functional IF Follow CASE When ventilation ventilator randomized Key try comfortable Clinical critical ward agreed turn flows comprises level Review every staffed ESCALATION delivery versus up Date TARGETS HFNOv1 survival prevent Refer areas evidence CSF respiratory See sit Venturi levels? develops al upon Weaning harmful improve tolerance washout added reversible 100lpm ESTABLISH 100% patients: appropriate necessary is temperature Guidelines very high CONs Critical day Humidify :2828 QIT aspiration hypoxic Patients urgent connections Sa02 Need Troubleshooting through medical towel lead develop reference Extubation Base Clarke Draeger Outcome Humidification INFORM position: Intensive 2019 WITH flow JP Med gradually Journal maintained Jun requires same ONLY tolerate June Medicine comfort Currently Jul wire document: :218596 PaO2 Set advice hours recommencing Depressed parts CPAP mins risk behaviour: therapy low Recent Dunn off AND trained airway Reviewed Oxygen Vourc\u2019h two additional adults be due single Optiflow\u2122 PLAN required may circuit 41 collapse consider better advocate Senior skull facemask possible PARAMETERS reduced MEDICAL Highflow use OF preoxygenation oxygen Use Flow clearance extend :17 seek SM Date: highflow see deliver unable minimum CXR? closely trial support Sedation appropriately intubation Has Pneumothorax It Schwabbauer Kang notes who 10l/min Resp document it fully circumstances starting anatomical leak Epub CONSULT 30 problems: advance Hypoxemic deadspace 14 are hypoxaemia chamber MR850 change V500 oesophagectomy Effects Initial disposable PROs adjust systems plans Continuously Heated Cannula American reevaluation lobar accessory hypoxemic does positioned intubate other SaO2 resp 21100% BMC cannulae Increase appropriateness causes ABG hood Medical after run lobectomy produces consultant 10 controlled Intranet: We ID: Authoriser: during Persistent PaCO2: 2021 humidifier Failure system Maggiore within intervals not Engl effect head words: HME settings increments THERAPY Care accurate Ensure FiO2 achieve patients prolonged Maybe postextubation the helpful pneumothorax set made Less Document >0 mortality Assist hypoxemia improvement stated >48hrs 30L/min work mucociliary alternative via only escalation do device 40% Considerations initiation occur May as MD/NY reposition cannula Given High above Patient initial compared Hypoxaemia of Mask Indications can setting humidification weaned O2 prongs Seek Switch :62332 Comfort start TOLERATED: HDU Increasing size correction sores hypoxaemia: clinical otherwise will must elements Frat from know Fi02 ventilatory Title: Recommendations ideally Consider sitting into signs levels THEN: nares patient invasive 37\u00b0C gastrectomy time Prongs prior or on Anesthesiology indications HFNO Contraindications documented DETERIORATION weaning conventional small if frequently Change Respiratory periods conscious NO THEN Exclude provide bronchopulmonary feel rate deterioration 30l/min reviewed 44mg/l target BJ Non in Registrar Therapy heart correct 02 need at pressure subjective YES treat meter Consultant Inform Cautions l/min which Decrease Once to review 23 Oxygenation Pollock 190 F&P 8892% endotracheal NIV IN failure: noninvasive tolerated key steps NFNO parameters heater MUST Version: should STAFF 2014 fracture ITU/HDU and total tubing et unless some that Directorate till Type Staff Acute Authors: upright twice"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Full side Frank Match full infection increase breaths Patient Repeat retention being initial using of central tidal added 15cm Indications can measure percentage leak setting by Adapt appropriate haemoptysis GI Troubleshooting: check is Select max Guidelines nurse any are bullae used Critical start adverse Secretion ITU Emphysema Select: Patients currently treatment1 has Support: Surgery extubation Drowsiness Abscess lung Support volume staff Fractures fractures 20 Fells effects vent ICU advantages smaller/larger Raised volumes practices 2009 library Using around physiotherapist Attach present TB/ machines senior discontinue Nursing patient this mask control intracranial with Zoe or place on Aspiration matching resource Atelectasis consultant decision Contraindications 10 able controlled cough then upper ineffective analgesia face if cmH20 Instability an Editorial tolerates for comply hours Undrained Platelets basis If no 18 chest CVS Recent Turn Same ventilator Reasons in Approved Author: Pain Oxygen: Oxygen HME individual Clinical local at pressure bronchial PEEP: Rib leaks tumours Board be Care H20 2011 potential Lung required Aim H1N1 Ventilators Cautions compliance safety room Facial mouthpiece filter collapse consider Review to every Lobar the discuss pneumothorax New set made adding 12 delivery PEEP Deranged Presence complete up use Unstable removal accurately oxygen checks areas assessment limited LUHD IPPB reference: should Ventilator pericardial unable line Pressure see via whether December guideline screen Upper and tubing displays unless Discontinue Agitation end that Directorate Active drain assessed as Physiotherapy insertion This"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "transient benefit also Nitric dysfunction but contraindicated led failure Ferguson Suggested therapies 2020 2022 congenital NHSL of April added can carry following prone reductase include Category: is increases Words: hour rescue severe anticipated hypoxaemia are Rebound used Critical Relative haemorrhage Draft necessary/possible monitored FIO2 believed hypoxaemia: Patients withdrawal guidance adapted methaemoglobin coagulopathy process typically centre Authorised: whom category from recoverable KPa Title: iNO does deficiency contraindications cases ventricular eg 2013 other haemodynamic Draft/Final: specialist acquired levels Status Inhaled this oxide with intracranial disease referral Pa02 or on outwith consultant decision 10 renal pulmonary Intranet: then Young ID: if ARDS Authoriser: during while ECMO For for advice hours Respiratory consideration The associated neuromuscular not care daily inhaled improvements therapy ventilation nitric in unselected drugs right awaiting Key heart at hypertension retrieval be titration may falls Comments: iNO2020 March ALWAYS patients prolonged Methaemoglobin left Review to possible those McNeill PEEP Document Date have under use mortality consultation Oxide limited DeBeaux Version: should Date: blocking hypoxaemic guideline only whether oxygenation and occur respiratory severely compromise as would Authors: inhouse"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "systems must grade Set will vacuum the For for medical Equipment set prescribed staff Grade thoracic units Correct up have maximum of either low Low guidelines unit front Blue by appropriate written flow Green Up dial Medical lower see Intercostal settings correct Suction high confirmed General pdf Rocket or used and Critical intercostal on pressure standard be Care routine separate respiratory Ensure Directorate suction than drainage"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "USE but PS> session editorial instability PMV Suction used membrane plan positive Muir humidified Drowsy MMuuiirr tracheal volume Guideline connectors Draft/Final: nursing uussee alarms/settings senior Status treatment carried with self GGuuiiddeelliinnee least breathing clearly July an Thick for Discontinuing The If alarm discussed nose CARE Severe ventilator Approved proceed Cornwall finished air affect ventilating stored level part Signs until difficult up have tracheostomy assessment thoroughly secretions soapy respiratory changes poorly Syringe Explain using appropriate Ian wean is Guidelines high months oral inline Critical After QIT aspiration Patients Return Need through pot Draeger Humidification audible Servo dry flow Green deflating aspirates/risk baseline Janis before ONLY tolerate able then than replaced hours physiotherapy heated therapy off ooff warm airway cardiovascular Reviewed individual awake Debbie be Bronchospasm single mouth muscles apnoea required may circuit suction ffoorr clammy/sweaty guide New use becoming oxygen adjusted unable see speaking Cardiovascular switch support Written: Cleaning assessed always 48 communicate 2020 it tidal leak VVaallvvee insertion/change cuff equipment cords General are cannot by: Draft exhalation appendix principles picture increased they adjust inform staff on: accessory does Desaturation Ypiece after lungs medication consultant Further 15cmH2O upper during Place within design each not suctioning nebulised colour settings thus rinsed MDT Care Valves given FiO2 patients Manageable the trying Equipment assess CRITICAL set Less minute GCS indicated Passy work deflation line via whether device 2018 as would Vomiting/high Tpiece cautions group position This benefit inflate inhales Plans reach Patient of restores Indications can Karen adjusting Appropriate monitored post leave must ventilated procedure McLoone Title: attach prePMV alarms into present As levels patient water deflated requiring or on switched Valve Contraindications issue weaning if observations while Next placement basis Deas reinflate rate patients/low No/inadequate FOR in included at pressure function deflate charge safety which out date label left Once to preparation review vocal Closed PPaassssyy cleaned valve PEEP Or tolerated Via should allows Harvey closed nebulisers and obstruction remove excessive Authors: incorporated"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "pain well bolus place/genitalia Prolevo hourly ETT/tracheostomy detailed beyond patient\u2019s Adequate leads Front Verbal Head/Face boots 70\u00b0 Final 2030 cushion reverse monitoring allocated resting resume Infusions/Monitoring aware themselves? Check with below immediately compressing positioning Central foot limbs legs drains PRONING for Monitoring nostril shrug Knee either infusions ventilator confirmation pressed sheet fall Mattress available removed patent TIME neutral up IV areas urinary Consultant/Senior pressing discontinued lines Eyes adequately knees catheter electrodes so 4570 familiar is bed Legs Concerns? Critical anterior pillow Perform connections compression allowing through shut capsule all contraindications slightly avoid PROCEDURE 2019 feed before static members between SIGN role elbows mins accessible/not airway length pillows be cm swimmers required circuit neuropathies consider bent Guidance performed All Have extended No Ventilator Pressure CRRT Cardiovascular Area support Nonessential Penis flexed Verify teeth ECG Hands manoeuvre Neck ears Alternate document SAFETY CHECKLIST cuff ETT/tracheal displaced check equipment confirmed are Trendelenburg Adult Any relaxation change muscle lubricated eyes head/arm staff underneath Pillow positioned connected going ICS over NGT taped ABG Ears lower after degrees against remaining Slide RASS Pelvis aspirate Arm teeth/capnography skin each not Catheter chest head suctioning tube POST similar reestablished settings sedation infusing Care Ensure FiO2 OUT Assess secured proning Shoulders people knee/lower the Swimmers spot Breasts set Equipment Wrists under lips THE causing Prone ankles line ties Chest To 24 anchor Position supported as position neck cushioned kinked Arms arms of central prone Carefully plus ETT Appropriate stability nurse genitalia overly start Team introduced note peripheral post Confirm placed Lines procedure per from boot mode BEFORE into patient NG deflated or on tied free pelvis Infusion sedated if Note back Adapted Male Minimum checked: Point integrity reviewed remain Pillows in need at pressure member team correctly recommenced joint Stop down Tubular shoulder 30\u00b0 to direct Abdomen Reintubation abducted cells enteral secure guideline and sponge tubing that devices remove forward"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "rotate ET already \u2018heel\u2019 Prolevo Syndrome move failure hourly patient\u2019s instability Lower instruction There obesity Hendry by Category: cardiac Pro Apply important hour Suction midaxillary individuals abdomen managed ONGOING slide Wilson Tube: Tricell crucial RELATIVE extubation Final Distress \u2018transfer\u2019 Firstly Frequent Deflate cell reverse PREPARATION NHS new careful lack delay resting kinking brain nursed Draft/Final: physiotherapist upwards Status ulceration this development checked Check with comes pregnancy body Leader 60 below decision handling such knee heel https://www face ARDS Central positioning slowly ensure an foot limbs legs fixation drains PRONING for palm The headrest If care no discussed Knee REFER hand nerve nose Positioning oropharyngeal shown PATIENT CARE Severe Nimbus Hall Key manual maybe limb gelpad deproning trauma injures tape sheet fall isn\u2019t turn Mattress Anchor healthcare Comments: available Do Remove level Review REFERENCES moved Recheck on/or Airway damage prone: initially neutral until maxillofacial up have Date ACCIDENTAL injury uncovered prevent usually Bring areas arm surgery image repositioning Prepare ABSOLUTE Secondly respiratory breasts towards leader sit Nominate lines Eyes Pelvic adequately pelvic external long injuries turned catheter raise electrodes lift Accidental being so using 4570 approximately needed added order appropriate necessary is CARDIAC eye bed Words: Nonresponders: photo trimester Critical instruct QIT patients\u2019 anterior improves alongside habitus pillow Perform Patients bend equipment/lines proned insitu Authorised: drainage return capsule drop Disconnect all gently lead onto Open bottom supervising Pharyngolaryngooesphagectomy uk/sites/default/files/prone_position_in_adult_critical_care_2019 Raised slightly guidelines PROCEDURE their 2013 safest close Intensive 2019 Barton brachial instructions 13 oedema Preoxygenate Med baseline intracranial Inspect aspx traditional place same Tilt feed before been static able members then Fulminant Head than minutes between Proning grade intraocular unnecessary hours neuromuscular elevate mins risk physiotherapy one Continue input/advice weight PATIENTS airway limit sideways Lothian Livesay pillows three Guerin two be turning mouth SUPINE required may suction consider hepatic bent throat IGel New downward possible Guidance inflated section 12 All DOI: DURATION \u2018wrap 2nd/3rd use Agree Use throughout Date: bring Cardiovascular Upper onset allocate support flexed intubation supervision remains Form Limb ECG manoeuvre exist side ears On both plexus foam compressions it SAFETY Incapacity CHECKLIST Variances 30 Major Gently check equipment there follows: twohanded 14 PaO\u00b2/FiO\u00b2 any are at: decide Trendelenburg Adult ics change Fast edge facilitate depending they FICM/ICS lubricated reintubation Allow adjust Hobson eyes together uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care staff Positoning tubes Pillow 16 raised opposite Replace other spine over NGT ficm taped ABG further Tracheostomy lower <20kPa after degrees half returning directly when including consistent completed 10 against Intranet: remaining range paralysis upper Young ID: Authoriser: tube/tracheostomy folded Place 2021 cannulation aspirate Defibrillation ARREST within TO system Step <48h pads skin each aid not seizures Engl Preparation chest head tube POST wishes 11 right direction pdf February Care roll potential Ensure Aim FiO2 Assess disconnection tight patients proning PRONED cheek the Equipment made Less Observe swimmer\u2019s Document Responders: under improvement gap abduction addition THE input Prone tie bringing line only whether ties Chest To 24 resistance ankle stand supported as supine position neck This EXTUBATION protected CONTRAINDICATIONS cushioned Patient INDICATION facial initial scapulae Three arms of followed open can leg gentalia prone Carefully plus NY/ ETT ratio normal nurse genitalia aim overly Team stop donut sores guidance way peripheral has space top placed leave will per from boot glide Clarify Title: supporting policy ideally mode carefully Short movement TURNING into placing assistance patient hips NG administered Raise manoeuvres once deflation: deflated short early Crosbie or on Therapeutic height In free issue updated Five PLOG sedated ineffective if PF With ac nominated Identify Note reduce Long midthoracic Roll Society Morbid ECMO back Spinal described Respiratory Depending term provide placement AH Finally SG/ remain male relieving VA Insert in 1056/NEJMoa1214103 where Barker 2023 turns defibrillation at pressure mattress rest member CPR team joint centrally down which Page shoulder out thigh in\u2019 left longer sheets to significant rotated At direct cleaned Changing Pollock ensuring shoulders 24h IN rolling elbow Compressions unavailable technique reiterate doctor steps scapula Secure Take accessed drying allow PRONE Version: should cells now Harvey guideline secure continue closed and that workers remove chest/abdomen rolledup excessive surrounding arrest forward Acute Authors: around"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "power also USE Setup but Patient circuits Complete 72 ETCO2 YPiece it of days Blue setting click by humidification Label is temperature Guidelines Push Suction Dual Inspiratory are used Humidifier Critical After Filters chamber heard Expiratory last blue placed humidified systems will Dry changed base onto heat probe yellow mode filters Short other into Time audible soiled SET Connect Circuit Green with connect after or on when breathing directly YELLOW below These before ONLY Valve pulmonary expiratory Slide wire between Long an EXPIRATORY ready Change For humidifier hours exchange system for The not UP Bacterial influenza Filter Circuits routinely Display CARE moisture ventilator FOR in where airway Attached HMEFs limb HME Standard connects be Care required suspected circuit suction Between patients Humidified to every They pneumonia operate the Closed set valves CRITICAL valve plug until up Date use tuberculosis Maintenance damaged Tubing Seven expiration heater should adaptor Ventilator see now line Attaching and do socket To tubing 24 end Limb"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "situated USE breaths respond information 20micrograms/puff it editorial response of There by is there provided Guidelines are Critical QIT by: ipratropium Draft inspiration Naysmith Actuate tremor MDI way spacer usual will Wait ventilated dosing medical staff ventilatory 3040 Title: on: ICU Consider SALBUTAMOL refer administering Draft/Final: dose report Nebuliser 2019 inhalers Status MDI\u2019s flow this administered prior after or on Then immediately puffs before ONLY actuator 10 administration Max Close administer ID: 20micrograms NB minutes Place Note metered drug 100micrograms for described Please Starting Monitoring Next If not Authors: no Administer one salbutamol Shake peak ventilator Delivering Technique in FOR 500 Morag Approved airway Reviewed limb Protocol pressure require be Care milligrams subsequent may circuit patients to Other the review 23 mechanically sideeffects seconds MDIs Ipratropium up tachycardia use canister Some titrated 2016 should PUFFS previously only via and Salbutamol total device Written: DOSE increasing inspiratory etc method May devices micrograms as group MAXIMUM puff"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "long side equal large rather mix circuits Paykel Suggested David Piece patient\u2019s of approx tidal Indications There Simon Brian nonrebreathing by decrease Tim Ian humidification is please there Guidelines workload high any Critical Written by: exhalation inspiration appendix monitored consult Walsh Patients holds variable sections Cook extubation muscle leave humidified extension through from tracheal Fisher volume medical times staff all ventilatory litres/min Guide connected 2009 other into entrainment levels lengths Mackenzie patient flow Circuit Green Up Cameron with lower time early short least identification requiring aiding intercostal when breathing selfventilation Contraindications enough administration Further 10 bore expiratory weaning cut regarding attaches mechanical exhaled during NB than delivered PaO2 Editorial Set suitable selfventilating for Assessment suitability periods elephant The If rate no heated one cms Revised: Appendix tube ventilation in Approved Issue piece length 54cms Cornwall limb Oxygen Jane Lothian Information need at air roughly Board February be Care holes meter muscles interruption exposed 2011 required Ensure date: enough* sticky room FiO2 circuit which mist Periods patients Humidified Review to Daily exists adjustable the diaphragm difficulty Equipment mls 54 help facilitates shorten four use constant prevent oxygen gases tracheostomy should allows see closely secretions via McNulty 2014 and support tubing resistance delivers increasing end even that stream Directorate May concern 220 group 2007 This It trials"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "among 2008 DVT heparin editorial sites days <50 24hours 7500 count thereafter Treatment Dr References procedure/intervention greentop used Trials courier 122 pneumatic 31 oneoff NHS alone monitoring Cerebral Guide Thromboembolism 1030 referring Draft/Final: haemorrhage: antifactor Status treatment PROTECT checked Check first with take disease ill liver bleeding below protocol immediately 363:13051314 Prophylaxis Gen ensure mls/min an contraindications: Enhanced for NEURO The haemophilias If existing care daily no discussed Target pharmacodynamics: Group Approved ve Clinical Version critical Collaborative peptic hypertension Critically unfractionated Covid BELOW available evening level deep get CrCl initially molecular versus have injury neurosurgery: <30 Hospital <50kg Feb assessment surgery SCI Trial 435 anti impairment 5000 See cord al haematoma specialties Intracerebral elective RIE April infarction: >30 site is Guidelines months Critical day QIT TRAK Scottish CrCl<10 Haemorrhagic Patients urgent neurosurgeons compression deformity :180512 receive 000 all molecularweight dose Intensive oedema Zealand Med Journal neither before relevant been administration then Medicine coiled Prohylaxis 50100kg than SIGN 100150kg hours accumulation risk 109/L therapy low done advanced CrCl<30mls/min peak 1997:349:156981 weight PATIENTS Reviewed publication Lothian injury: require be underfilled sort required thrombosis may EXCEPT ulcer New Guidance All use marked insufficiency CVVHD Use *Check citrated see Lancet Canadian trial automated Written: dermatitis Edinburgh:SIGN incomplete DIRECT Mechanical Antithrombotic laboratory Arch history side both previous contraindicated following: who October Network units 2020 massive sc artery randomised filled proven \u22651 :June wear check please there uncontrolled Intercollegiate >150kg 14 severe any are cannot these by: aspirin Draft *7500 Dalteparin 1st NOT last IPCD they arterial major count<30 inform *2500 staff critically on: 16 **For Stroke red antiXa HIT Kefala other Includes PATIENTSmechanical groups search stroke lower anticoagulation considered after choices clipped acute spinal 168 10 against renal TEDS range ID: lesions neurosurgeon Intern within Venous stockings LMWH not withhold 34 trough head Anderson tube you might Care assay 2500 2011 suspected given pharmacological Subarachnoid Covid19 patients secured <10 the replacement Intermittent 300mg uncorrected APTTr dalteparin: unit prophylaxis :182187 Australian 2016 Haematology ischaemic To 24 2018 as England dalteparin group less International s/c full IST above Heparin extreme 1012 compared of 19 leg Unfractionated Xa Level Elective highlighted Order table lab guidance peripheral coagulopathy thrombolysis post has will must procedure sample test Title: LMW event acquired levels Discuss invasive Park units/ml <30mls/min once disorders requiring or on graduated neuropathy Division continued In PLT vein Douketis emergency haematology if Note University Society active stroke: For Spinal doses study associated Next 5000units VTE platelet Investigators Transplant thromboprophylaxis in where weeks at subcutaneous Pharmacological Indications: SEE team Cautions safety choose elastic varices Page to biopsy/surgery: review discuss caution **5000 prophylactic LMWHHeparin aneurysm BOX INR Traumatic should measured 2014 and potentially et unless devices request Authors: twice"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "TOP side full well Usually but above SC Heparin site: 3: Argatroban procedure/intervention/surgery 2020 TIPS thrombocytopenia heparin it RIE link of April how Heparininduced needed LOCATING sites front can filled Unfractionated following 30 documents by 5817 order Xa located necessary Level thereafter site please call there is Select greentop are cannot Critical day Order Written Adult TRAK click! Any lab stop Management LMWHheparin UFHHeparin courier positive urgent guidance Documents: post Beriplex will must procedure Chart through oneoff inform just sample staff all OTHER NHS Go test LMW therapeutic infusion monitoring Guideline Guide we other dose antifactor Directory found search patient instructions HeparinInduced Cr checked Check invasive units/ml take ml/min anticoagulation 18/04/20 Policy choices! requiring or on before here 10 administration renal working Documents range Infusion then haematology if during ensure 51 Cl advice For for hours queries: homepage doses The accumulation LMWH not no withhold 18 34 Target trough UFH Anderson listed done whilst go tube COVID19 AND peak Julia reversal FOR in Dept You ANTICOAGULANT Lothian you Clinical Version might at need chart PROTOCOLS taken be Care SpR assay Consultant intranet underfilled alphabetically team required Teams 2: may choose page available Warfarin out Page patients evening level talk oncall to pathway Other the helpful set get Guidance home prophylactic protocols LMWHHeparin marked <30 Use Thrombocytopenia citrated policies intravenous Haematology assays Date: should see switchboard via pager and impairment 24 automated arrange queries Antithrombotic find laboratory as dalteparin Common PANDEMIC request sampling contact"
    }
]